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ABSTRACT 
Motivation and study design 
Iron deficiency is.a common condition in infancy, particularly in lower socio-economic groups. In Cape 
Town it remains a~problem in spite of public health measures taken against it: a recent survey found a 
prevalence of iron deficiency anaemia of 34% in healthy 1 year old term infants who had ready access 
to a municipal health clinic where iron fortified milk formula is sold at subsidized·prices. 
The consequences of iron deficiency extend beyond anaemia- to involve all organ systems including. the 
immune system. Since Helen Mackay's report in 1928 of a striking decrease in incide~ of infection in 
infants treated with iron, clinicians have assumed that iron deficiency predisposes to infection. Despite 
· a sound theoretical basis for this belief, the clinical evidence for the assumption is poor as studies to 
date have displayed methodological deficiencies. 
On the other hand, iron is also essential for the growth of micro-organisms. As such, supplemental 
iron may predispose to infection. Indeed there is much laboratory and clinical evidence to show that 
excess iron can result in the recrudescence of quiescent infections and increase the virulence of newly 
acquired infections. Thus, the competition between host and parasite may sometimes hinge on the 
relative availability of iron and it has been speculated that excess iron in infant milk formula may 
increase susceptibility to infectious diarrhoeal disease. 
The problem addressed by this thesis was to determine the utility of increasing the level of iron 
fortification of infant milk formula. Three questions were posed: 
Does increasing the level of iron fortification of conventional infant milk f onnula 
improve the iron nutrition of 11onnal infants fed on the fonnula? 
Does increased iron fortification of infant milk f onnula alter immunity as reflected by 
incidence of infection and laboratory tests of immune function? 
Are there any hannful effects of increasing the quantity of iron in conventional inf ant 
milk fonnula? 
A double blind randomized trial was carried out in 1983 and 1984 to answer these questions. A group 
of 149 healthy, well nourished infants from a lower socio-economic community of so called Cape 
Coloureds were followed from the age of 3 months to 1 year. Half of the infants, the Control group, 
were given a commercially available infant milk formula (Lactogen Full Protein) which has 8.3 mg Fe/ 
100 g formula and 37 mg ascorbic acid/ 100 g. The other half of subjects, the Test group, were given 
the same milk formula but fortified with iron to a concentration of 40 mg Fe/ 100 g·. The children 
were examined every 3 or 4 weeks and any infection or history of infection was noted. Laboratory tests 
were done at the start of the trial and again on completion. During the trial, laboratory tests were 
performed only if clinically indicated. The tests included full blood count and differential analysis, red 
cell zinc protoporphyrin, plasma ferritin, plasma and hair zinc and lymphocyte subtyping with 
monoclonal antibodies. Within each group, half of the infants were randomly selected for assay of 
neutrophil bactericidal activity. The other half were assayed for lymphocyte blastogenic response to 
stimulation with phytohaemagglutinin. Tests of delayed cutaneous hypersensitivity to Candida antigen 
and PPD were done and all children and their mothers had antibodies to tetanus and polio determined. 
Results 
74 infants in the Control group started the trial and 62 completed it. In the Test group, 75 infants 
began and 70 completed the stud~. 
Intake of milk and solid foods was not quantified, but the ages of weaning and of introduction of new 
foods were determined. The Control and Test groups did not differ significantly on any test item. The 
mean age of completion of weaning was 3.60 months for the Control group and 4.04 months for the 
Test group. The Control group was first given meat or fish at a mean age of 5.19 months; the Test . 
group had meat or fish introduced to their diets at a mean age of 4.36 months. These differences were 
not statistically significant. 
The children in the Control group were lighter and shorter than the Test group at the end of the year .. 
Mean standard deviation scores for weight were 0.23 and 0.48 respectively (P = 20% ), while for length 
the SD scores were -0.13 and 0.06 (P = 20% ). 
Effect of iron fortification on iron status 
After 9 months on the milk formulas, the iron nutrition of the Control group was significantly poorer 
than that of the Test group for several indicators. At the age of 1 year, mean haemoglobin 
concentrations were 11.49 g/dl and 11.85 g/dl for the Control and Test groups respectively (P = 4%). 
The red cell width distributions were 15.53% and 14.44% (P = 0.05%). Red cell zinc protoporphyrin 
. • The milk formulas were made up and donated by Food and Nutritional Products (Pty) Ltd. 
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levels were 3.95 ug/dl and 3.41 ug/dl (P = 4%) and the geometric mean ferritin levels were 17.3 ug/dl 
and 29.0 ug/dl for the 2 groups respectively (P = 0.04%). 
Effect of iron fortification on incidence of infection and immune function 
The results of the individual immune function tests did not differ significantly between the 2 groups. 
Forty eight hours after the delayed cutaneous hypersensitivity tests the mean diameters of induration 
were 8.05 mm and 7.03 mm (P = 43%) in the Mantoux test and 8.88 mm and 9.75 mm (P = 56%) in 
the Candida test for the Control and Test groups respectively. 
The geometric mean tetanus and polio antibody titres were 93 and 115 (P = 44%) and 35 and 47 (P = 
16%). 
Lymphocyte subtypes, ie B cells, total T cells, helper-inducer cells, suppressor-killer cells and 
helper:suppressor cell ratio did not differ between the 2 groups. 
The Control group responded less well than the Test group in the lymphocyte phytohaemagglutinin 
stimulation test and in the bactericidal assay but the difference did not reach statistical significance. At 
one year of age the PHA stimulation indices were 140% and 142% for the Control and Test groups 
respectively. In the bactericidal assay, the percentage of the initial inoculum that survived at 1 hour 
was 105% for the Control infants and 94% for the Test group. 
The statistical power of the immune function tests was not higher than 24% and usually well below that 
level. 
The Control group had more infections than the Test group; an average of 6.42 infections per child per 
year compared with 5.86. When incidence was considered in sub-categories, the Control infants had 
more infections than the Test group for Minor, Moderate, and Severe infections as well as for 
gastrointestinal infections, oral thrush, pyoderma, conjunctivitis and "other" infections. Only for 
infections of the respiratory tract did the Control group have a lower incidence than the Test group. 
No difference came close to reaching statistical significance and the power of the study to detect a real 
difference equal to that observed was 18%. The 95% confidence interval for the difference in 
incidence of all infections ranged from -1.61 infections per child per year to 0.49 infections per child per 
year. 
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Risks of iron fortification 
As zinc and iron compete for absorption it was expected that the Test group would have lower zinc 
levels than the Control group. This was corroborated by both plasma and hair analyses. Plasma zinc 
was 90.61 ug/dl in the Control group and 83.53 ug/dl in the Test group (P = 5%). Hair zinc 
concentrations were 142 ug/g and 129 ug/g respectively (P = 54%). 
Apart from the lower mean zinc levels in plasma and hair, the study found no evidence of possibly 
harmful effects of iron supplementation. In particular, the Test group experienced a lower incidence of 
diarrhoeal disease than the Control group. 
Discussion and Recommendations 
Possible confounding factors 
The trial of the infant milk formula controlled rigorously for factors which have confounded the 
interpretation of most previous studies of the role of iron in infection and immunity. The children were 
selected on the grounds of good health and excellent nutrition. That they maintained this throughout 
the study may be partly due to the milk formula which was granted to the families, and partly due to 
the selection of children from better liome environments. 
Possible confounding factors which may not have been controlled by the stratified allocation procedure 
were indicated by non-significant trends in completion rate, weaning, and introduction of solid foods. 
All these factors could weigh in the Test group's favour when considering indices of iron nutrition, 
measures of immune function or risks of increased iron fortification. 
However the weight that should be assigned to these possible confounding influences is limited by 
several methodological weaknesses. In the subsidiary surveys, ages were calculated from the mother's 
recollection of events and recorded in months rather than decimals of a year. Also, age of introduction 
of a food item is likely to be a poor proxy for quantity of food ingested and it gives no indication 
whether or not the food was consumed with milk formula. 
Effect of iron fortification on iron status 
The increased iron fortification was shown to improve the iron status of the Test group with statistically 
significant differences for haemoglobin, red cell distribution width, plasma ferritin and red cell zinc 
protoporphyrin. The absolute magnitude of the improvement in iron status was small, and the effect 
may not be clinically important. 
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Two related questions for further research arise from this aspect of the trial. Why did the Control 
group not achieve an iron status equivalent to infants in similar trials overseas? And, why did the extra 
iron fortification not produce a greater disparity in iron status between the 2 groups? 
With regard to the first question it may be noted that nadequate intake of formula is unlikely as the 
families were given generous quantities of milk and the children maintained excellent growth. 
Increased loss of iron from chronic blood loss is an unlikely cause of the suboptimal iron status as 
hookworm is uncommon in infants in the Western Cape and other causes of chronic blood loss are 
rare. The most promising avenue for future research is the determination of the balance in the diet 
between inhibitors and facilitators of iron absorption. 
With regard to the second question, ie the failure of the Test group to achieve a large improvement in 
iron status, one may speculate that similar factors were partly responsible. However, from previous 
studies of iron absorption and the effect of ascorbic acid, it would have been expected that the 
fortification program would have had a greater effect on the Test group than that observed. 
Further studies are required to answer these questions and to provide quantitative data for planning 
future trials. Specifically, the effect of ascorbic acid on the absorption of iron from cow's milk based 
infant formula needs- to be measured at levels of iron fortification up to 40 mg Fe/100 g formula, and 
measurements of percentage absorption from test meals need to be correlated in the same subjects 
with response to long term programs of iron fortification. 
Efforts to improve the iron status of normal infants in the community by fortification of infant formulas 
should be based on results from such studies since the availability of extra iron added to conventional 
infant formulas is so low. Certainly, cow's milk formulas should be fortified to a level of at least 8.3 mg 
Fe/100 g and they should contain ascorbic acid in a molar ratio to iron of at least 1.4:1, and possibly as 
high as 4:1. 
Effect of iron fortification on incidence of infection and immune function 
The results of the laboratory tests of immune function showed no statistically significant effect of the 
increased quantity of iron in the milk. Correlations with iron status per se were inconclusive because of 
the small difference in iron status between the Test and Control groups. 
The results of the study of incidence of infection were similar. The increased iron fortification caused 
no statistically significant change and correlations of iron status with infection rates were inconclusive 
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due to low statistical power. However, an intriguingly consistent pattern was apparent: children in the 
Test group had fewer infections than those in the Control group in 8 of 9 categories of infections. The 
Test group had almost 10% fewer infections than the Control group. This translates to a potential 
saving of 56 infections per 100 infants per year. 
Clearly then, trials to define the relation between iron status and immune function more precisely are 
required since a possible public health benefit of this magnitude can not be ignored. The difficulties 
such studies will have in attaining adequate statistical power must be noted. The present study was 
designed to detect a difference in infection rates of 1 infection per child per year. The sample size 
calculations yielded 65 as the minimum number required in each group, assuming that the standard 
deviation of infection rate was 2.5. With the data from the present study it can be estimated that a 
minimum of 230 infants would be required in each group to detect a difference of 0.59 in infection rates 
with standard deviations of 2.8 and 3.3. 
Besides increasing the number of subjects, steps to increase statistical power might include extending 
the period of observation and increasing the disparity in iron status between control and test groups. It 
will be particularly important to learn if there is a threshold level of iron status below which 
susceptibility to infection is increased. The present study provides a hint that, if such a threshold exists, 
it could be relatively high. 
The mechanisms by which iron influences immune function require further ·clarification. It is unlikely 
that stuc:lies utilizing current immune function tests and the design of the present trial can economically 
reach adequate statistical power. New methods must be sought to address this question. For example, 
the time course of repair of iron deficiency in moderate to severe cases could be correlated with the 
change in immune function tests. But, measures to control for the confounding effects of infection and 
malnutrition would need to be included. 
Risks of iron fortification 
The increased iron fortification was shown to be safe and, in particular, not to increase susceptibility to 
diarrhoeal disease. It was associated with lower zinc levels, but there was no evidence that .this was 
harmful. 
Nevertheless, future studies of iron fortification should take care not to interfere with zinc absorption 
since zinc deficiency has well known deleterious effects. The mo!~ ratio of iron to zinc should be 
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maintained at about 2.8 mol Fe/mol Zn. And the effect of iron fortification on the absorption of other 
divalent metallic ions should be monitored. 
Conclusion 
In conclusion, it may be stated that increasing the level of iron fortification of cow's milk infant milk 
formula is not sufficiently effective in improving iron status to warrant a change in commercial practice. 
But, the potential rewards of improved iron status are such that further studies should be undertaken 
with increased fortification of iron, ascorbic acid and zinc. 
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And as a multitude of laws often only hampers justice, so 
that a state is best governed when, with few laws, these are rigidly 
administered; in like manner, instead of the great number of 
precepts of which logic is composed, I believed that the four 
following would prove perfectly sufficient for me, provided I took 
the firm and unwavering resolution never in a single instance to 
fail in observing them. 
The first was never to accept anything for true which I did not 
clearly know to be such; that is to say, carefully to avoid 
~ 
precipitancy and prejudice, and to comprise nothing more in my 
judgment than what was presented to my mind so clearly and 
distinctly as to exclude all grounds of doubt. 
The second, to divide each of the difficulties under 
examination into as many parts as possible, and as might be 
necessary for its adequate solution. 
The third, to conduct my thoughts in such order that, by 
commencing with objects the simplest and easiest to know, I 
might ascend little by little, and as it were, step by step, to the 
knowledge of the more complex; assigning in thought a certain 
order even to those objects which in their own nature do not stand 
in a relation of antecedence and sequence. 
And the last, in every case to make enumerations so 
complete, and reviews so general, that I might be assured that 
nothing was omitted 
Rene Descartes 
A discourse on method 
AD 1637 

CHAPTER 1 INTRODUCTION 
Prevalence of iron deficiency 
Nutritional iron deficiency is common m infancy in both affluent and poor societies. Accurate 
assessment of the extent of iron deficiency is difficult because diagnostic criteria often differ from study 
to study. Nevertheless, it is the most common single nutrient deficiency and by far the most common 
cause of anaemia in infancy. 
Iron deficiency in the Western Cape 
Surveys of infants in the Western Cape have shown the prevalence of iron deficiency anaemia to range 
from 55% in the 1960's to 34% in the 1980's. Studies in other countries in similar communities have 
not differed greatly from this order of magnitude. But the prevalence of the condition does vary from 
population to population depending on a number of factors. The maximum prevalence is between 10 
and 15 months of age when the child is growing most rapidly. Besides direct nutritional influences, the 
most important correlate with iron deficiency in infancy is socio-economic class; race and sex are much 
· less important determinants. 
Consequences of iron deficiency 
The consequences of iron deficiency obviously depend on the severity of the disorder and are by no 
means limited to anaemia and its effects. The systemic manifestations of iron deficiency include: 
anorexia, malabsorption, loss of weight, impaired physical perfonnance and, in severe anaemia (with 
haemoglobin less than 4 g/dl), heart failure. Behavioral changes have been attributed to iron 
deficiency - even in the absence of anaemia. 
Iron and immune function 
Of special interest for the present study are the observations linking iron deficiency with impaired 
immune function and increased susceptibility to infection. In 1928 Helen Mackay, a leading London 
paediatrician, published the first evidence implicating iron deficiency with an increased incidence of 
infection. Her results were striking, but subject to criticism on methodological grounds. Although 
. several clinical trials have since been made and many laboratory experiments have been performed 
there is still controversy over the putative link between iron and immunity. And there is also evidence 
to suggest that iron therapy may exacerbate infections, or increase susceptibility to malaria and perhaps 
other infections. On balance, the case against iron therapy is not strong and no studies have shown any 
increased risk of infection from the quantities of iron used to fortify infant milk formulas. 
1.2 IRON NUTRITION AND IMMUNITY 
Motivation for the study 
In view of its high prevalence and the wide spectrum of its consequences, iron deficiency would seem to 
be a key target for preventative public health measures. 
An effective method of preventing nutritional iron deficiency in infancy is the fortification of infant milk 
formulas with iron. Infant milk formula is a convenient vehicle for iron fortification in Cape Town 
since dried milk powder is provided by the City Council at subsidized prices to families with young 
children. A recent survey in Heideveld, a lower socio-economic community in Cape Town of so called 
Cape Coloureds, found a prevalence of iron deficiency anaemia of 34%(267). This was in healthy 1 year 
old full term infants who had ready access to the municipal clinic where milk formula fortified with iron 
and ascorbic acid is sold at subsidized prices. 
From the foregoing it may be seen that iron deficiency is a common problem in infants in Cape Town 
and that the efficacy of current public health measures leaves substantial i:oom for improvement. 
Aims of the study 
1. Trial of increased iron fortification of infant formula 
The problem addressed by this thesis was to determine the utility of increasing the level of iron 
fortification of infant milk formula. Three specific questions were posed: 
Does increasing the level of iron fortification of conventional infant milk formula 
improve the iron nutrition of normal infants fed on the formula? 
Does increased iron fortification of infant milk f onnula alter immunity as reflected by 
incidence of infection and laboratory tests of immune function? 
Are there any harmful effects of increasing the quantity of iron in conventional infant 
milk formula? 
2. Infant Feeding Practices 
The principal study provided the opportunity for a survey to be made of feeding practices. The 
purpose of the feeding survey was to compare practices before and after the trial in order to document 
any effect that the trial itself may have had on the customs of mothers in the community. 
CHAPTER 1 INTRODUCTION AND SUMMARY 1.3 
. Methods employed 
1. Trial of increased iron fortification of infant formula 
A group of infants from a lower socio-economic community of so called Cape Coloureds was studied 
from the age of 3 months to 1 year. Half of the children, the Control group, were given a popular 
infant milk formula (Lactogen Full Protein) which contains 8.3 mg Fe per 100 g powder and 37 mg 
ascorbic acid per 100 g powder. The other half, the Test group, were given, in a double blind manner, 
the same formula fortified with 40 mg Fe per 100 g. At the beginning and at the end of the study tests 
were made of iron status and immune function. During the study the children were examined every 3 
weeks in an attempt to document every infection as accurately as possible. The children were selected· 
from a lower socioeconomic community in Cape Town, and, in order to obviate the confounding 
effects of malnutrition or severe illness, the infants were carefully screened to ensure that only healthy, 
well nourished children participated in the trial. 
2. Infant Feeding Practices 
Infant feeding practices were surveyed in the community before the trial began and again 9 months 
later when the trial was well under way and every mother attending the clinic was aware of it. The 
feeding practices of the mothers participating in the trial were also documented for comparative 
purposes. 
Structure of the thesis 
The preceding paragraphs have outlined the background and motivation for the study, posed the 
questions addressed in this thesis and briefly described the protocols of the studies performed. 
Chapter 2 briefly reviews the physiology and pathophysiology of iron metabolism in order to provide 
the background necessary for the subsequent detailed and critical surveys of studies that are 
particularly relevant to the present research.. The review selects from the vast literature on iron and 
only in the areas related to the questions addressed in this study does it attempt to be comprehensive. 
Particular emphasis is placed on studies of the role of iron in susceptibility to infection since, not only is 
this of especial relevance to the present study, but also there has been no comprehensive critical review 
of such work to date. Present understanding of the association between iron status and behaviour is 
summarized. A synopsis of the physiology of iron absorption is given, but the issues of iron fortification 
and supplementation are treated in some detail. 
The design of the study is detailed in chapter 3. Ethical considerations in conducting such studies in 
children are weighed. The protocols for the principal study on iron fortification and immunity and the 
surveys on feeding practices are presented. This chapter also covers the planning of the project is in 
detail. Attention is drawn to important features in the design of the study. Comprehensive analyses 
1.4 IRON NlJTRITION AND IMMUNITY 
support decisions to choose particular features in the design where there were attractive alternatives. 
Chapter 3 also describes the laboratory methods and materials used and the data processing and 
statistical procedures employed. 
Chapter 4 relates socio-cultural data from the trial in order to portray the community within which the 
study was undertaken. Much of the material is anecdotal, but it aims to provide the reader with 
sufficient information to assess the validity of comparisons that he or she might wish to make with 
other studies. 
Results from the surveys of infant feeding habits are presented in chapter 5. 
The results from the main study are reported and discussed in chapter 6. 
The conclusions and recommendations for further studies are presented in chapter 7 which ends with a 
summary of the contributions of the present work. 
The appendices include the bibliography, as full a tabulation of results and statistics as is practical as 
well as other material that might need to be referenced such as the composition of the Control and 
Test infant milk formulas. 
With us ther was A DOCTOUR OF PHYSIC, 
In al this world ne was ther noon him lik 
Wel knew he the olde Esculapius, 
And Deiscorides, and eek Rufus, 
Olde Ypocras, H aly and Galye; 
Serapion, Razis and Avicen; 
Aven-ois, Damascien and Constantin; 
Bernard and Gatesden and Gilbertin. 
Of his diet mesurable was he, 
For it was of no superfiuitee, 
But of greet norissing and digestible. 
His studye was but litel on the Bible. 
· The Canterbury Tales 
Geoffrey Chaucer 
circa AD 1386 
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CHAPTER 2 LITERATURE REVIEW 
Introduction 
The area surveyed 
This chapter reviews iron status with particular emphasis on iron deficiency under the rubrics of 
epidemiology, physiology, pathophysiology, clinical classification and prevention. 
The epidemiology of iron deficiency reveals that it is an internationally widespread public health 
problem in lower socio-economic communities. The Cape peninsula is no exception as iron deficiency 
is common in infants seen at local health care facilities. 
The physiology of iron deficiency is briefly reviewed with particular emphasis on the role of iron in the 
immune system. The pathophysiology of iron deficiency is broadly sketched in order to show the wide 
range of changes in this condition. The principal research project was concerned with iron nutrition 
and immune function; therefore the literature describing effects· of iron deficiency on immune function 
is examined in some detail. Both infection and nutrition are shown to be related to iron status in a 
complex interdependency. This makes the design and interpretation of scientific studies difficult and 
prone to confounding variables. 
The main aim of this chapter is to review published· studies on the relationship between iron deficiency 
and infection in order to provide a comprehensive bibliography up to August 1987. Each pertinent 
study is critically examined for its strength and weakness in testing the hypothesis of a causal· 
relationship of iron deficiency to susceptibility to infection. To place these studies in context it was · 
necessary to review the evidence from studies on laboratory animals and to survey studies on the 
relationship between iron excess and susceptibility to infection. 
The reason that particular emphasis is laid on this aspect of the literature is that, although there have 
· been many reviews of the role of iron in immune function, there has been no comprehensive and 
critical review on iron deficiency and susceptibility to infection. Also, while laboratory work has 
established fairly conclusively the changes in tests of immune function in iron deficiency,. clinical studies 
of susceptibility to infection in iron deficient infants have been suggestive, but inconclusive because of 
methodological problems. 
Studies of laboratory tests of immune function in disturbances of iron metabolism are also reviewed, 
particularly with regard to studies of iron deficiency in infancy. 
• Published in the scientific press, including peer review journals and proceedings or abstracts of scientific congresses. This is a 
wider field than that covered by Medline, but it excludes newspapers and magazines. 
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Clinical classification of iron status is discussed, and difficulties in diagnosis highlighted. Public health 
measures to prevent iron deficiency and its consequences usually rely on the fortification of staple 
foods and/ or the pharmacological supplementation of the diet with iron medications for groups at 
increased risk for iron deficiency. The relevant literature is surveyed in order to ascertain the viability 
of the intervention on which this study is based. 
Finally, as iron is but one of a number of nutritional fa7tors that affect health, the importance and 
possible confounding effects of imbalance in other elements, such as zinc, is summarized .. 
The goals of the review 
'this survey of the literature aims to provide the theoretical framework for understanding both the 
motivation for the project and the design of the study. The literature on iron is vast. This survey 
therefore relies on secondary sources, such as authoritative reviews in books and journals, for most of 
the subject matter covered. Only with respect to iron deficiency and immune function is an attempt 
made to review original scientific reports comprehensively. And only those articles that relate to iron 
deficiency and infection in infancy are critically reviewed in detail. 
Criteria for assessment of studies and literature review 
A critical review of a study aims to assess the validity of the author's claims and the strength of the 
conclusions. Evaluation can only be based on the reported design, methods, data and analysis. 
Guidelines have been taken from two principal sourcesC137• 6). Authors should have included 
information on the objective of their research and the hypotheses tested. The _eligibility criteria for 
admission to the study should have been described and information given on whether the subjects were 
assigned to treatment groups blindly and randomly in order to minimize selection bias. Other 
procedures designed to reduce bias include the patients' blindness to treatment, lllld the investigators' 
blindness when assessing outcome. The methods section of the report should have explained the 
randomization procedure, and laboratory and clinical. methodologies. Treatment compliance and 
complications should have been described and reasons and numbers of subjects lost to follow-up 
should have been given. The statistical analyses should have been described and the power of the study 
should have been estimated. Finally, potential sources of bias or confounding factors should have been 
identified and controlled for, either in the design or in the analysis of the study. Few studies explicitly 
identified these criteria, but in most it was possible to infer much of the information and to 
discriminate between mere assertions and factual argument. 
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The methods used in the literature survey 
Most references were obtained from citations in other review and original articles. The Institut.e of 
Child Health subscribes to the Medical Research Council's MIDS (Medical Information Dissemination 
System). This service provides a computer search each month of most recent additions to the 
Medlars/Medline database of medical literature. The search strategy is set to include publications on 
iron and immune function, but it excludes most work performed on animals and articles not in English, 
Afrikaans, Dutch or German. An additional search of the Medline/Medlars database was performed 
on 4 August 1986 using the "Paperchase" system at the Beth Israel Hospital in Boston. This identified 
22410 articles with the keyword "iron". Of these, 297 also included the keyword "infection". No 
exclusions were made on the basis of language or because a study was performed with animals, 
Evaluation of methods 
The bibliography for immune function and iron status aims to be complete. It is, of course, not 
possible to know what has been missed, but the results of the "Paperchase" search do give an indication 
of how closely the goals are met. 
It is probably safe to assume that any serious scientific work of importance before 1970 would have 
been cited in one of the articles reviewed, and would therefore have been identified. Since 1970, the 
Medlars/Medline database would have indexed any article of interest in this review. Although the 
keywords assigned to an article may not accurately reflect its contents, the concepts of "iron", "immune 
function" and "infection" are broad enough in their scope to have been included in most articles 
pertinent to this research. 
The "Paperchase" search was performed after an extensive period of collecting references. While it 
located 297 articles of potential interest, many were irrelevant. Of these, 102 had not been identified 
before, mainly because they related to studies in animals or were published in a foreign language. 
(This was not unexpected as this type of reference had previously been specifically excluded.) Only one 
(Russian) article(320) was of possible direct importance to the question of the relation between iron 
status and immune function in infancy. 
It would seem therefore, that the literature review is likely to be as complete as could be hoped for with 
respect to articles published on susceptibility to infection in iron .deficient infants, and comprehensive 
in respect of studies relating immune function to iron status in general. · 
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Epidemiology of iron deficiency 
Difficulties in comparing studies 
A digression is here necessary to indicate a preliminary difficulty in determining the 
incidence of anaemia in infancy, namely the lack of any standard of comparison. 
HMM Mackay, 1928(3t4) 
The difficulties that Helen Mackay recognized in 1928 are still with us today, better defined but not yet 
resolved. The following list details important factors that need to be evaluated when studies of iron 
status are compared. 
Intrinsic biological variability 
As with all biological variables, the measures of iron status have a degree of intrinsic variability so that 
a level that is normal for one individual may be high or low for anotherC356). A diurnal cycle may 
compound the intrinsic variability. Serum iron and transferrin saturation exhibit pronounced diurnal 
variation, and even when measurements are made at the same time of day the individual variability is of 
the order of 35 per cent<103). 
Variation between and within laboratory methods 
Modern studies often employ the Coulter counter to measure the haematological indices of iron status. 
The consequent standardization of equipment, methodology and calibration techniques has made 
reliable comparisons possible between studies of different Iaboratories<117, 120). Older studies have to 
be interpreted in the light of the methods employed. For example, the studies of Dr Mackay in London 
between 1925 and 1927 measured haemoglobin according to oxygen combining power and reported 
results as a percentage<3t4), but later work showed that the laboratory calibrations resulted in 
haemoglobin levels that are 7 per cent lower than they ought to be<315). 
Erythrocyte protoporphyrin is sometimes measured as FEP (free erythrocyte protoporphyrin) in ug/dl 
red blood cells and sometimes as ZPP (zinc protoporphyrin) in ug/g haemoglobin. FEP and ZPP 
results can be compared, with a simple calculation, as there is a linear relationship between the two 
measurements: 
ZPP == 0.83*FEP • 3.4(324)_ 
The coefficient of variation of erythrocyte protoporphyrin is about 9% (between laboratories). This is 
about double the coefficient of variation between laboratories for red cell indices measured on the 
Coulter countei120). 
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The method of specimen collection 
The manner in which blood specimens are obtained (eg art~rial, capillary, or venous bleeding) can 
influence laboratory test results, although if care is taken the differences are negligible(ll7)_ 
Developmental changes 
During the first 2 years of life, developmental changes take place in the indices of iron statusC435). 
Rapid growth often requires more iron than is available in the diet and iron stores are diminished, if 
not depleted. The consequent difficulty in distinguishing pathological from physiological changes has 
led to the concept of a physiological anaemia of infancy<162). 
Sex 
· Although indicators of iron status vary markedly with gender in adults, the differences are minimal in 
infancy<527). 
Race 
Racial differences in haematological indices and other measures of iron status have often been noted. 
But, when the confounding effects of genetic conditions (eg thalassemias and haemoglobinopathies), 
. socio-economic class and nutrition are controlled there seems to be no intrinsic racial difference in 
respect of haematologic testsC527• 531). 
Nutrition 
Inadequate nutrition is directly reflected in changes in haematologic variablesC314• 75). 
Infection and inflammation 
Acute and chronic infections and inflammatory diseases alter the metabolism of iron and hence the 
indicators of iron status. Chronic infections and inflammatory diseases lead to a microcytic anaemia. 
The response to any inflammatory process includes a drop in serum iron and rise in serum ferritin. 
The highest levels of serum ferritin are found in hepatitis as liver cell damage releases iron stores into 
the circulation(SZ4). 
Socio-economic class 
When differences in nutrition and exposure to infection are controlled there seems to be no significant 
difference between socio-economic classes(290). 
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Altitude 
Haemoglobin concentration rises in response to the decrease in oxygen at high altitudes. Haematologic 
studies conducted at a significant elevation need to be adjusted for altitude effects for meaningful 
comparisons to be made. Approximate comparability of haemoglobin can be obtained by adding lg 
Hb/dl per 3000 meter elevation(l35)_ 
Diagnostic criteria 
A fundamental problem in comparing studies of iron status is that there is no universally accepted 
method for grading iron status. The principles are not controversial; iron deficiency manifests itsei 
with decteased haemoglobin, decreased haematocrit, decreased mean cell volume, decreased plasma 
ferritin and increased plasma transferrin. The problem is that each of these indices has a wide 
variability, largely independent of the other indices. Any single measure used as a test for iron status 
has poor discriminatory power. Such qualitative statements ought to be quantified by data on 
sensitivities, specificities and predictive values for diagnostic tests, but there are few studies that begin 
to reach this basic level. Test results may be combined in classification schemes to increase 
discriminatory power, but the selection of measures and choice of cut-off levels between normal and 
abnormal are often arbitrary. The problem is difficult enough to be the subject of a book length 
treatise itself and is further analyzed below. 
Prevalence of iron. deficiency - International studies 
In a recent review of iron deficiency Lanzkowsky(SZ7) concludes that the prevalence of iron deficiency 
anaemia (in lower socio-economic communities) varies from 17 to 44 per cent, while that in white 
middle class communities ranges from 1.4 to 6.3 per cent. 
Table 2.1 below contains results from a selection of surveys of anaemia. While the table shows that 
direct comparison between almost any two of the studies has to be qualified with details of 
methodology, the table also demonstrates that anaemia is a common problem, particularly in poorer 
communities. The following section shows that these surveys of anaemia can be taken, for practical 
purposes, to indicate the extent of iron deficiency in the populations studied. 
Estimating iron deficiency from low haemoglobin levels 
In the absence of any better single measure, haemoglobin has often been used as a screening 
instrument to estimate the extent of iron deficiency in populations·. This is justified on two accounts: 
In a population of otherwise healthy infants, iron deficiency is the most common cause of anaemia, and 
the prevalence of anaemia is greatly reduced by programs of iron fortification and supplementation. 
• The issues of diagnosis and classification are discussed in more detail below. 
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Drawbacks in using haemoglobin as an indicator of iron deficiency include those discussed above, the 
fact that decreased haemoglobin levels are a late manifestation of iron deficiency and that specificity, 
sensitivity and predictive value of the test have not been published for infants. 
~ Factors that would cause haemoglobin to over-estimate the prevalence of iron deficiency include all the 
other causes of anaemia. Factors that would cause haemoglobin to under-estimate the prevalence of 
iron deficiency include cases of latent iron deficiency and cases with haemoglobin levels higher than 
that chosen as the lower limit of "normal" but which would respond to extra dietary iron with a rise in 
haemoglobin. 
Percentile curves for haemoglobin have been published by Dallman et at<124). These were established 
by excluding subjects with laboratory evidence of iron deficiency, thalassemia minor and/ or 
haemoglobinopathy. The lower limit of haemoglobin in 1 year old children was found to be 11.0 g/dl. 
Bird et al41) found a prev.alence of 10.4% of thalassemia and/or haemoglobinopathy in so called Cape 
Coloured infants with mean cell volume less than 60 fl. It can thus be inferred that the prevalence of 
thalassemia and/ or haemoglobinopathy in children selected on the basis of a haemoglobin level less 
than 11.0 g/dl is likely to be well under 10% in Cape Coloured infants. For haemoglobin levels greater 
than 11.0 g/dl the proportion of children with thalassemia and/or haemoglobinopathy is likely to be 
even less. Use of a haemoglobin level of 11.0 g/dl to diagnose iron deficiency anaemia is thus unlikely 
to include more than 10% iron replete individuals in otherwise healthy infants. 
The false negative rate is difficult to estimate as no published studies address this issue. Dallman et 
af-123) found that 35% of 1 year old infants with haemoglobins less than 11.5 g/ di responded to iron 
treatment with a rise in haemoglobin of at least 1 g/ di. It is unlikely that as many as 35% of infants 
with haemoglobins above 11.0 would respond to iron treatment so this can be taken as an upper limit, 
but 10% would perhaps be a reasonable estimate. 
The argument can be extended to show that at values of haemoglobin level less than 11.0 g/ di the false 
positive rate in diagnosing iron deficiency anaemia is likely to remain around 10% while the false 
negative rate would increase. 
Population studies have used haemoglobin in 2 ways to estimate iron deficiency. Some have reported 
the mean haemoglobin while others have reported the prevalence of anaemia based on a ''cutoff" level 
of haemoglobin. The mean allows a more precise comparison between studies and but the prevalence 
of anaemia is of more direct interest to the clinician. As there is no generally accepted diagnostic level 
of low haemoglobin, different workers have used different criteria and· published prevalences of 
anaemia are not directly comparable. 
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Table 2.1 summarizes the results from a number of studies. The prevalence of anaemia has varied 
from absent(387• 52) in well off communities to 60% in lower income groupi135). The mean 
haemoglobin varied from 12.5 g/dl(3B7) to 11.1 g/dl(261). The noteworthy feature of table 2.1 is the 
demonstration of the relation between haemoglobin and economic status. The conclusion is that iron 
deficiency is a universal problem in poor societies. 
Table 2.1 Surveys of anaemia in infancy 
Ref. Author Date Age Mean Prevalence Comments 
No. (months) Hb of anaemia 
(g/dl) Hb "cutoff" 
185 Fuerth 1959 12 11.8 6% 10 White, middle class 
1969 9 11.9 3% 10 White, middle class 
162 Farquhar 1963 12 12.1 2% 10 White, well off 
7 Andelman 1966 12 76% 10 Non-white, poor 
302 Lovric 1970 6-36 12.2 3% 10 • All classes 
/ no change with SEC 
387 Owen 1971 12-33 11.6 14% 10 Lower-lower class 
12.0 8% Upper-lower class 
12.4 1% Lower-middle class 
125 0% Upper-middle class 
502 Vacquez-Seone 1971 9-.36 11.1 23% 9.8 Non-white, poor 
1984 9-36 11.8 1% 9.8 Non-white, poor 
74 Burman 1972 12 11.75 ? White, middle class 
261 Katzman 1972 10-36 11.1 18% 9.8 Lower SEC 
135 Derman 1978 13-24 ? 60% 11.5 Black, 1200m 
53% "Coloured", 1700m 
141 Drigger 1981 12 ? 22% 11.5 White, middle class 
38% 11.5 Black, poor 
18% 11.5 Asian 
28% 11.5 Other 
440 Sadowitz 1983 9-12 ? 8% 11 Lower SEC 
52 Brault-Dubuc 1983 12 12.3 0% 10 White, well off 
3.3% 11 
316 Madanat 1984 6-12 ? 37% 10.5 •• ?lower SEC 
12-18 ? 38% 
KEY Ref. No. Number of reference in bibliography 
Author ' First author of anicle 
Date Date study was published or conducted 
Mean Hb Mean haemoglobin concentration in g/dl 
Prevalence of Fe def Prevalence of iron deficiency anaemia 
Hb 'cutoff" Lowest level of haemoglobin regarded as nonnal 
SEC Socio-economic class 
1200m, 1700m Altitude at which study subjects resided 
? No data published 
Diagnosis on Hb, and blood smear 
.. Diagnosis on Hb and transferrin saturation at least 16% 
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Prevalence of iron deficiency · Cape Peninsula 
Lanzkowsky (1960) 
The first survey of anaemia in infants in Cape Town was published in 1960 by Lanzkowskf 288). Fifty 
five per cent of "Coloured" infants between 10 & 11 months and 11 & 12 months had a haemoglobin 
concentration of less than 10 g/ dl. The lowest haemoglobin levels were found in inf ants between 1 and 
2 years of age. As capillary blood specimens were taken with adequate precautions and haemoglobins 
were measured with the oxyhaemoglobin method the results are comparable with those obtained in 
present day laboratories. As was argued above, the prevalence of anaemia can be taken to indicate a 
reasonable approximation of the prevalence of iron deficiency. 
Robertson and Sundgren (1972) 
In 1972 Robertson and Sundgren(420) reported on a survey conducted in Cape Town City child Welfare 
Clinics. Apparently healthy, thriving children in the age group between 7 and 11 months had a 
prevalence of 42% of anaemia defined as a haemoglobin concentration less than 10 g/ dl. For the age 
group 12 to 24 months the prevalence of anaemia rose to 60%. Capillary blood was taken and a direct 
reading hand-held haemoglobinometer used to make the measurements of haemoglobin. This method 
is accurate to 0.5 g/dl with careful calibration. A direct quantitative comparison with other studies 
would be invalid, but the extent of anaemia is readily apparent. 
Kirsten et al (1984) 
The most recent study, by Kirsten et aP61), examined 240 infants from a lower socio-economic Cape 
Coloured community. There were 20 infants in each of 12 age groups ranging from 1 to 12 months. 
This was the frrst study that attempted to classify the iron status of the children using multiple criteria 
in an attempt to be more specific and sensitive. Iron deficiency anaemia was found in 34 per cent, and 
haematological evidence of iron deficiency without anaemia was present in a further 19 per cent. 
Ma.king the inference from low serum ferritin levels, 27 per cent had diminished iron stores. 
A sophisticated classification scheme was employed to take into account developmental changes in the 
first year of life. The reference values used in the diagnostic protocol are given in table 2.2 below. Iron 
deficiency anaemia was diagnosed when the haemoglobin was below the reference level together with 
at least one low result for mean cell volume and mean cell haemoglobin. 
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Table 2.2 Haematological reference values for infants 
Age Hb MCV MCH F erritin ( ug/ dl) 
(mo.) (g/dl) (fl) (pg) Low Very low 
1 11.1 93 27 150-215 <150 
2 95 81 27 64-98 <64 
3 10.0 80 24 21-36 <21 
4 10.0 74 24 13-21 <13 
5-12 10 74 24 8-12 <8 
Notes From Kirsten etaf-261) 
A recent study of the prevalence of beta thalassaemia and abnormal haemoglobinsC41) allows the above 
results to be adjusted for the possible inclusion of haemoglobinopathies in cases categorized as iron 
deficient anaemia. This survey found 10 per cent of children with a mean cell volume less than 60 fl 
were either carrying the beta thalassaemia gene or had an abnormal haemoglobin. The study by 
Kirsten et al found 131 children with a low mean cell volume. (The reference volumes for each age 
group are listed in table 2.2.) As the reference mean cell volume was never as low as 65 fl, a 
conservative estimate of the number of children with a haemoglobinopathy is 10 per cent of 131, which 
equals 13. Subtracting this from the 81 children diagnosed as having iron deficient anaemia, the 
prevalence can be recalculated: (81-13)/240 = 28 per cent. This conservative estimate may well be 
lower than the true figure as the estimated number of haemoglobinopathies surely errs on the side of 
too many. The point is that iron deficiency is very common in this socio-economic group. 
Venous blood was taken and full blood counts made on a Coulter Counter model S. The results are 
therefore comparable with studies from most modern laboratories. 
Summary 
The conclusion to be drawn from these three surveys of iron deficiency is that, in lower socio-economic 
Cape coloured communities, iron deficiency anaemia affects at least one quarter of infants under the 
age of one year. Iron deficiency without anaemia affects about the same proportion. 
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Physiology of iron 
Iron balance 
The following paragraphs give a schematic account of the physiology of iron balance. Details on the 
complex and sometimes controversial mechanisms are not given as this is beyond the scope of this 
thesis. 
Absorption 
Iron is one of the most abundant elements in the earth's crust. However, all cellular organisms find its 
availability low as both the ferrous (Fe2+) and ferric (Fe3+) ions are highly insoluble at neutral pH. 
Special systems are required by all forms of life to absorb and transport iron<326). Bacteria synthesize 
and excrete high-affinity iron chelating agentsC368). The roots of plants secrete substances that 
augment iron absorption<58). Mammals have several mechanisms for the absorption of iron: haem iron . 
is absorbed intact by the intestinal mucosal cen<326) and non-haem iron is absorbed in the proximal 
small intestine whose mucosal cells contain ferritin and transferrin(2Sl). The availability of dietary iron 
is highly variable and dependent on the content of the diet. Non-haem iron is generally poorly 
absorbed - less than 10 per cent is taken up by the subject. The absorption is inhibited (less than 5 per 
cent) by tannates and phosphates found in cereals and augmented (10 to 30 per cent) by fish, meat and 
ascorbic acid(356). Haem iron is highly available - between 20 and 40 per cent being absorbed in the 
iron depleted subject and this fraction is not affected by the composition of the diet<164). About 50 per 
cent of breast milk iron is absorbed, but only 5 to 10 per cent of iron in infant milk formulas is taken 
up<438, 434), and as the iron content of food increases, the percentage of iron absorbed decreases<48>. 
The amount of milk fat, the addition of carbohydrates and acidification of milk do not influence the 
absorption of iron<482). 
Transport and storage 
Iron is transported to sites of storage and utilization bound to transferrin - a 77 000 MW protein that 
can bind 2 atoms of iron. Cells acquire iron by highly selective receptor-mediated endocytosis of 
tr~nsferrin(lZ7). Excess iron is stored as soluble ferritin or as insoluble haemosiderin<524). In the 
formation of haemosiderin part of the protein shell of ferritin is removed and the molecules are 
aggregated. Ferritin has been detected in every type of human cell so examined, but particularly high 
concentrations are found in liver, spleen and bone marrow where it is continually degraded and 
resynthesized. The average ferritin molecule stores about 2000 iron atoms and has a life span of a few 
daysC164). 
The amount of ferritin circulating in the blood parallels the concentration of storage iron in the body: 1 
ug of ferritin per litre of serum is equivalent to about 140 ug of storage iron per kilogram body 
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weight(l64) Tissue ferritin differs from serum f erritin which is partly glycosylated and almost entirely 
free of iron<164). 
Losses 
In the absence of bleeding, iron losses are very small; basal physiological losses, mainly from skin, the 
gastrointestinal tract and urinary epithelium, have been calculated to be 0.014 mg/Kg body massC204) 
per day for the non-menstruating adult. In infancy, the daily loss has been calculated to be between 0.4 
and 1.2 mg iron/Kg body weight(529). The higher rate of loss in infancy reflects the larger epithelial 
surface area (skin, gastrointestinal and urinary tracts) relative to body weight. The losses are increased 
if pasteurized cow's milk is used rather than formula or breast milk and in the presence of diarrhoea. 
Growth 
The normal infant is born with sufficient iron stores to meet the needs of the first four to six months. 
But, as the average infant triples its body weight and doubles its body iron in the first year, the 
nutritional needs for iron at 0.5 - 0.8 mg iron/day are very high in relation to the energy intake<204). In . 
later childhood, the daily iron requirement for growth falls to 0.2 • 0.3 mg iron/day, but rises again 
during the adolescent growth spurt. 
Homeostasis 
Iron absorption is increased in the presence of iron depletion and decreased in the face of iron 
overload. 
A specific storage protein, ferritin, regulates the supply of iron in response to acute or excessive 
demands for the element. 
Iron is highly conserved; losses are minimal and most iron from catabolized cells is circulated for re~ 
utilization. 
As the life of a red cell is 110 days on average, the total turnover of iron greatly exceeds the rate at 
which it is absorbed and lost. Senescent red cells are trapped in the spleen and phagocytosed by 
reticuloendothelial cells. Iron is released from haemoglobin, taken up by plasma transferrin and 
transported to the bone marrow for incorporation into the haemoglobin of new red blood cells. About 
80 per cent of internal iron exchange follows this cycle through the erythron and macrophage<164). 
In the normal situation, iron balance is precarious; the dietary intake of iron in humans is 1 to 2 per 
cent of that in other mammalsC164) and the diet of the poorer segment of the world's population 
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contains very little available iron. At times of high physiological demands, such as pregnancy· and 
infancy, the requirements are qften not met and the consequences of iron deficiency become manifest. 
Biochemical functions of iron . The immune system 
Polymorphonuclear leukocytes and phagocytes 
The polymorphonucleocyte is of particular interest with respect to iron deficiency since the cell has 
many iron-containing constituents. The primary granule is formed in early maturation of the 
polymorphonucleocyte. This contains myeloperoxidase, an iron-containing enzyme, which may 
contribute to the antimicrobial function of the cell. Its clinical importance is uncertain however, since 
congenital deficiency of ~yeloperoxidase does not seem to increase susceptibility to infection<355• 206>. 
The so called specific granule is formed during and subsequent to the myelocyte stage. The specific 
granule contains cytochrome B, an iron-containing enzyme, that is believed to be required for the 
oxidative burst that occurs following phagocytosis<35s)_ It seems that the respiratory burst plays a key 
role in the killing of some, but not all, bacteria by neutrophils since patients with chronic 
granulomatous disease (in whom the oxidative burst is absent) are markedly susceptible to certain 
infections<206, 355). 
It has been proposed that oxygen free radicals produced in iron-catalyzed reactions are responsible for 
the killing of phagocytosed bacteria(352). The biochemistry of oxygen free radical production and 
subsequent reactions is complex and only partly understood. The conclusions of Halliwell and 
Gutteridge in a recent review<206) may be briefly summarized by the following statements. It has been 
clearly established that superoxide radical is produced in vivo during the respiratory burst of phagocytic · 
cells. Superoxide is highly reactive in hydrophobic environments, but poorly reactive in bulk aqueous. 
solution. Similarly, hydrogen peroxide is produced in vivo and is poorly reactive in aqueous solutions 
under physiological conditions. But, unlike superoxide, it. can cross biological membranes. The extent 
of the participation of the cytochromes and other iron containing complexes in the production of 
oxygen free radicals has not yet been fully delineated, but the potential for iron deficiency to disturb the 
functioning of the polymorphonucleocyte is clear. 
In iron overload, the toxic metabolites of oxygen damage polymorphonucleocytes and cells of normal 
tissuesC501). 
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B and T lymphocytes 
B and T lymphocytes depend on iron for the normal function of many subcellular systems, but the 
biochemical roles of iron compounds and enzymes have not been as clearly defined for these cells as 
for phagocytic cells. 
In the mouse, the response of lymphocytes to stimulation with concanavalin A has been shown to 
depend on transferrin-bound iron<318). No defect was noted in the cells of iron-deficient mice in the 
response to the mitogen, but the serum of the iron-deficient mice was less able to support thymidine 
incorporation by stimulated lymphocytes·. 
Biochemical functions of iron - Other systems 
All cells require iron for their growth. (This fact has prompted the suggestion that tumour growth 
might be able to be controlled by limiting the supply of iron by blocking transferrin receptorsC354>.) 
Tables 2.3 and 2.4 summarize the distribution and function of iron containing compounds in the normal 
human. 
Table 2.3 Distribution of iron compounds in normal adult humans** 
Per cent 
normal 
body iron 
65% 
10% 
10% 
9% 
5% 
<1% 
<1% 
<1% 
<1% 
<1% 
<1% 
<1% 
<1% 
Notes .. Modified from ( 460) 
• Author's tables 2 and 4 
Compound 
Haemoglobin 
Ferritin 
Myoglobin 
Haemosiderin 
Unknown 
Transferrin 
Cytochrome c 
Cytochromes a, a3, b 
Peroxidase 
Catalase 
Flavoproteins 
Hydroxylases 
Oxidases 
Amount 
of iron 
(Grams) 
2.600 
0.400 
0.400· 
0.360 
0.200 
0.007 
0004 
? 
? 
? 
? 
? 
? 
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_Table 2.4 Function of iron compounds in normal humans * 
Class Compound Primary function 
1 Proteins which store a Ferritin & Iron storage 
& transport iron b Haemosiderin Iron storage 
C Transferrin Iron transport 
d Lactoferrin Bactericidal/ regulation 
of bone marrow cell 
differentiation 
2 Haemoproteins which a Haemoglobin Oxygen transport to 
bind oxygen reversibly tissues 
3 Iron and molecular a Oxygenase Controlled catalysis 
oxygen b Oxidase of reactions involving 
molecular oxygen 
4 Enzymes containing iron: 
a Haemoproteins which a Cytochrome l\llono-oxygenase:one 
react with molecular p450 oxygen atom 
oxygen incorporated in the 
substrate 
b Tryptophan Catalyzes oxidation of 
oxygenase tryptophan to N-formyl-
kynurenine . 
C Cytochrome Reduces molecular 
oxidase oxygen to water 
b Haemoproteins which a Hydroper- Oxidize water molecules 
react with peroxides oxidase at the expense of 
hydrogen peroxide 
C Iron-sulfur proteins a Ferredoxins Electron transfer 
mediators in the more 
negative regions of 
electron transport 
b Flavoproteins Liver enzymes of wide 
aldehyde oxidase substrate specificity 
sulfite oxidase 
xanthine oxidase 
xanthine dehydrogenase 
C Aconitase Conversion of citric 
acid to cis-aconitate 
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Table 2.4 (continued) · 
* Function or iron compounds in normal humans 
Class 
d Non-haem oxygenases 
Note • Modified from (324) 
Compound 
a Prolyl 
hydroxylase 
b Lysyl 
hydroxy lase 
c Phenyl alanine 
hydroxylase 
d Tyrosine 
hydroxylase 
e Tryptophan 
hydroxy lase 
Iron dependency of micro-organisms 
Introduction 
Primary function 
Collagen triple helix 
stabilization 
Amino acid metabolism 
(pteridine dependent) 
Iron i~ a nutrient required by most, if not all, living ceus<516• 155): "If life without iron exists it is probably 
to be found among certain members of the lactobacilli"(36S). Pathogenic bacteria, fungi and protozoa all 
have an absolute requirement for iron<368• 295). Bacteria whose virulence has been shown to be 
enhanced by exogenous iron include Escherichia coli, Klebsiella Pneumoniae, Pseudomonas 
aeroginosa, Listeria monocytogenes, Staphylococcus aureus, Bacillis anthracis, Yersinia pestis, 
Mycobacterium tuberculosis, Neisseria gonorrhoeae, Shigella flexneri, 'and Vibrio cholerae<391• 342• 
67, 70) 
This requirement for iron by micro-organisms has important implications, both theoretical and 
practical, on iron supplementation, fortification and therapy. This is because administration of iron 
may facilitate infection by overloading the iron sequestrating capacity of the host and thereby make 
iron accessible to the invading organism<102l. 
Parenteral administration of iron-dextran has been associated with increased infectious morbidity and 
mortalityC31• 376• 19• 17). Oral iron therapy has been associated with recrudescence of malaria, brucellosis 
and tuberculosis<361). 
Macfarlane et a/313) have speculated that iron treatment in kwashiorkor may be associated with 
increased mortality from infection. However, there is no evidence that iron supplementation in infant 
milk formulas at the levels commonly used today has any adverse effects<47). 
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The evidence linking iron administration in humans to increased bacterial virulence is comprehensively 
reviewed by Stockman(434). Kochan(Z70) SUID.marizes studies in animals which have shown that the 
administration of iron promotes the development of bacterial infection. In conditions of iron overload 
such as haemochromatosis, siderosis and repeated blood transfusions, patients show a greatly increased 
susceptibility to infectious disease(295, 512). 
Bacterial growth - Iron & iron binding products 
The history of the discovery of the iron binding factors in tissue fluids which provide their bacteriostatic 
properties is reviewed by Kochan(27o). Key observations were that the bacteriostatic nature of serUID. is 
neutralized by iron or by heating to 65°C. Transferrin, · ferritin and Iactoferrin all bind iron so 
effectively that most micro-organisms are not able to utilize the iron bound to these proteins. Serum 
from iron deficient patients is less able to support the growth of bacteria in vitri328). · The mechanisms 
by which iron binding proteins inhibit microbial growth are reviewed in greater detail by Bullen(69). 
Bacterial virulence - Effect on pathogen 
Pathogenic bacteria often have unusually efficient means of acquiring and utilizing iron under the 
restricted conditions in physiological fluids and tissuesC457• 81). 
According to their fate in serum, bacteria can be divided into serum-sensitive and serum-resistant 
groups. The serum-sensitive bacteria are dependent on siderophores or exogenous iron to meet their 
requirements, while the serum-resistant bacteria can use their stored iron to meet growth needs(SOO). 
Bacteria are able to utilize iron bound to haemoglobin, haem and haematin except when these 
molecules are bound to haptoglobin, haemopexin and/or albumin(SOS)_ 
Griffiths et aP98) review the ·experimental evidence implicating plasmids as the determinants for 
certain virulence factors. Vibrio anguillamm is a fish pathogen whose virulence is dependent upon its 
ability to sequester iron. Upon losing the plasmid that carries the genetic code for the iron 
sequestering system, the bacterium loses its virulence. More pertinent for humans is the plasmid Col V 
which seems to provide E. coli with a mechanism which allows it to grow significantly faster in the 
presence of transferrin. 
Escherichia coli acquires iron by specialized systems, including the aerobactin system which has a 
markedly higher prevalence in pathogenic strains than in isolates from faeces(Bl). 
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Bacterial virulence - Effect on host 
Idiopathic haemochromatosis has been associated in a case report with Listeria monocytogenes 
meningitis and reduced phagocytic activity which recovered after a course of phlebotomy to reduce iron 
overload to normal(SOO). (Yersinia enterocolitica is more commonly associated with idiopathic 
haemochromatosis and the evidence for this and other effects of iron overload are reviewed in more 
detail below.) 
Bacterial virulence • Effect on bacterial secondary metabolism 
BarclayC16) tabulates and describes in some detail toxic factors produced by Pseudomonas aeruginosa, 
Clostridium perfringens, Clostridium tetani, Corynebacterium diphtheriae and Shigella shigae 
when they are subject to an environment with low levels of available iron. He also describes 6 outer 
membrane proteins of Escherichia coli produced under limitation of iron. These are all involved in 
the acquisition of iron and are potential determinants of virulence. 
The iron concentration in culture medium controlled the production of two siderophores, toxin A, 
proteases and membrane proteins that bind the siderophore-iron comple:i523). 
"Small quantities of iron bound specifically to human transfenin were found to stimulate infection with 
Neisseria meningitidis strain MlOll in mice 11<231). 
Fungal requirements for iron 
NeilandsC368) has reviewed the data on iron assimilation ~ystems in fungi. Siderophores supply fungi 
with iron via a shuttle mechanism. Their production is increased in response to iron starvation. Iron 
plays a role in germination and sporulation in some species . 
. Protozoa} requirements for iron 
Desferrioxamine has been shown in vitro to inhibit the growth of Plasmodium f alciparum and Murray 
et af.360• 361) have found a lower prevalence of malaria infestation in iron deficient Somali nomads . 
. The mechanism of immunity to malaria may be dependent upon iron containing enzymes. Allison and 
Eugui(S), and Clark and Hunt<97) have proposed that asexual forms of malaria parasites may be killed 
within the erythrocyte by "oxidant stress". le H20 2, 0 2- and other reactive oxygen intermediates. 
Summary 
In summary it can be simply stated that iron is an essential nutrient for all microbial forms of life (with 
the possible exception of the non-pathogenic lactobacilli). Organisms often have specialized systems 
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for procuring iron because its salts are so insoluble. Availability of the element is often rate limiting 
for growth of microbes. 
Pa tho physiology of iron deficiency 
Non-immunological effects 
A number of textbooks and half a dozen recent reviews summarize the effects of iron deficiencyC241• 290• 
119
• 
381
, 
484
• 
441
• 
118). When Lanzkowsky called iron deficiency a "systemic disease•{290) his words may 
have been selected for their dramatic spotlighting of the non-haematological consequences, but they 
were well chosen. For no physiological system is spared although the haematologic consequences are 
most prominent. The following paragraphs list, in point format, the major consequences of iron 
deficiency. Original references are not cited except for immunologic and behavioural effects. If more 
information is required, the interested reader may use one of the previously cited review articles as a 
starting point in locating more information. 
Iron deficiency • Blood and bone marrow 
BLOOD 
Haemoglobin 
Haematocrit 
Mean cell volume 
Mean cell haemoglobin 
Mean cell haemoglobin concentration 
Red cell distribution width 
Erythrocyte protoporphyrin 
Ferritin 
Transferrin/Total Iron Binding Capacity 
Transferrin saturation 
Iron 
Blood smear microscopy 
decreased 
decreased 
decreased 
decreased 
decreased 
increased 
increased 
decreased 
increased 
decreased 
decreased 
hypochromia 
microcytosis 
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Red cell biochemistry 
Free protoporphyrin 
Red cell membrane stiffness 
Red cell life span 
Autohaemolysis 
Susceptibility to sulfhydryl inhibitors 
Red cell hexokinase 
Globin synthesis 
Glycine incorporation into haem 
Adenosine triphosphate (ATP) 
ATP stability 
2,3-diphosphoglycerate (2,3-DPG) 
Catalase 
Susceptibility to H202 
Glutathione peroxidase 
Glutamic oxaloacetic transaminase (EGOT) 
Glycolytic enzymes 
Potassium 
Lactate production 
NADH-Methaemoglobin reductase activity 
Bone-marrow 
Stainable iron 
Sideroblast count 
Erythropoiesis 
DNA synthesis 
RNA synthesis 
Response to treatment 
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increased 
increased 
(alpha globin monomers associated with membrane) 
decreased 
increased 
increased 
increased 
decreased 
(alpha chain decreased more than beta) 
decreased 
normal or decreased 
decreased 
decreased 
decreased 
increased 
decreased 
increased 
increased 
increased 
increased 
increased 
decreased 
decreased 
ineffective 
decreased 
decreased 
When iron deficiency is treated with adequate doses of iron, haemoglobin rises about 1 g/ dl 
per week and there is a modest reticulocytosis of up to 10 per cent. This is slow compared to 
the response to treatment of megaloblastic anaemia which may produce a reticulocytosis of 
up to 50 per cent. The reason for this difference may be that the marrow in iron deficiency is 
hypoplastic with a defect in cellular proliferation as well as a defect in cellular maturation. 
Iron deficiency · Gastrointestinal tract 
Symptoms and signs 
Anorexia 
Pica 
Failure to thrive 
Exudative enteropathy 
Laboratory tests 
Gastric acidity 
Absorption: Xylose 
Fat 
Vitamin A 
Biopsy histology 
Disaccharidase activity 
Cytochrome oxidase activity 
Succinic dehydrogenase 
reduced 
reduced 
reduced 
reduced 
normal 
reduced 
reduced 
reduced 
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Iron deficiency - Cardiovascular system 
Symptoms and signs 
Heart rate 
Cardiac output 
with severe anaemia 
Cardiac development 
Tolerance to digitalis 
Iron deficiency - Skin and mucous membranes 
Laboratory tests 
Iron content of skin, nails, hair 
Cytochrome ox:idase in buccal mucosa 
Iron deficiency • Musculo-skeletal system 
Symptoms and signs 
Growth indices (weight, height) 
Work performance 
X ray bones ( notably skull) 
Myoglobin 
Cytochrome C 
Iron deficiency· Behaviour 
Introduction 
increased 
increased 
decompensation 
hypertrophy 
increased 
decreased 
decreased 
decreased 
decreased 
"hair on end" 
decreased 
decreased 
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The possible importance of the behavioural effects of iron deficiency is becoming widely recognized. 
Much recent research has sought evidence that irol'l deficiency may impair cognitive function, affect 
and activity. Such abnormalities are clearly unfavourable at any stage of life, but in infancy they pose 
the threat of permanent impairment by interfering with intellectual and emotional development. 
There have recently been several comprehensive reviews(l30, 157• 292• 4o3). This section briefly 
summarizes results from biochemical and animal research; original works are not cited. Human 
studies are categorized according to age and only those involving the use of the Bayley Scales of Infant 
Development are discussed in detail. For a full bibliography and exhaustive analysis of the strengths 
and weaknesses of studies published between 1974 and 1985 the reader is referred to the authoritative 
review by Lozoff and Brittenham (304) 
Note on the definition of behaviour 
Behaviour may be quantified by measures of physical activity, by procedures for rating non-cognitive 
constructs such as affect, arousal, motivation and fearfulness, and by performance on tests of cognition 
such as learning and problem solving. Although it is often convenient to treat these categories as 
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independent they are often closely dependent on each other. For example, if arousal is impaired, 
spontaneous activity and problem solving will also suffer. In the infant, the distinction between .the 
cognitive, non-cognitive and motor aspects of behaviour is less clear, and, in the laboratory animal, the 
distinction is even more difficult. 
The Bayley Scales of Infant Development(23) (BSID) have been used in most studies of the role of iron 
status in irifant behaviour. The BSID evaluate infant development using three sets of scales. 
{l) The Mental Scale is designed to assess sensory-perceptual acuities, discriminations, 
and the ability to respond to these; the early acquisition of "object constancy" and 
memory, learning and problem solving ability; vocalizations and the beginnings of verbal 
communication; and early evidence of the ability to fomz generalizations and 
classifications, which is the basis for abstract thinking. Results of the administration of 
the Mental Scale are expressed as a standard score, the MDI, orMental Development 
Index. 
(2) The Motor Scale is design.ed to provide a measure of the degree of control of the 
body, coordination of the large muscles and finer manipulatory skills of the hands and 
fingers. As the Motor Scale is specifically directed towards behaviours reflecting motor 
coordination and skills, it is not concerned with functions that are commonly thought of 
as "mental" or "intelligent" in nature. Results of the administration of the Motor Scale 
are expressed as a standard score, The PD/, or Psychomotor Development Index. ... 
(3) The Infant Behaviour Record is completed after the Mental and Motor Scales have 
been administered. The /BR helps the clinician assess the nature of the child's social 
and objective orientations towards his environment as expressed in attitudes, interests, 
emotions, energy, activity, and tendencies to approach or withdraw from stimulation. (23) 
The Mental and Motor Scales yield summary scores, the MDI and PDI, which are adjusted for age so 
that the norm is 100 with a standard deviation of 16 for all age groups between 2 and 30 months. The 
IBR consists of 30 scales on which the tester rates the infant's behaviour and, in contrast to the MDI 
and PDI, generates no natural summary measure. MathenyC331) has suggested a weighted linear 
combination of items of the IBR to give 7 or 8 summary factors. Matheny's method was employed in 
the amilysis of results in the present research and is discussed in more detail below. 
Biochemical studies 
Metabolic processes which. are dependent upon iron include oxygen transport and storage 
(haemoglobin, myoglobin), oxidative phosphorylation, neurotransmitter metabolism and DNA 
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synthesis·. Alterations in any of these processes could have major effects on the functioning of the 
nervous system but there is not much detailed information available about the metabolic role of iron in 
human brain and neural tissues. In the adult, the basal ganglia have concentrations of iron comparable 
to those found in the liver, spleen and bone marrow - the major storage sites for iron. Brain iron 
concentrations rise gradually from birth, increasing tenfold by adulthood. Early iron depletion in the 
rat leads to a depletion of iron in the brain which is not repaired by treatment even though anaemia 
and liver non-haem iron are promptly restored to normal. 
Defects in thermoregulation, conversion of thyroxine to thyronine and increased urinary excretion of 
catecholamines have been noted. 
Animal studies of behaviour 
Studies· of behaviour in iron deficient rats have shown deficits in reactivity, responsiveness, level of 
arousal, attentiveness to environmental stimuli and spontaneous activity··. The diurnal pattern of 
spontaneous activity is also disturbed. However, no evidence has been found for derangements of basic 
cognitive performance. 
Studies of behaviour in adults, adolescents & children 
Pica has long been recognized as a consequence of iron deficiency although the reason remains 
unclearC349, 332, 287, 201, 428, 416, 29). 
Iron deficiency anaemia has been clearly shown to limit peak physical performance and field work 
suggests that it also limits economic productivity<146• 22). . 
A number of studies have found associations between iron deficiency and measures of cognition such 
as IQ tests and scholastic achiev~ment but all these studies suffer from methodologic inadequacies that · 
limit the conclusions that can be drawn. 
Studies of behaviour in infants 
Infancy is a particularly important period in which to study the effects of iron deficiency on behaviour. 
This is because iron status reaches a nadir between 12 and 24 months of age and the effects of iron 
deficiency on the brain and behaviour may be prolonged in spite of treatment. The published studies 
of behaviour in infancy that have attempted to define the impact of iron deficiency are reviewed in 
greater detail than the other work which does not directly relate to the present research. 
• Lozoff 130> is a good staning point for a wider review and a fairly extensive bibliography. 
• • Lozor/130> is also a fine source for references to original work in this field. 
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Oski and HonigC383• 233) were the first to study the effects of treatment of iron deficiency on infant 
behaviour. They administered the Bayley Scales of Infant Development to 24 iron deficient anaemic 
infants whose ages ranged from 9 to 26 months. Half were treated with intramuscular iron dextran and 
the other half were given placebo. The BSID-were administered a second time 5 to 10 days after 
treatment. The treated group had a significant rise in the MDI score, but the change was not 
significantly different from the change in the placebo treated group. There was a similar non-
significant trend towards improvement in the POL While showing some intriguing tendencie~ this 
study was unable to answer two critical questions: Is the behaviour of iron deficient inf ants impaired 
with respect to iron sufficient controls? and, How much of the change in the second administration of the 
BSID is due to a training effect rather than a specific effect of iron treatment? 
At least five subsequent studies and the present project have attempted to replicate these results and 
avoid at least some of the methodologic problems inherent in Oski and Honig's design. 
Lozoff et at<3°5> studied the acute effects of oral iron treatment on the behaviour of iron deficient 
anaemic infants aged 6 to 24 months. The MDI showed a trend towards improvement when the 15 
treated iron deficient infants were compared with the 12 untreated iron deficient infants or the 40 iron 
""' replete controls. The PDI showed no definite tendency in a similar comparison. Examining the pre-
treatment results for the effects of anaemia revealed significantly lower MDI and PDl scores in the 
iron deficient group. To assess the influence of age and iron status the MDI score was subjected to a 
correlation analysis with a rating of iron status in three age groups, 6 - 12 months, 13 - -18 months and 
19 - 24 monthsl306>. The MDI ·scores were normal for the two younger groups, but in the 19 - 24 
months bracket the MD I scores were lower than average and correlated strikingly with iron status. 
In Santiago, Chile, Walter et a/S01) tested 37 infants at the age of 15 months with the BSID before and 
after an 11 day regimen of oral iron therapy. The 10 babies with iron deficiency anaemia had MDI 
scores that averaged 10 points lower than those of the iron depleted and iron replete babies. The MDI 
scores of the iron deficient babies improved with treatment by 10 points, whereas the iron sufficient 
group improved by one point. 
A second study by Oski and HonigC384) sought to defme the effects of iron treatment on non-anaemic 
iron deficient infants. These workers selected 38 infants between 9 and 12 months of age, all of whom 
had haemoglobin concentrations greater than 11.0 g/ di. All were treated with intramuscular iron 
dextran and the Bayley scales were administered immediately before and 7 days after the injection. 
The infants were placed into one of four graded categories according to their serum feiTitin, 
erythrocyte protoporphyrin, and mean cell volume. The pretreatment MDI scores were lowest for the 
iron deficient group, but the normal group's mean MDI fell between those of the iron depleted group 
and the iron deficient group. After treatment the iron deficient group had a clear rise, .statistically 
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significantly different from those of the iron replete and iron depleted groups. The authors speculated 
that the reason for the similar results in the iron depleted and iron replete groups might be that neural 
function is not affected by mere depletion of iron stores but is affected by tissue deficiency. 
Deinard et af.1'30) and Johnson and McGowanC2Sl) in two observational studies tested 1 year old infants 
with the BSID. Deinard et al used serum ferritin to categorize the iron status of their 34 subjects who 
all had haemato«;rits greater than 33%. Johnson and McGowan used haemoglobin levels of 105 and 
115 g/ d1 as the upper and lower limits in the selection criteria for their iron deficient and iron 
sufficient groups. Neither study found remarkable differences in POI or MDI. 
The non-cognitive aspects of behaviour are less easily quantified. Lozoff and Brittenham(304) have 
suggested that analysis of the IBR shows abnormal ratings for iron deficient infants in two classes of 
summary scores. One class characterizes affect and the other describes orientation to tasks. Iron 
deficient babies also improved with treatment. 
Other investigators have found isolated items on the IBR that are altered in iron deficiency and its 
treatment. Oski and Honig<383) reported that infants became more alert, responsive and better 
coordinated. Walter et af..5°7' noted an improvement after treatment in co-operativeness and listening· 
to sounds, while Deinard et aP'30) found the iron deficient infants to be more fearful, more vocal, less 
visually and auditorally attentive and less likely to mouth toys. Johnson and McGowan reported no 
difference in their study(2Sl). The IBR has 30 items that are scored. No study took account of the 
relatively high probability of finding "significant" differences purely by chance when making so many 
comparisons. 
Lozoff et a/..307) analyzed the interaction between mothers and infants at play and found that anaemic 
babies were not more irritable nor more distractible but that they did maintain closer contact with their 
mothers. This was interpreted as a manifestation of disturbance in affect. In a similar study Johnson 
and McGowanC251) found no differences. 
Summary 
None of these 6 projects completely satisfied the methodologic requirements for unambiguous 
demonstration of a behavioural effect of iron deficiency and the specific fmdings of one study are not 
directly comparable to those of any other study due to differences in ages of the children, criteria for 
iron status, treatment of iron deficiency and timing of administration of the BSID. Nonetheless, the 
pattern of results clearly suggests an impairment of mental developmental test scores in iron deficiency 
anaemia, especially in older infants, and that treatment with oral or intramuscular iron improves the 
scores before a clinically important response in haemoglobin has taken place. Table 2.5 summarizes 
the results of these studies. 
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---------=-=-:----------====-=--=-=#--------=---~----=-~-~-=---===~-;-==-------=---=-~-=-=~-~==----w==--=-----=-=-==--------==------=-=--===-=--~-------~----------=•= 
AUTHOR 
Hwood 
Webb 
Webb 
Webb 
Tucker 
Sulzer 
Pollitt 
Pollitt 
REF 
No. 
A D U L T 
154 
AGE 
CROUP 
> 20 yr 
A D O L E S C E N T 
513 
513 
514 
490 
C H IL D 
4BB 
404 
3B3 
12 - 14 yr 
12 - 14 yr 
12 - 14 
Youths 
4 - 5 yr 
10.B y 
9.5 y 
... 
yr 
NIJYIBER 
IN STUDY 
47 
T 92 
C 101 
T 92 
C 101 
T 74 
C 36 
A 69 
A 230 
Tt 43 
Tp 35 
Cr 16 
C:p 25 
Tr 10 
Tp 10 
Cr 19 
Cp 21 
IRON 
STATUS 
Hb < 10.5 g/dl 
Hb < 11 .5 g/dl 
Hb > 14 .0 g/dl 
Hb < 11,5 g/dl 
Hb < 11.5 g/dl 
Regression on Sf 
Hb < 10,5 g/dl 
Hb < 11, TRF < 16% 
II 
Hb>11.9, TAF > 19% 
II 
Hb < 11.5, etc 
II 
Hb > 13, etc 
fl 
PART 1 
INTERVENTION 
Oral iron 
Observation 
Observation 
Observation 
Observation 
Observation 
Oral iron, 5m 
Placebo 
Oral iron, 5m 
Placebo 
Oral iron, 4m 
Placebo 
Oral iron, •4m 
Placebo 
RESULTS 
(Test group compared with Ccntrol group) 
Psychomotor performance: No significant difference 
lowa·Test of Basic Skills: (T - C) worse p < 0.025 
Latency of visualization of after image: Increased 
Behavior Problem Checklist: Disruptive, irritable, restless 
Asy!lllletric EEG, greater verbal fluency, poorer nonverbal test 
Battery incl vocabulary, IQ, association: worse 
School achievement test: (T1 - C1) : worse P < 0.001 
Placebo treatment I no change 
Iron treatment: (Tr2 - Tr1) I l11proved, P < 0.001 
(Tr2 - Cr2) LO\iler, P < 0.005 
!llatching familiar figure test: 
Placebo treatment 
Iron treatment: 
{T1 - C1): worse p < 0.05 
no change 
(Tr2 - Cr2); No difference 
(Tr2 ~ Tr1) : In-proved, P ·< 0,05 
IRON AND BEHAVIOUR/COG NIT I V'E FUNCTION 
======================================================================================--------------------------===--=-======-----------------------------------------
AUTHOR REF 
No. 
AGE 
GROUP 
NLUIIBER 
IN STUDY 
IRON 
STATUS 
INTERVENTION RESULTS 
(Test group compared with Control group) 
==========------===----===============-=-===---------==========-----=====-----===============-=----------=-==--=======-===---------=-====================~====--==----
I N F A N T 
Oski 3B3 9 - 26 m T 12 Hb < 10,5 g/dl etc IM Imferon Bayley Scales (12 - 11) - (C2 - C1): PDI = + 6.B3 
C 12 Hb < 10.5 g/dl etc Placebo MDI = + 7.5 
p < 5% for IBR: 15, 26, 27 
Oski 384 9 - -12rn C .10 Hb >10.9, Normal IM Imferon Bayley scales (1, 2, 2-1): MDI 9D.B, 97 .o, 6.2 
Ta 10 Hb >10.9, fRT < 12 II MDI 94.6, 100.2, 5.6 
Tb 10 Hb >10.9, FEP > 30 ti MDI 83.9, 104.4, 20.1 
Tc B Hb >10.9, MCV < 70 " MOI 85.5, 109.1, 23.6 
IBR: unremarkable, no trends 
Walter 507 15 m C 15 Hb > 10.9, etc Oral iron Bayley scales (l, 2, 2-1): MDI = 113, 112, 
Ta 12 Hb > 10.9, etc II MDI 10B, 113, -5 
Tb 10 Hb < 11.0 II MDI = 98, 10B, 10 
IBR: 4, 17 improved 
Lozoff 305 6 - 24 m Tr 15 Hb < 10.6 g/dl etc Oral iron Bayley scales (1, 2, 2-1): MDI= 82.7, 89.B, 7 .1 
Tp 12 " Placebo MDI 91.5, 97.0, 5.5 
Cr 19 Hb > 12.0 9/dl Oral iron MDI= 9B.6, 104.1, 5.5 
Cp 21 " Placebo PIDI = 102.0, 107 .1, 5.1 
Bayley scales ( 1 • 2, 2-1 ): POI: No change 
Bayley scales ( 1, 2, 2-1): !BR not reported 
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IRON AND BEHAVIOUR/COG NIT I V
0
E FUNCTION 
======~=======~==~===:===~======~=============================================~===================~=------------------------------------------------------------------
AUTHOR 
Lozoff 
Deinard 
REF 
No. 
306 
130 
Cantwell BO 
AGE 
GROUP 
INFANT 
6 24 m 
11 13 m 
6 -1Bm 
NUMBER 
IN STUDY 
(continued) 
C 11 
Ta 3 
Tb 7 
Tc 4 
Ta 34 
Tb 21 
C 157 
T 
C 
32 
29 
IRON 
STATUS 
Hb > 12.0 g/dl 
Hb > 12,0, FRT 
Hb > 12.0, etc 
Hb < 12, etc 
( 13 
HCT > 33; FRT < 10 
HCT > 33, FRT 10 19 
HCT > 33, FRT > 19 
Hb < 9.6 
Hb > 11.4 
PART 3 
INTERVENTION 
Observation 
II 
II 
" 
Observation 
II 
II 
Nil 
Imferon 
RESULTS 
(Test group compared with Control group) 
Bayley Scales (MDI): 120.7 
91.6 
MLR -> 56% Fe status, 
12% for age etc 
: 82 
: 73.4 
Bayley Scales (POI); No correlation 
Bayley Scales (POI, MDI) 109.8, 
103,B, 
109.1, 
120,e 
116.3 
121 .5 
IBR: S, 16, 17, 24 : Increased fearfulness, Others less 
Uzgiris & Hunt Ordinal Scales: No differences 
At 7 years of age Clumsiness increased, IQ decreased 
: 
CHAPTER 2 LITERATURE REVIEW 2.29 
Iron deficiency • Other tissues 
Tissues other than those or the immune system and systems covered above 
Cytochrome C (haem containing) reduced 
Cytochrome ox:idase (haem containing) reduced 
Succinic dehydrogenase (iron dependent) reduced 
Aconitase (iron dependent) reduced 
Monoamine ox:idase reduced 
Urinary noradrenaline increased 
Tyrosine hydroxylase reduced 
Pa tho physiology of iron deficiency 
Immunological effects 
The literature review up to this point has tried to provide the background necessary for understanding 
the research reported in this thesis. Review articles have been cited whenever possible although, on 
occasion, original articles have been selected for their ability to document a point. The following 
section attempts to be as comprehensive as possible in covering the literature on iron and immune 
function in infancy. 
Interactions - Nutrition, infection, immunity 
Nutrition and immune function 
In endeavouring to determine the effect of iron deficiency on immune function it is important to be 
able to control for the effects of other nutritional deficits. If the diet is inadequate as far as iron is 
concerned, it is also likely to be inadequate in trace elements, proteins, fats, vitamins and energy. Iron 
deficiency itself may also lead to anorexia, malnutrition and disturbances in metabolism that result in 
impaired growth<35s). In clinical studies, unless the iron deficiency is clearly due to blood loss, it is not 
possible to attribute variations in immunological 
tests to one specific dietary deficiency such as iron<63). 
Kwashiorkor, marasmus, and deficiencies of specific nutrients impair immune responses. These 
include reduced antibody response to antigenic stimulation, depressed delayed cutaneous 
hypersensitivity, and impaired in vitro tests ofT lymphocytes, B lymphocytes and phagocyte5'388• 33• 112• 
407, 9, 57) 
Experiments with animals control for these confounding effects by comparing animals on an iron 
deficient diet with 2 sets of controls on an adequate diet. One set of controls is fed ad lib, and the 
other set is pair-fed the exact quantity consumed by the iron deficient animalsC283). Inferences from 
human observations, which cannot be as carefully controlled, should be appropriately qualified. 
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Infection and immune function 
Infections with a number of bacterial, viral and protozoa! agents have been shown to lead to anergy<63>. 
These organisms include Mycobacterium tuberculosis, measlesC112). LA v~m, infectious mononucleosis, 
influenza, hepatitis :8, polio, rubella, and chicken pox. Changes in tests of immune function include an 
impairment in delayed skin reactions to tuberculin and candida antigen, and in mitogenic lymphocyte 
transformation in vitroC310• 165• 321• 117). In no clinical study is it possible to exclude intercurrent 
infection as a cause of immunologic abnormalitie5'63>, although certain experimental designs are better 
controlled than others for such confounding factors. 
Another complicating factor is that leukocytosis itself, whether accompanying infection or not, is 
associated with a significant degree of anergy<216). 
Infection and nutrition 
The relationship between iron, nutrition and immune function is complicated by the fact that infection 
may precipitate malnutrition and malnourished persons are more susceptible to infection<90>. 
These effects of infection on immune function make it difficult to interpret studies of immune function 
performed in iron deficient subjects who are also infected. 
In addition to its effects on nutrition in general, infection may interfere with absorption, transport to 
and release from storage of ironC278, 279, 280, 2'J7). 
Host control of available iron 
Part of the host's defense mechanism against infecting micro-organisms is control of available iron<518• 
16
• 
197). This is accomplished by: 
1 The chelation of iron, thus removing it from the environment. Chelators such as transferrin 
in serum, lactoferrin in phagocytes and both transferrin and lactoferrin in breast milk and 
cow's milk exhibit bacteriostatic properties'66• 102, 270). Lactoferrin-iron complexes are more 
stable than transferrin~iron complexes at the low pH levels within lysozymes in phagocytes. 
Lactoferrin is also found in other secretions such as semen, tears and cervical mucus. 
2 The reduction of the concentration of iron in the blood(lS, 270• 149). Mechanisms include 
reducing the absorption of iron from the gut<36), blocking the return of iron from the 
reticuloendothelial system to transferrinC296), increasing sequestration of iron in tissue 
storesC32), and accelerated removal of iron from the plasma transferrin pooiC295• 296). 
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3 Raising the body temperature; bacterial siderophore production is critically sensitive to 
temperature in some species. Injection of Pasteurel/a multocida into rabbits was followed 
by fever and a marked fall in plasma iron; the inhibitory effect of low iron on bacterial 
growth in vitro was dependent on febrile temperaturesC268). Similar results have been 
obtained for Salmonella typhimurium(189) but do not seem to have been extended to in vivo 
models of infection. 
Possible mechanisms for the control of the hypoferraemic response are more extensively reviewed by 
Beisel <32), Letendre(:31l) and Ballentyne(lS). 
Iron deficiency and laboratory tests of immune function 
The following sections review the evidence from laboratory tests for the role of iron deficiency in 
causing immune dysfunction. The tests are grouped according to the part of the immune system that 
they measure. The grouping is somewhat artificial in that few parts of the immune system can be 
considered in isolation. For example, the production of antibodies by the B lymphocyte is dependent 
upon a complex interaction with macrophages and T lymphocytes. The oversimplification that is 
necessary for structuring the presentation of the laboratory data should not be allowed to contaminate 
the interpretation of the results in terms of basic mechanisms. 
Iron deficiency and humoral immunity 
It is convenient to consider the function of the B lymphocyte under this heading as well as complement. 
The B lymphocyte produces antibody in response to an antigenic stimulus. There is a complex 
dependency of B cells on macrophages, T helper /inducer cells and T suppressor cells. Laboratory tests 
of B cell function in iron deficiency have included measurement of immunoglobulin levels, 
determination of isohaemagglutinin concentrations, the response to immunization with specific agents, 
(in animals) the distribution of B lymphocytes in splenic tissue and the differentiation response in vitro 
to stimulation with lipopolysaccharide. 
Immunoglobulin production - Non-specific 
Serum IgG and lgA have been reported to be normal in iron deficiency(93, 92• 88• 311• 445). Serum IgM 
was reported in the same studies to be normal or increased(SS, 311). Where it was increased, there is 
suspicion that this may have been due to recent infection. 
Salivary lgA (3ll) and isohaemagglutininsC312) were also within normal limits in two studies. 
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Secretory IgA in the gastrointestinal tract, however, has been reported to be increased in healthy 
infants who had been fed iron.fortified milk for the first 8 weeks of life(274). 
Immunoglobulin production . Specific 
The results of tests of response .to immune function are not always consistent. ChandraC93) 
documented normal responses to immunization with tetanus toxoid and typhoid O and H antigens in 
children with iron deficiency anaemia. The control group used for comparison was not described. 
Macdougall(Jll) found that response to immunization against diphtheria was diminished, but that 
response to typhoid O and H antigens was comparable to the control group. The numbers of subjects 
was small, and the iron deficient group may have been suffering from the confounding effects of 
infection and/ or malnutrition. 
Nalder et a!364) found a clear dose-response relation between the degree of iron deficiency and the 
depression of response to immunization with tetanus toxoid in rats. However, as iron deficiency 
induces malnutrition, the depressed antibody response may have been due to the effects of 
malnutrition. This supposition is contradicted by the study of Kuvibidila(2Sl) who reported a 
depression of response to immunization with sheep red blood cells in mice fed an iron deficient diet. 
No such depression was·found in pair-fed controls. 
Malakhovsky(J20) reported similar immune responses to natural infections in anaemic children and in 
non-anaemic children. The micro•organisms inclu?ed staphylococcus, Shigella dysenteriae, Salmonella 
typhimurium, Escherichia coli, Adenovirus and parainfluenzavirus •. 
B cell function 
In a study of B cell stimulation with bacterial lipopolysaccharide, KuvibidilaC283) found that cells from 
iron deficient rats had a diminishe.d response. In vitro repletion by mouse transferrin, haemin or ferric 
chloride did not restore responsiveness to bacterial lipopolysaccharide. The percentage of B cells in 
spleen cell suspension was statistically lower and morphologic changes were noted in electron 
microscopy of treated splenic cells in culture. Iron deficient mice<281) sensitized in vivo with sheep 
erythrocytes generated fewer plaque forming cells per 106 spleen cells or 106 B lymphocytes. 
• Evaluation of this report is difficult because it is not easy to understand the serological methods in the translation from the 
Russian. 
• 
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The roles of T cells and macrophages in antibody production 
The roles of the macrophage, T helper cell and T suppressor cell in the production of antibodies in iron 
deficiency have not been studied(2Bl). 
Complement 
Tests of complement levels in iron deficiency have shown CH50 and C4 to be normal(Jll, 92) and C3 to 
be decreasei93), norm.al(92) and increasei311). In no study was malnutrition and/or infection 
satisfactorily excluded. However, it would seem that complement levels are not changed in any 
important way in iron deficiency. 
Summary and conclusions 
In summary, the best scientific evidence for an effect of iron deficiency on humoral immunity is the 
work of Kuvibidila with laboratory mice. The clinical studies have involved small numbers of patients 
and none excluded confounding effects of infection and malnutrition, but it would seem that antibody 
response is depressed, at least to certain classes of antigens, although gross immunoglobulin and 
complement levels are normal. 
Table 2.6 Iron status and immune function 
Immunoglobulin and complement levels in iron deficiency. The table indicates the directions in 
which iron deficient groups differed from control groups. Non-significant trends are shown by 
enclosing them in parentheses. Where there is no clear trend an N is placed in the table. 
=--=•::r.;11=s-eccaaa=mm==scaa:m:-==:=-mrm1::1:::::i:::e==:==r=--==-a:aaaa--==--=-===----=-ama::a=-••=-im=---=,=-: 
REF I Author I SERUM IMHUNOGLOBULJNS iHETEROHAEH-ilSOHAEHAGGLUTININS IS4LJVAI SERUM COMPLEMENT: 
NIJ!rberl I lgG l lgH I lgA IAGGf.UTININSl ant; A I anti B I IgA I CH50 l CJ l C4 I 
-=-==---:====--=csc=cr=:=:aaam=:==•==:::ta=io---==m•--===r--=-act:1:---====--m:::sa=••Q-==-=oa:a-=-====-I 
, I 
93 
92 
275 
311 
312 
320 
445 
Notes: 
!Chandra I (I) I 
!Chandra N 
IKrantman (D) 
IMacDougall N 
: MacOouga l l 
IMalakhovskyl 
:sawitsky N 
TEST RESULTS 
D Decreased 
I (D) (D) (D) I 
N N N N 
(I) (D) 
(I) N N N I 
N N 
N N N 
N N 
N No change I Increased 
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Table 2.7 Response to immunization in iron deficiency. The table indicates the directions in 
which iron deficient groups differed from control groups. Non-significant trends are shown by 
enclosing them in parentheses. Where there is no clear trend an N is placed in the table. 
•111-aa::1111111---~··=--=-cn:=---aailll•-~-•mCla_ca_aa _____ alllda=_.__.__aa:m•a-aa--N-l 
REF IAuthor IMMUNIZATION AGENT l B CELL STIMULATION I 
NuniJerl . l TETANUS lMISCELLANEOUSIDIPHTHERIAI TYPHOID l SHEEP l WITH BACTERIAL 
I TOXOID I (see note) l TOXOID lO ag Hag l RSC I LIPOPOLYSACCHARIDE I 
aat11a-a==a-•;am=:a-•=-c:acr=:1aa=c:nsa--=---a.:i:·.r:.:mm•mD---=s=r _______ a:ar..._ ___ m•s::m1== J 
93 !Chandra N 
281 JKuvibidila I 
283 lKuvibidila I 
312 l MacDouga 11 I 
320 lMalakhovskyl 
364 JNalder D 
NOTE 
Miscellaneous: 
TEST RESULTS 
D Decreased 
N N 
N 
D 
(D) (D) N 
N 
Staphylococcal antigen, Shfgella dySenteriae, Saloonella typhi (Wida]), 
Adenovirus, Parafnfluenzavirus all nonnal seroconversfon rates or titre 
N No change I Increased 
Iron deficiency and T cell function 
Tests of T cell lymphocyte function in iron deficiency have included absolute counts and relative 
proportions of T cells, cytolytic activity and blastogenic response to mitogens. The results of all such 
studies found in the literature search are summarized in tables 2.8, 2.9 and 2.11 and are discussed 
below. 
T cell absolute number & .proportion of lymphocytes 
Table 2.11 shows that 4 studies of iron deficiency have found a decrease in the percentage of T ce11sC39, 
93
• 
275
• 
473) and one study has reported a normal proportion of T cell/92). The absolute number of T 
cells was only reported by one groul275) who found it to be depressed. No fundamental mechanisms 
have been proposed to account for these findings but Kuvibidila et ai<283) have suggested that there 
may be a block in haemopoietic cell differentiation. 
·( 
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Lymphocyte blastogenic stimulation 
The response of T lymphocytes to stimulation with a wide variety of mitogens has been reported to be 
depressed in 11 studies listed in table 2.8 •. Only two reports of unchanged or increased blastogenic 
response ·of lymphocytes from iron deficient patients were located in the literature search<277• 243>. 
Neither report includes an estimation of the probability of not detecting a real change (ie the type II 
error). 
Many of the clinical studies do not allow the confounding effects of over- or under-nutrition, vitalllin or 
zinc deficiency and infection to be ruled out. The most sophisticated experiments ( as is to be expected) 
were performed on laboratory miceC281• 283). The test group, which was fed an iron deficient diet was 
compared to: 
a control group, fed ad libitum an iron sufficient diet 
a pair-fed group, fed the iron sufficient diet, but limited to the quantity consumed by the iron 
deficient group. 
a repleted group which had been fed the iron deficient diet until they were anaemic and then 
fed the iron sufficient diet (for 7 - 14 days) until their haemoglobins had been restored to 
normal 
The results showed a marked and consistent depression of response to PHA and to Con A in iron 
deficiency with restoration to normal levels in the iron repleted mice. 
The rest~ration of blastogenic responsiveness contradicts the hypothesis proposed by Joynson et a/243) 
and Bhaskaram et at<39) to explain their failure to demonstrate such a return to normality. Their 
theory was that response to mitogens is delayed after repletion of iron status. 
KuvibidilaC281) reported that in vitro repletion by mouse transferrin (10 - 30 ug/ml) and ferric chloride 
(0.25 • 1 ug/ml) partially restored responsiveness to stimulation by PHA, but not Con A and also 
decreased the responsiveness in the two control groups. Haemin (05 · 5 uM) partially restored 
responsiveness to PHA and Con A stimulation in T lymphocytes, and decreased the response of the 
controls to both mitogens. In vivo repletion restored mitogenic response after 10 days of feeding on an 
iron supplemented diet. 
• Srikantia<473l reported a decreased response to PHA stimulation but the statements made in the text do not agree with the 
data tabulated. I have assumed that the statements are correct and that there is a typographical error in the table. 
Macdougall et al 1975<311> studied lymphocyte transformation in response to stimulation by phyto-haemagglutinin and candida 
antigen in 15 iron deficient infants, 11 of whom were anaemic. Both the latent iron deficiency group and the anaemic group 
had significantly lower incorporation of 3H-thymidine than the controls. Ten patients were retested two to three months 
after treatment with intramuscular iron dextran. No statistical tests were published, but the published data were sufficient 
to allow a paired t test to be made. This yielded significance levels of 0.002 and 0.02 for phytohaemagglutinin and candida 
respectively. Unfortunately, no controls were retested so the reasons for the improvement can not be assigned with 
confidence to the treatment. 
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The results of tests of T cell response to mitogens in the face of iron deficiency are not entirely 
consistent, but the best controlled study and overall impression indicate that iron deficiency is 
associated with a reduction in response. 
Possible mechanisms for this reduction have been suggested by Kuvibidila et af'2J>,3). They assert that 
decreased mitogenic responses may be partly, but not entirely, due to decreased percentages of mature 
T cells (assessed by density of anti- antigen on the cell surface). The reason for this assertion was 
that they failed to reverse mitogenic responses by enriching the T cell fraction by using nylon wool to 
remove null cells. These authors further hypothesize an increasing effect of iron deficiency on less 
mature T cells (Con A responsive) compared to the more mature PHA responsive cells. An alternative 
mechanism could be an increase in null cells resulting in interference with PHA responsiveness. More 
likely alternatives are the possibility that lymphocytes from iron deficient subjects interact poorly with 
mitogens and/or have a decreased survival in vitro. 
Lymphokine production 
MIF (migration inhibitory factor) production m response to Candida antigen and to PPD was 
depressed in iron deficient patientsC255) 
Cytolysis 
Cytolysis· of tumour cells was depressed in iron deficient mice<277). 
Several possible mechanisms for this defect in T cell function are proposed by the authors. Iron 
deficiency might lead to a decrease in the proportion of mature lymphocytes which are sensitized and 
become cytotoxic or respond to non-specific mitogens. Or, it might lead to a defect in the sensitization 
process itself. A third possibility is that the killing capacity of ea.ch cell might be reduced. Or, ther~ 
may be some combination of the hypothesized mechanisms. Qualitative impressions of microscopical 
examination of sensitized splenic cells incubated with tumour cells were that iron deficiency did not 
impair the ability of attacker cells· to contact and adhere to target cells. This suggests that iron 
deficiency is most important at the level of cell lysis. 
• The experiment employed cytolytic cells harvested from the spleen and peritoneal cavity. The a1,1thors cite a previous study in 
which the percentage ofT lymphocytes in spleen cell s1.1spension was found to be approximately 50, 44 and 27% in the 
control, pair-fed, and iron deficient groups respectively. The authors state, witho1.1t data, that the peritoneal cells included 
macrophages as well as lymphocytes. The st1.1dy is incl1.1ded in this section on the assumption that T cells would have been 
central to the cytolytic fonction even for the peritoneal cells. 
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Delayed cutaneous hypersensitivity 
Table 2.9 summarizes the results of 10 studies of delayed cutaneous hypersensitivity in iron deficiency. 
Nine authors report diminished responses to 23 tests of 9 different sensitizing agents. Two authors 
report 2 tests which showed a normal response to ppo(93) and to DNFB(366). These 2 "negative" 
" 
reports contrast with the 23 "positive" reports. The evidence for an impaired delayed cutaneous 
hypersensitivity is thus fairly strong, although it must be stated again that the results of clinical studies 
are open to potential confounding influences from malnutrition and infection. The one carefully 
controlled study on laboratory animals confirms the clinical investigations(284). 
Kuvibidila(2Bl) reported that a single injection of parenteral iron dextran 24 hours before the recall 
dose of DNFB restored responsiveness to normal. 
No mechanisms have been proposed to account for this effect of iron deficiency although 
KuvibidilaC281) noted that iron deficiency did not impair sensitization, and both Kuvibidila et aiC284> and 
Krantman et a/275) theorized that it may involve factors such as monocyte chemotaxis, local 
inflammatory response by mast cells and lymphokine production. The latter perhaps due to decreased 
ribonucleotide reductase activity. 
Summary and conclusions 
Laboratory tests of immune function are particularly sensitive to methodology. The results of 
lymphocyte biastogenic stimulation depend on duration of incubation at each stage as well as culture 
media and other factors. For this reason comparisons of results between different laboratories should 
not be made without careful validation of the procedures employed(63>. 
In summary, the clinical evidence is suggestive of a decrease in the proportion of T cells, impairment of 
delayed cutaneous hypersensitivity and lymphocyte biastogenic response to mitogens including 
phytohaemagglutinin, candida antigen, concanavalin A, · pokeweed mitogen, tetanus antigen and 
purified protein derivative of Mycobacterium tuberculosis. The studies on laboratoi:y animals confirm 
the clinical observations and show that cytolytic activity is also impaired .. In addition, the sensitization 
step does not seem to be affected. Although these laboratory studies seem conclusive, they have all 
been performed in one laboratory and independent confirmation by other workers would substantially 
strengthen the hypothesis of iron deficiency causing a defect in T cell function. 
The biochemical mechanisms for these effects of iron deficiency remain to be elucidated although 
many papers note the impairment in DNA synthesis found by Hershko(223) and the inhibition of 
ribonucleotide reductase found by Hoffbrani229). An interesting surmise was made by Gross et 
aP99\ namely that iron deficiency may interfere with folate metabolism since folate deficiency 
adversely affects cellular immunity. 
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Table 2.8 T Lymphocyte stimulation tests in iron deficiency. The table indicates the directions 
in which iron deficient groups differed from control groups. Non-significant trends are shown by 
enclosing them in parentheses. 
REF IAuthor 
Nuni:Jer: 
39 !Bhaskararn I 
92 !Chandra 
93 !Chandra 
169 !Fletcher 
199 !Gross 
255 !Joynson 
275 lKrantman 
277 lKulapongs 
285 IKuvibidfla; 
283 lKuvibidilal 
311 I MacDouga 11 l 
445 lSawitsky 
473 JSrikantia 
TEST RESULTS 
D Decreased 
L YHPHOCYT£ STIMULATION 
HITOGEN ' I
.. 
MISCELLANEOUS 
PHA I C4NDIDA1 CON A I PWM I PPO I TETANUS! 
D 
D 
D 
D 
(D) 
(D) 
( I} 
D 
D 
D 
D 
(0) 
(D) 
D 
' ' ' 
0 
(0) 
I Increased 
I 
' I , 
I 
D 
(O) 
jl)'111phokine production: Decreased 
,. 
' 
!Cytolysis of t1JJOOur cells: Decreased! 
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Table 2.9 Delayed cutaneous hypersensitivity in iron deficiency. The table indicates the 
directions in which iron deficient groups differed from control groups. Non-significant trends are 
shown by enclosing them in parentheses. Where there is no clear trend an N is placed in the table. 
• I 
••••cn1aaoa••===••••a:•:a•a•D==ew:ta•a••••:nn:n:1 .. ;&aa::::::aa.t11••i11u:s-=:s::-...--=--•a~•=•m==-•----enaaa=---=*='=a:, 
I 
REF : Author : AGENT 1 
Nu*rl lONCB l PHA I CANOIOA l PPO l HulTf}s l Trichophytonl SK/SD 1Diphtherial Tetanus l 
I toxoid I toxoid I 
=--=--===-••t::ss:::a=sa=-=-==-a•••==l:l••a===----c•~=---=•---=-=------.m-a::S211:••====•••a:=::1a:=-=rcs f 
39 lBhaskaram: 
lChandra 
N I t 
93 
92 
91 
:chandra 
:chandra 
(D) 
D 
D 
N 
(D) 
(D) 
(D) 
D 
D 
(D) 
D 
D 
D 
D 
D 
199 :Gross N 
255 :Joynson D D 
275 lKrantman I . I D D 
284 lKuvibidilal D 
311 : Macdouga 11 l D 0 D 
Test results 
0 Decreased N No change I Increased 
Abbreviations: 
ONC8 01nitrochlorobenzene PHA Phytohaemagglutinin SK/SO Streptokinase/Streptodornase 
PPD Purified protein derivative of Hycobacterium tuberculosis 
Iron deficiency and polyrnorphonuclear leukocyte function 
Neutrophil and macrophage function has been measured in iron deficiency by several tests summarized 
in tables 2.10 and 2.12. The tests include reduction of nitroblue tetrazolium (NBT), chemotaxis, 
opsonic activity, phagocytic activity, bactericidal activity and activity of the iron containing oxidative 
· enzymes NADPH-oxidase, myeloperoxidase (MPO) and catalase. 
Opsonic activity 
The neutrophil has surface receptors for the Fe portion of IgG and for complement C3b. If a 
bacterium has been coated with either of these substances its contact with a neutrophil and subsequent 
phagocytosis is facilitated. This process of rendering bacteria more "digestible" is not considered under 
the, perhaps more appropriate heading of humoral immunity because it (and chemotactic activity) are, 
in the literature, usually grouped together with more direct tests of polymorphonucleocyte (PMN) 
function. 
' 
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Chandra and Sarayi93) reported that opsonic activity of plasma for Candida albicans was normal in 
iron deficient children. Foroozanfar et af.114) found it to be diminished in ''professional blood donors" 
who were ''profoundly iron deficient, anaemic and ma/nourished", often selling up to 900 ml blood a 
week. 
For Staphylococcus aureus, opsonic activity of the serum or plasma from iron deficient individuals was 
reported to be normal(S8). 
Opsortic activity does not appear to be severely affected in iron deficiency.. This is compatible with 
observations of normal levels of IgG and complement in iron deficiency. 
Phag9cytosis 
The phagocytic activity of PMNs has been reported to be normal in iron deficiency for Candida 
albicans by Chandra and SarayaC93), for Staphylococcus aureus by Chandra(88) and for Staphylococcus 
aureus, Streptococcus pneumoniae and Salmonella typhimurium by Moore and Humbert<352). 
Moore and Humbert also report a decreased phagocytic activity for Candida a/bicans which returned 
to normal on restoration of iron status. 
The latter authors speculated that there might be a reversible, Candida-specific membrane defect in . 
PMNs in iron deficiency. 
These studies lead to the conclusion that there may be a minor impairment of phagocytosis in iron 
deficiency. 
Killing activity 
Polymorphonuclear leukocytes contain lactoferrin which appears to play an essential role in killing 
phagocytosed bacteria. If the intra-cellular iron-binding protein is saturated with iron, by exposing the 
. \ 
cell to ferritin-antibody complex for example, the bactericidal power of the cell is greatly reduced(65). 
The reason may be that lactoferrin withholds iron from intra-cellular micro-organisms 
Rohrer et a/<424) reported that macrophage mediated tumouricidal activity is decreased in iron deficient 
mice compared to both pair-fed and ad iibitum fed mice. 
Bactericidal activity has been found to be decreased for Staphylococcus aureus in 8 stuq.ies (see table 
2.10). It has also been reported to be decreased for Candida albicans in 2 studies and Escherichia 
coli in 2. In one study each it has been normal for Escherichia coli, Streptococcus pneumoniae and 
Salmonella typhimurium • 
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Staphylococcus aureus, Candida albicans, Escherichia coli and Salmonella typhimurium are catalase 
positive organisms, while Streptococcus pneumoniae is catalase negative. Catalase negative organisms 
lack the protective effects of catalase and thus can be killed after phagocytosis by self-generated ~02• 
In contrast, catalase positive organisms, once ingested by the phagocyte must be attacked by the ~02 
originating from the PMN in conjunction with the peroxidase-halide system<352). 
Moore and Humbert<352) point out that if neutrophil oxidation is defective in iron deficiency then there 
would be a defect analogous to that in chronic granulomatous disease. The normal killing of 
Streptococcus pneumoniae and decreased killing of Staphylococcus aureus, Candida albicans and 
Escherichia coli in iron deficiency are consistent with this hypothesis. Salmonella typhimurium is 
catalase positive, and it might have been expected that it too would not be killed efficiently in iron 
deficiency. Moore and Humbert propound the hypothesis of Okamura and Spitznagd374) that 
Salmonella typhimurium (which has a peculiarly long intra-cellular sutvival) is normally killed by non-
oxidative mechanisms dependent on the bacterium's lipopolysaccharide structure .. 
In summary, iron deficiency seems to produce a microbicidal defect similar to, but less severe than, 
that of chronic granulomatous disease. The defect manifests itself towards catalase positive micro-
organisms such as Staphylococcus aureus and Candida albicans. The possible biochemical 
mechanisms are discussed in detail below. 
Chemotaxis 
Macdougalf311) reported normal chemotactic activity of Escherichia coli endotox:in activated serum in 
iron deficient children. The chemotaxis of their PMNs was also within normal limits. Foroozanfar et 
aP74) in "professional blood donors" found that chemotactic activity and chemotaxis were reduced. 
Their subjects were malnourished as well as iron deficient. The evidence for a depression in 
chemotactic activity and chemotaxis is thus no more than suggestive. 
No mechanism was proposed to explain the defect in chemotaxis and chemotactic activity. 
Leukocyte al~aline phosphatase 
Celada et aJC85) found a direct relationship of haemoglobin to leukocyte alkaline phosphatase in 
neutrophils as iron status was manipulated in rabbits by bleeding them and then treating them with 
iron dextran . 
. The authors noted that leukocyte alkaline phosphatase may have different functions in the rabbit and in 
man as it is located in different sub-cellular structures. They also noted that the enzyme bas no known 
role in bactericidal activity, but that it is elevated in response to bacterial infection. The authors cite a 
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case report of a patient with selective leukocyte alkaline phosphatase deficiency who presented with 
recurrent infections and was found to have granulocytes with reduced bactericidal activitf 86). 
Hexose monophosphate shunt activity 
Latex particle· hexose monophosphate (HMP) shunt activity was measured in granulocytes by Yetgin et 
al(SZ6). The iron deficient group had a mean stimulation index significantly lower than that of the 
healthy control group. The patients were malnourished as well as suffering from iron deficiency 
anaemia. The authors did not hypothesize a cause for the reduction in HMP shunt activity, but did 
discuss its significance. 
The authors imply that it may play a similar role in the polymorphonucleocyte to its function in the 
erythrocyte. In the red cell, the hexose monophosphate shunt provides NADPH for the reduction of 
oxidized glutathione (G-S-S-G) to reduced glutathione (2G-SH}'326). This reaction is aitalyzed by 
glutathione reductase. In turn, reduced glutathione removes I:S02 from the erythrocyte in a reaction 
catalyzed by glutathione peroxidase: 
2G-SH + H20 2 ---- > G-S-SG + 2l:SO 
The authors did not explain how this might affect the bactericidal capacity of the granulocyte. As I:S02 
is important in killing bacteria it would seem that if its degradation was decreased, bactericidal capacity 
might be increased (if the polymorphonudeocyte was not damaged itself). Also, in favism where 
glutathione peroxidase is deficient, the affected individuals do not suffer from increased susceptibility 
to infection<239) as might be expected if decreased degradation of I:S02 impaired the phagocyte. 
A second function of the hexose monophosphate shunt, but not discussed by these authors, is the 
provision of pentoses for nucleotide and nucleic acid synthesis<326). It is tempting to speculate that it 
may be the depressed hexose monophosphate shunt activity that is responsible for the decreased 
synthesis of DNA that has been observed in iron deficiency. Or, perhaps, the situation is vice versa, as 
the enzymes of the hexose monophosphate shunt have not been reported to be dependent on iron. 
NBT reduction 
Table 2.10 shows that nitroblue tetrazolium reduction has been found to be diminished in 4 studies and 
within normal limits in 4 other studies. NBT dye is reduced to a visible blue colour by superoxide 
produced by NADPH-oxidase in the PMN during the phagocytic-induced metabolic burst. Infection 
increases NBT reduction activity and may be the reason for the normal test reported in 4 of the clinical 
studies. In one of the studiel226), the NBT reduction test was used only as a qualitative screen to 
exclude patients with chronic granulomatous disease. 
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The qualitative nature of the NBT test is unfortunate because it allows no more than a crude estimate 
of oxidative activity to be made. NADPH-oxidase includes a moiety of cytochrome b which contains 
iron. Iron deficiency might decrease the quantity or activity of cytochrome b(352). 
Myeloperoxidase activity 
In the search for metabolic mechanisms for the defect in killing activity noted in iron deficiency, intra-
cellular myeloperoxidase has been measured in tissue macrophages and circulating neutrophils. Table 
2.12 summarizes these studies (and others). Myeloperoxidase was reduced according to 6 reports. 
(Higgs and ~ ells used a qualitative screen of myeloperoxidase activity to exclude its deficiency in their 
study of iron deficiency in chronic muco-cutaneous candidiasis<226) .) 
The defect in bactericidal activity found in iron deficiency would seem to be, at least in part, due to 
myeloperoxidase deficiency. 
Catalase activity 
Sagone et d 441) found a trend towards decreased levels of catalase activity ( and myeloperoxidase) in 
granulocytes from iron deficient patients. These authors noted that catalase contains iron and plays an 
important role in oxidative killing by phagocytes. 
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Table 2.10 Neutrophil and macrophage stimulation tests in iron deficiency. The table indicates 
the directions in which iron deficient groups differed from control groups. Non-significant trends are 
shown by enclosing them in parentheses. Where there is no cleat trend an N is placed in the table. 
REF I Author f Opsonic IPhagocyticlBactericidall ChenKJtaxis: I NBT I Hyelo- I HHP :catalasel 
l l PLASMA l CELLS I 
Nunberl lActivityl Activity: Activity JClass. Alt.IC/ass. Alt. lReduct.:peroxfdase: 
aoaa ____ mlD:J:U1tc:n::==a==i=:s====----==------aaamma ____ ~---=--=--m•-••oaas-.==.a=t._;a, 
9 lArbeter 
11 :eaggs 
85 :celacta 
93 lChandra 
88 lChandra 
92 !Chandra 
IN: Ca 
IN: Sa 
174 lforoozanfar:o: Ca 
259 lKatsushima. 
226 lHiggs 
225 lHigashi 
277 IKulapongs 
311 . l Macdouga 11 
328 
352 
lMasawe 
lMoore 
424 !Rohrer 
441 lSagone 
473 :srikantia 
506 :waiter 
526 JYetgin 
Notes: 
IN: Sa 
IN: Ca 
IN: Sa 
l(D): Sa 
JN:St 
ID: Sa 
ID: Sa 
lD: Sa 
lO :Ca 
I 
I • 
IN: Ee 
10: Sa 
l l (D): Sa 
IN:Sa,Sp,StlN: Sp, St 
ID:Ca 
IN: Sa 
:o: Sa, ca 
10: tUIOOUr 
ID: Ee 
ID: Sa 
ID: Sa 
I • 
I 
D 0 D 
N 
D 
D 
D 
N 
N 
N 
0 
N 
D 
D 
(0) 
N 
0 
0 
(O) 
N 
Sa Staphylococcus aureus Sp Streptococcus pneunr:miae St SalnKJnella typhilfl.lrium 
Ee Escherichia coli Ca Candida albfcans 
0 Decreased N Nonnal I Increased 
(O) 
0 
Cherootaxis was ireasured using either the subject's plasma or cells, and employed either the classical or 
the alternate pathway for activation (with Ag/Ab complex or endotoxin). 
Summary and conclusions 
The work reviewed above provides fairly strong evidence for reduced phagocyte killing in iron 
deficiency, similar to, but less severe than the defect in chronic granulomatous disease. The source of 
the defect seems not to reside to any important degree in chemotaxis, opsonic activity or phagocytosis, 
CHAPTER 2 LITERATURE REVIEW 2.45 
but to stem from decreased activity of iron contammg oxidative enzymes viz myeloperoxidase, 
NADPH-oxidase and catalase. The hexose monophosphate shunt may also be ineffective in 
polymorphonucleocytes in iron deficiency, but the significance of this is not clear. 
Iron deficiency and lymphoid tissue 
White blood cells 
Table 2.11 summarizes the results reported from microscopic studies of white blood cells in iron 
deficiency and table 2.12 summarizes results from biochemical studies. 
The results from clinical studies may include confounding effects of infection and/ or malnutrition. 
Giving more weight therefore to the laboratory animal studies leads to the conclusion that total white 
blood cell count, lymphocyte count, neutrophil count and T and B lymphocyte number and proportion 
may all be decreased in iron deficiency. KuvibidilaC281) reported that null lymphocytes were increased 
in iron deficient mice. 
Monocytes, basophils and eosinophii counts seen to be unaffected by iron deficiency. 
Morphological abnormalities have been reported by Beard et a1(2S) and Cbanarin et at<86) for 
neutrophils, by Jarvis et af-249) and KuvibidilaC281) for lymphocytes in iron deficiency. 
Bone marrow 
Chronic iron deficiency often results in hypercellularity of the bone marrow. The studies on bone 
marrow changes in iron deficiency that are discussed below did not characterize the cellular 
distribution. It would be interesting to know how the erythroid and myeloid lines are affected. Is there 
a delay at a specific stage in development, or are all stages from the common stem cell equally 
affected? 
.Kuvibidila(28l) has presented evidence that iron deficiency results in a delay in the maturation of 
monocytes in mice. Tavasom(493) described delayed marrow regeneration following correction of iron 
deficiency in chronic iron deficiency in rats. 
Sawitsky( 445) report~d that granulocyte proliferation m 1 of 5 patients with iron deficiency was 
depressed in in vitro bone marrow culture as measured by tritiated thymidine labelling. 
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DNA synthesis in bone marrow has been noted to be diminished in iron deficiency by Hoffbrand et 
a/..229), Hershko et af-223) and Kuvibidila<281>. The rate of RNA synthesis was not affected although the 
total content of RNA/109 nucleated cells was decreased(223). 
Spleen 
The changes to splenic histology induced by iron deficiency in rabbits were described by Rodvien et 
af..423). The white pulp was enlarged and the red pulp congested with red cells. Ultrastructural 
changes to macrophages, lymphocytes and reticular cells included abnormalities in mitochondria, 
endoplasmic reticulum and membrane structure. 
Rothenbacher et af-430) studied histopathological changes induced by chronic severe iron deficiency in 
rats. Both the white pulp and the red pulp were markedly decreased. The spleens were half the size of 
those of the controls and constituted a smaller percentage of body weight. Although it was cited, The 
authors did not discuss the discrepancies from the study of Rodvien et al. 
Kuvibidila and co-workersC282• 281• 43o) reported a decreased percentage of T and B lymphocytes in 
splenic tissue. The same laboratory also observed that the weight of the spleen in relation to the total 
body weight increased in laboratory mice. 
No reports have been published of studies in human of the pathophysiology of the spleen in iron 
deficiency. 
Thymus 
The weight of the thymus was decreased in iron deficient miceC281) and ratsC430>. The T lymphocyte 
component was greatly decreased in the iron deficient rats, while the epithelial cell component was 
relatively increasei 430). 
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Table 2.11 Leukocyte counts and morphology in iron deficiencr. The table indicates the 
directions in which iron deficient groups differed from control groups. Non-significant trends are 
shown by enclosing them in parentheses. Where there is no clear trend an N is placed in the table. 
REF I Author : WBC llyrrphocytelMonocytelBasaphillEosinophfllPolyrrvrphl Nucleated I T Cells 18 cells! 
NuntJerl ;109/1 I 109/1 I Count l Count I Count l Count !Spleen cellsl No. % I SMlg : 
••••---•1=1:=••===-=a-•zcn==-•-==-•===-•••a---=-m=------ISalll---••m•-••--=•••c----aaa:sCh:J_aa:_-=r••i 
39 IBhaskaram 
93 !Chandra 
92 !Chandra 
169 I fletcher 
275 !Krantman 11.5 
283 IKuvibidi la 7.8 
473 1Sr1kantia 
/ 
>1.89 
3.0 
D 
If N (D) 
N 
N N D 
D 
D 
N ff 
(1) (D) (I) 
D 
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Table 2.12 Biochemical and morphological studies in iron deficiency. The table indicates the 
directions in which iron deficient groups differed from control groups. 
REF l Author 
Numberl 
12 :Baggs 
11 :Baggs 
25 !Beard 
85 !Celada 
86 :chanarin 
223 :Hershko 
225 !Higashi 
226 !Higgs 
229 IHoffbrand 
249 !Jarvis 
259 lKatsushima 
283 IKuvibidila 
282 IKuvibidila 
n 
n n 
354 !Munn 
n I tt 
I 
352 !Moore 
423 JRodvien 
n tt 
STUDY ANO RESULTS OF IRON DEFICIENCY 
:oecreased ff\Yeloperoxidase in macrophages & neutrophils 
:Decreased 111Yeloperoxidase positive cells in lamina propria & submucosa 
!Neutrophil nuclei hypersegrrented, giant metaff\Yelocytes 
!Leukocyte alka.line phosphatase decreased and rose with hael!llglobin 
!Increased segmentation of neutrophils 
:Decreased nucleic acid synthesis in bone marrow 
jMyeloperoxidase reduced in l!Klnocytes and neutrophils 
IMyeloperoxidase normal in chronic mucocutaneous candidiasis with iron deficiency 
:oesferrioxamine inhibited DNA synthesis(? inhibited ribonucleotide reductase) 
!Lymphocyte mitochondria were swollen, and vacuolated 
!Decreased leukocyte peroxidase in a case of hypochromic anaemia 
!Decreased nucleated cells in spleen 
:oecreased T lymphocytes in spleen 
:weight of spleen/lOOg body weight increased: Ratio of dry to wet weight incr;eased 
!Weight of thymus and liver decreased 
:oecreased ONA synthesis in lymphocytes 
:Decreased plaque fanning cells (B lymphocytes) after sensitization by sheep red blood celli 
lMyeloperoxidase reduced in granulocytes 
!Spleen: enlarged white pulp and congested red pulp. Splenic macrophages, lymphocytes&. 
:reticular cells: changes in mitochondria, endoplasmic reticulum and membrane structure 
430 :Rothenbacher!Impaired T & B cell lymphopoiesis 
441 :sagone !Trend towards decreased granulocyte catalase & myeloperoxidase 
445 1Sawitsky . !Labelling index of granulocyte proliferative compartment of bone marrow depressed 
493 ITavasolli !Impaired regeneration of marrow tissue 
Summary and conclusions - Lymphoid tissue in iron deficiency 
Total white cell count, lymphocyte count, neutrophil count, and T and B lymphocyte number and 
proportion seem to be depressed in iron deficiency. The spleen and thymus may be both relatively and 
absolutely diminished in weight, and their histology indicates disturbed production of lymphocytes. 
Bone marrow growth and metabolic activity are diminished with decreased nucleic acid content and 
DNA synthesis. The evidence is stronger for some effects than others and is broadly consistent. 
I 
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Iron as a modulator of immune function 
The regulation of the immune system is pivotal in understanding the defense against infection and the 
role of iron and associated molecules ( citrate, lactoferrin, isoferritins ( acidic and basic), and other 
uncharacterized factors) is gradually being worked out. There is a growing body of literature in this 
complex area and this section does not attempt to review this comprehensively. The aim is rather to 
highlight'a few studies in order to emphasize the importance of the concept of regulation. 
The role of iron as a possible modulator of the immune system was investigated by Munn<354) • In 
vitro assays of human lymphocyte function were made where the concentration of ferric citrate, 
transferrin, lactoferrin, ferritin or haemin was varied at differing stages of the response to various 
mitogens. Iron modulated the immune response of B cells, enhancing or depressing the assay 
depending on the concentration. Munn did not attempt to relate the findings to the physiological 
response in vivo other than to speculate that iron may play a regulatory role in modulating immune 
function. 
The uptake of tritiated thymidine and uridine was increased in PHA stimulated lymphocytes by iron-
transferrin in serum free medium, and not by iron or apoferritin<396). Similar results were obtained for 
concanavalin A stimulated lymphocytes<318). 
Iron bound to transferrin enhances lymphocyte response to stimulation with PHA(396). Interleukin-2 
stimulates T lymphocyte production, at least in part, by induction of transferrin receptors on these 
cells(367). 
Ferric citrate enhanced the proliferative response of peripheral blood lymphocytes to PWM and 
suppressed the response to PHA and Con A. Ferritin (iron content not stated) had no effect on PWM 
stimulation, but suppressed the response to PHA and Con A stimulation<61). 
Ferric citrate significantly suppressed the expression of the OKT3 and OKT4 molecules in PWM 
stimulated lymphocytes. The helper/suppressor ratio was decreased and the transferrin receptor 
(OKT9) was significantly enhanced. Three other activation-associated markers were not changed by 
iron, viz OKia, OKTlO and the receptor that forms thermostable erythrocyte-rosettes<62). 
Transferrin, in the absence of serum, augmented proliferation of human lymphocytes to 
phytohaemagglutinin, concanavalin A and pokeweed mitogen<8). The response appeared to be 
independent of the metal content. 
It has been suggested that lactoferrin, transferrin and acidic. iso-ferritins may act as regulatory 
molecules in suppressing myelopoiesis, the production of granulocytes and macrophages by controlling 
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the availability of iron to specific target cell5'59). This hypothesis is very controversial and the 
interested reader is referred to Broxmayer et af-.59), Munn(354) and to Nishiya et af.369) for detailed 
discussion on the apparently conflicting nature of experiments in this area and more extensive guides to 
the literature than Olli be provided here. 
Iron status and infection - Animal studies 
The intention in this thesis is to concentrate on clinical studies of the relationship between iron status 
and infection. Animal studies could not be ignored, however, as they allow more precise testing of 
hypotheses in experiments that could not be conducted in humans. 
Table 2.13 summarizes a representative, but incomplete, selection of such studies .. As all the studies 
involved intentional infection of the experimental animal with a specific organism it seemed logical to 
classify the reports according to the type of organism. To allow this body of work to be placed in 
perspective, the table also shows classes of organism which have not been studied. Some major gaps in 
our knowledge are thus made evident. 
The investigation with the broadest spectrum seems to be that of Payne<39l) who examined the 
dependency on iron of various strains of several species of gram-negative bacteria. The results are 
summarized in table 2.13 part 6. From this work, Payne derived a classification scheme that reflects 
the efficiency of iron acquisition by bacteria and the clinical consequences. 
Bacteria were categorized according to their virulence in the face of altered iron status in the chick 
embryo. 
Class I bacteria remained equally virulent in spite of increased iron or the presence of iron binding 
proteins. These organisms have particularly effective iron acquisition systems that are not limite~ by 
physiological concentrations of iron or by iron binding proteins such as conalbumin. 
Class II bacteria are normally virulent, but cannot obtain iron from iron binding proteins which thus 
render them avirulent. 
Class III bacteria are normally relatively avirulent but are enhanced in the presence of available iron. 
These organisms have less eff ec:tive systems for the acquisition of iron. 
Class IV bacteria are avirulent irrespective of iron status. 
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Classes I, II, and III have iron acquisition systems of decreasing efficiency. The summary in Table 2.13 
does not show that the iron acquisition systems may be strain specific. A particular species may have 
strains of differing Payne classes. 
These notions are useful in interpreting the studies listed in Table 2.13. They concentrate attention on 
the effects of iron on the pathogen. But, the virulence of an organism depends on its invasiveness in 
relation to the host's immunity. In Payne's model the host's immune function was held constant (apart 
from acute changes in iron status). Many of the studies in Table 2.13 do not do this and hence Payne's 
scheme could be misleading if applied without due consideration of the above factors. 
The pattern shown by the results of the tabulated studies is that many bacteria, fungi and protozoa are 
reduced in virulence by iron restriction in the host and enhanced by readily available iron. 
One study that allows effects of iron status to be estimated for both host and pathogen is that of 
HartC209> who found in the rat that moderate iron deficiency protected against induced pyelonephritis 
but that severe iron deficiency reduced resistance. The numbers of test animals in this experiment 
were small, and it would have enabled much more confidence to be placed in the results if 4 or 5 
different degrees of iron deficiency had been employed and had shown the U-shaped trend expected 
from the conclusion drawn by the author. 
The studies on nematode helminths are interesting. All showed increased virulence with iron 
deficiency. The most likely reason for this is that the parasites are able to obtain sufficient iron for 
their needs from the host irrespective of the host's iron status and that iron deficiency renders immune 
function less effective. 
The studies on the effects of iron status on resistance to viral infection should be interpreted cautiously. 
The most likely reason for ferric ammonium citrate enhancing virulence of mouse hepatitis virus is that 
it is directly toxic to the live/510>. Not much confidence can be placed in the "negative" results of the 
study. on the effects of iron deficiency on viral infection since this had only 4 calves in the test and 
control groups and employed an attenuated strain of parainfluenza virusC350>. Clearly, larger studies 
with virulent viruses from the entire spectrum of types of viruses are required. 
TABLE 2.13 
Ref 
Number 
Author 
IRON STATUS AND INfECtION: ANIMAL STUDIES: EFFECTS OF IRON DEFICIENCY 
DATE ANIMAL PATHOGEN RESULTS 
Effects of iron deficiency/chelation 
==----------------------------------------------------------------------------------------------------------------------------~-~-====~======================~=====-======= 
BACTERIA: gram-positive cocci 
BACTERIA: gram-negative cocci 
392 Payne 1978 Chick embryo 
390 Payne 1975 Chick embryo 
231 Holbein 1981 Mouse 
298 Letendre 1984 Mouse 
BACTERIA; enteric gram-negative·bacilli 
66 Bullen 1972 Guinea pig 
65 Bullen 1979 Guinea-pig 
64 Bullen 1975 Guinea-pig 
209 Hart 1982 Rat 
257 Kampschmidt 1974 Rat 
12 Baggs 1974 Rat 
11 Baggs 1973 Rat 
254 Jones 1977 l\'louse 
271 Kochan 1978 ll'louse 
296 Puschmann 1977 Mouse 
448 Schade 1944 Mouse 
268 Kluger 1979 Rabbit 
BACTERIA: other aerobic bacteria 
490 Sword 1966 l\'louse 
Neisseria gonorrhoeae 
Neisseria gonorrhoeae 
Neisseria rneningitidis 
Neisseria meningitidis 
Escherichia coli 
Escherichia coli 
Escherichia coli 
Proteus mirabilis 
Salmonella species 
Salmonella typhimurium 
Salmonella typhimurium 
Salmonella typhimurium 
Salmonella t yphimuriurn 
Salmonella t yphimurium 
Shigella dysenteriae, 
Yersinia nultocida 
Listeria 110nocytogenes 
Part 1 
Staphylococcus 
Strains from disseminated infections not inhibited by conalbumin 
Relatively avirulent strains were inhibited by conalbumin 
Iron bound to transferrin enhanced infection 
Increased resistance to infection 
Lactoferrin ~ transferrin were bacteriostatic 
Unsaturated oral lactoferrin reduced gut colony counts 
Less bacterial growth with G.-pig milk (lactoferrin, transferrin) 
Moderate iron deficiency protected against pyelonephritis 
LEM induced hypoferraemia and protected against infection 
Less resistant to challenge 
Increased susceptibility to infection 
Desferrioxamine decreased survival with wild type infection 
Less resistant to challenge 
Increased resistance to intraperitoneal infection 
Increased susceptibility to infection 
Growth inhibited by fever & hypoferraemia 
Desferrioxamine increased·resistance 
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TABLE 2.13 IRON STATUS ANO INFECTION: ANIMAL STUDIES: EFFECTS OF IRON DEFICIENCY 
===============;===========================·~===========--==================================---------=-=-~-=====================--------------=------~---------------------
' Ref Author- DATE ANIMAL PATHOGEN RESULTS 
Number Effects of iron deficiency/chelation 
============================================~========-·=======================================------------~~==================---------------------------------------------
BACTERIA: anaerobic bacteria 
228 Hill 1918 Mouse 
PAYNE'S CLASSIFICATION OF GRAM NEGATIVE BACTERIA 
391 Payne 
KEY 
Class I: Virulent: 
Class II: Virulence 
Class III: Virulence 
Class IV: Avirulent 
1911 Chick embryo 
unaffected by iron status 
inhibited by iron-binding proteins 
enhanced by added ii-on 
even with iron supplementation 
"anaerobes" 
Neisseria gonorrhoeae 
Shigella flexneri 
Shigella dysenteriae 
Vibrio cholerae 
Neisseria rneningitidis 
Escherichia coli 
NB Classification is strain specific, but is not 1ndicated in the tabulation 
BACTERIA: Mycobacteria, Spirochetes, higher bacterial actin01nyces, nocardia 
FUNGI 
153 
468 
Elin 
Sofaer 
1914 
1982 
Mouse 
Mouse 
Candida albicans 
Candida albicans 
Part 2 
CLASS 
II ,III 
11,III 
II ,Ill 
II ,III 
Ill 
III 
Increased susceptibility to infection 
Positive correlation between infection and transferrin sat. 
Anaemic mice tended to have increased infection & colonization 
~ (j 
to) ! a ;" w ~ w 
~ 
N 
-
t-4 
"'I 
-
0 ;l = 
"' S" I -= ,.,, s:., = "' er 
ii' ~ !") .... ;s· = 
~. ~ a· 
s:., 
-CJl 
-= e: 
n, 
,.,, 
TABLE 2.13 IRON STATUS AND INFECTION: ANIMAL STUDIES: EFFECTS OF IRON DEFICIENCY 
===========~==============~~===================;~===~=-----=-=-------======-=-=--------·-------------------------------------------------------------------=~=====-===~-==== 
Ref 
NlJITlber 
Author DATE ANIMAL 
RICKETTSIACEAE, MYCOPLASMA, CHLAMYDIA 
PROTOZOA 
144 
286 
Duncombe 
Lalonde 
HELMINTHS: intestinal 
179 Foster 
116 Cutm1ins 
142 Duncombe 
143 Duncombe 
405 Porter 
1980 
1984 
nematodes 
1936 
1976 
1977 
1979 
1935 
Mouse 
Mouse 
Dog, 
Rat 
Rat 
Rat 
Rat 
cat 
HELMINTHS: tissue nematodes, cestodes, trematodes 
VIRUSES 
350 l'lollerberg 1975 Calf 
PATHOGEN 
Giardia muris 
Trypanosoma cruzi 
AncylostOl!la caninum 
Nippostrongylus brasiliensis 
Nippostrongylus brasiliensis 
Nippostrongylus brasiliensis 
Nippostrongylus 11K.Jris 
Parainfluenza-3 virus 
Part 3 
.• "l:,,J! (. ! , 1 t • '~ 
RESULTS 
Effects of iron deficiency/chelation 
Decreased infestation 
Desferrioxamine and iron deficiency decreased mortality 
Increased infestation 
Delayed worm expulsion due to block in lyaphocyte function 
Decreased efficacy of mebendazole and ferbendazole 
Decreased efficacy of mebendazole 
Increased infestation 
No difference in infection rate or virulence in B calves 
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TABLE 2,13 IRON STATUS AND INFECTION: ANIMAL STUDIES1 EFFECT OF IRON EXCESS/SUPPLEJYIENTATION 
Ref 
Nurrtier 
Author DATE ANIMAL PATHOGEN RESULTS 
Effects of iron excess/supplementation 
==============================-==-=-===============---===.===================================--------------------=-==========-------------- . 
BACTERIA: gram-positive cocci 
186 Fusillo 1974 
131 de Maria 1978 
BACTERIA: gram-negative cocci 
392 Payne 1978 
39D Payne 1975 
78 Calver 1976 
145 Dupuy 1983 
230 Holbein 1980 
231 Holbein 1981 
298 Letendre 1984 
BACTERIA: enteric gram-negative 
197 Greiger 1973 
509 Ward 1983 
45 Bornside 1970 
66 Bullen 1972 
65 Bullen 1979 
64 Bullen 1975 
168 Fletcher 1969 
256 Kadis 1984 
380 Osborne 1968 
399 Polk 1971 
400 Polk 1973 
53 Brewer 1982 
325 Martin 1963 
Mouse 
Chick embryo 
Chick embryo 
Mouse 
Mouse 
Mouse 
Mouse 
Mouse 
bacilli 
Iguana 
Mouse 
Mouse 
Guinea pig 
Guinea-pig 
Guinea-pig 
Rat, Mouse 
Pig 
Pig 
Mouse 
Guinea-pig 
Mouse 
Mouse & rat 
Staphylococcus aureus 
Staphylococcus aureus 
Neisseria gonorrhoeae 
Neisseria gonorrhoeae 
Neisseria meningitidis 
Neisseria meningitidis 
Neisseria meningi ti dis 
Neisseria meningitidis 
Neisseria meningitidis 
Aeromonas hydrophila 
Bacteroides fragilis + E. coli 
Escherichia coli 
Escherichia coli 
Escherichia coli 
Escherichia coli 
Escherichia coli 
Escherichia coli 
Escherichia coli 
Escherichia coli 
Escherichia coli 
Klebsiella pneunoniae 
Klebsiella pneumoniae 
Part 4 
Enhanced infection 
FAC & iron-dextran had no effect on pulmonary infection 
Mortality of relatively avirulent strains was enhanced 
Iron increased mortality to challenge dose of bacteria 
Mucin plus iron abrogated resistance to infection 
Iron dextran increased virulence of pathogenic strains 
High serum, but not tissue, iron-dextran promoted infection 
Iron dextran injection increased infection rate 
Increased mortality from Fe ·injection 
Ferric ammonium citrate decreased survival 
Virulence promoted by ferric ammonium citrate & haemoglobin 
Iron & haematin abolished bacteriostasis 
Guinea-pig milk+ haematin enhanced bacterial growth 
Parenteral iron salts enhanced renal abscess formation 
Mortality to oral challenge enhanced by oral but hot IM iron 
Enhanced virulence 
Ferric ammonium citrate enhanced virulence 
Enhanced infection 
Ferric ammonium citrate (FAC) increased mortality 
Intraperitoneal ferrous ammonium citrate enhanced virulence 
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TABLE 2.13 IRON STATUS ANO INFECTION: ANIMAL STUDIES: EFFECT OF IRON EXCESS/SUPPLEMENTATION 
-===-===·=============================~==============~===================~=-==-----------------------------------------------------------------------------------=-
Ref 
Number 
Author DATE ANlfllAL PATHOGEN RESULTS 
Effects of iron excess/supplementation 
-===================================~=====================~=========--·------------------------------------------------=-----------=--------------------------------
BACTERIA: enteric gram-negative bacilli (continued) 
264 Khimji 197B Guinea-pig 
343 Miles 1976 Guinea-pig 
67 Chandlee 1965 Mouse, g.-pig 
209 Hart 1962 Rat 
67 Chandlee 
71 Bullen 1974 Mouse, Rabbit 
175 Forsberg 1972 
325 l'lartin 1963 
227 Hill . 1979 Chicken 
466 Smith 1977 Chicken 
373 O'Brien 1962 Mouse 
254 Jones 1977 Mouse 
271 Kochan 1976 Mouse 
406 Puschmann 1977 Mouse 
446 Sawatzki 1963 Mouse 
422 Robins-Browne 1979 Mouse 
421 Robins-Browne 1965 Mouse 
240 Jackson 1956 Mouse 
66 Bullen 1967 Guinea-pig 
72 Bullen 1966 
BACTERIA: other aerobic bacteria 
96 Clark 1905 Chicken egg 
490 Sword 1966 Mouse 
173 Ford 1976 
525 Wright 1961 Mouse 
Klebsiella species 
Klebsiella species 
K. pneumoniae, S. typhimurium 
Proteus mirabilis 
Ps aeruginosa, S typhi, str~ptococci 
Pseudanonas aeruginosa 
Pseudomonas aeruginosa 
Pseudanonas aeruginosa 
Salmonella gallinarum 
Salmonella gallinarum 
Salmonella typhi 
Salmonella typhimurium 
Salmonella typhimurium 
Salmonella typhimurium 
Salmonella typhimurium 
Yersinia enterocolitica 
Yersinia enterocolitica 
Yersinia pestis 
Yersinia septica 
Yersinia septica 
Campylobacter jejuni 
Listeria monocytogenes 
Vibrio cholerae 
Vibrio vulnificans 
Part 5 
.: ,.c; .'.'I'.'··, l 't :.' ,1 
Iron chelators enhanced skin infectivity 
Ferric iron enhanced infection by 11 of 16 bacterial strains 
Enhanced virulence 
Virulence not enhanced 
FAC, haemoglobin & haematin increased mortality 
Enhanced infection 
lntraperitoneal ferrous ammonium citrate had no ill effect 
Oral parenteral iron decreased morta'lity and morbidity 
Fe-EDTA, but not Fe sulfate or chlorid~, reduced mortality 
Ferric ammonium chloride increased virulence 
Iron overload decreased survival after ,infection 
FAC and desferrioxamine increased virulence 
Decreased resistance to intraperitoneal infection 
Parenteral iron chelates abolished.resistance to infection 
Parenteral iron increased mortality 
lron-dextran & desferrioxamine increased virulence 
Ferrous sulfate enhanced virulence 
Haematin & FAC abolished passive immunity 
Enhanced infection 
Iron increased rate of infection 
Ferric and ferrous salts increased virulence 
Enhanced infection 
Virulence was increased by desferrioxamine, FAC & CCl 
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TABLE 2.13 IRON STATUS AND INFECTION: ANIMAL STUDIES: EFFECT OF IRON EXCESS/SUPPLEIYENTATION 
=====-======---==============================;=======~----=====================·=====--------=----=-=-;-=======~============--=------------------------------------
Ref 
Number 
Author DATE 
BACTERIA: anaerobic bacteria 
68 Bullen 1967 
ANil'lAL PATHOGEN RESULTS 
Effects of iron excess/supplementation 
Guinea-pig Clostridium welchii Haematin & FAC abolished passive irmiunity 
BACTERIA: fllycobacteria, Spirochetes, higher bacteria: actinomyces, nocardia 
FUNGI 
153 Elin 1974 i'buse 
RICKETTSIACEAE, fllYCOPLASl'IA, CH...AMYDIA 
PROTOZOA 
362 Murray 
286 Lalonde 
1975 
1984 
HELMINTHS: intestinal nematodes 
452 Scott 1970 
Rat 
fllouse 
Sheep 
HELMINTHS: tissue nematodes, cestodes, trematodes 
VIRUSES 
510 Warren 1968 i'buse 
Candida albicans 
Plasmodium berghei 
Trypanosoma cruzi 
Haemonchus contortus 
lllouse hepatitis virus 
Part 6 
FAC reversed non-specific protection induced by endotoxin 
Virulence increased with iron-dextran 
Virulence increased with iron-dextran 
Oral iron protected lambs 
Ferric ammonium citrate (FAC) enhanced virulence 
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Iron status and infection - Clinical studies 
Introduction 
The research conducted by Dr Helen Mackay between 1925 and 1927 provided the first evidence for a 
causal relationship between iron deficiency and susceptibility to infectioaC74). In spite of methodologic 
difficulties, her report<3t4) still remains the.best evidence for a deleterious effect of iron deficiency on 
propensity to infection. 
Many of the subsequent positive reports in the literature are anecdotal and have little scientific weight, 
and the negative reports do not, as a rule, give enough information to enable the studies to be 
evaluated. In addition, some of the observations have been made as a "by-producttt of studies with aims 
other than to clarify the relationship between iron status and infection·. 
The following sections analyze the published evidence relating iron status and propensity to infection in 
humans. Iron excess ( or increased iron availability) and its role in promoting infection is examined. 
Iron deficiency and its role in either promoting or preventing infection is then explored. Research 
reports are classified and discussed according to the manner in which their studies are presented since 
this corresponds with the confidence that can be placed in their results. 
Most reports on the relation of iron deficiency to infection can be classified as anecdotal as they do not 
present details of methods and data. These studies are reviewed, principally because they have often 
been quoted in support of the hypothesis that iron deficiency lowers resistance to infection. While such 
observations may be allowed to raise one's curiosity, no weight should be attached to their implications 
until their methods and data have been subjected to the scientific review process. 
Helpful, but inconclusive are the studies of prevalence of infection which are covered in the next 
section of the review. The studies which employ multiple dietary interventions, including iron, are of 
the same methodologic standing as prevalence studies and are included in the same section. 
Lastly reviewed are those studies whose reports contain enough detail about the methods and results to 
enable the reader to evaluate the conclusions. Prospective studies of incidence of infection provide a 
study design which effectively tests the hypothesis that iron deficiency predisposes to infection. The 
greatest weight should be attached to the conclusions drawn from these studies. 
This system for categorizing studies is convenient for classifying their results and assessing the 
importance of their conclusions. However, an inconvenience manifests itself when a research project 
involves the testing of several hypotheses. While these hypotheses may be closely related conceptually, 
• An intent expressed by the investigator before the study can add to its strength<13>, 
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the sub-projects often involve radically different research designs. It is thus sometimes necessary to 
consider one report from the literature under several headings. While this detracts from the evaluation 
of such studies in themselves, it facilitates the synthesis of results from the entire body of literature in 
what it is now fashionable to call a meta-analysi/439). 
The following two sections group reports according .to the relation of infection to iron excess or iron 
deficiency. This dichotomy is sometimes difficult to apply. In such cases the decision on where to 
place the study has been made on the likely availability of iron to the micro-organism. The case report 
that begins the next section illustrates this rule as well as adding an historical dimension to the survey. 
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Iron excess and susceptibility to infection 
When a very young physician, I was called to see the wife of an architect suffering from 
neuralgia, a pale woman, presenting every appearance of chlorosis: I prescribed large 
preparations of iron, according to Hutchinson's method of treating neuralgia. In less 
than a fortnight, there was a complete change: the young woman acquired a ravenous 
appetite, and an unwonted vivacity: but her gratitude and my delight did not last long. 
The excitement soon became fever: and the restored color of the cheek became every 
evening more.ardent than it had been when she was in good health. A short cough 
supervened; and in less than a month from the commencement of the treatment, there 
appeared signs of phthisis which nothing could impede ... 
I do not blame the iron for having caused this calamity; but I do blame myself for having 
cured a condition, perhaps, favorable to the maintenance of the tuberculous affection in 
a latent state. 
A Trousseau 1868 
Lectures on Clinical Medicine 
Translated by Sir John Rose Cormack 
New Sydenham Society 1872, Vol 5 p 97" 
• l am grateful to Murray er aP61l for drawing my attention to Armand Trousseau's illuminating lecture on True and false 
chlorosis. 
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Introduction 
In conditions associated with systemic overload or increased intravascular availability of iron, such as 
haemochromatosis, sickle cell anaemiaC262), thalassaemia major, siderosis, malaria, bartonellosis, 
hepatitis, louse-borne relapsing fever and multiple blood transfusions, patients show an increased 
susceptibility to infectious disease. Pearson and Robinson review this body of work critically(394>. 
There are so many potentially confounding factors in these observations that a causative role for iron 
status in the susceptibility to infection can remain no more than an attractive hypothesis. For· this 
reason only clinical studies of the effects of iron excess (principally through administration of iron 
treatments) are individually reviewed in any detail in this section. 
Kwashiorkor 
McFarlane et al (1970) 
McFarlane et at<313) studied 40 patients with kwashiorkor. Of the 13 patients who were known to have 
died, only 2 had serum transferrin greater than 0.4 mg/ml. The initial mean serum transferrin level 
was three times as high in the 16 patients who were known to have survived at least two weeks. And, 
two weeks after hospitalization the difference between the 2 groups was even greater • 1.30 mg/ di 
compared to 0.33 mg/dl. 
The authors state that the patients were treated with oral ferrous sulfate or intramuscular iron-dextran 
but give no details of doses or time relationships with respect to treatments, test measurements and 
death. No details of infections in these patients are presented. 
The authors calculated that by day 4 the serum ttansferrin level in survivors was sufficient to bind a 
total of 3.4 ug of iron which "far exceeds the concentration of iron found in their serum". The serum 
transferrin in those who died was sufficient to bind only 0.55 ug of iron and this would "leave an 
appreciable concentration of free iron in the plasma". 
The study suggests that serum transferrin may be, an accurate prognostic factor for death in 
kwashiorkor. It also suggests that it would be unwise to overwhelm iron transport mechanisms in 
severely malnourished children. But in this retrospective study the evidence to implicate iron overload 
as a causative factor in susceptibility to infection is too incomplete to warrant the certainty attribu,ted to 
it by some authors· 
Ethical considerations aside, a scientific study of the efficacy and side effects of iron in severe 
kwashiorkor would employ a clinical trial to compare outcomes in groups of children treated · 
• For example 32 
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identically, except for iron therapy. This would not be possible in the clinical situation, but it should be 
possible to test this conclusion with an animal model. 
Urinacy tract infection 
Briggs (1963) 
Iron-sorbitol-citric acid complex was used as a pyrogen in 10 healthy subjects, 9 patients with chronic 
urinary tract infection and 5 patients with structural disorders of the kidney(SS). No change in pyuria 
was found in subjects without infection, but in 7 of the 9 patients with renal tract infection 25 mg of 
iron-sorbitol produced more than 100% rise in white cell excretion. No patient suffered a clinical 
exacerbation of disease. 
The authors conclude by stating that, although there was no proof of iron·sorbitol provoking infection, 
"it may be a wise precaution to avoid the use of iron-sorbitol in patients with an active infection of the 
urinary tract". 
Scott (1962) 
Scott< 453), in a case report, described the development of a urinary tract infection in a patient being 
treated with both oral iron and parenteral iron-sorbitol-citric acid complex for iron deficiency anaemia 
of pregnancy. 
Scqtt (1963) 
Iron-sorbitokitric acid complex was used to treat 80 antenatal patients for anaemiaC457). Pyelitis 
developed in 5 of 62 patients with simple iron deficiency anaemia and in 7 of 18 patients who had 
concomitant folic acid deficiency. 
· The author speculated that the urinary tract infections were caused by increased iron levels in the urine 
- 30% of the injection being excreted by the kidneysC55). In the face of concomitant folic acid 
deficiency, patients are less able to utilize the iron and more will be available to pathogens. 
This study provides a caveat for physicians, but the scientist would have preferred a control group for 
comparison. 
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Neonatal septicaemia 
Barry,Reeve(1973,1976,1977) 
· · · · d f al · · B d R (ZO, 19• 17• 18) observed a s'1gnifi1cant In an ep1dem10Iogical stu y o neonat sepsis, arry an eeve 
increase in the incidence of Gram-negative sepsis in Polynesian infants given iron-dextran within the 
first seven days of life. Comparisons could be made to the rate of infection in untreated European 
infants born at the same time and to untreated Polynesian infants born at a later date. 
This evidence that iron-dextran increases susceptibility to severe Gram-negative infection in the 
neonatal period is corroborated by the results of Becraft, Dix and Farmer(3l) in studies on the 
phagocytic and antibacterial functions of blood from 7 neonates, median age 5 days, before and after 
intramuscular iron-dextran. Bacteriostasis of serum was lost post treatment, and leukocyte chemotaxis 
was inhibited by post-treatment serum. The bactericidal capacity of neutrophils, opsonizing capacity of 
serum and generation of chemotactic stimulus showed no change with treatment. 
Because it has been reported that iron-dextran does not bind with transferrin<218), Barry and Reeve 
suggested that Escherichia coli may be capable of utilizing the iron bound to dextran(ZO). 
Anecdotal reports of observations in the United StatesC293), South Africa<212) and ScandinaviaC442) have 
not associated iron-dextran injections in infants with increased infections. This may be because the 
practice outside New Zealand was to administer the iron later in life when transferrin levels and 
production are higher or because of other differences such as dose or exposure to infection. 
Tropical infections 
Byles, D'Sa (1970) 
The response to total dose infusion of iron-dextran was studied in 1000 women who were pregnant or 
in the puerperium<77). The iron dextran was administered in 4 regimes with and without promethazine 
and/or chloroquine. In comparison with the other regimes, treatment including chloroquine was 
associated with Teductions in: 
Local phlebitic reactions (as might be consistent with an anti-inflammatory effect). 
Plasm odium f alcipamm in blood films of those with generalized reactions. 
Non-allergic generalized reactions. 
The results are compatible with iron-dextran aggravating subclinical malaria infection. It would have 
enabled more weight to have been put on this conclusion if blood films had been screened for malaria 
before as well as after treatment with iron dextran. The conclusions presented by the authors require 
the assumption that the reduction in generalized reaction in the chloroquine treated group was due to 
2.64 IRON NUTRITION AND IMMUNITY 
an anti-plasmodium effect and not the anti-inflammatory effect (which it displays in rheumatoid 
arthritis and discoid lupus erythematosus). 
Murray et al (1975) 
Murray et af.-36'2) observed the attack rate for malaria in patients and their relatives (who, in accordanc~ 
with local custom, had accompanied them to hospital). The study took place during the Sahelian 
drought in the early 1970-s and all subjects were underweight. Patients and their relatives were given 
skim milk, grains and multivitamins without iron. 
Mean transferrin saturations on arrival, on day 2 and on day 5 were 54%, 96% and 76%. Mean serum 
iron levels were 143 ug/dl, 250 ug/dl and 222 ug/dl on the same days. Attacks of malaria occurred in 
74 of 181 subjects, with a peak on the fifth day after arrival. 
The authors speculated that the food supplements may have caused the abnormal rise. in serum iron 
and saturation of _transferrin and that this made iron more readily available for plasmodia. 
To test this hypothesis the authors infected 40 rats with Plasmodium berghei. Half of the rats had 
been injected with iron-dextran two weeks previously in order to increase their iron stores. The treated 
rats had higher percentage saturation of transferrin, higher serum iron and shorter latencies to peak 
parasitaemia and death than the control rats. 
Murray et al (1978 1) 
The MurraysC361• 360) observed a group of 137 iron deficient Somali nomads who were being treated 
for starvation. The 66 nomads in the control group had 7 episodes of infection, while the 77 individuals 
in the test group who were given 900 mg ferrous sulfate daily as well as the food supplement had 36 
episodes of ittl'ection. The infections included malaria, tuberculosis, brucellosis, schistosomiasis, and 
pyogenic skin infections. The absence of mosquitoes and milk products make it likely that these 
infections were the result of recrudescence of suppressed disease(361). However, as Keusch and 
Farthing(263) note: ''It is somewhat strange that schistosoma ova were found in 11 of 71 untreated 
individuals compared to only 2 of 66 placebo-treated subjects*. Since it is biologically impossible for this 
to reflect new infection during the 30-day observation period, the findings raise the question of some 
hidden sample selection. At the very least, these data are in need of independent confinnation and careful 
reinterpretation" • 
• Chi square analysis with Yates continuity correction yields P < 0.05. This was not noted by the authors. 
' 
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Murray et al (19782 ) 
Murray et af:363) reported on the attack rates for cerebral malaria in 99 children admitted with a 
diagnosis of malaria. The children came from an area in Niger where all were suffering from famine 
malnutrition. The 23 children who were treated for cerebral malaria had higher serum iron levels, 
greater saturation of transferrin and lower serum folate levels than those who did not. The cerebral 
malaria was restricted to children being re-fed on grain. The milk diet of nomads seemed to protect 
them against cerebral malaria. 
The attacks of malaria were almost certainly due to a recrudescence of the disease as there had been 
no rain or mosquitoes for eight months. 
The authors discuss a number of possible mechanisms for this phenomenon... Of interest in the 
present context is their remark that the changes in iron metabolism were most marked in the children 
with cerebral malaria, but that their experimental design did not allow cause to be distinguished from 
effect. 
Oppenheimer et al ( 19 a 6 ) 
Oppenheimer et aP76) in a placebo controlled trial of prophylaxis of iron deficiency in infancy found 
that infants who had been treated with iron dextran had a higher incidence of malaria. This rigorous 
study provides sound evidence for iron dextran promoting malarial infestation. Because of its 
importance this work is discussed in detail below in the section where the role of iron deficiency in 
protecting against or promoting infection is examined. 
Y ersinia enterocolitica 
Melby et al (1982) 
Melby et aP37) reported two cases of Yersinia enterocolitica septicaemia in young children who had 
accidentally ingested excessive amounts of iron medication. Both children were treated with oral and 
parenteral desferrioxamine and at least one child had evidence of pre-existing colonization by Yersinia 
enterocolitica. 
The authors theorized that iron utilization by the Yersinia may have been facilitated by the iron and 
desferrioxamine since desferrioxamine is a siderophore (produced by Streptomyces griseus) and has 
been shown to enhance growth of Yersinia enterocolitica in vivoC491). 
• See also 359 
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This kind of case report serves as a clearwarning to clinicians, but provides little scientific evidence for 
a causal relationship without conjunction with evidence from the laboratory where the critical variables 
can be manipulated independently. 
Mofenson (1987) 
In a letter to the New England Journal of Medicine, Mof enson et af-348) report on a case of Yersinia 
enterocolitica septicaemia in a 15 month old boy who presented to hospital with bloody diarrhoea 10 
hours after ingestion of approximately 30 tablets of ferrous sulfate. He was treated with syrup of ipecac 
and intramuscular desferrioxamine. His twin sister, who did not ingest ferrous sulfate, had mild 
diarrhoea and Y. enterocolitica was isolated from her stools. 
The authors drew attention to the experimental situations in which desferrioxamine enhances the 
virulence of Y. enterocolitica. 
Robins-Browne et al (1983) 
Robins-Browne et a1<422• 76) found marked deposits of haemosiderin in the viscera of 3 patients who 
died from Yersinia enterocolitica infection. Although the patients had "an underlying illness, the 
presence of which may have predisposed to infection", the authors felt 'that the siderosis was "evidence 
that iron overload increases susceptibility to infection". The clinical evidence is circumstantial and based 
upon a series of three patients. On its own, this evidence would carry little weight, but the authors 
corroborated it with observations on the effect of intra-peritoneal ferric ammonium citrate on 
susceptibility to infection by Y. enterocolitica in mice. Six of nine mice that received 109 organisms and 
200 ug of iron died, but only 3 of 32 mice died when they were given the same number of bacteria and 
100 ug or less of iron. 
Summacy 
Indirect evidence of the effect of excess iron on host defense mechanism has been adduced from 
clinical observations of associations of infection with intravascular haemolysis. Systemic salmonellosis 
is associated with malaria and bartonellosisC518). 
Host Associated Iron Transfer Factor (HAITF) is a low molecular weight iron binding protein found in 
many tissues including normal serum. In vitro HAITF is capable of increasing iron uptake and 
multiplication of Gram negative bacteria and capable of increasing the virulence of Salmonella 
typhimurium. The serum levels of HAITF are increased by a factor of approximately 3 in 
thalassaemia and it has been suggested that this may be the reason for the increased susceptibility of 
these patients to infection<253). Studies of iron absorption have shown that transferrin is a passive 
. 
' 
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recipient of released iron and that intracellular events control the release of iron. Intestinal absorption 
of iron is not suppressed in normal human volunteers whose transferrin has been completely saturated 
by infusion of ferric ammonium citrate and in patients with thalassaemia major it is increased despite 
very high transferrin saturation(224). Iron bound to transferrin is protected from forming harmful 
oxygen free radicals and is. generally unavailable to micro-organisms. Non-transferrin plasma iron may 
thus escape the protective mechanism afforded by transferrin<224}. 
Iron overload in haemodialysis seems to impair phagocytic activity of neutrophill512). Sound 
theoretical reasons and circumstantial clinical evidence point to iron as a causative factor in the 
infections to which patients with kwashiorkor so often succumb. Clinical evidence also implicates iron 
dextran treatment as a factor in neonatal sepsis, urinary tract infection and malaria. Oral iron 
preparations have been associated with Yer:sinia enterocolitica and "tropical" diseases such as malaria, 
tuberculosis, brucellosis, and pyogenic skin infections. 
Although most studies suffer from methodological inadequacies, the sum of the evidence is strongly 
suggestive of a deleterious effect of iron on susceptibility to sepsis in neonates treated with .iron dextran 
and· to malaria and perhaps other infections in all age groups treated with either oral or parenteral 
iron. 
Before prescribing iron the clinician would do well to follow Trousseau and distinguish true from false . 
chlorosis! 
Iron· deficiency and susceptibility to infection 
Introduction 
The literature on iron deficiency and its role in infection is reviewed in 4 sections. The anecdotal 
reports in the first section are scientifically unimportant, but have been uncritically cited in the 
literature·. The second and thitd sections discuss studies with confounding factors and retrospective 
studies. Such research designs may suggest an association ( or lack of association) but cannot 
distinguish cause and effect. The fourth section reviews prospective· controlled studies. The results 
from these studies deserve to be taken seriously. 
• A citation analysis was not made but a number of instances of such citations are documented in order to validate this 
statement. 
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Evidence for iron deficiency protectint: ai:ainst infection 
Malaria and other Tropical infections 
Retrospective or prevalence studies 
Masawe et al (197 4) 
Purpose: The study aimed to determine the prevalence of infection in adult patients with various 
anaemia5'330). 
Ascertainment: Consecutive admissions to an adult medical ward with haemoglobin less than 10 g/ dl. 
Laboratory methods: Haematologic profiles were obtained with a Coulter counter model~S. 
Study grouping and design: Patients were dassified into 5 classes of anaemia and were screened for 
the presence of infection, viral, bacterial and protozoal. 
Results: Most of the protozoal and helminthic infestations occurred in the iron deficient group and 
. most of the bacterial infections were in the megaloblastic, haemolytic and refractory anaemias. 
Interpretation of results: An observational study such as this can draw no conclusions about causal 
relationships. In addition, with no information as to the prevalence of infections and anaemias in the 
general population, no valid inferences can be drawn from the association of certain anaemias. 
The causes of admission to hospital may determine the patterns of association of one factor with. 
another without one factor being causally dependent on the other; they might have . a common source. 
SteinC478) exemplified this fallacy by pointing out that the reasons for admission to a medical ward in a 
general hospital in Milwaukee were such that iron deficiency anaemia would be associated with a lower 
prevalence of infection because the cause was often occult bleeding, ·whereas other anaemias were 
associated with debilitating disease and infections. 
Conclusion: The study shows that, in Dar es Salaam, iron deficiency is often associated with malaria 
and helminthic infestations while bacterial infections are associated with other anaemiasC147). 
Although. this association is strong, no conclusions about the causal influence of iron deficiency on 
susceptibility to infection can be drawn. 
Masawe and Swai (1975) 
In a letter to the Lancet, Masawe and Swai<329) report on results of a survey of anaemia and infection 
in 42 children and young adults. The study was an extension of that discussed in the previous section. 
' 
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The-prevalence of bacterial infection was 10% in the group with no iron stores shown on bone marrow 
examination and 50% in those with positive iron stores. For malaria, the prevalences were 30% and 
50% respectively. The caveats on conclusions apply as for the previous study. 
Murray et al (1978) 
The Murrays(J6l), in a pilot study·, observed 19 infections in 64 Somali nomads who had normal iron 
status but O infections in 26 nomads who were iron deficient. 
This kind of clinical anecdote would certainly justify further epidemiological studies, but, in itself 
cannot carry much weight as a scientific argument for the hypothesis that iron deficiency is protective 
against infections in general. The two groups may not have been comparable in terms of ascertainment 
and exposure to infection. Future studies should have at least a case-control design if they are not 
prospective in nature. 
Prospective, controlled studies 
Murray et al (1980) 
A group of 35 Maasai"* given one 300 mg tablet of ferrous sulfate weekly for one year had significantly 
more cysts, amoebae and sera positive for Entamoeba histolytica than 75 tribesmen not given the 
ironC358). Six of the iron-treated group had attacks of malaria, but none of the 35 control group were 
affected. These findings are suggestive of a protective effect of iron deficiency and a deleterious effect 
of oral iron-treatment on resistance to infection by Entamoeba histolytica and malaria. 
I 
Oppenheimer et al (1986) 
Purpose: The object of the study by Oppenheimer et af.377• 379, 378• 376) was to examine the 
effects of iron therapy on infectious morbidity. 
Ascertainment: The subjects were healthy infants recruited at birth from infants born in hospital to 
mothers resident nearby. 
Grouping: The infants were paired according to sex, domicile and birth weight. 
Iron intake: At two months of age 3 ml of either iron-dextran or placebo was given intra-muscularly in 
a double blind fashion. 
Laboratory methods: Haemoglobin was measured by the cyanmethaemoglobin method with a 
Corning colorimeter. Thin and thick blood films were examined for malaria. 
• See study 2 above, under the section on iron excess and susceptibility to infection 
• • The authors use this spelling 
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Study design: The infants were followed up 1 week after the injection and then at the ages of 6 and 12 
months. At the follow·up visits a history of infections during the previous two weeks was taken. The 
infants were weighed and examined for signs of infection. 
An increased prevalence of malaria was found in the iron treated group. This difference was 
statistically significant for parasitaemia at both 6 months and 12 months. It was also statistically 
significant for splenomegally at 12 months (and almost significant at 6 months). The iron treated group 
had a higher prevalence of Plasmodium falcipamm , P. vivax and P. malariae. 
Mala!ia could not be incriminated in any of the 12 deaths that occurred. There were five deaths in the 
iron group and 7 in the placebo group; no further details on the auses of death are given, but it is 
likely that most of them were due to infections. 
Interpretation of results: 1 exposure to infection: By matching infants for domicile and following the 
two groups simultaneously the experimental design minimized unequal exposure to infection in the two 
groups. 
Interpretation of results: 2 blinding: The study was double blind. 
Interpretation of results: 3 haematology: No haematological results were given, but it seems 
reasonable to assume that the markers of iron status were "better" in the group treated with iron-
dextran. 
Conclusion This is probably the best designed study in the literature to test the hypothesis that 
iron status is associated with susceptibility to infection. The one drawback is that the incidence of 
infection could not be obtained as follow-up took place at 6 and 12 months. This allowed a point-
prevalence of infection to be determined at these two ages. 
This might not be a serious drawback in determining susceptibility to chronic infections such as 
malaria, but it would lead to an important loss of discriminatory power in determining the difference in 
morbidity caused by acute illnesses of short duration such as the common respiratory and diarrhoe.al 
infections of infancy. 
Ethical considerations will prevent similar studies being undertaken to corroborate the effect of iron-
dextran in infancy on susceptibility to malaria. It would however be useful to repeat this sort of study 
outside the tropics where protozoa! diseases are not a problem as resistance to such diseases differs in 
many important ways from resistance to viral, bacterial, fungal and helminthic infections. 
I 
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In short, the administration of intra·muscular iron-dextran in early infancy seems to increase 
susceptibility to malaria. No conclusions are possible about the risk of other infections, although the 
mortality data would argue against a similar increased risk for other k:in,ds of infection. 
Evidence against the promotion of infection by iron deficiency 
Candidiasis 
Studies with anecdotal reports 
Jacobs et al (1973) 
In a brief abstract, Jacobs et af.242) reported that oral candida counts were not increased in patients 
with iron deficiency anaemia and did not change with treatment. The one patient who had oral 
candidiasis did not respond to iron therapy either. If they had stated the number of patients with 
lesions of the oral mucosa it would have facilitated comparison with the paper by Higgs and WellsC226). 
Retrospective or prevalence studies 
Walker et al (1973) 
Walker et af..505) compared the prevalence of oral candidiasis in 12 iron deficient anaemic individuals 
with that in 12 matched controls. This was done before and after iron treatment. Mycological 
examinations were not significantly different from the controls and did not alter with iron treatment. 
Clinical candidiasis was present in 1 iron deficient patient and did respond to iron treatment whereas 4 
controls had clinical infection with Candida. The authors did not calculate the probability of not 
detecting a difference between the iron deficient group and the controls. This study offers weak 
evidence against iron deficiency predisposing to candidiasis. 
Adults 
Prospective, controlled studies 
Vellar et al (1974) 
Purpose: The object of the study by Vellar et al5°3) was "to examine if iron in therapeutic doses 
might have an effect on the prevalence of upper respiratory tract infections in healthy young adult men and 
women". 
Ascertainment: The subjects were 97 physical education students in generally healthy condition. No 
further details of selection or exclusion criteria are given. 
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Grouping and icon intake: The 81 students with normal haemoglobin concentrations were allocated to 
one of two groups by an undocumented method. One group was treated with a placebo while the other 
group was treated· with ferrofumarate to provide 60 mg elemental iron per day. The 5 males with 
haemoglobin levels less than 14 mg/dl and 11 females with haemoglobin concentrations less than 12.5 
mg/dl were allocated to the group to receive iron. At the completion of the study the actual 
consumption of iron and placebo tablets was recorded but not reported. 
Laboratory methods: The methods by which the haematologic parameters were measured were not 
reported. 
Study design: A history of upper respiratory tract symptoms was taken, a physical examination 
performed and blood tests made on six occasions about eight weeks apart. The number of upper 
respiratory infections thus diagnosed was recorded for the 5 follow-up examinations. 
Results: After 2 months there was no difference in the mean haemoglobin levels of the iron and 
treatment groups.· 
The authors present their data in enough detail for the following table to be compiled. 
Table 2.14 Iron treatment and upper respiratory infections. Number of upper respiratory 
infections diagnosed in S examinations of 97 healthy young men and women over a period of about 40 
weeks. 
INFECTION 
NO INFECTION 
TOTAL 
IRON 
93 
137 
230 
==== 
PLACEBO 
77 
95 
172 
==== 
TOTAL 
170 
232 
402 
-=== 
The proportion of infections in the placebo group averaged 44% per examination, while the 
corresponding figure for the iron treated group was 40%. This difference is not significant ( chi square 
equal 0.59, p>O.l). 
Interpretation of results: 1 exposurt to infection: There seems little possibility of any bias in exposure 
to infection with this experimental design. 
Interpretation of results: 2 blinding: The study was certainly blinded for the subjects, but no mention 
is made of b~nding for the investigators. 
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Interpretation of results: 3 haematology: Inclusion of the subjects with low haemoglobin 
concentrations in the iron-treatment group may have led to a small bias towards incorporating subjects 
more susceptible to infection. Since there was no difference in the mean haemoglobins of the iron and 
placebo groups from the time of the first re-examination, this bias is likely to be small. 
There was little difference between the haematological parameters of individuals with a history of 
infection and those without. This mitigates against acute upper respiratory infections as being a 
significant cause of anaemia. 
Conclusion: "It is necessary to be cautious in the interpretation of the iron/placebo comparison with 
regard to the prevalence of infection: the iron-treated group was not strictly comparable at the start of the 
experiment"". If the infections are counted from the second re-examination period, the iron-group had 
an average of 32% infections at each point while the placebo-group had a mean of 40% infections. 
This trend in favour of the iron-treated group was not significant and is not consistent when the 
infections are analyzed according to sex or for individual examination periods. The authors conclude 
that "iron medication has no particular phannacological effect" on the resistance to acute upper 
respiratory infections in otherwise healthy young adults. 
The study does not warrant so strong a conclusion, particularly without an analysis of the type II error. 
It would have been helpful if the authors had calculated confidence limits for the effect of iron 
treatment. 
The conclusion that may be validly drawn from this study is that iron supplementation may have a small 
effect in reducing susceptibility to acute infection of the upper respiratory tract in healthy young adults. 
Infants 
Studies with anecdotal reports 
Marsh et al (1959) 
Marsh et al-323) in a study involving 74 infants, followed three groups of children from birth to 9 
months of age. One group was given an iron-fortified milk formula and the other two groups were 
given different formulas without extra iron. Mean haemoglobin levels in the three groups at 9 months 
of age were 12.69, 10.46 and 9.67 g/dl. No data on infection were presented, but the authors stated 
"While this study was not designed to measure accurately differences in growth or relative susceptibility to 
illness, gross observation revealed no significant diff erences110 • 
• page m 
.. page 409 
These conclusions can have little 
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weight in refuting the existence of an association of iron deficiency with susceptibility to infection, but 
they may be taken to indicate tnat such an association can not be large. 
Farquhar (1963) 
Farquhar<162) studied 44 infants who were given either a daily supplement of multi-vitamins or multi-
vitamins with iron from the age of one month to one year*. _ The author stated that the "iron 
supplement prod1'ced a statistically significant incre~e in haemoglobin and haematocrit levels at three, 
six, and nine months of age, but the difference w~ not statistically significant at one year. This difference 
did not reflect in the height and weight measurements or in the general well-being of these well-nourished, 
healthy inf ants." 
No further descriptions of illness or data are given to support this anecdotal conclusion. 
Malakhovsky Yu E et al (1983) 
Malakhovsky et az<320) followed 103 infants for 9 to 12 months. The children were examined weekly 
and 79 of them were given an iron tonic in a double blind fashion. The study has been included 
together with the anecdotal reports because many critical issues were not defined in the report. The 
critical factors include details of the ages at which children entered and completed the study, from what 
age and for how long the iron supplement was administered, the ages at which iron status was 
determined and the periods over which infections were monitored. The difficulty in ascertaining these 
facts from the report may be partly due to the problems inherent in working with a translation; the 
original is in Russian. 
The authors stated that susceptibility to infe~tion was not related to haemoglobin status. Importantly, 
they qualified this statement by saying that it might not be true for severe iron deficiency ( defined by 
haemoglobin concentrations below 9.0 g/dl). 
The authors also stated, somewhat at variance with their first conclusion, that repeated infections were 
associated with the development of anaemia. 
This study can be taken as suggestive evidence against a large effect of iron deficiency on the 
.susceptibility to infection. 
Prospective, controlled studies 
Burman (1972) 
Purpose: The purpose of this study<74) was to determine the normal range for haemoglobin in healthy 
infants during the first 2 years of life and to observe the effects of iron supplementation. 
• Cited as evidence that iron status does not relate to susceptibility to infection (Ul9). 
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Ascertainment: Parents living within a prescribed area of Northwest Bristol whose children were born 
between June 1965 and February 1966 were invited to participate in the survey. Reasons for exclusion 
included illegitimacy and low birth-weight, but many parents refused to co-operate. 
Nutrition: Only well nourished infants were entered into the study. 
Socio-economic class: The "numbers in social classes IV and V were low" and as a whole the group 
was relatively affluent. 
Feeding and iron intake: No feeding intervention was made, but, from the age of 3 months, children 
were given either placebo or 10 mg elemental iron daily as ferric hydroxide. 
Laboratory methods: Toe or finger prick capillary blood samples were taken and analyzed for 
haemoglobin with the cyanmethaemoglobin technique. 
Study grouping and design: Children were allocated alternately by birth order to receive either 
placebo or iron tonic. Blood samples were made at intervals of three months. In the intervening 
months a health visitor went to the home to collect data about illnesses and checked on the supply of 
medicine. 
Results: "Tize administration of iron made no difference to the incidence of infection in this study". 
Interpretation of results: 1 diagnosis of infection: Infections were diagnosed on history at a monthly 
follow up by health visitors. The author acknowledged that recall of illnesses is unreliable, even from 
conscientious parents. The statistics of morbidity can therefore not lay claim to much accuracy or 
precision, and in fact, no statistics are given. 
Interpretation or results: 2 exposure to infection: The two groups seem comparable with respect to 
exposure to infection, although only qualitative comments on socio-economic class supplement the 
statement which implies that the two groups were studied contemporaneously. 
Interpretation or results: 3 blinding: The study was possibly blinded with respect to the subjects, but 
the study team would surely have known the difference between mist. mbra and mist. nigra. 
Interpretation or results: 4 haematology: Standard laboratory methods were used. The author states 
that the haemoglobin vs age curves for the "iron" and "no-iron" group differ at the 5% significance level, 
and that most of the difference occurred during the second year of life, particularly towards the end. 
... 
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Two comments may be made on the author's observations. Firstly, the haemoglobin level of the "iron" 
group was higher at the start of the study than that of the "no-iron" group. This was a constant trend -
as might be expected. The author's unusual statistical method may merely be confirming that this 
initial bias was maintained at each subsequent test of haemoglobin. The analysis would have been 
more meaningful had the initial haemoglobin been controlled for. The interpretation of the effect of 
the iron supplementation should take this imbalance between the two groups into account. 
At 12 months of age, the mean increase in haemoglobin was 0.68 g/dl for the "iron" group and 0.46 g/dl 
for the "no-iron" group. An optimistic estimate of the result of a t test gives p = 13%. The reason for 
the iron supplementation making so little difference to the haemoglobin is probably due to the poor 
absorption of iron in the form of ferric hydroxide<134). 
Conclusion: The author concludes that iron supplementation had no effect on morbidity. As the 
regime employed had little effect on haemoglobin it is hardly surprising that no reduction in morbidity 
was observed. Furthermore, while the author states that there was no difference in observed 
morbidity, he does not calculate (he probability of a type II error<210). In other words, the chance of 
the study missing a real difference in infection rate is not given. In addition, with the questionable 
precision in diagnosis by history up to 4 weeks after an illness, there is no doubt that little weight 
should be put on the author's conclusions with regard to morbidity and iron status. Unfortunately this 
study is often uncritically cited in review articles to refute the hypothesis that iron deficiency 
predisposes towards infection·. 
Evidence for the promotion of infection by iron deficiency 
Herpes Jabialis 
Studies with anecdotal reports 
Chandra et al (1977) 
In a conference report Chandra et azC91 ) observed that patients with recurrent herpes labialis had lower 
percentage saturations of transferrin than healthy controls; no data were given. 
• See for example, 241, 290, 308, 275, 485, 102, 89, 91 
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Candidiasis 
Studies with anecdotal reports 
Cawson (1963) 
2.77 
Two cases with oral candidiasis were reported by Cawson to have responded to treatment with ferrous 
gluconate for their iron deficiency anaemia<84). 
Retrospective or prevalence studies 
Rose (1968) 
Rose(426) studied 25 consecutively referred .patients with angular cheilitis and 25 controls matched for 
age, sex and use of dentures. The premise for the study was that Candida albicans is an important 
aetiological agent", but ''since candida infections are regarded as 'diseases of the diseased', a search for 
other factors capable either of assisting the ftmgus or acting 'in their own right' to produce the disease 
suggests itself'. 
The group with cheilitis had lower mean haemoglobin levels, lower plasma iron, increased total iron 
binding capacity and decreased saturation of transferrin and more cases of iron deficiency anaemia. 
Taken in conjunction with previous evidence that Candida albicans is implicated in angular cheilitis 
this study provides evidence for an association between iron deficiency and fungal infection of the oral 
mucosa. In this design cause and effect are impossible to separate. 
Higgs and WeIJs (1972) 
In a survey of 31 patients with chronic mucocutaneous candidiasis Higgs and Wens<226) fo~d 23 with 
iron deficiency anaemia. The criteria for diagnosis of anaemia were not presented and there was no 
control group against which comparisons could be made··. 
Davidson et al (1977) 
Haemoglobin, serum ferritin and serum iron were measured in 43 patients with recurrent genital 
thrush, 31 patients with non·recurrent candidiasis and in 26 controls by Davidson et aP29). The mean 
haemoglobin level was significantly lower in the first group, but the authors comment that this result 
was biased by two "outliers". Serum ferritin levels were greatest in group 1 and serum iron levels were 
lowest in that group. The differences were small and not statistically significant. 
• The author cites several studies to support this assertion 
• • The second part of their report deals with the effects of iron treatment and is discussed below. 
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Jenkins et al (1977) 
Oral candidiasis was studied in 108 patients by Jenkins et af'2SO). The lesions were classified as either 
chronic hyperplastic (21 patients) or atrophic candidiasis (87 patients) according to clinical, 
microbiological and histological criteria. Patients and healthy controls were classified as iron deficient 
if the percentage saturation of transferrin was less than 16%. 
Iron deficiency was found in 33% of patients with hyperplastic lesions, in 14% of patients with atrophic 
lesions and 14% of controls. The association was significant at the 10% level for hyperplasia. The 
authors discuss the pathogenesis of the two types of lesions and speculate on the differing roles that 
iron deficiency might play. Of note is their recognition that cause and effect relationships would be . 
elucidated if treatment with iron could be shown to effect a cure. As this was a retrospective study 
they were not able to do this. 
Prospective, controlled studies 
Fletcher (1975) 
Fletcher et a/169> studied 29 adult patients with chronic iron deficiency anaemia caused by blood loss. 
Matched· controls were found in the same hospital practice. Mouth lesions were present in 16 of the 
anaemic patients and Candida albicans was cultured from the saliva of all patients with mouth lesions 
and 8 of the 13 without lesions. None of the controls had mouth lesions and 13 of the 29 patients had 
Candida albicans isolated from saliva. The mouth lesions and candida counts improved within a 
month of starting 200 mg ferrous sulfate bd. The authors comment that the susceptibility to candidiasis 
may be due to alterations in the oral mucosa. They noted a decreased lymphocyte count and a 
depressed response of lymphocytes to stimulation with PHA. On treatment with oral .iron, the lesions, 
candida infection and lymphocyte count returned to normal as the haemoglobin level was restored, but 
before iron stores ( as measured by serum iron and total iron binding capacity) had been repleted. The 
response to PHA stimulation did not return to norm~ until iron stores were replenished. 
Conclusion This study supports the hypothesis of a ddect in cell mediated immunity in iron 
deficiency predisposing to candidiasis, but the weight that can be attached to this conclusion is limited 
by the small numbers involved. 
Higgs and Wells (1972) 
Purpose: The purpose of this study<226) was to characterize chronic mucocutaneous candidiasis and to 
investigate its association with iron status. 
Ascertainment: The 46 patients were located as the result of an "extensive search" and 31 were 
investigated for iron status. 
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Study grouping and design: Eight patients had reduced or absent bone marrow iron stores and 
haemoglobin concentration greater than 11.7 g/dl. Four of these were randomly assigned to receive a 
total dose infusion of iron-dextran and 4 were given placebo tablets for 2 months. 
Results: Three test patients improved but none of the patients on placebo improved. 
The authors remark that it was possible to assess 11 patients in total who had been treated with iron 
and that 9 had responded to treatment. 
Interpretation: The numbers are small and details of ascertainment and selection are not reported. 
Although the results support the hypothesis that iron deficiency impairs immune function, the 
mechanism proposed, viz an epithelial defect, may not account for the hypothesized susceptibility to 
other infections with other classes of organisms. It may be that a different mechanism is operative in 
these patients. 
A second difficulty in interpretation arises in determining the cause of iron deficiency. Did the chronic 
mucocutaneous candidiasis perhaps cause the iron deficiency? Or was there ~other factor that was 
responsible for both the candidiasis and the difficulty in maintaining normal iron stores in these · 
patients? 
Conclusion: This small study is relevant to a specific and unusual infection but it would be difficult to 
justify extrapolation from the results to the thesis of a generalized susceptibility to infection in iron 
deficiency. 
Adults 
Studies with anecdotal reports 
Basta and Churchill (1974) 
Chandra et af.91 ) state that Basta and Churchill(2l) "reported a higher prevalence of acute and chronic 
infections in the iron-deficient anaemic group compared with the non-anaemic group". Assessment is not 
possible since the inter-library loan service was not able to retrieve this report. 
Retrospective or prevalence studies 
Basta et al (1979) 
Basta et ai<22) compared morbidity scores and period prevalence of infection between anaemic 
(haematocrit < 38%) and non-anaemic workers on an Indonesian rubber plantation. 
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"Period prevalence of systemic or local infection was almost twice as high in the anaemic men as in the · 
non-anaemic". The differences in bronchitis, influenza and diarrhoea were notable. "Disease 
morbidity was scored and showed a significant correlation (P < 0.01) with haemoglobin". 
Apart from the usual difficulties in interpreting retrospective and prevalence studies, evaluation is 
hampered by the lack of control for nutritional status. This particular group were severely nutritionally 
restricted and it is possible that the anaemic members were suffering from deficiencies other than iron 
that would have confounded interpretation of the results. Nutritional indices were not compared 
between the two groups. 
It seems strange that the anaemic group had a higher: period prevalence of reported infections than the 
non-anaemic group but had a lower morbidity score. The authors state that the morbidity score was 
significantly correlated with haemoglobin levels. One wonders whether the correlation was positive. ie 
whether lower morbidity scores tended to be associated with lower haemoglobins. The authors stated 
that episodes of illness were scored from O to 3 according to duration and severity but did not state 
whether the higher scores were assigned to longer and more severe illnesses. If this was not the case, 
the apparently contradictory results would be resolved. 
It is difficult to draw a conclusion from the conflicting results of this study. 
Giles et al (1962) 
Giles and Brown<193) found an association between the prevalence of bacteriuria and haemoglobin 
concentration in pregnant women; urinary infection was less than half as common in 447 non-anaemic 
pregnant controls as in 463 anaemic pregnant women. The authors argued that it was more likely that 
the anaemia was the result of urinary tract infection, partly because the haemoglobin responded to 
antibacterial treatment in some patients and partly because no plausible mechanism has been proposed 
by which iron deficiency might predispose to infection. 
Abramson et al (1971) 
In a survey of 652 women attending an antenatal clinic Abramson et af.2) found haemoglobin levels of 
12.10 g/dl and 12.48 g/dl in patients with and without bacteriuria in the first and second trimesters. In 
the third trimesters the haemoglobin levels were 11.70 and 12.22 respectively. The authors failed to 
find an association with age, parity, social class, date of immigration or diet. This makes it more-likely 
that the low haemoglobin concentration was a result of infection than of primary iron deficiency which 
would correlate with several of the above variables. 
Savage et al (1967) 
Savage et ai(444) surveyed more than 5000 pregnant women and found no association between 
haemoglobin level and bacteriuria. 
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Prospective, controlled studies 
Basta et al (1979) 
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Purpose: The purpose of the study of Basta et af.22) was "to determine: ( 1) whether anemia in low-
income workers affected physical endurance, their actual productivity, and their resistance to infection, and 
(2) whether iron supplementation could diminish iron deficiency anemia and raise work output in this 
population". 
Ascertainment: ttA total of 302 male plantation workers, 16 to 40 years old, [were] selected randomly 
from a list of 400 workers". 
Nutrition and diet: The workers ate a restricted diet. Rice was rationed and extra income was spent 
on edible leaves and fruits. Mean height for the sample was 157.4 cm and mean weight was 46.9 kg. 
These are both less than the third centile for 18 year old males on the NCHS growth charts. The 
authors remark that the bench height of the Harvard Step Test was reduced in order to make it more 
suitable for Indonesians. 
Iron intake: The Iron group took, under supervision, 100 mg of ferrous sulfate daily. 
Laboratory methods: Blood samples were obtained by finger prick for determination of haematocrit 
and haemoglobin and for microscopical examination for malarial parasites and red cell morphology. 
Haemoglobin was measured with the cyanmethaemoglobin method. 
Study grouping and design: The trial consisted of 2 groups: a Placebo group who received a daily 
placebo tablet and a small income supplement to encourage them to continue to participate for the 60 
days of intervention and an Iron group who received a daily ferrous sulfate table and the income 
supplement. (A third group who received neither placebo tablet nor financial inducement was tested 
haematologically but· data on infectious morbidity in this group were not given). Examinations were 
conducted before and immediately after the intervention study. Diseases reported to have occurred in 
the 4 weeks preceding the first examination were recorded. 
Results: Pre-intervention: These are discussed in the section above where studies of prevalence are 
reviewed. 
Results: Post-intervention: "Morbidity scores decreased in both anaemic groups, but more significantly in 
that receiving iron and payment (P < 0.001) than in that receiving placebo and payment (P < 0.02) ... 
There was a dramatic decrease in the pr.evaience of infections in both the anemic and non-anaemic iron-
payment groups, whereas little change was observed in placebo-payment groups". 
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Interpretation of results: 1 nutrition: The subjects in this study were nutritionally deprived. It is 
possible that deficiencies other than iron were also present in the anaemic group. It is thus not 
legitimate to assume that iron. treatment was the only factor in decreasing morbidity. 
Interpretation of results: 2 analysis: The authors' statement of their results is potentially misleading 
and does not agree with the tabulated data . 
.It is tempting to conclude that the iron supplement was efficacious because the decrease in morbidity 
score was more significant (P < 0.001) for the iron treated anaemic group than for the placebo treated 
anaemic group (P < 0.02) •. The comparison should not be between the P values but between the 
changes in morbidity scores (0.48 and 0.41) and a statistical test of significance should be made on this. 
Figure 2.1 (which was compiled from the authors' table 5) should illustrate the fallacy and that there 
was, for practical purposes, no difference between the changes in the placebo and iron treated anaemic 
groups. 
• At least one reviewer seems to have fallen into this trap<108l. 
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Figure 2.1 Mean morbidity scores and prevalence of infection in Indonesian workers before 
and after treatment with placebo or 100 mg ferrous sulfate daily for 60 days. 
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The decrease in infection rate experienced by the anaemic group was 0.51 while for the non-anaemic 
group it was 0.09. The corresponding figures for the iron treated and placebo treated groups are 0.38 
and 0.21. It would have been interesting to have seen an analysis of covariance to estimate the relative 
contribution of temporal effects and iron treatment. From the above analysis one might estimate that 
the iron had about half the influence of the other, undefined interventions. 
Conclusion: figure 2.1 is a nice demonstration of the Hawthorne effect. ie that the study itself had an 
impressive result on the morbidity of the workers (assuming that the exposure to infection remained 
constant). The interventions responsible may have been the extra attention given to the workers, their 
improved nutrition as a consequence of the higher wages they received, or other factors. The study 
does show a small, ( and probably non .. significant) trend supporting the hypothesis that iron deficiency 
predisposes to infection. 
Infants 
Studies with anecdotal reports 
Tonkin (1970) 
Tonkin(496• 497) conducted a trial of intramuscular iron-dextran in the prevention of iron deficiency 
anaemia of infancy in which full term., appropriate for gestational age, babies.were either offered oral 
iron supplementation for one year or given two injections; each equivalenr to 50 mg elemental iron. 
The intramuscular iron prevented the development of anaemia and at one year the mean haemoglobin 
levels in the two groups were 11.96 mg/dl and 10.98 mg/di respectively. 
The author stated that the "two groups, test and control, did not show any marked differences in 
morbidity either of reported illnesses or of defects found at examination." 
The author then presents the results of an analysis of the association of haemoglobin level with 
morbidity. Respiratory tract illness found on examination was significantly more common in the 
groups with lower haemoglobin. The results for reported respiratory tract conditions and for other 
infections, both on examination and by history, were variable in trend. 
The conclusion drawri from this is that "the advantages of an improved haemoglobin became evident". 
This inference is invalid. If iron treatment improves iron status and, concomitantly, resistance to 
. infection, then one would have expected the test group to have had fewer infections than the control 
group. The numbers of children were small and they were examined only at intervals of three months 
during the year they were followed. This would be adequate reason for missing a protective effect of 
iron treatment, and it would have been helpful if the author had calculated the probability of doing so. 
More importantly, if infection depresses haemoglobin levels {as we know it doesC270)), then it would be 
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expected that lower haemoglobin levels would be associated with increased numbers of infections. The 
author's results can validly support this latter, weaker, hypothesis. 
Howell (1972) 
This study has been cited by several authors(308• 9l) in favour of iron deficiency increasing susceptibility 
to infection. The inter-library loan service was unable to provide me with a copy of Howell's report. 
Dallman (1981) 
It was reported in a conferenceC126) that the US Public Health Service had in the 1960-s conducted a 
study in which iron-dextran or placebo was given to about 200 new born infants; The incidence of 
infections was "about equal" in the two groups but more deaths occurred in the placebo group. No.data 
were given. 
Heimendinger and Undritz (19S5) 
In a study of the effects of ferrous gluconate supplementation in children in institutions, Heimendinger 
and UndritzC215) remarked that infections were less frequent in children with improved haemoglobin 
levels·. No data were given to support this assertion. 
Lovric (1970) 
Lovric(302) stated that 458 children in hospital had a mean haemoglobin level of 10.6 g/ dl while a 
matched°* control group of healthy children had a mean of 12.0 g/dl. Although he stated that there 
was a higher prevalence of infection in the hospitalized children than in the controls, no data were 
given and no association was sought with infection and haemoglobin level. Little weight can be 
attached to this study in testing the hypothesis of a causal relationship of iron deficiency with 
susceptibility to infection. 
Moe (1963) 
In support of the contention that iron deficiency predisposes to infection, Moe(347) offered the 
observation that 5 of 7 infants admitted to hospital with anaemia (Hb < 8 g/ dl) developed signs of 
infection during their stay. No mention is made of. the reasons for admission, and no control cases 
were used as a comparison. 
Salmi et al (1963) 
Salmi et af 442) stated in an abstract that a group of about 30 premature infants had twice the "incidence 
of infections" experienced by a group of about 60 infants who were given iron supplementation. No 
further data are given#. 
• Cited in 503 
•• Unstated, but presumably matched for age and sex 
# Cited in support of the hypothesis that iron deficiency predisposes to infection(484• !OZ)_ 
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Shaw and Robertson (1964) 
In a retrospective survey of 797 admission to Columbus Children's Hospital in Ohio, Shaw and 
Robertson<459) found "a lower percentage of infants admitted to the surgical service were anaemic than of 
those admitted to the medical service". Two thirds of the 194 admissions with Hb < 10.0 g/dl were 
prompted by an infectious process. 
This study's results may be added to the body of circumstantial evidence in favour of an increased 
susceptibility to infection in iron deficiency .. 
Stekel (1981) 
A similar anecdote reported in a conferenceC126) relates that infants ~nan iron fortified milk formula, 
acidified with ascorbic acid, had a lower incidence of diarrhoea than the controls. No data are given. 
an.dlit seems that the two groups may not have been subject to the same exposure to infection as the 
report could be taken to indicate that they were in separate parts of the city of Santiago. No weight can 
be attached to the conclusions made from these observations without a full report on the methods, 
materials and results of the study. 
Werk.man et al (1964) 
This study(S20) has been (mis)used to support the assertion that iron deficiency is associated with 
increased susceptibility to infection·. The authors interviewed 28 mothers at least 1 year after their 
children had been treated in hospital for iron deficiency anaemia and compared them with the mothers 
of 28 control children. Little data is offered by the authors, but they do state that on follow~up the 
previously iron deficient children had a mean haemoglobin of 11.52 g/ dl and that they had more 
illnesses than the control group. The mean haemoglobin level of the control group is not sta.ted nor is 
the nature and number of illnesses further defined. There is. nothing t~ support ( or to reject) an 
association of iron deficiency with susceptibility to infection. 
Retrospective or prevalence studies 
Fortuine (1966) 
Fortuine075) studied the association between outcome in acute purulent meningitis and initial 
haemoglobin levels in 69 Alaskan natives. A fatal outcome was more likely the lower the initial 
haemoglobin. The author recommended that preventive measures include treatment of anaemia. 
The cautions detailed in the section above apply equally well to the implied conclusion that iron 
deficiency predisposed to infection. 
•• Cited by89 
• "a group of infants and toddlers with iron deficiency anemia incurred more illness, among other behavioural manifestations, 
than a control group of non-deficient children'm. 
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Fuerth (1971) 
In a brief report published in 1971, Fuerth(lSS) reported on a study undertaken in 1959 in which the 
haemoglobin levels of 1 year old children were analyzed for correlation with the number of illnesses 
per child during the first two years of life. No statistically significant correlation was found although 
there was a trend in favour of the children with higher haemoglobin levels. 
No analysis of the types of anaemia or illnesses was reported, but iron deficiency would be the most 
common cause of anaemia and infection the most common cause of illness. These uncertainties make 
it difficult to conclude from this study that iron deficiency either does or does not have an association 
with susceptibility to infection·. 
Oppenheimer (1980) 
A retrospective study<375) of the prevalence of anaemia in infants admitted with bacterial meningitis or 
.. 
pneumonia found mean haemoglobins well below the local normal values . 
The author contends that, since the weight for age of the children indicated normal nutrition, there was 
no increased susceptibility to infection caused by generalized malnutrition and that it was more likely 
that pre-existing anaemia was an aetiological factor in the infections than vice versa. The facts that 
most patients were seen within 36 hours of development of symptoms and that there was a significant 
variation in haemoglobin between the aetiological groups were offered as further reasons for the 
putative role of iron deficiency in the infections. 
This study provides circumstantial evidence for the theory of increased susceptibility to infection in iron 
deficiency and suffers from the defects of retrospective studies. As the author concludes: "These 
questions could be answered only by a controlled prospective trial of iron administration to inf ants in this 
community" 
Reeves et al (1984) 
Most of the authors reviewed in this chapter argue either for or against a causal role for iron deficiency 
in increasing susceptibility to infection. In contrast, Reeves, Yip, Kiley and Dallman<412) concluded 
from an interesting study of unique design that "upper respiratory and other mild antecedent infections 
commonly predispose to iron deficiency (probably because of a decrease in iron absorption)". 
These authors estimated the rate of infection retrospectively in a group of 291 well one year old infants 
attending a routine health maintenance clinic by questioning the parents of the children. Half the 
• This has been cited as evidence against such an association(-189) 
.. Necessary because of altitude greater than 1500 m for 1 hospital. 
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children were treated for three months with an iron supplement providing 3 mg iron/kg/ day while the 
remainder were given. a placebo. 
Prior infection was significantly associated with lower initial haemoglobin levels. 
Children who did not have a history of prior infection did not respond (haematologically) to treatment 
with iron or placebo. Children who did have a history of prior infection showed a. haemoglobin 
response to treatment with placebo or with iron. The response was greater in those who had more 
infections and was greater in the iron treated group than in the placebo group. 
The authors speculate that iron absorption is sufficiently depressed during infection to affect 
haematological and other indicators of iron status. In addition they hypothesize that the higher 
haemoglobin response in infants with prior infections "suggests that both iron deficiency and 
inflammatory disease played interactive roles". 
This seems the most parsimonious explanation for these results. It would have been interesting to 
know the response of the other measures of iron status to the treatments. More interesting would have 
been the test of this theory by performing a similar analysis of the relationship of rates of infection 
between the ages of 12 and 15 months and haemoglobin levels. One would have expected a similar 
relationship to have been found with little or no effect by treatment with placebo or iron. This seems 
such an obvious observation to make that one wonders if the result was not perhaps negative. 
Bondestam et al (1985) 
Serum iron and other trace elements were measured in 28 children, median age 3.5 years, admitted to 
hospital for investigation of recurrent infections(44)_ Thirteen healthy children, median age 15.5 years 
served as controls. Statistically significant decreases were found for serum iron and zinc, but not for 
copper and magnesium. Mean serum transferrin and caeruloplasmin levels were almost identical in 
the two groups. Ferritin and red cell indices were not reported. 
The authors · postulated that "the changes in the trace element status observed in this study are the 
combined effects of infection and malnutrition", and remarked that "the possible role of trace element 
deficiency in predisposing to or perpetuating undue susceptibility to infections in children remains to be 
elucidated". Their proper caution in interpretation is not matched by reviewers who find in this study 
evidence for a causal role of iron deficiency in infection or evidence for a lack of protection of iron 
deficiency against infection·. The data do not contradict this hypothesis, but they are equally consistent 
with the converse interpretation of a causal influence of infection on iron deficiency. 
• See for example 152 
; 
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Studies with multiple independent variables 
Arbeter. et al (1971) 
2.89 
This study(9) is mentioned only because it has been cited by reviewers in support of the hypothesis that 
iron deficiency predisposes to infection: ''Arbeter et al found that malnourished Colombian children 
showed a remarkable decrease in infections (particularly gastro-enteritis) following con-ection of their iron 
deficiency and, incidentally, of their malnutrition as wel/'{235)*. 
In fact, the report by Arbeter et al is difficult to interpret and does not support the conclusions cited 
above. Families in a remote Colombian village were provided with free medical care for their children. 
In addition, panela, the local staple of unrefmed sugar, was sold in two forms: either unmodified, or 
fortified with protein, vitamins and minerals, including iron and calcium. The group receiving the 
fortified panela showed no difference in height or weight from the control group, but did have a 
decreased incidence of clinically overt malnutrition and of infectious diseases. No haematological data 
are presented. The tabulation of infections diagnosed omits the period of observation and (for most 
age groups) omits the number of children observed. It is therefore not possible to calculate rates of 
infection ... Thus it would not be valid to attribute any changes to the fortification program, let alone to 
any single constituent such as iron. 
Jacobs and George (1952) 
Purpose: "The purpose of the stlldy was the careful clinical evaluation of a group of young inf ants, half of 
whom, were to be fed the standard hospital diet, the other half to be fed the same diet to which strained 
meat was added as a supplement, in such a quantity as to increase the daily protein intake approximately 
25%'{244). 
Ascertainment: Healthy children were alternately assigned to the test and control groups. 
Nutrition: Birth weight was greater than 2.3 kg for all infants. 
Socio-economic class: The children were housed in an institution and most were awaiting adoption or 
foster home care. 
Feeding and iron intake: Strained meat was added to the milk of test infants until spoon feeding was 
possible at about three months of age. 
Laboratory methods: Blood samples were obtained from heel pricks and haemoglobin concentrations 
were determined with an Evelyn photoelectric colorimeter. 
• Other reviewers have also misquoted this report, eg 152, 91 
.. For example, per year per 100 children 
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Study grouping and design: Infants were admitted alternately to the test and control groups. The 
·-· 
examining physician and laboratory staff were not informed of the allocation. Examinations were 
performed monthly. 
Results: The only illnesses which occurred during the period of study were upper respiratory infections 
and gastrointestinal disturbances. Results are presented as a comparison of morbidity rates between 
the test and control group, with the test group having 60% of the morbidity rate of the control group in 
aggregate. When compared in age groupings, the test group had lower morbidity rates in 8 of 9 age 
categories. 
Interpretation of results: 1 diagnosis of infection: This is not discussed, but presumably, children in an 
institution would not have had a significant illness without the study team being notified. One would 
assume that recording of infections was therefore reasonably complete and accurate. 
Interpretation of results: 2 exposure to infection: "Analysis of morbidity rates according to ward was not 
possible because of the regular, periodic change in ward assignments with increasing age. No major 
outbreaks of infection occun-ed during the study and minor seasonal outbreaks in the respective wards 
offered equal exposure to both groups, since alternate bed assignment was maintained within the wards". 
Interpretation of results: 3 blinding: The study was blinded to investigators. 
Interpretation of results: 4 Nutrition: Weight gain in the meat fed group was significantly increased. 
Interpretation of results: 5 haematology! The test group had higher median haemoglobin levels with 
less variation than the control group. 
Conclusion: This study suggests that meat favorably influences resistance to infection. The intention of 
the study was to increase the protein intake of the infants by a adding meat to the diet. It is not 
possible to ascribe the results of the intervention to a single nutrient, such as iron, in the face of so 
many other associated nutritional differences. 
Karp and Merz (1986) 
Karp and Meri258) have documented from a study of 70 adults that chemotherapy for acute leukemia 
is associated with increased serum iron levels and decreased total iron binding capacity ( and thus also 
increased percentage saturation of transferrin) as compared with pre-treatment values. Fungal 
infections occurred in those patients with the earliest and/or greatest reduction in total iron binding 
. capacity. Effective anti.fungal therapy was associated with a return to normal of total iron binding 
capacity. 
~. 
' 
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The alteration in iron metabolism may contribute to the susceptibility to fungal infections or, less 
probably, may merely be a marker of such vulnerability. The study design does not allow the 
determination of the relative contributions to altered resistance to infection by leukemia, chemotherapy 
and altered iron metabolism. 
Prospective, controlled studies 
Mackay (1928) 
Purpose: The purpose of Dr Mackay's studf314) was to define the prevalence of anaemia in infancy, to 
observe its ill-effects and to test prophylactic and therapeutic regimens. 
Ascertainment: Infants were referred to the Queen's hospital for Children, London, :'for consultation or 
light treatment"•. All infants were less than or equal to 18 months of age on admission. 
Nutrition: "The great majority were under nonna/ weight as judged for instance by Griffith's standard 
weight curve." 
Socio-economic class: The infants came from "a poor and overcrowded district in the East end of 
London". 
Feeding: All infants were given full cream dried milk sweetened with cane sugar, sufficient to provide 
about half a litre a day to a baby weighing 5Kg. Cod-liver oil and either orange or tomato juice were 
ordered as a regular supplement. Weaning off milk began from the age of 8 months. 
Iron intake: The infants admitted to the study in 1926 and 1927 were given iron in the form of "iron and 
ammonium citrate" • either as a sweetened syrup or as a fortification to the dried milk .. The daily dose 
was adjusted to between 4.5 and 9 grains. Since 1 grain of ammonium ferric citrate contains 80 mg of 
iron, the daily iron intake can be calculated to be between 360 and 720 mg. 
Laboratory methods: Blood samples were obtained by heel or finger prick. Haemoglobin was 
measured with Haldane's haemoglobinometer which gives results expressed as a percentage of 13.8 g 
Hb/dl. In a subsequent report it was stated that the haemoglobin results were consistently 
underestimated by 7%(315>. 
Study grouping and design: The Control group consisted of infants admitted to the study in 1925/1926 
and the Test group consisted of infants who were admitted in 1926/1927 and given iron 
• One of the therapies being evaluated was the mercury vapour quartz lamp which had been found useful for the management 
of rickets. Needless to say, it had no effect on haemoglobin level. 
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supplementation, Attendance at the follow up clinic varied from several times a week to once a month. 
The period of observation varied from 1 to 12 months and averaged 2.98 months for the Control group 
and 3.31 months for the Test group. 
Results: The Control group experienced about twice as many infections as the Test group in both 
summer and winter. When the diseases were grouped into "specific fevers", diseases of the respiratory 
• tract, diseases of the digestive tract and other infections, a similar relation held . 
Interpretation of results: 1 exposure to infection: Dr Mackay recognized the occurrence of an 
epidemic of diarrhoeal disease in the Control period and, taking this into account, disclaimed the 
validity of inferences drawn from comparison of the statistics of digestive tract disease. As the average 
weekly mortality in London for respiratory disease was comparable for the two groups, in 
contradistinction to that for diarrhoeal disease··, she claimed that the incidence statistics for 
respiratory illness and specific fevers could be used to inf er a causal relationship between iron 
deficiency and infection. ' 
Equal mortality rates from one period to another do not imply equal morbidity rates, ( although they 
would be compatible). To compare two groups of infants for infection rates, both groups should be of 
similar age distribution, and exposed to the same opportunities for infection; the groups should be 
studied over the same period, in the same location, and their social contacts should be similar in 
frequency and type. 
Interpretation of results: 2 demographic comparability: The report does not give precise age details or 
compare variables such as number of siblings and socio-economic class which might act as a proxy for 
exposure to infection. Few details of ascertainment are given; it is possible that children with infections 
were selected for the Control part of the study and that healthier children were referred during the 
Test part of the study. 
Interpretation of results.: 3 blinding: The study was open to both investigator and subject and this may 
have led to (unintentional) bias in ascertainment of subjects, in collection of data, or in interpretation 
of results. 
Interpretation of results: 4 nutrition: The average weights at the beginning and at the end of 
observation of a group of Control cases are compared with a _group of Test cases. The numbers in 
these groups, 176 and 62, are very different from the numbers of infants whose morbidity was observed, 
235 and 87. As no explanation is given of the derivation of these groups, extrapolation to the morbidity 
• Author's tables D and E and Chart XVI 
•• Author's table C 
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study groups may not be valid. The Test cases seemed to start the study with age and weight very 
similar to the Control cases but complete the trial with an improved weight gain·. However, in both 
the full morbidity study and in the smaller weight study, the Test cases were observed for longer than 
the Control cases (3.31 cf 2.98 months and 21.7 cf 14.4 weeks). The sources of these differences would 
be expected to bias the groups with respect to both nutrition and morbidity and, as Dr Mackay 
recognized, this "makes a fair comparison difficult" ... 
Interpretation of results: 5 haematology: The graphically presented data show a striking difference in 
cases given iron, prophylactically or therapeutically, compared to Control infants. Reading from the 
graphs, converting from the units employed (100% = 13.8g Hb/dl blood), and multiplying by 1.07 to 
correct for calibration ertors<74) one may estimate that the averaged haemoglobin of the Test cases was 
11.3 g/dl and that of the Controls was 10 g/dl on completion of the trial. 
Conclusion: No statistical tests were made, and the data presented is not complete enough to enable 
such analyses to be made now. However, formal statistics would not be necessary to convince of the 
effectiveness of iron therapy and they would not obviate the methodological problems in interpreting 
the morbidity study. 
Taking all these objections into consideration one is still left with a strong impression that the iron 
fortification may have increased the resistance to infection of the Test group infants. 
James and Combes (1960) 
Purpose: The purpose of the study of James and Combes<247) was to "study the health record of 
a group of prematu~e infants maintained in a state of abundant iron nutrition". 
Ascertainment, Grouping, Nutrition: Two hundred and five consecutive prematurely born babies, who 
weighed 2000g or less and had survived at least 24 hours were allocated by random selection to either a 
test group to receive iron-dextran or to a control group who received standard care. Of the 181 who 
survived the neonatal period, 84 received iron-dextran and 97 did not. 
Socio-economic class: The socio-economic class of the families was not reported. 
Feeding: The feeding practices were not discussed other than that mothers were advised on 
milk formula usage and introduction of solids. 
• Author's table F 
•• page 140 
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Iron intake: When infants in the test group reached 2000g weight they were given 1ml of iron-dextran 
daily for 5 days to provide a total of 250 mg of elemental iron. Babies in the control group received 
supplemental oral iron preparations if their haemoglobin declined below 7 g/ dl. 
Laboratory methods: Haemoglobin was determined by the oxyhaemoglobin method. 
Study design: After discharge from the nursery, babies were seen monthly. ''Additional data covering 
morbidity and mortality in both groups of inf ants were obtained from study of the hospital records and 
from the vital statistics of the Dallas City and County Health Departments." 
Results: The test group had, on average, 1.14 respiratory and diarrhoeal infections in the first year, and 
1.83 illnesses per infant attending the outpatient department. The corresponding figures for the control 
group were 1.20 and 1.85. The differences were not statistically significant. 
Interpretation of results: 1 exposure to infection: Random allocation of infants to the study groups 
would have tended to minimize bias in exposure to infection that might be caused by geographic or 
demographic bias. The method of randomization is not explained however, and it may itself have been 
open to (unconscious) bias. 
The groups were studied simultaneously, but follow-up was better in the control group. The longer 
period of observation and the suggestion that there was "a greater maternal desire to provide good care", 
may have tended to increase the number of infections recorded for the control group. 
Interpretation of results: 2 demographic comparability: Apart from the caveat noted in the previous 
paragraph, demographic comparability is not discussed. 
Interpretation of results: 3 blinding: Presumably the study was not blinded as blinding was not 
reported. 
Interpretation of results: 4 nutrition: The weight gain in the two groups of infants was very similar 
over the first year. A difficulty in accepting this statement at face value is that the evidence for this 
conclusion is a comparison between two smaller sub-groups whose selection (or exclusion) criteria are 
not reported°. 
Interpretation of results: haematology: An unstated number of the test group had a mean 
haemoglobin of 11.5 g/dl at one year of age and none had "significant anaemia". The mean 
haemoglobin of the control group was not stated; but of 48 infants, "only 5 inf ants reached the age of 
• Authors' figure 1 
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011e year with a haemoglobin level greater than 9.5 g/dl without having supplemental iron, and almost all 
developed a significant degree of anaemia during the first year of life". 
Conclusion: Although the intervention employed ensured a large difference in iron nutrition between 
the two groups, the results are difficult to interpret as:· 
1 The drop-out rate was more than 50%, with a large difference between the two groups. 
2 The number of infections was not related to the precise number of infants followed or to the 
precise period for which they were followed. 
The first problem is a potentially important source of bias and the second is an important source of 
error in calculating morbidity rates. 
Taking these two factors into account, one may note the trend in favour of the group who had iron-
dextran. There is no justification in using this study as unqualified evidence against a relationship 
between iron status and susceptibility to infection·. 
Andelman and Sered (1965) 
Purpose: The study was "designed to determine the effects of feeding an iron-containing milk formula for 
aperiod of 6 to 9 months to an inf ant population manifesting a high incidence of iron-deficiency anaemia 
and a high rate of infectious morbidity'~7). 
Ascertainment: Term infants under 4 weeks of age whose birth weight had been greater than 2.5 Kg 
were randomly selected from those destined to attend Child Welfare Stations in the Eighth Health 
District of Chicago. The method of randomization is not explained nor is the allocation to Test and 
Control groups discussed. Some bias may have been present in the selection as 37% of the Test group 
were enrolled on discharge from hospital, while all the Control infants were enrolled at the Welfare 
Station. 
Nutrition: The mean birth weights of the two groups of infants were 7.1 lb and 7.0 lb. 
Socio-economic class: The study population was considered to be the lowest socio-economic of the 
city. 
Feeding and iron intake: The Control group received an evaporated milk formula with separate 
vitamin supplementation but no extra iron. The Test group were given a milk formula containing all 
essential vitamins and 12 mg of iron per quart of reconstituted formula. Strained foods were initiated 
* As for example in 308 
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at 3 months of age and by the time the infants were 6 months old, full diets of formula, cereal, egg, 
meat, vegetable, and fruit had been prescribed. 
Laboratory methods: Blood samples were obtained by heel prick. Haemoglobin values were 
determined by the cyanmethaemoglobin method. 
Study grouping and design: A Test group of603 infants and a Control group of 445 infants were given 
their respective formulas from entry till the age of 6 to 9 months and periodically examined till they 
were 18 months old. The frequency varied from every 4 weeks for the first 6 months (the paper is not 
clear on this point) to every U weeks for the last 6 months. The overall dropout rate was 30% by one 
year of age and 95% by 18 months of age. Infants for whorn the haemoglobin fell below 10 g/dl were 
removed from further observation. This criterion resulted in 76% of the Control children and 9% of 
the Test infants being prematurely excluded from the study. 
Results: The Test group had significantly fewer respiratory infections than the Control group during 
the period of iron supplementation and the six months thereafter·. 
Interpretation of results: 1 diagnosis of infection: No information is given on how infections were 
diagnosed
0
, nor on the incidence of infections other than those of the respiratory tract. The intervals 
between visits were longer than the period for reliable recall of illnessC74). 
Interpretation of results: 2 exposure to infection: While the Test and Control groups came from 
similar families, mean .maternal parity being 3.3 and 3.2 respectively*, no information is given as to 
whether the two groups were followed simultaneously. 
Interpretation of results: 3 blinding: The study was not blinded and no reason is given for the 
discrepancy in the numbers allocated to the two groups. 
Interpretation of results: 4 Nutrition: No difference in weights or lengths was apparent during the 
study*#. At 12 months the average weight was 9.71 Kg for both groups. This is 96% of the expected 
weight at that age; presumably therefore, both groups were well nourished. 
• Author's figure 10 
•• Although Pearson (:!94) states that this was by questioning the parents 
# Author's table 1 
## Author's tables 2 and 3 
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Interpretation of results: 5 haematology: Differences in haemoglobin concentration became 
statistically significant at 9 to 12 weeks and at one year the average haemoglobin concentrations were 
11.9 g/dl and 10.4 g/dl in the Test and Control groups respectively. 
Conclusion: The pronounced difference in respiratory tract infections may have been due to the 
difference in iron status but the problems in evaluating ascertainment, allocation, blinding, and 
diagnosis make this inference uncertain. It would have lent strength to the study if the incidence of 
other infections had been discussed. 
Cantwell (1972) 
Purpose: The purpose of Cantwell's studyC79) was to test the efficacy of iron-dextran in preventing 
anaemia in late infancy. 
Ascertainment: All Maori mothers who delivered in Hawkes Bay Hospital in 1965 were invited to join 
the study. 
Exclusions: Neither criteria for exclusion nor numbers of children excluded were specifically discussed. 
It can be inferred from the report that infants were excluded from the trial if their parents declined to 
participate or if they were premature. Children in the control group who became severely anaemic 
were treated with parenteral iron. The author states that they "then ceased to be controls". Other 
reasons for dropping out of the trial were not mentioned. 
Socio-economic class: "The majority of Maori families in the Hawkes Bay area belong to the lower socio-
economic groups". 
Feeding: The justification for employing parenteral iron-dextran as the source of iron in this study was 
that the ''Maori mother tends to prolong bottle feeding with her infant until the age of two years. She is 
slow in introducing foods rich in iron". 
. Iron intake: Iron-dextran injections were begun on the second day of life and continued daily for a total 
of 5 injections. The total dose of elemental iron was 250 mg. The author calculated the total 
requirement for iron in the first year of life to be 284 mg in a typical infant growing from 3.5 kg at birth 
to 10.5 kg at one year. 
Laboratory methods: Blood samples were obtained by finger prick. Haemoglobin was measured with 
a standardized photocolorimeter using the cyanmethaemoglobin method. 
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Study grouping and design: Babies born on the odd days of the month were treated. Haemoglobins 
and haematocrits were measured serially at approximately three month intervals·. The rate of 
hospitalization for the infants was calculated for the two year period of observation. 
Results: The Control group experienced about 35% more admissions to hospital for infections than the 
Test group. When acute wheezy bronchitis and asthma are excluded from the calculations, the Control 
group had twice the admission rate of the Test group. 
Interpretation of results: 1 exposure to infection: The criterion of admission on alternate days would 
have ensured equal temporal exposure to infection. 
Interpretation of results: 2 demographic comparability: The infants were all resident in the Hawkes 
bay area, so the two groups were probably demographically similar. It would have been useful if the 
report had tested some measure of expected similarity between groups such as birth order or gender. 
Interpretation of results: 3 blinding: The study was open to both investigator and subject and this may 
have led to (unintentional) bias in collection of data, or in interpretation of results. 
Interpretation of results: 4 nutrition: Measures of nutrition such as weight and height were not 
reported. 
Interpretation of results: S haematology: The iron-treated group had statistically significantly higher 
haemoglobin levels than the untreated controls for all the age groupings from the age of 3 months to 27 
months. In contrast to the Test group, the control group had a striking decline in haemoglobin to a 
nadir of 8.9 mg/ ell at 15 to 18 months. 
Interpretation of results: 6 calculation of admission rates: The author does not elaborate on the 
definition of admission. It would seem that it refers to both attendance. at an outpatient clinic and to 
admission to a hospital ward since infections include impetigo and meningitis and the admission rate is 
extraordinarily high. 
In general, the calculation of admission rates is subject to several potential errors. Whert comparing 
rates for two groups, both the denominator and the numerator should be comparable. 
The data on which the calculations of admission rate are made are not described in this study with 
sufficient clarity to enable the validity of the admission rate to be confirmed. But unclear details in 
• Not stated by the author, but inferred from his 3. 
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determination of the admission rate arouse the suspicion that the rates may not be strictly comparable 
as the following analysis de;111onstrates. 
The size of the control and test groups on admission to the study is 144 and 94 respectively. The author 
states that 21 children were removed from the control group after treatment for severe anaemia. Yet 
the admission rate is calculated from 61 admissions in 144 children over two years. The admission rate 
should be calculated for those children who were followed for the full two year period. 
The author does not discuss the reasons for excluding treated children, but there is an argument 
against such exclusions. If the study is regarded as a trial of the efficacy of iron-dextran in the neonatal 
period in preventing infections in the first two years of life, the approach should be that all children 
ought to be included, regardless of treatment for medical reasons after allocation to their study 
grouping. It is difficult to estimate the size of the potential error, but it is probably not large. 
In a second type of test of the effects of iron-dextran, the author compares total hospital admissions for 
Maori infants under the age of two years in the Hawkes bay and Gisborne area for the years 1964 to 
1967. Admissions declined in the Hawkes bay area, but not the Gisborne area in 1965 and 1966. In 
1967 there was an epidemic of viral respiratory infections in Hawkes Bay, but not in Gisborne. 
On inspection it would appear that the iron-dextran might have been responsible for the decline. The 
author implies that the children in Hawkes Bay had an increased exposure to infection in 1%7 and that 
this year was not strictly comparable. The argument could equally well be applied to the results for 
Gisbome in the two previous years. 
No details on population size, growth and economy are given. It would have made direct comparison 
simpler if rates rather than admissions had been given. 
Conclusion: This study provides fairly strongly suggestive evidence for a loss of resistance to infection 
in iron deficiency in infancy. One wonders why it seems to have been ignored in review articles on the 
subject 0. 
Summary and Conclusions 
The above review shows that, although much has been written about the relation of iron status to 
infection, there have been few controlled trials, and no study has been free of methodologic defects in 
design or omissions in reporting. 
• As for example in 235 
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The body of evidence is strong enough to warrant clinical zeal in treating and preventing iron 
deficiency, but with due caution to risks of increasing susceptibility to (new or recrudescent) infection. 
The risks are especially great in patients who might become hyperferraemic ( as for example 1n 
kwashiorkor or in neonates) or in those living in tropical areas where malaria is endemic. 
There is reason to believe that iron deficiency is causally related to increased susceptibility to infection, 
but this association has not been properly established. It is important that this be done since iron 
deficiency is common and easily treated. 
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CLASSIFICATION Of REPIJlTS ANO STUDIES ON HYPOTHESES THAT REL.ATE IRON STATUS TO A PREOISPOSITON TO INFECTION 
-------------------------------------------~---------------------------------------------=----------------------------=----------------------------------------------------
REF AUTHOR 
NUYJBER (first) 
TEST OF 
HYPOTHESIS 
INTERVENTION 
HYPOTHESIS 1 : IRON EXCESS INCREASES SUSCEPTIBILITY TO INFECTION 
19 Barry Support Iron-dextran 
346 l'lofenson Support Oral iron overdose+ desferrioxamine 
453 Scott ? Support Iron-sorbitol-citrate 
55 Briggs ? Support Iron-sorbitol-citrate 
454 Scott ? Support Iron-sorbitol-citrate + oral iron 
313 l'lacFarlane ? Support Iron-dextran + refeeding in kwashiorkor 
422 Robins-Browne ? Support Observation: histology at post mortem 
76 Butzler ? Support Observation: case report 
337 Melby ? Support Oral iron overdose+ desferrioxamine 
HYPOTHESIS 2: IRON DEFICIENCY INCREASES SUSCEPTIBILITY TO INFECTION 
Prospective controlled trials 
314 i'lackay Support Fortification of milk formula 
7 Andelman Support Fortification of milk formula 
226 Higgs Support Iron-dextran plus oral iron fumarate 
79 Cantwell Support Iron-dextran 
169 Fletcher Suppoi:t Ferrous sulfate 
247 James ? Support Iron-dextran 
503 Vellar ? Support Ferrofumai:ate (60mg Fe) 
22 Basta ? Support Ferrous su,l fate 
74 Bui:man ? No support Fortification of milk formula 
242 Jacobs ? No support "Iron therapy" 
Part 1 
RESULTS 
effect of intervention on infection 
Increased incidence of Gram-negative septicaemia 
Yersinia enterocolitica septicaemia 
Urinary tract infection precipitated in 1 patient with IOA 
Increased pyuria in patients with chronic renal tract infection 
Urinary tract infection precipitated 
Death was associated with low initial transferrin 
3 patients dying from Yersinia entercolitica septicaemia had siderosis 
Child with thalassemia had Yersinia enterocolitica septicaemia 
Yersinia enterocolitica septicaemia 
Decreased infections: Respiratory, gastrointestinal, "specific", other 
Decreased respiratory infections 
Chronic mucocutaneous candidiasis improved in 3 of 4 pts & O of 4 ctls 
Fewer actnissions to hospital 
Oral candida counts fell and ll'Outh lesions improved 
Trend towards fewer respiratory and diarrhoeal infections 
Trend towards fewer respiratory infections (4oi vs 44i) 
Decreased infections and morbidity score 
No difference in infections (but, also little change in Hb) 
Oral Candida albicans colony counts were unchanged after treatment 
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TABLE 2.15 IRON STATUS AND INFECTION 
CLASSIFICATION Of REPCRTS ANO STUOIES ON HYPOTHESES THAT RELATE IRON STATUS TO A PREOI5PD5ITON TO INFECTION 
REF' AUTHOR 
Nlfl1BE R ( first ) 
Studies of prevalence 
176 fortuine Support Observation 
226 Higgs Support Observation 
169 fletcher Support Observation 
426 Rose ? Support Observation 
185 fuerth ? Support Observation 
91 Chandra ? Support Observation: serun transferrin saturation 
250 Jenkins ? Support Observation 
3?S Oppenheimer ? Support Observation 
44 Bondestam ? Support Observation: serum iron, transferrin 
232 Jacobs ? No support Observation 
320 fl1alakhovsky ? No support Observation 
412 Reeves ? No support Oral iron supplement 
Prospective, controlled studies. Multiple variables including iron status 
244 Jacobs ? Support Strained meat · 
258 Karp ? Support Observation: serun iron, transferrin sat. 
Part 2 
. ,,·' 
Low Hb associated with a poor prognosis in purulent meningitis 
IDA in 23 of 31 chronic mucocutaneous candidiasis 
Oral.mucosal lesions and candida colony counts increased 
Plean SI in patients with angular cheilitis decreased 
Trend: number of illnesses negatively correlated with Hb 
Patients with recurrent herpes labialis had lower J Sat 
Hyperplastxc oral candidosis more common in ID 
Prevalance of ID increased in infants with meningitis or pneunonia 
SI, but not Tf, depressed in children with recurrent infections 
Oral Candida albicans colony counts same as controls 
Incidence of infection not increased in IDA 
Haemoglobin response associated with rt1mber of previous infections 
Significantly fewer respiratory and gastrointestinal infections 
Patients with AML & fungal infection had reduced transferrin saturation 
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TABLE 2.15 IRON STATUS AND INtECTION 
CLASSIFICATION OF REPORTS AND STUDIES ON HYPOTHESES THAT RELATE IRON STATUS TO A PREDISPOSITON TO INFECTION 
----------------------=-----------~-----------------------------------------------=========~==========-===================~==========-----======:=====~------------;======= 
REF AUTHOR 
NI.PIBER (first) 
TEST OF 
HYPOTHESIS 
INTERVENTION RESULTS 
effect of intervention on infection 
==== -====~==~~----------------------------=~==========-=-===========================---------------------------------------------------=--------------======~~=------------
Anecdotal Reports 
215 Heimendinger 
442 Salmi 
84 Cawson 
347 Moe 
459 Shaw 
126 Dallman 
302 Lovric 
21 Basta 
126 Stekel 
323 l'larsh 
162 Farquar 
520 Werkman 
497 Tonkin 
? Support 
? Support 
? Support 
? Support 
? Support 
? Support 
? Support 
? Support 
? Support 
? No support 
? No support 
? No support 
? No support 
Ferrous gluconate 
Observation: infection rate 
Iron replacement therapy 
Observation:incidence of infection 
Observation 
Iron dextran 
Observation: haemoglobin 
Observation 
Fortification of infant milk formula 
fortification of infant milk formula 
Supplementation with oral iron 
Observation: post treatment for ID 
Iron dextran 
HYPOTHESIS 3: IRON DEFICIENCY PROTECTS AGAINST INFECTION 
361 f'lurray Support Observation 
356 f'lurray Support Ferrous sulfate 300 mg weekly 
376 Oppenheimer Support Iron-dextran 
361 Murray Support Refeeding after famine+ FeS04 
77 Byles Support Iron-dextran 
330 fllasawe ? Support Observation 
II II II II 
362 fflurray ? Support Refeeding after famine 
329 fllasawe ? Support Observation 
332 fflurray ? Support feeding: grain or milk 
Abbreviations: Hb Haemoglobin 
10 Iron Deficiency % Sat 
IDA Iron Deficiency Anemia 
Part 3 
Children in institutions had fewer infections 
Decreased rate of infection experienced by test group 
Two patients with oral candiasis were cured 
S Of 7 children with Hb < Bg/dl developed infection in hospital 
Hb < 10g/dl present in 29% medical and 15% surgical adnissions 
Treatment associated with fewer deaths, but equal infection rate 
Children in hospital had lower Hb and nore infections 
Acute and chronic infections nore prevalent in IDA 
Decreased infantile diarrhoea 
30 children in test group had no nore infections than 44 controls 
No difference in "well being" 
Children continued to have nore infections AFTER treatment 
No marked difference in norbidity between Test·& Control groups 
Malaria, brucellosis, tuberculosis & other infections decreased in ID 
Increased attack rate of Entamoeba histolytica 
Increased incidence of malaria and splenomegaly 
Recrudescence of malaria, brucellosis, tuberculosis, other infections 
Chloroquine prevented recrudescence of malaria 
Protozoal and helminthic infections less prevalent in IDA 
Bacterial infections nore common in IDA 
Transferrin saturation, serum iron & plasmodial parasitaemia increased 
Malaria and bacterial infections less common in iron deficiency 
Cerebral malaria in grain-fed children, but not in milk fed children 
SI Serum Iron 
Percentage saturation of transferrin 
Tf Transferrin 
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2.104 IRON NUTRITION AND IMMUNITY 
Classification and diagnosis of iron deficiency 
The effects of iron deficiency are well described and include decreases in haemoglobin, haematocrit, 
mean cell volume, mean cell haemoglobin, red cell distribution width, serum iron, serum ferritin, 
percentage saturation of serum transferrin and increased red cell protoporphyrin. The accepted patho-
physiological model of the consequences of decreasing iron status is attractively clear and explanatory: 
As an iron sufficient individual becomes iron deficient the first manifestation is a reduction in iron 
stores. After depletion of iron stores, haematopoiesis is affected, the red cells become smaller and 
hypochromic and erythrocyte protoporphyrin rises. Finally, the haemoglobin falls. The "natural" 
grouping, according to this model, would be into the following classes with the associated test results*: 
IRON STATUS 
Replete 
Depletion of stores 
Impaired haematopoiesis 
Iron deficiency anaemia 
TEST RESULT 
All normal 
Decreased serum ferritin 
Increased red cell ZPP 
Decreased MCV and MCH 
Decreased Hb, HCT 
These principles of classification are clear and widely accepted. But, their application to determine an 
individual's iron status is problematic. Hence there is an extensive literature on the practical problems 
of diagnosis and classification··. The problems arise because the above classification scheme does not 
allow each individual to be put into one and .only one class. The reason for this is that each class above 
has different tests constituting the decision criteria, and the test results are not simply dependent on 
each other as assumed in the pathophysiological model. For example, a particular individual may have 
· a low haemoglobin level, but the serum ferritin could be within the normal range. There are three 
reasons for this uncomfortable state of affairs. 
Firstly, the pathophysiological model represents a trend rather than absolute constraints on behaviour. 
The model "expects" each test to behave as well as the proverbial "gold standard" in measuring the 
condition with which it has been associated. In actuality, each test is a rather indirect measure of the 
particular level of iron status with which it is associated. 
Secondly, the biological range of "normal" values is wide, and often age and sex specific. This makes 
the setting of upper or lower limits difficult and arbitrary even when a particular multiple of the 
standard deviation is taken from the mean or a specific percentile range is calculated from the 
distribution of results. 
• The selection of tests is for illustrative purposes and far from complete 
.. See for example 29, 34, 46, 56, 75, 94, 103, 105, 106, 120, 123, 124, 125, 135, 141, 148, 163, 200, 213, 222, 245, 260, 269, 272, 
273,316,322,351,397,408,417,435,436,440,527,430,531 
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And thirdly, the results .of tests are often affected by confounding factors. For example, infection can 
increase serum ferritin and decrease haemoglobin concentration resulting in the awkward case used as 
an illustration above. The classification scheme assumes the absence of disease or variations from 
normal. Clinical judgement is required to apply the classification rules for individuals with 
inflammation, haemoglobinopathies etc. Studies of populations either exclude such cases or assume 
that their effect is negligible. 
The literature on classification and diagnosis contains didactic and instructional articles, assessment of 
new tests or refinement of established tests (for populations or for individuals), and review articles. 
The only article that is reviewed here is chosen because it describes the classification scheme used in 
the work reported in this thesis, and because it is practical and used in the Department of Paediatrics 
and Child Health, University of Cape Town. The reader who is interested in other practical aspects of 
this fascinating and frustrating problem is referred to the articles cited above. The theoretical aspects 
are discussed by BloisC43), Kraupel-Tayloi276) and MurphyC357). 
Kirsten et a/.267) used haemoglobin concentration, mean cell volume, mean cell haemoglobin and 
ferritin to classify infants between the ages of 1 and 12 months. A table of limiting values dividing the 
normal from the abnormal for each test and for 6 different age groups was derived from published 
data·. These reference values were then used in the decision criteria for their classification of iron 
status. A child is nonnal if all tests have normal results. Diminished iron stores was diagnosed if the 
ferritin was low. Haematological iron deficiency categorizes those children with low mean cell 
haemoglobin and mean cell volume. The criterion for diagnosis of iron deficiency anaemia is a low 
haemoglobin together with at least one of mean cell haemoglobin and mean cell volume below the 
normal limit. 
Like other classification schemes of iron deficiency, this does not unambiguously assign all possible 
combinations of test values into one diagnostic class. The example of the child with normal ferritin and 
low haemoglobin illustrates this. 
Like other classification schemes, it has tried to improve specificity and sensitivity by including multiple 
criteria using the inclusive or to conjoin potential sub-categories. The price to be paid for this is the 
(unlikely) confusion in classifying a case with low haemoglobin, but normal mean cell volume and 
normal mean cell haemoglobin. The nosologist usually will establish a catch-all category of other to 
tidy away this sort of non-conforming case. 
• The table is reproduced as 2 above. 
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Prevention of iron deficiency 
Iron supplementation and fortification 
Public health programs to combat iron deficiency 
With iron deficiency being the most common single nutrient deficiency much effort has been devoted 
to combating this disorder. This section discusses strategies for developing public health programs to 
reduce the prevalence of iron deficiency in a population. The following sections review the technology 
of food fortification with particular reference to infant milk formulas, factors influencing the absorption 
of iron, studies on iron absorption, trials of iron fortified infant milk formulas and risks of iron 
fortification. 
The World Health Organization has published a useful model of the development of national public 
health programs aimed at nutritional anaemiasC415). The first step is to define the problem of iron 
deficiency ie its extent and severity. This is done by determining the status of the population, 
identifying areas and groups at risk and by setting goals for acceptable levels of indicators of iron status 
such as mean haemoglobin. 
The second step entails a pilot trial of iron supplementation or fortification, depending on the 
prevalence and severity of iron deficiency. In areas with a moderate prevalence of iron deficiency, food 
fortification may be the best approach in increasing dietary intake since programs may be directed at 
whole communities or at particular vulnerable groups such as infants. 
With the experience gained from the pilot trial, large field trials may be implemented to test the 
feasibility of national programs. 
Technological issues in fortification of food with iron 
In implementing a program of iron fortification the food and the additive must satisfy certain 
requirements to be acceptable. The food must be widely consumed in adequate amounts and must be 
processed with strict attention to quality control. A suitable additive must be compatible with its food 
vehicle, readily assimilated and stable under locally available storage conditions. 
Vehicles for iron fortification in infancy 
Selection of a food for fortification with iron is a relatively simple task for infants. In fact most infant 
cereals and milk powders are routinely fortified with iron in various formsC310). 
CHAPTER 2 LITERATURE REVIEW 2.107 
Sources of iron for fortification 
Hurrell has provided a thorough overview of the technology of iron fortification<237). The most 
common form of iron added to infant milk formulas is ferrous sulfate, although ferrous ammonium 
citrate, ferrous citrate, ferrous gluconate and ferrous lactate are sometimes employed. The iron in 
ferrous sulfate is as least as well absorbed as iron in the other salts. 
Sources of iron commonly used for cereals are elemental iron, ferric pyrophosphate an4 ferric 
orthophosphate. These sources of iron are considerably less bioavailable than iron from ferrous 
sulfate, but the ferrous salts reduce product quality and shelf life unless it is kept in an airtight 
container. 
Factors influencing the absorption of iron 
Factors influencing the bioavailability of iron include its chemical properties and the presence of 
inhibitors and/ or facilitators of iron absorption. 
Chemical properties of iron that affect its bioavailability 
Oxidation states 
Iron is added to food as elemental iron or as ferrous (Fe2+) or ferric (Fe3+) salts. Ferrous iron is 
rapidly oxidized to ferric iron in the presence of oxygen. In a suitable chemical environment, ferrous 
iron may be formed by the oxidation of elemental iron or the reduction of ferric iron. 
Solubility 
The solubilities of ferrous iron at pH 7 and pH 8 are 10·1 M and 10·3 M. Ferric iron has a solubility of 
10·3 M at pH 2, but only 10·18 at pH 7. Thus, although both ferric and ferrous ions are readily soluble 
in the acid condition of the stomach, the ferric ion is insoluble in the slightly alkaline conditions of the 
small bowel where iron absorption occurs. In alkaline solution both ferric and ferrous iron tend to 
form their respective hydroxides which are insoluble. 
With few exceptions (eg ferric hydroxide, ferric orthophosphate and ferritin) all non-haem iron in a 
meal exchange with a common pool of ionized iron, and it is from this pool that absorption takes place. 
Haem is absorbed intact and the iron freed after it has been taken up from the lumen into the mucosal 
cell. 
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Formation of complexes 
Iron can react to form up to 6 coordinate bonds with ligands. Such a complex is termed monodentate 
if 6 ligands each form 1 bond with an iron atom; bidentate if 3 ligands each form 2 bonds with an iron 
atom and so on. A ligand is called a chelate when 2 or more atoms from the same ligand participate in 
the bonding of a complex. Different ligands may bond with the same atom to form mixed complexes. 
Binding to complexes is often highly pH dependent. 
In the acid conditions of the stomach most iron is released from complexes into a common pool and 
ferric iron is ~educed to ferrous iron in the presence of reducing agents such as ascorbic acid. In the 
small intestine the pH rises and this favours the reformation of complexes. Bioavailability of iron is 
determined by the solubility of the complexes, their affinity for iron and the extent to which insoluble 
hydroxides form. In general, ferric iron binds more strongly with ligands than ferrous iron. Ligands 
that chelate iron to form. insoluble complexes or complexes with very high affinity for iron inhibit its 
absorption. Examples include phosphates, oxalates, dietary fiber, tannins and phytate. Ligands that 
form soluble chelates with iron enhance its absorption. Amino acids, citrate and ascorbate are in this 
category. 
Haem iron is not susceptible to binding by ligands. 
The single most important determinant of bioavailability of iron is the quantity of animal tissue in the 
meal. The factors responsible have not been conclusively identified, but certain amino acids may act as 
ligands and cysteine certainly is important. 
In summary, the effect of a given ligand on iron availability depends on its concentration, its chelating 
efficiency (which is often highly pH dependent) and the types and ·concentrations of competing ligands. 
· The interaction of the factors that influence the bioavailabilty of iron is so complex that it is not yet 
possible from chemical properties to · predict quantitatively either the percentage· absorption or the 
effect on iron status. Such effects must be determined by direct measurement. 
Facilitators and inhibitors of iron absorption 
Factors that enhance the absorption of iron from a meal have been reviewed by Charlton and 
Bothweu<97). · Animal tissue, ascorbic acid and other organic acids such as lactic, citric, malic and 
tartaric acids promote iron absorption. 
Absorption of iron is inhibited by cereals, soya bean and bran; the responsible agents include 
polyphenols, tannins (present in tea, coffee and other foodstuffs) and phytates<97). A common 
preservative, EDTA, may decrease the availability of iron, depending on the presence of other ligands, 
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but it has been used to fortify refined sugar with iron. The major components of an infants diet that 
may contain inhibitors are cereals and soya bean based infant formulas. 
Rios et a/419) found similar values for the absorption of iron from cow's milk based formula and soya 
bean based formula, 3.9% and 3.4% compared with 5.4%. Interpretation of this study is difficult 
because they did not report the levels of ascorbic acid in the formulas. Other workers have reported a 
markedly lower bioavailability of iron in soya based infant formulas(133). Gillooly et a/194) found that 
the geometric mean absorption of iron from soya based formulas rose from 1.8% with no ascorbic acid 
to 7.7% with a molar ratio of ascorbic acid to iron of approximately 8:1. A direct comparison was 
made with a similar cow's milk formula at two concentrations of ascorbic acid. At a molar ratio of 
ascorbic acid to iron of approximately 2 the geometric mean absorption from the soya formula was 
2.4% and from the cow's milk formula 5.3%. Doubling the ascorbic acid content raised the respective 
absorptions to 7.2% and 19.5%. When the individual measurements were adjusted to a reference 
absorption of 40% the difference between the cow's milk and soya formulas was even more striking. 
Cook and Bothwen(l04) review a number of other studies on iron absorption from soya products and 
conclude that most recent studies suggest that soya impairs the absorption of non-haem iron. Varied 
explanations have been offered for the conflicting results, but these require confirmation. 
Iron absorption from breast milk is considerably more efficient than that from cow's milk or infant 
formulas. The reason for this is unknown but may be due to increased concentrations of ascorbic acid, 
cysteine, ,inosine and taurosine or decreased levels of phosphate(l04). 
In summary, the bioavailability of iron in a meal depends on the form of the iron and the presence of 
inhibitors and facilitators of absorption. The presence of meat in a meal or a glass of orange juice after 
the meal can greatly increase the absorption of iron, while a cup of tea after the meal can largely 
. suppress its assimilation. 
Iron absorption from infant milk formulas 
This section considers firstly some technical issues in the measurement of absorption of iron from food 
and then reviews studies of iron assimilation from infant milk formulas. The following section 
considers reports on the efficacy of programs of fortification of infant milk formulas in improving iron 
status. 
Measurement of food iron absorption 
Iron absorption from foods has been measured in several different ways(l04). It can be estimated from 
the change in iron status after introduction of a particular dietary regime. It may be calculated from 
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metabolic balance studies using chemical measurements of iron intake, excretion and losses. Or it may 
be deduced from the retention of radioactive iron ingested in a test meal. 
The first method, while being the "bottom line" in measuring the efficacy of a food fortification 
program, is a crude and ineffective method of determining the availability of iron from a particular 
compound in a particular food. The reasons for the unsuitability of this method include the 
assumptions that must be made in calculating total body iron and total iron intake and, more 
importantly, the fact that assimilation of iron is regulated according to iron status. 
Chemical methods of quantifying metabolic balance studies of iron are too imprecise for use in infancy. 
The most accurate method of measuring iron absorption in infancy has been to determine the 
incorporation of radioiron in circulating blood 10 to 14 days after a test meal. This method has been 
validated in adults by comparison with measurements of total body radio-activity. The method depends 
upon the existence of 2 common pools of iron in the gut viz haem iron and non-haem ir~n. le the 
proportion of iron absorbed from a test meal can be equated to the proportion of added radioiron that 
is absorbed (with a few exceptions that were noted above). 
A major methodologic problem in iron absorption studies is the enormous variation in percentage 
absorption which makes it difficult to compare results. The effect of the large day-to-day variation in 
absorption for any particular subject has been reduced by administering the test dose of iron over 
several days. The variability in biological response may be reduced by expressing absorption of iron as 
a percentage of the absorption from a "reference" dose of ferrous sulfate and ascorbic acid given in the 
fasting state. In studies designed to assess iron bioavailability the optimal approach has been to 
administer 2 ( or more in adults) meals to the same individual. The best statistical summary measure of 
absorption is the geometric mean since this is less affected by "outliers" than the arithmetic mean. The 
geometric mean is lower than the arithmetic mean (with data in the range obtained in absorption 
studies). 
Studies of iron availability in infant foods are often performed in iron replete adults. Extrapolation of 
the results to infants depends on a number of assumptions which have not yet been validated, but are 
probably methodologically sound(l04). 
Studies of iron absorption from cow's milk infant formulas 
The bioavailability of iron in infant milk formulas is highly dependent on the presence of ascorbic acid. 
This was shown by Derman et at'136) who conducted studies iii adult women of iron absorption from 
cow's milk based infant formula. When the molar ratio of ascorbic acid to iron was increased from O to 
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2 and from 2 to 6.3 the (arithmetic) mean percentage absorption rose from 7.2% to 19.6% and from 
21.9% to 35.7%. 
In a series of similar studies.conducted in infants aged between 5 and 18 months Stekel et af..482• 125) 
found geometric mean absorption of iron from formulas without added ascorbic acid to range from 
2.9% to 5.1 %. Higher mean absorption values, 5.9% to 11.3% were obtained from formulas with 
supplementary ascorbic acid. 
Gillooly et af..194) reported geometric mean absorption of iron by adult women from cow's milk based 
infant formula. These workers found that doubling the ascorbic acid content raised the percentage 
absorption of iron from 5.3% to 19.5%. 
The percentage absorption of iron from cow's milk based formulas that have not had added ascorbic 
acid has ranged from 2.9% to 19%(125• 136• 334• 418• 434• 438• 482). In view of these findings it has been 
accepted that, while cow's milk formulas do not promote the absorption of iron, they have substantially 
less inhibitory effects than infant cereals or solid foodsC104). .. 
These studies are analyzed in more detail in the following chapter. 
Trials of iron fortified infant milk formulas 
The effectiveness of iron fortification of infant foods in improving the iron status of a population has 
been shown in a number of studiesC7• 125• 323• 346• 347• 432• SOZ). These studies are summarized in table 
2.16 and discussed below. 
Marsh et af..323) compared a cow's milk based formula containing 12 mg Fe per litre and 55 mg ascorbic 
acid per litre with the same formula without iron and with evaporated milk. The milks were given to 3 
small groups of term and preterm infants from birth to 9 months of age. The group receiving the iron 
fortified milk had a mean haemoglobin of 12.69 g/dl at 9 months compared with 10.46 g/dl and 9.67 
g/ dl in the other 2 groups. 
Andelman and Sered(7) compared the same iron fortified milk with evaporated milk in infants from a 
low socio-economic population. The milk was given from discharge or the first clinic visit until 6 to 9 
months of age. At 1 year of age the mean haemoglobin level in the group receiving the iron fortified 
formula was 11.9 g/ dl, while the control group had a mean haemoglobin of 10.4 g/ dl and about 76% of 
these infants were considered to be anaemic at some stage during the study. in contrast, only 15% of 
the infants receiving iron fortification were considered anaemic at 1 year. 
"'t 
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In a small study Saarinen compared the haemoglobin, mean cell volume, percentage saturation of 
transferrin and serum ferritin levels in infants who received 1 of 3 different milks. The mean 
haemoglobin level at 1 year of age in the group who were fed an iron fortified cow's milk formula was 
12.9.· and none were classified as iron deficient. In the group who received an unfortified infant milk 
formula the haemoglobin level was 12.7 g/dl and 4% were diagnosed as iron deficient. The group 
whose source of milk was the breast had a mean haemoglobin level of 12.4 g/ dl and 7% were classed as 
iron deficient. Table 2.16 gives the criteria for classification of iron deficiency employed in this report. 
Dallman et af..l2S) and Steke1<479) reported on similar trials conducted in a low socio-economic group in 
Chile. In a pilot study, cow's milk formula fortified with iron was compared to the same milk without 
iron. At 9 months of age 14.8% of the infants on the fortified milk had haemoglobin levels below 11 
g/dl. The prevalence of anaemia among infants fed the unfortified formula 27.7%. In an effort to 
improve the bioavailability of the iron in the milk a second pilot study was performed with a group of 
infants who were given cow's milk formula with 15 mg Fe and 100 mg ascorbic per litre. This group 
had mean haemoglobin levels· of 12.2 g/dl and 12.5 g/dl at 9 and 15 months of age compared with 11.1 
g/ di and 11.4 g/ di in the control group who received unfortified formula·. The prevalence of anaemia 
at 9 months of age was about 7.5% and 34.7% in the respective groups. A large field trial was then 
implemented and reduced the prevalence of anaemia at 15 months of age to 5.5% from 29.9%. Mean 
haemoglobin levels improved to 12.2 g/dl from 11.2 g/dl at 15 months. 
These results are summarized in table 2.16 below. It is important to note that the results are directly 
comparable for neither the mean haemoglobin levels nor the proportion of children classed as iron 
deficient. Since each study used different criteria to diagnose iron deficiency, the diagnosis rate of iron 
deficiency differs. Also, since the studies removed children from further observation who turned out to 
be iron deficient during the study, both the mean haemoglobin levels and the prevalence of iron 
deficiency will be improved in the remaining infants. This effect is largest for the groups with poorest 
iron nutrition ~nd thus tends to diminish the difference between test and control groups. Nevertheless, 
the table does provide a clear indication of important trends. 
It should also be noted that none of these trials reported the methods of ascertainment and group 
assignment and that none of the studies were blinded. This leaves open the possibility that subjective 
factors may have introduced a bias into the composition of the groups. 
With these caveats in mind, comparison of the studies leads to some interesting conclusions. 
• The haemoglobin levels were read from figure 1 in the author's paper 
• The values for mean haemoglobin were obtained from the graphs in figure 2 of Steket's papei479). The same pa'P!:r 
contains the ascorbic acid concentrations of the milk formulas used by Marsh et a/(323) and Andelman and Serel?). 
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The infants in the study of Saarinen who were given cow's milk formula without added iron in fact 
achieved a higher mean haemoglobin and a lower prevalence of iron deficiency than infants in the 
other studies who received milk with iron, and in some cases, ascorbic acid as well. The same milk 
formula fortified with both iron and ascorbic acid was associated with mean haemoglobin levels of 
12.69 g/dl and 11.9 g/dl in the studies of Marsh et al and Andelman and Sered. It thus seems that 
excellent iron status may be achieved in infants who are fed an adequate solid diet, irrespective of the 
composition of the milk formula. It also seems that iron in a formula is of most benefit to those infants 
who have the least adequate solid diet. 
A corollary to this conclusion is that infants in a lower socio-economic community may benefit from 
infant milk formulas with more bioavailable iron than has been provided in the studies cited. 
Table 2.16 Trials of irou forlilied infant milk formula 
STUDY Marsb1 Marsb1 Andelman2 Saarinen3 
CHARACTERISTIC Term Premature 
Criteria for iron deficiency 
8 g/dl6 8 g/dl6 11 g/dl7 Haemoglobin below 10 g/dl 
Beikost Nil Nil Advised Vits + advice 
MILKS COMPARED 
1 Type Formula Formula Formula Formula 
Fe (mg/di) 12 · 12 12 n 
Vit C (mg/di) 55 55 55 
2 Type Formula Formula Evaporated Formula 
Fe (mg/di) 1 1 1 1 
Vit C (mg/di) 55 55 
3 Type Evaporated Evaporated Breast milk 
Fe (mg/di) 1 1 1 
Vit C (mg/di) 
RESULTS: Mean Haemoglobin (mg/di) [Age (months))8 
Group 1 12.69 [9} 12.49 [9] 11.9 [9] 12.9 [12] 
Group2 10.46 9.40 10.4 12.7 
Group] 9.67 8.55 12.4 
RESULTS: Proportion Iron Deficient 
Group 1 N/A N/A N/A 0% 
Group2 N/A N/A N/A 4% 
Group3 7% 
NOTES: N/A Not Available . 
Dallman4 
Pilol 1 
11 g/dl 
Advised 
Formula 
15 
Formula 
1 
N/A[9] 
N/A 
14.8% 
27.7% 
Dallman4 
Pilot 2 
11 g/dl 
Advised 
Formula 
15 
100 
Formula 
1 
12.3 [9] 
11.3 
7.5% approx 
34.7% 
Stekel5 
Field 
11 g/dl 
Advised 
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CHAPTER 2 LITERATURE REVIEW 2.115 
Risks of iron fortification 
Risk of infection 
Hegenauer and Saltman<214) and Fomon et al Pl) reviewed the literature and concluded that the 
clinical and experimental evidence suggests that oral iron supplements and iron fortification present a 
minimal public health risk of increased susceptibility to infection. However, the European Society of 
Paediatric Gastroenterology and Nutrition (ESPGAN) in their guidelines on infant nutrition<156) 
warned that iron in infant formula which exceeded the binding capacity of lacfoferrin might increase 
the susceptibility of infants to infection with Escherichia coli. The source of their concern was the study 
by Bullen et a/66) which measured the effect of haematin on bacterial colonization after challenge with 
Escherichia coli in new born, suckled guinea pigs. This was found to increase bacterial counts. In the 
same report it was noted that the bacteriostatic effect of human milk on Escherichia coli was abolished 
by the addition of sufficient ferric ammonium citrate to saturate iron binding. The ESPGAN paper 
noted that the clinical relevance of these findings was questionable for milk formula stored and 
prepared under hygienic conditions. 
Risk of decreased absorption of zinc and other metals 
Dietary iron ( organic and inorganic) has been shown in many stUdies to inhibit the absorption of 
zinc(499, 470, 98, 418, 438, 317, 236, 150, 114, 529, 183, 211, 238, 335). However, at least one study has not 
confirmed the competition for absorption between iron and zincC443), Most studies have used isotope 
studies to determine absorption and plasma zinc to determine zinc status but hair zinc levels were 
shown to be lower in malnourished infants than in normal children<139). 
The evidence for a competitive interaction between iron and zinc in the diet is reviewed by 
S0lomonsC469) who also considers the consequences for human nutrition and nutritional programs. He 
concludes that "conscious adjustment of the Fe/Zn ratio in human diets, foods and therapeutic nu(:ients 
should become a priority". 
The reason for this concern is that zinc deficiency includes amongst its many manifestations growth 
retardation<195) and impairment of the immune system<211• 33• 32>. 
Hurley et atC236) in a review of trace metal interactions state that, as for iron and zinc, there is a similar 
inverse relationship between the absorption of iron and manganese and their concentrations in the diet 
but that the dependency of copper absorption on iron concentration in the diet was unimportant. 
Other interactions were not discussed. 
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Risk of iron overload 
Bothwell and Charlton<47) have suggested that the risk of increasing the prevalence of iron overload in 
the population does not outweigh the benefits offered by programs of fortification of infant foods. The 
group at particular risk for early iron overload from fortification programs are idiopathic 
haemochromatosis homozygotes. The overall prevalence of this 'disorder is not known, but there are 
areas in North America and Europe where it is as high as 1 in 300 to 500 of the population<47). 
Risk of anaemia in vitamin E deficiency 
Williams et af.522) have suggested that in small . premature infants the development of vitamin E 
deficiency may lead to anaemia if they are given iron fortified milk formulas. The mechanism. is 
postulated by the authors to be loss of protection by vitamin E against lipid peroxidation. 
Risk of gastrointestinal symptoms 
In a summary of feeding recommendations for normal infants Fomon et af171) observed that: Some 
physicians are opposed to the use of iron{ortified formulas because of the belief that such feeding results 
in fussiness, colic, spitting-up, diarrhea, or constipation. Other physicians, including the authors, use iron-
! ortified formulas regularly and consider such manifestations relatively uncommon. Unfortunately, no 
study that satisfactorily resolves this controversy has been reported in the literature. 
Conclusions 
The literature review revealed some useful guidelines for planning a fortification program and outlined 
factors influencing the bioavailability of iron. With reference to infant milk formulas it was noted that 
ascorbic acid is an important facilitator of iron absorption and that iron is less available from formulas 
based on soya bean. It was shown that iron status in infants depends on both the source of milk and 
additional foods taken. In upper socio-economic communities the level of iron fortification in infant 
milk formula is less important than it is in lower socio-economic communities where the beikost. is of a 
poorer quality. In lower socio-economic communities optimal iron nutrition has not been achieved 
with infant milk formulas fortified at levels employed in studies reported to date. 
That we must examine, not the final, but the efficient, causes 
of created things. 
Likewise, finally, we will not seek reasons of natural things 
from the end which God or nature proposed to himself in their 
creation (i.e. final causes), for we ought not to presume so far as 
to think that we are sharers in the counsels of Deity, but, 
considering him as the efficient cause of all things, let us 
endeavour to discover by the natural light which he has planted in 
us, applied to those of his attributes of which he has been willing 
we should have some knowledge, what must be concluded 
regarding those effects we perceil!e by our senses; bearing in mind, 
however, what has been already said, that we must only confide in 
this natural light so long as nothing contrary to its dictates is 
revealed by God himself. 
Rene Descartes 
The principles of philosophy 
AD 1646 



CHAPTER 3 STUDY DESIGN, METHODS AND MATERIALS 
Introduction 
This chapter describes the problem addressed by the thesis, outlines the design and protocol, details 
the planning of the trial and documents the methods and materials employed. 
The problem addressed by the study 
In Cape Town the municipal health clinics provide at subsidized prices cow's milk formula fortified 
with iron and ascorbic acid to families with young children. Yet surveys such as that of Kirsten et 
af.267) have found a disturbingly high prevalence of iron deficiency in otherwise normal infants. The 
review of the literature in chapter 2 showed that infants in lower socio-economic communities certainly 
benefit from the fortification of infant milk formulas with iron but that this often does not achieve 
optimal iron nutrition in the population. From 5 to 10 percent c:if the infants may still be considered 
iron deficient in spite of being fed with a formula containing 25% more iron and 100% more ascorbic 
acid. than that employed in a popular commercial product. 
The primary aim of the study thus was to see if increased iron fortification of a conventional infant milk 
formula would result in improved iron nutrition in healthy full term infants. 
The literature review in chapter 2 showed that iron deficiency impairs a number of laboratory tests of 
immune function and that it may increase susceptibility to infection. The second aim of the study thus 
was to document any changes in immune function tests and susceptibility to infection that might follow 
from increasing the quantity of iron in the milk formula. 
The third aim of the study was to determine if the additional iron in the milk formula was associated 
with any risks. In chapter 2 a number of potential risks of iron fortification were identified and 
discussed. It was noted that authorities considered the risks to be minimal but that data establishing 
the safety of high levels of iron fortification of infant milk formula have not been published. The risks 
include an increased susceptibility to infection, particularly infectious diarrhoeal disease, decreased zinc 
absorption and gastrointestinal upsets. 
The following section describes the design of the clinical trial that was made of an infant milk formula 
with the concentration of iron substantially increased. Advantage was taken of the study infrastructure 
to conduct surveys of the infant feeding habits in the community and of the socio-economic 
characteristics of the participating families. These surveys not only provided independently valuable 
descriptive data but allow the main study to be placed in its social and economic context. Their 
protocols are described at the end of this chapter. 
3.2 
Study design - Iron fortification trial 
Acknowledgements 
IRON NUTRITION AND IMMUNITY. 
The protocol for this study was drawn up with the assistance of Prof H de V Heese and in consultation 
with Prof DW Beatty. 
Protocol 
The study employed a prospective, stratified, double blind, controlled trial of iron fortified milk 
formula in which a group of infants were studied .from the age of 3 months to 1 year. Half of the 
children, the Control group, were given a standard milk formula (Lactogen Full Protein) which 
contains 8.3 mg Fe/100 g formula and 37 mg ascorbic acid/100g formula. The other half of the 
subjects, ie the Test group, were given the same milk powder supplemented with extra iron to give 40 
mg Fe/ 100g formula. Mothers were provided with sufficient milk formula to give their child the lesser 
of 180 ml/kg/day or 1.5 liters/day. 
The data. collected on entry to and exit from the study included biographical details, the weight, length 
and skull circumference, evidence for possible infection (if any), full blood count with differential 
enumeration, either leukocyte phytohaemagglutinin stimulation response or neutrophil bactericidal 
index, lymphocyte subtyping and estimation of T and B cell numbers and proportions, delayed 
cutaneous hypersensitivity to PPD and candida antigen, and plasma antibody levels to polio and 
tetanus. Plasma antibody levels to polio and tetanus were also determined in the mother when the 
child was 3 months old. On entry, a sample of faeces was cultured for pathogenic viruses, and on exit 
each child had swabs for viral culture taken from the nasopharynx and rectum. Zinc concentrations 
were determined in plasma and hair at the start and on completion of the trial. 
Each child was seen every 3 or 4 weeks and subjected to a clinical examination with. recording of 
weight, length, head circumference and any features suggestive of infection. The child's caretaker was 
specifically asked if the child had had symptoms of infection or had been taken to a doctor, hospital or 
clinic since the previous examination. 
The data collection form is reproduced in appendix 6. 
Children excluded for reasons of iron deficiency and infants found to be iron deficient at the end of the 
study were treated with oral iron supplementation for 3 months. 
Care was taken to avoid ethical problems that might have arisen from using an inf ant milk formula in a 
setting where breast feeding is actively encouraged. 
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Important design features and the reasons for the decisions and choices that were made in designing 
this experiment are detailed in the following sections. 
Eligibility criteria 
As ill-health and malnutrition adversely affect the immune system the eligibility criteria were designed 
to select a group of healthy, well-nourished children in order to avoid co~founding factors. The 
. selection criteria included the following: 
Birth weight at least 3000 g 
Weight at 3 months at least 5000 g for girls and 5500 g for boys 
No serious illness before entry to the study 
No blood transfusions before entry to study 
The prospective controlled trial is such a well accepted paradigm that it does not in itself require 
explanation. It is however worthwhile elaborating briefly on the care with which the Control group was 
designed to be comparable to the Test group at the start of the trial and to be exposed to equivalent 
environmental influences. For these epidemiological reasons as well as logistic constraints the children 
had to come from a circumscribed area in a relatively homogeneous lower socio- economic group. 
Bonteheuwel, a city council housing estate, was chosen because it fulfilled these criteria, was close to 
the Red Cross War Memorial Childrens Hospital, and had Cape Town City Health Department clinic 
facilities within easy walking distance of all residents. 
If children from disparate social backgrounds and residential areas had been studied, their exposure to 
sources of infection and perhaps their susceptibility to infection would have been heterogeneous. It 
was hoped that the choice of Bonteheuwel would minimize the differences in susceptibility and 
exposure to infection between children in the study. 
Although enrollment took place over an extended period, approximately equal numbers of infants from 
each group were entered into the study each month. The intention was to avoid the bias that 
differential enrollment would have had on the exposure to infection experienced by the two gtoups. 
Ascertainment 
Mpthers in Cape Town use a number of hospitals and maternity units to deliver their children. These 
facilities mail notification of birth to the primary health clinic serving the the area in which the mother 
· resides. In Bonteheuwel, virtually all mothers deliver their children in one of the recognized health 
care facilities. Since the notification system works efficiently, the Bonteheuwel municipal health clinic 
has an accurate record of births in the area it serves. These notifications of birth were used to 
ascertain the children in the study. 
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Control and Test group allocation and "blinding" 
Each month, from April 1983 to August 1983, the birth notifications for the previous month were 
obtained for Bonteheuwel and the name and address of the mother, her parity, any complications 
during pregnancy, the date of birth and sex and weight of the child were extracted. 
Children were admitted monthly to the study and were allocated to their group, Test or Control, by a 
computer program that discarded children with a birth weight less than 3000 g and then performed a 
stratified match on two_ potentially confounding variables. These were the number of previous · 
pregnancies of the mother, and birth weight. The reason for stratifying the infants according to their 
weight and the parity of the mother was that it was hoped that this would control, in the best available 
way, for susceptibility and exposure to infection. Weight was used as a proxy for nutritional and socio-
economic status and parity as a proxy for number of possible infectious contacts. 
The allocations were made before the children had been seen or the parents contacted. The parents, 
the study team and the laboratory staff were unaware of the group allocations until the end of the study 
and all laboratory investigations had been completed. Each child was allocated a unique code number 
by a computer program. The list of names, code numbers and Test/Control group assignment was 
kept by staff of Food and Nutritional Products so they could label the correct tins of milk formula for 
each child with his or her name. 
Exclusions and drop-outs 
Of the first 157 children allocated to the study, 2 were excluded because their haemoglobin was less 
than 9.0 g/dl and 6 parents declined the offer to participate. No children had medical reasons for 
exclusion such as a blood transfusion or serious illness. Of the 149 children that began in the trial, 10 
mothers withdrew for personal and domestic reasons and 7 families moved away from the study area; 
132 children completed the study. Details of the children that dropped out are tabulated in appendix 1 
and completion rates for the Test and Control Groups are presented with the other results for the 
study. 
Study size 
Estimation of the number of subjects required to reach a meaningful conclusion from the study proved 
a difficult task. As will be shown below it was expected that a conclusive difference in iron status would 
be shown with a relatively small number of subjects. The possible benefits and risks of increas~d iron 
fortification that the study aimed to determine centered on immune function and susceptibility to 
infection. Since infection is the important factor from the point of view of the child, parent and health 
care system, the number of subjects was established so that a clinically important difference in infection 
rate would be detected with a high degree of probability. 
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There was little assistance to be gained from the literature in estimating the "normal" number of 
infections experienced by a group of normal infarits. This is partly because there are few published 
studiesC354• 472• 475) with adequate data, and partly because infectious morbidity is so dependent on 
social, economic and geographic factors that generalization from one community to another is often 
not valid. 
The study with the best data for our planning purposes was found in the study of MackayC314) made in 
the nineteen twenties. From the data given in her report it is possible to calculate that the incidence of 
infection in the control group was 4.16 per child per year and in the iron group it was 1.99 cases per 
year, the difference being 2.17 infections per child per annum. No study was found where the standard 
deviation of incidence of infection of normal infants could be estimated. 
As a rough guide the following calculation was performed: 
If the trial intervention resulted in a "saving" of one infection per child per year, and the 
standard deviation· of the incidence of infection was 2.5, the number required in each group 
to reach a statistical significance level of 5% with a type II error of 10% is: 
N = ((1.96 + l.28)*2.5/1)2 = 65.6 
le the total sample size should be at least 132 subjects. It was decided to attempt to enroll 150 
subjects, 75 in each group, as the errors in the above calculation could not be estimated. Given the rate 
at which subjects could be enrolled (10 per week), the duration over which the study could be held (2 
years), and the capacities of the laboratories and study team, the target of 150 subjects was. the practical 
limit within these resources. 
Reason for fortification as an intervention strategy 
The intervention strategies that were considered in the design of the study were: 
1 The use of intra-muscular iron dextran to prevent iron deficiency from occurring in a group 
of children 
ii The use of supplementation with oral iron preparations 
m The use of fortification of a common food 
The first strategy was rejected because intra-muscular iron dextran has not found general favour as an 
agent in preventing the development of iron deficiency in groups at risk. The reason for this general 
reluctance may be due to the nature of administration (it is a painful injection) and to fears about 
possible untoward side-effects of the drug. These include lingering doubts about the danger of . 
inducing sarcomas, concern about the risk of increasing susceptibility to infection and concern about 
the possibility of idiosyncratic reactions<529). The risks are small and these concerns are not sufficient 
to inhibit the use of intra~muscular iron dextran in treating established iron deficiency, but, where the 
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alternative exists of a painless, safe, effective and "transparent" method of prophylaxis of iron 
deficiency, the latter must be chosen(l4), 
The second strategy considered was that of iron supplementation. Oral iron supplementation is 
effective in. preventing iron deficiency but poor compliance with prescribed drug regimes is a 
ubiquitous problem in medical practice. In view of previous experience in Cape Town it was 
considered that compliance with a prophylactic medicine would be low in spite of steps that could be 
taken to persuade mothers to administer the iron preparation as advisel. 
The final strategy considered for the experiment was to fortify a common infant food with iron. This 
has the advantages of safety, ease of delivery and increased compliance<479), 
One doubt that remained was of the efficacy of the intervention. The analysis that provided the 
decision in favour of this strategy is given in the following three sections. 
It may be asked why, given the not inconsiderable problems involved in conducting this sort of field 
trial, an animal model was not used instead. There are 2 principal reasons. Firstly, since the 
effectiveness of a food fortification program depends on the delivery system, acceptability of the 
product and other cultural and logistic factors, such programs will always require verification by means 
of field trials. Secondly, experiments on animals have provided convincing evidence for disturbances of 
laboratory tests of immune function in severely iron deficient rats<281• 121). It has not been possible 
however, to develop a suitable animal model for the incidence of common infections in infancy. 
Reason for infant milk formula as vehicle 
Various foods have been used as vehicles for fortification of iron and infant cereals and milk powders 
are routinely fortified. Extensive reviews of the subject have been published eg references (14, 94). 
Criteria identified by the World Health Organization for practical vehicles for iron fortification are that 
"The vehicle should be one that is already consumed in adequate amounts by the people in need; one that 
is available for fortification in relatively few centres so that quality can be adequately controlled and 
monitored; one that is suitable for f ortijication on a large scale; and one that results in a product which is 
stable under e.1:treme conditions of storage and does not alter the palatability of the food"(4lS). 
Infant milk formula meets these conditions since the health clinics of the City of Cape Town provide a 
milk powder at subsidized prices to families with infants and young children at a time when milk forms 
a major part of their diet 
• Kirsten G and Heese H de V, personal communication. Also see the comments of Stekel on page 189 of reference 479 
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Lactogen Full Protein was used for the trial as Food and Nutritional Products (Nesti) offered to 
supply standard and modified formulas free of charge and to assist in implementing the double blind 
protocol. The one important criterion in selecting the milk formula was that it should be based on 
cow's milk protein and not soya bean since such such preparations may have decreased iron 
absorption(l04). 
The commercial infant milk formula employed in the study for the Control group contains 37 mg of 
ascorbic acid per 100 g formula and 8.3 mg Fe (as ferrous sulfate) per 100 g of powder. The 
reconstituted formula contained 12 mg Fe/land 53 mg ascorbic acid /I. The molar ratio of ascorbic 
acid to iron is 1.41. 
With 40 mg Fe/ 100 g, the Test formula contained 58 mg Fe /1 of reconstituted milk and the molar 
ratio of ascorbic acid to iron was 0.29. 
The reasons for using ferrous sulfate as fortificant, for choosing the fortification levels of 8.3 and 40 mg 
Fe/100 g, and for not increasing the ascorbic acid fortification in the Test formula are given in the 
following paragraphs. 
Reason for ferrous sulfate as fortificant 
Forms of iron employed for fortification of infant milk formula include ferrous sulfate, ferrous 
fumarate, ferrous gluconate and ferrous lactate. Ferrous sulfate is cheap and relatively easily absorbed 
(compared to other non-haem iron products), but is quite chemically reactive and can impair storage of · 
formula which is not in a sealed container(237). However, ferrous sulfate is successfully used in many 
commercially available infant milk formulas and most studies of absorption of iron from infant milk 
formulas have employed it. The decision to employ it in the trial was not difficult. 
Reason for choosing 8.3 mg Fe/lOOg as the level of fortification for the 
Control group 
(a) Ethical considerations 
Having decided on the structure of the experiment, the levels of iron in the milk offered to the Control 
and Test Groups had to be set. The statistical power of the study to detect differences in iron status, 
immune function and incidence of infection would have been improved if a (third) group had been 
given unfortified formula, but this would not have been ethical in view of the known risks of iron 
deficiency. 
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(b) Considerations of ability to generalize conclusions 
To assess the relative risks and benefits of increasing the concentration of iron in the Test group, the 
Control group had to have a conventional formula.· The milk offered to the Control group therefore 
was fortified with the amount of iron present in commercially available Lactogen Full Protein. An 
additional reason for using a commercially available milk formula for the Control group was that such 
formulas are sold at subsidized prices at municipal health clinics. The results of the study would 
therefore be readily generalizable to the community. 
(c) Estimations of effect on iron status 
(i) Experience in Cape Town 
In Heideveld, a similar community to that chosen for the present study, Kirsten et a/241 found a mean 
haemoglobin level of 10.5 g/dl in 1 year old infants. These were all healthy infants who regularly 
attended a municipal primary health care clinic where infant milk formula (fortified with iron and 
ascorbic acid) was available at a subsidized price. With the present study's protocol it was expected 
that the selection criteria would exclude a certain proportion of children at higher risk for developing 
iron deficiency. In addition, making fortified milk freely available would tend to raise the average level 
of iron nutrition in the Control group from what it would have. been with no intervention. These 2 
effects could not be quantified, but it was expected that the mean haemoglobin of the Control group 
would be about 1 g/ dl higher than that found in Heideveld by Kirsten et al. 
In effect, a "target" level of haemoglobin for the Control group at 1 year was set at 11.5 g/ dl. Some 
uncertainties in predicting this target are discussed in the following 2 sections. 
(ii) Similar international studies 
The results of several studies of iron fortification are discussed in chapter 2 and summarized in table 
2.16. This shows that infants fed on similar milk formulas had mean haemoglobin levels that varied 
from 11.9 g/ di to about 12.9 g/ dl. Infants from Finland had higher mean haemoglobin levels and a 
lower incidence of iron deficiency even when the group given unfortified formula is compared with 
other groups given the formula with the largest amount of iron and highest ratio of ascorbic acid to 
iron·. Prediction of the results of a program of iron fortification may thus be made in qualitative rather 
than quantitative terms. It was further concluded in chapter 2 that infants in lower socio-economic 
communities might benefit from increases in the iron fortification of infant milk formula. 
• This statement assumes the qualifications expressed in the review in chapter 2. Some mean haemoglobin levels were 
obtained from graphs rather than from text in the papers cited and criteria for defining iron deficiency <liffer. These 
reservations notwithstanding, the data are adequate to make the point that iron nutrition depends on the total diet rather 
than just on~ component. 
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(iii) Effects of genetic, socio-economic class and cultural factors 
The effect of the prevalence of individuals with thalassemia or an haemoglobinopathy on the means of 
measures of iron status in populations is likely to be small and can be disregarded in the calculations 
used in planning studies of iron fortification. Justification for this assertion rests on studies of patients 
at the Red Cross War Memorial Childrens Hospital by Bird et af41). These workers found that 10.4% 
of "coloured" children with a mean cell volume less than 60% had a haemoglobinopathy or a 
thalassemia._ The order of magnitude of the effect that such conditions might have on measures of iron 
status in the population may be estimated. If 1 % of 1 year old children have a mean cell volume less 
than 60 fl, then 1 in 10 of these infants might be misdiagnosed as iron deficient. Ie about 0.1 % might 
have either a thalassaemia syndrome or an haemoglobinopathy but be misclassified as iron deficient. It 
can thus be concluded that measures of the iron status of a population should not be affected to a 
significant extent by such conditions. 
Reasons for choosing 40 mg Fe/lOOg as the level of fortification for the Test 
group and not altering the concentration of ascorbic acid. 
(a) Optimal iron status 
The mean haemoglobin level of a well nourished group of Canadian infants was 12.2 g/dl(SZ) and the 
mean haemoglobin level of one year old infants who do not have evidence of iron deficiency has been 
reported to be 12.5 g/dl by Dallman et a1'124) and 12.7 g/dl by Saarinen and Siimes<435). These results 
indicate the mean haemoglobin level in communities with optimal iron status. It was felt that, with 
excellent iron fortification, the Test group could achieve a mean haemoglobin concentration of 12.0 to 
12.5 g/dl. 
(b) Considerations of iron absorption and ascorbic acid 
(i) Recommendations of the World Health Organization 
The decision to set the level of fortification of iron at 40 mg Fe/100 formula was made on the basis of 
an "educated guess" since the literature had no specific guidelines. Dallman et ai025) have shown that 
the percentage absorption of iron from infant milk formula decreases as the dose increases, but that 
total absorption continues to increase, albeit at a diminisliing rate. It was also known that iron 
absorption is enhanced by ascorbic acid and that the World Health Organization had recommended 
that "it would seem advisable for infant formulas to include both an absorbable iron salt and ascorbic 
acid with an iron:ascorbic acid ratio of at least J:10"<415). Assuming this ratio is mass:mass it is 
equivalent to a molar ratio of ascorbic acid to iron of 3.17. The WHO recommendation was based on 
data from absorption studies on cereals which have inhibitory effects on iron absorption. The 
recommended ratio of ascorbic acid to iron is therefore probably excessive for cow's milk based 
formulas. 
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(ii) Data on the association of ascorbic acid with iron absorption 
Chapter 2 reviewed several studies which have shown that ascorbic acid improves the absorption of 
iron from infant milk formula. In 3 studies of a formula with 15 mg iron per litre Dallman et af125) 
found that 100 mg ascorbic acid improved the absorption of iron from 5.5%, 4.0% and 4.9% to 12.0%, 
10.7% and 11.3% (geometric means). Subsequent work has confirmed this and their results are 
summarized in table 3.1 and figure 3.1. (This does not include the data from Dallman et al since it 
seems that Stekel included it in his report.) The table and figure show the relationship between the 
molar ratjo of ascorbic acid to iron and percentage absorption of iron. Each study confirms the 
increase in iron absorption with increased ascorbicacid:iron ratio. 
The next section presents an analysis of an attempt to predict the percentage iron absorption from lines 
fitted by the least squares technique to the published data. 
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Table 3.l Iron absorption from infant milk formulas 
\ 
STUDY IRON ASCORBIC ACID [Fe]/[AA] ABSORPTION 
(mg/I) (mg/I) mol/mol % Std Dev N 
2 15.0 0 0.00 · 2.9 4.3 23 
2 15.0 0 0.00 2.9 3.6 12 
2 15.0 0 0.00 2.9 3.2 12 
2 15.0 0 0.00 3.0 4.7 10 
2 10.0 0 0.00 3.1 5.3 23 
2 15.0 0 0.00 3.4 3.4 13 
2 15.0 0 0.00 3.6 3.8 13 
2 10.0 0 0.00 3.7 6.9 35 
2 10.0 0 0.00 4.0 6.7 15 
2 15.0 0 0.00 4.4 5.2 13 
2 15.0 0 0.00 4.4 5.7 39 
2 15.0 0 0.00 4.7 45 11 
2 15.0 0 0.00 4.7 4.3 12 
2 10.0 0 0.00 5.1 6.2 16 
2 12.7 0 0.00 7.2 9.4 12 
2 19.0 10 0.17 3.4 4.2 19 
2 15.0 25 0.53 3.4 3.9 12 
2 19.0 40 0.67 8.8 8.1 12 
2 15.0 50 1.06 5.5 6.3 12 
2 12.0 55 1.45 10.3 12.2 22 
2 15.0 75 1.59 8.3 6.1 20 
2 12.7 80 2.00 19.6 14.5 12 
2 12.7 80 2.00 21.9 28.9 10 
2 20.0 133 2.11 5.3 8.25 12 
2 20.0 133 2.11 6.9 13.6 13 
2 15.0 100 2.11 7.9 8.8 13 
2 15.0 100 2.11 10.2 10.1 39 
2 15.0 100 2.11 11.3 9.1 13 
2 10.0 100 3.17 5.9 12.7 14 
2 15.0 200 4.23 7.9 9.7 12 
2 20.0 267 4.23 19.5 27.9 7 
2 12.7 254 6.34 55.7 30.9 10 
2 15.0 400 8.45 6.1 5.9 10 
2 15.0 800 16.91 11.8 11.8 11 
NOTES 
l; Derman DP, Bothwell TII, Torrance JD, Bezwoda WR, Charlton RW, Mayet FGH. Importance of ascorbic acid 
in the absotption of iron from infant foods. Scandinavian Journal of Haematology 1980; 25: 193-201 
Arithmetic means and standard deviations reported 
2: Stekel A, Olivares M, Pizarro F, Chadud P, Lopez I, Amar M. Absotption of fortification iron from milk formulas 
in infants. American Journal of Clinical Nutrition 1986; 43: 917-922 
Geometric means and standard deviations reported 
3: Gillooly M, Torrance JD, MacPhail AP, Mills W, Mayet F. The relative effect of ascorbic acid on iron absotption 
from soy-based and milk based infant formulas. American Journal of Oinical Nutrition 1984; 40: 522-527 
Geometric means and ranges reported; the mean of the range is tabulated in the Std Dev column 
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Figure 3.1 The relation between percentage iron absorption and molar ratio of ascorbic acid to iron in 
infant milk formulas from the studies of Derman et al, Stekel et al and Gillooly et al. 
; 
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(iii) Prediction of% iron absorption from regression analysis 
Linear regression analysis was performed on the data in table 3.1 in order to estimate the 
bioavailability of iron in the infant milk formulas employed in the present study. The results are 
summarized in table 3.2 and figure 3.1. Figure 3.1 shows the regression lines that were fitted by least 
squares to the 3 sets of investigations. To facilitate relating this analysis to the present study vertical 
lines in figure 3.1 indicate the ratio of ascorbic acid to iron in the Control and Test formulas. 
For example, from the data of Derman et al it was calculated by this technique that the Control group 
would absorb 17% of the iron present in the milk and the Test group would absorb 8.37%. If the 
infants ingested on average 500 ml of formula per day ( a conservative amount), they would be receiving 
5.98 mg and 28.83 mg iron respectively. The predicted amounts absorbed are 1.02 mg per day and 2.41 
mg per day. 
This analysis applied to the data from the other studies gave estimates of total iron absorption varying 
from an impossible -1.57 mg/day to 1.94 mg/day for all studies combined. It may be concluded that 
this technique does not allow an accurate prediction to be made of the amount of available iron in the 
Test formula. This is not surprising since the simple linear regression analysis ignores factors such as 
the iron status and age of the subjects, the presence or absence of other facilitators and inhibitors of 
iron absorption and the size of the meal. Linear regression also implies a simple ( and improbable) 
chemical relationship between ascorbic acid and bioavailable iron in a complex environment. 
. Table 3.2 Prediction of iron absorption from regression analysis 
ABSORPTION ABSORPTION 
Percentage from 500 ml formula ( mg) 
STUDY Const coeff control Test control Test 
Derman 6.09 7.74 17.00 8.37 1. 02 2.41 
stekel 4.92 0.46 5.58 5.06 0.33 1. 46 
Gillooly -7.30 6.34 1. 63 -5.44 0.10 -1.57 
Combined 6.40 1.14 8 •. oo 6.74 o. 48. 1.94 
NOTE Least squares analysis was applied to data in the published studies (see text for references). Percentage 
absorption of iron was modeled as a linear function of the molar ratio of ascorbic acid to iron. The linear 
regression coefficients were then used to predict the percentage and actual amounts of iron absorbed from 500 ml 
of the Test and Control infant milk formulas. The Control formula had a molar ratio of ascorbic acid tQ iron of 
1.41 and contained 11.96 mg Fe per liter when reconstituted. The values for the Test formula were 0.29 and 57.66 
respectively. 
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(iv) Estimation of iron absorption from comparison with therapy 
The quantity of iron offered to the Test group was therefore assessed in a different way. The accepted 
dose for therapeutic administration of ferrous sulfate in clinical iron deficiency is 6 mg/kg/ day at the 
Red Cross War Memorial Childrens Hospita1<111). Since the Test milk had 40 mg Fe /100 g, an infant 
would be provided with 5.8 mg/100 ml of r~constituted formula. If the infant ingests 100 ml 
formula/kg body mass, he or she is provided with 100% of the therapeutic dose of iron, Md with an 
intake of 50 ml/kg, 50% of the therapeutic dose of iron is provided. Thus, a conservative estimate of 
the amount of iron provided by the Test formula was at least 50% of the therapeutic dose. 
From these considerations it was felt that infants in the Test group would have sufficient absorbable 
iron to ensure that their iron status would be replete even if they were taking less than half the formula 
prescribed. 
(v) Calculation of% iron absorption from target iron status 
A third way of assessing the suitability of the level of 40mg of Fe/100 g is to estimate the extra iron 
required by the Test group to increase their average haemoglobin by 1 g/dl but maintain equal iron 
stores. Assuming that the average well nourished infant weighs 10 kg at the age of 1 year, has a blood 
volume of 80 ml/kg and has a haemoglobin level 1 g/ dl greater than a similar control infant, then he or 
she will have an additional 30 mg of iron in haemoglobin. Averaged over 9 months the extra daily 
absorption is 0.11 mg Fe/day. If the child is taking (a conservative estimate of) 500 ml formula pet day 
this extra iron should come from the 58/2 = 28.5 mg Fe/day in the milk formula. The increase in total 
absorption required is therefore 0.11/28.5 = 0.38%. It seemed not unreasonable to expect a 382% 
increase in iron fortification to cause at least a 0.4% increase in absorption·. 
A similar calculation may be made for changes in total body iron by using plasma ferritin to estimate 
iron stores. This would confirm the point that a small increase in iron absorption was expected from a 
very large increase in iron fortification. The method is based on such controversial assumptions about 
the quantitative relationship of plasma ferritin to iron stores in infancy that the exercise is not not 
worth repeating here. 
(vi) Consideration of effect of ferrous sulfate on milk formula 
It may be asked why the level of fortification was set at 40 mg Fe/100 g and not 30 mg Fe/100 g or 50 
mg/100 g. The decision was essentially arbitrary, but was based on discussions with the manufacturer 
and was as high as was felt possible without compromising the quality of the milk with respect to 
colour, taste and shelf life. It is of interest to note that a survey of 53 infant milk formulas in the USA, 
• Calculated from: 100*(40-8.3)/8.3 = 382. 
j 
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Japan and Europe found the iron content to range from 0.06 mg Fe/I to 58.5 mg Fe/1(310). The latter 
- concentration was found in 6 formulas for sale in the USA and is essentially equivalent to the 57.7 mg 
Fe/I in the Test formula. 
(vii) Number of experimental variables and interpretation of 
results 
A final remark on the decision not to increase ascorbic acid is necessary. The analysis above provided 
grounds for expecting that manipulation of the level of .-iron in the milk formula would result in a 
sufficiently large differentiation between the iron status of the Control and Test groups. 
An additional factor that argued against the simultaneous manipulation of iron and ascorbic acid was 
the desire for a clear interpretation of results. It was felt that interpretation of results from the 
experiment would be clearer if the only experimental variable was the level of iron fortification. If the 
Test milk had differed from the Control formula with respect to both iron and ascorbic &cid there 
would have been 2 experimental variables and it would have been difficult to assign outcome effects to 
the one or the other. 
Quantity of milk provided for infants 
In order to ensure that all infants ingested their full milk dietary requirements from the age of three 
months to one year, parents were given a generous supply of the milk formula viz 180 ml/kg/day or a 
maximum of 1.5 ml per day. To discourage family members from consuming infant formula some 
studies have used acidified milk powder<479). The feasibility of this strategy was explored with the help 
of health care workers familiar with the community. The common consensus was that acidified' milk 
would be unpopular with mothers. Consequently, a conventional infant milk formula was selected and 
mothers were given more than the average infant could have ingested. 
The milk was issued at the regular examination that each child underwent every 3 weeks. Mothers who 
were breast feeding (partly or wholly) were encouraged to continue nursing their infants, but were 
given the appropriate milk formula if they asked for it. 
The study team attempted to promote the practice of breast feeding in the community and it was felt 
that, if breast feeding mothers were not issued with the milk formula, this might discourage mothers 
from nursing and correctly reporting their infant's feeding habits. Similar reasoning led to the decision 
not to disqualify breast fed infants from participation in the study. 
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Reasons for entry at 3 months 
The greatest demand for iron is between 3 and 24 months and the highest prevalence of iron deficiency 
anaemia in term infants is in the second year of life. Many programs of iron supplementation or 
fortification for normal infants begin around the third month and continue until 9 to 15 months of age. 
Three months was a convenient time for entry into the study since simple criteria could be employed to 
select the healthy, well nourished infants required for the study and this time marked the start of 
increased iron requirements. 
Reasons for follow up period of 9 months 
The period between 3 and 12 months is a time when infant milk formula provides the bulk of many 
childrens' diets and thus provides an excellent opportunity for food fortification programs. A. prime 
requirement of the study was that children be followed for a sufficient length of time for the incidence 
of infection to be determined with confidence. Follow up to the age of 1 year satisfied the 
requirements of being able to determine the effect of the increased iron on both iron status and 
incidence of infection. 
Selection of laboratory tests 
(i) Volume of blood 
For ethical reasons it was decided that not more than 10 ml of blood would be taken from the children 
on each of the 2 occasions they were to be tested. This constrained the number of laboratory tests that 
could be performed on each sample and the reasons for excluding certain desirable tests are discussed 
in the following sections. 
(ii) Measures of iron status 
The study employed the full blood count (with differential count), plasma ferritin • and red cell zinc 
protoporphyrin as indicators of iron status. Since micro methods were not available at the time, it was 
decided that plasma iron, total iron binding capacity and percentage saturation of transf errin would not 
be measured. Characterization of the iron status of the subjects in the study would have been more 
complete had these variables been measured. Cook and Finch(lOS) have recommended that the iron 
status of populations be assessed by means of the haemoglobin, percentage saturation of transferrin, 
free erythrocyte protoporphyrin and serum ferritin. However, plasma iron,'total iron binding capacity 
and percentage saturation of transferrin have not proved to be very useful diagnostic tools in i:L,uants •. 
• For teasons explained below blood was collected into heparinized tubes and measurements were thus made on plasma rather 
than serum. 
• Heese H de V.: personal communication' 
I 
CHAPTER 3 STUDY DESIGN, METHODS Al~ MATERIALS 3.17 
Both transferrin and serum iron have wide normal ranges in 1 year old infants with no other evidence 
of iron deficiency<124, 527). Dallman(l20) has discussed the analytical and biological variations of 
laboratory tests and the implications for diagnosis of anaemia and iron deficiency. Conceptually, the 
transferrin saturation would seem to be a most useful indicator of iron deficiency. However, since it is 
calculated by dividing the concentration of serum iron by total iron binding capacity and multiplying by 
100, it will reflect the laboratory and biological variations of both serum iron and total iron binding 
capacity. (Unfortunately, Dallman did not report the coefficient of variation for transferrin saturation.) 
According to Dallman, serum iron has a biological coefficient of variation of about 28% while the 
coefficient of variation for total iron binding capacity is from 5 to 14%. The analytic and biological 
variations are generally lower for the other indicators of iron status. 
Dallman et af.-1'25) advised that haemoglobin, mean cell volume and serum ferritin or free erythrocyte 
protoporphyrin be used in population surveys of iron status. The relative utility of percentage 
saturation of transfetrin was not discussed in this paper but presumably was felt to be lower than that 
of serum ferritin or free erythrocyte protoporphyrin. 
Cook et al1°7) studied 326 adults to establish normal ranges for serum ferritin. They· found the within-
subject variation in serum iron and percentage saturation of transferrin to be as great as the variation 
within the group. The total iron binding capacity and serum ferritin were more <:onsistent. 
Derman et af.-135) studied children between the age of 1 and 6 years of age and reported statistically 
significant correlations of serum ferritin with age, haemoglobin, percentage saturation of transferrin 
and serum iron. The low correlation coefficients for serum iron and percentage saturation of 
transferrin ( all were less than 45%) indicate that these measure are largely independent of serum 
ferritin. The authors concluded that "the accuracy of detection of individuals with Fe-deficiency anaemia 
in a population is substantially improved if two independent measures of Fe deficiency are used in 
combination". 
Hershko et af.-197) assessed the iron status of a group of rural children and reported the sensitivities of 
serum ferritin and percentage saturation of transferrin in detecting individuals with iron deficiency 
anaemia defined as haemoglobin less than 11.0 g/ dl and red cell protoporphyrin greater than 40 ug/ di. 
Of 23 · individuals with iron deficiency anaemia, serum ferritin was less than 16 g/1 in 19 (83%) and 
saturation of transferrin was less than 16% in 20 (91%). It would have been useful if the sensitivity of 
serum ferritin combined with percentage saturation of transferrin had been reported. It would then · 
have been possible to assess if the 2 tests are equivalent or complementary in diagnosing iron 
deficiency anaemia. 
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Dallman et af..11:J) studied the ability of several tests to predict a response of at least lg/dl in the 
haemoglobin level of 1 year old infants after. a therapeutic trial of iron. The tests were the mean cell 
volume, percentage saturation of transferrin, free erythrocyte protoporphyrin and serum ferritin. None 
could reliably predict a response in haemoglobin levels and the tests were partly complementary. (It is 
of interest that about 10% of the responders were not identified by any test.) The authors did not 
compare the relative utility of the tests with each other or discuss what would have been lost if 1 test 
had been omitted. 
Cook and Finch(lOS) have stated that the percentage saturation of transferrin is roughly equivalent to 
the free erythrocyte protoporphyrin in assessing iron status. 
It thus seemed that there would be a minimal opportunity cost in foregoing the iron, total iron binding 
capacity and transferrin saturation tests in the present study and that iron status would be fairly well 
characterized by the use of the full blood count, plasma ferritin and red cell zinc protoporphyrin. 
(iii) Measures of immune function 
In order to characterize the immune status of the subjects a battery of immune function tests were 
applied. 
The numbers and proportions of B lymphocytes and subtypes of T lymphocytes were determined with 
antibody techniques. An incidental benefit of the study was the ability to determine normal ranges for 
the laboratory. 
Leukocyte function was measured in half of the children with the response of lymphocytes to 
stimulation with phytohaemaglutinin. Samples from the other children were subjected to a neutrophil 
bactericidal assay. Each child had the same test at both 3 months and 12 months in order to minimize 
the effects of inter-subject variation. A side benefit again of the study was the ability to describe 
normal ranges for these tests in infants. 
The response to immunization with polio and tetanus was determined. These measured different.arms 
of the immune system since the polio vaccine was live virus administered orally and the tetanus vaccine 
was a toxiod administered intramuscularly. 
Delayed cutaneous hypersensitivity was measured with the Mantoux test and candida antigen test. 
These tests indicate both exposure to the agent inducing immunity and the ability of cell mediated 
immunity to respond to a challenge. 
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(iv) Measures of viral carriage rate 
If iron status influences immune function or if iron fortification affects bowel flora it might be expected 
that the carriage rate of viruses might differ between the 2 study groups. For this reason fecal material 
was tested at both 3 and 12 months and nasopharyngeal swabs were tested at 12 months. An incidental 
benefit was the ability to describe the pattern of viral infection in healthy infants in the community; an 
opportunity that does not present itself often to laboratories which receive most of their specimens 
from hospital patients. 
(v) Sociological characterization 
Data was collected to define certain social and economic characteristics of the families in order to 
place the study into its social context. This included information on age, education marital status and 
occupation of parents, living conditions and numbers of children in the family. 
Project team 
The project was conducted by myself, then a registrar in the Department of Paediatrics and Child 
Health. I was fortunate to have the assistance of Mrs D Phillips, a health educator, as my assistant for 
the duration· of the trial. Mrs Phillips traced subjects, coordinated the project with the operations of 
the Bonteheuwel Health Clinic, ensured that subjects kept their appointments, assisted in the 
examination room, made innumerable home visits to participating families, helped trace patient ftles in 
hospital record departments, administered the questionnaires, and assisted in the entry of data and its 
preliminary analysis. 
The entire project was directed by Professor H de V Heese who initiated the study. Professor DW 
Beatty provided guidance and advice at all stages. Where I have been especially indebted to others for 
particular parts of this undertaking I have acknowledged this in the text. The assistance of many other 
. individuals and institutions is acknowledged at the beginning of this thesisa 
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Study Design - Social survey of participating families 
Introduction 
In order to place the main study in its social context, a survey was made of the participating families to 
supplement the limited demographic data gathered· at the examinations of each child. Restricted 
resources did not allow the detailed investigation that a sociologist would have recommended, but the 
survey did allow the community of Bonteheuwel to be described with a measure of objectivity. 
Acknowledgements 
The questionnaire was designed in consultation with Mrs D Lynch, social worker. 
Protocol 
Each family was visited by the research assistant and asked to complete a questionnaire. The visits 
took place after the family had been participating for at least 3 months. The data collected was: 
Date of each immunization 
Result of WR test on mother during pregnancy 
Place of birth 
The names of all hospitals and doctors from whom health care had been sought 
The caretaker of the child during the day and at night 
The names of all siblings 
The type of housing: council house or shack 
Whether the house belonged to the family or was rented 
Whether the family was lodging with in~laws, or with others 
The mother's religion 
Whether there was a television set in the house 
The ages of the child's parents 
The names of any household members with pica 
The names of household members with tuberculosis 
The data that was collected on entry to the study included: 
The marital status of the mother 
The educational attainments of the mother and of the father 
The occupations of the parents 
The principal source of income for the family and whether this was regular or irregular 
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Whether the family was living alone or with others· 
Whether the child was cared for by one or both parents 
The number of adults in the house 
The number of siblings 
The number of rooms used for sleeping 
Study Design • Survey of infant feeding practices 
3.21 
Mothers attending the immunization clinic at Bonteheuwel were questioned on their infant feeding 
practices. The survey was performed over three weeks on two occasions; in April 1983 before the 
principal study commenced and again in October 1983 when the study was well under way. The data 
collection sheets are shown in appendix 6. The study design and results are given in chapter 5. 
Ethical Considerations 
Introduction 
Research involving children and infants often poses difficult ethical problems of consent, risk versus 
benefit, rights of the individual and society, review and approval by independent committees, and the 
distinction between and specific difficulties of therapeutic and non-therapeutic research. As medical 
ethics has become a topical subject in recent years, the researcher can fmd in .the literature much of the 
guidance required (393, 248, 294, 178, 4, 10, 303, 1, 82,411, 467, 464,495). 
The Medical Research Council stipulates that any research worker who receives its support should 
adhere to its document ''The Ethical Code and Practice for Clinical Investigations on Human 
Beings'l..471>. The University of Cape Town has requirements for review of projects as described in the 
next section. 
The non-therapeutic aspects of the research reported in this thesis involved no risk or discomfort to 
subjects or their families. The research that involved injections and blood sampling was justified by the 
therapeutic benefits obtained in comparison with the minimal risks and minor procedures involved. 
Written consent was obtained from parents before admission to the trial, but parents were free to 
withdraw at any stage from the study. Two did in fact do so shortly before their children were due for 
their second blood sample and delayed hypersensitivity skin test. Bonteheuwel is a small community 
and every family in the trial was friendly with several other participants. One may speculate that if 
there had been general dissatisfaction with the study methods, the dropout rate would have been much 
greater. 
• This question was poorly worded in the entry examination and was rephrased for the social survey 
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The project thus complied with the formal ethical requirements and attempted to meet the informal 
ethical requirements of professional peers and the local community. 
Research and Ethics Committee approval 
A requirement of the University of Cape Town for all studies under its auspices which involve human 
subjects is that the protocols should be approved by the independent Ethical Review and Research 
Committee in accordance with the Helsinki and Tokyo Declarations of the World Medical Assembly. 
One requirement of the committee is that fully informed consent be obtained from the subjects, or, as 
in this case, from their legal guardians. The present study adhered to these requirements. 
Copies of the authorizations from the Ethics and Research Committee are included in appendix 2. 
Parental consent 
Signed consent was obtained from the mother or father of each child. There was one exception in the 
case of an orphan where consent was obtained from the legal guardian and foster mother. The form 
that parents were asked to sign is included in appendix 6 
The promotion of breast feeding 
It was recognized that there was a possibility that the design of the study might create the impression in 
the community that formula feeding was to be preferred to breast feeding. The precautions that were 
taken to avoid this are detailed in the section on the design of the main study. 
It was considered important to document possible effects of the study on infant feeding practices in the 
community. The surveys that were made in order to do this are described in chapter 5. 
Potential side effects of iron fortification 
Increased susceptibility to infection 
The literature review in chapter 2 cited a number of studies that have suggested a role for excess iron 
in promoting infection. The conclusion was that, although there was a theoretical risk, there is no 
clinical or experimental evidence to implicate iron fortification of infant milk formula in increasing 
susceptibility to infection. However, no studies have conclusively documented the safety of such 
formulas. It was hoped that the study would provide such evidence. The steps taken to accomplish are 
described in the clinical methods section below. 
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Decreased zinc absorption 
The zinc status of the infants was determined because iron has been reported to interfere with zinc 
absorptionC469) and zinc deficiency can impair growth(lS3) and immune function(33). 
Gastrointestinal symptoms 
It was noted in chapter 2 that there was a lingering concern that iron fortification might be a cause of 
diarrhoea, constipation, colic and fussiness. For this reason, the caretakers of the infants were 
specifically asked at their first 3 or 4 visits if they had noticed any such symptoms. 
Anaemia 
Iron fortified milk has been thought to lead to anaemia in small premature infants who are deficient in 
vitamin E(SZ2). The postulated mechanism is promotion of lipid peroxidation by iron in the face of 
diminished protection of cell membranes by vitamin E leading to increased haemolysis. This 
phenomenon has not been described in full term infants. 
As premature infants are particularly at risk for vitamin E deficiency for the first few weeks of life, it 
was considered unlikely that the levels of iron fortification used in the present trial would constitute any 
risk of haemolysis in well nourished infants at the age of three months. 
Iron overload 
The risk of increasing the prevalence of iron overload was reviewed in chapter 2. The consensus in the 
literature is that iron fortification poses little or no risk to infants. 
Painful procedures and blood sampling in infants 
The main study involved the taking of a blood specimen and the administration of two intracutaneous 
injections to healthy infants at the ages of 3 and 12 months. It was decided on ethical grounds to limit 
attempts at venesection to 2 skin punctures. 
In the main study, the tests that were made, particularly the full blood count, were judged to be 
beneficial to the infants in that they provided a screening for disease. In an ideal situation with 
unlimited resources it would not be unreasonable to do such screening routinely. 
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Useful guidelines were found in a statement by the Medical Research Council of Great Britain(393). 
The authors state: 
" ... it is clearly within the competence of a parent or guardian of a child to give 
pennission for procedures intended to benefit that child when he is not old or intelligent 
enough to be able himself to give a valid consent. . .. preventives are given to people who 
are not, at the moment, suffering from the relevant illness. But the ethical and legal 
considerations are the same as those that govern the introduction of a new treatment." 
Treatment of Iron Deficient Infants 
Infants discovered to be iron deficient on entry to the study (2 infants), incidentally during the study (2 
infants) and on discharge from the study (57 infants) were treated with oral iron supplementation for 3 
months. 
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Clinical methods and data collection 
The data coUection forms used during the study'are shown in appendix 6. These and the full tabulation 
of statistical analyses list the clinical and laboratory variables studied for each child. The sections 
below· note methods used where this is important to establish the validity, accuracy or precision of the 
variable concerned. 
Age 
At each examination the age of each child was recorded in decimals of a year as recommended by 
Tanner et al491>, using their table to calculate the ages. For analysis of ages at entry to and exit from 
the study the age was calculated from the appropriate dates with an accuracy of one day. These dates 
were also used to determine the precise duration each child was under observation, and hence, an 
accurate measure of the incidence of infection. 
Weight 
Each occasion an infant was examined he or she was weighed on an Seca infant scale. The same scale 
was employed throughout the study and it was periodically checked with a standard weight. For 
analytic purposes the first and last recordings were used to establish weight gain during the study 
period. 
Standard deviation score for weight 
A computer program performed a linear interpolation for both weight and age to estimate the standard 
deviation score for weight (SD-W score) from the NCHS growth tables. 
Length 
The length of an infant was measured on an "infantometer", a board with a fixed foot-stop and a 
, 
headboard that moved along a scale marked in centimeters and millimeters. To obtain a reproducible 
result it was necessary for both team members together to position the infant and adjust the 
headboard. 
Standard deviation score for length 
The standard deviation score for length (SD-L score) was measured from the NCHS tables by a 
method similar to that used for SD-W score. 
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Skull circumference 
Skull circumference was measured with a tape measur~ around the forehead and over the inion. 
Diagnosis of infection 
The incidence of infection in the children was probably the most important information to be acquired 
by the study. Hence, a special effort was made to determine the infection rate as precisely as possible. 
In order to do this, and to facilitate comparison with other studies an operational definition was 
adopted for infection. A set of criteria were specified from which all diagnostic decisions were made as 
objectively as possible. For purposes of analysis, infections were graded according to severity and 
classed in one of eight groups according to organ system affected viz conjunctivitis, gastro-enteritis, 
respiratory tract infection, pyoderma, oral thrush and "other'. 
This section describes first how episodes of illness were ascertained and then describes the sequence of 
decisions that had to be reached in order to: 
1) Diagnose the reason for a visit to a medical practitioner as an infection. 
2) Count the infection as a discrete episode of morbidity. 
3) Grade the severity of the infection. 
4) Group the infection by organ system. 
This section then concludes with a discussion of the difficulties in determining infection rates precisely, 
accurately and in a manner which facilitates comparison with other studies of incidence of infection. 
Ascertainment of episodes of infection 
Each child was examined and a pertinent history was taken every three weeks throughout the study 
period. Any infection discovered was noted in the child's research folder. 
A member of the study team was available for consultation by the study families every weekday 
morning at the Bonteheuwel Health Clinic in addition to their regular three weekly appointment. 
Parents were also encouraged to use other available health care facilities if they so wished. Some 
mothers and fathers thus consulted private practitioners, municipal health clinics or provincial hospitals 
when their child was ill. Parents were encouraged to report each episode of illness as soon as possible 
after consultation with another source of health care and the details were noted. 
The diagnosis of these events was not made from the history obtained from parents but from the 
original records of the private practitioner, clinic or hospital. At the end of the study, I drew up a list of 
all clinics, hospitals and private practitioners that had been used as a source of medical care for any 
subject. At each clinic and hospital thus indentified, the patient index was searched to see if any 
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subject* had been registered as a patient. I then scrutinized the medical records for all registered 
subjects and noted any infections. All general practitioners that had treated any subject were contacted 
by post and by telephone and asked to assist in tracing episodes of infections in all the study patients. I 
requested that I be given the date, diagnosis and treatment prescribed for all infections suffered by 
study subjects. From these sources and my own files a single consolidated record of episodes of 
infection was constructed for each subject. 
Diagnosis 
Diagnosis of an infection, whether by myself or by another doctor, involved "clinical judgment" applied 
to the textbook criteria of history and physical examination. When it seemed clinically indicated, I ( and 
some hospital based doctors) sought confirmation of the infection by bacteriological and fungal culture. 
Infections were counted according to the following criteria: 
Pyoderma (including impetigo, folliculitis and abscesses) was the only type of skin infection counted. 
Prolonged infections may have been counted more than once, but only if diagnosed on consultations at 
least 15 days apart. 
Recurrent wheezing was counted as one respiratory tract infection for every 10 episodes of lower 
airways obstruction. 
Concurrent symptoms were counted as multiple infections, except: 
Diarrhea with systemic and/or respiratory symptoms was enumerated as one gastro· 
intestinal infection. 
Conjunctivitis with respiratory symptoms was counted as one respiratory tract infection. 
Respiratory tract symptoms together with otitis media was counted as one respiratory tract 
infection. 
When there was more than one pathogenic organism isolated from one specimen, each organism was 
counted separately. The episode was counted as one infection. 
In cases of otorrhoea where multiple bacterial species were isolated, and each was considered to be 
probably non-pathogenic, the organism was coded as "mixed" but the incident was counted as 1 
infection. 
• Including those who had NOT volunteered that they had been there. This was necessary because parents sometimes omitted 
to tell us that they had consulted other sources of health care. 
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Grading of infection 
Grading of infection was made on "clinical judgn1entn. 
Grade 1 Minimal disease; no treatment indicated. 
Grade 2 Moderate disease; treatment warranted. 
Grade 3 Severe disease; hospital treatment required. 
Grouping of infection 
Infections were grouped according to the organ systems for final analysis. Only grade 2 and 3 
infections were grouped. 
Oral candidiasis was the only infection grouped on pathogen. Aphthous ulcers were grouped under 
respiratory tract infections. 
Eye infections were limited to bacterial <!onjunctivitis. Pharyngoconjunctivitis was included with the 
respiratory tract infections. 
Diarrhoea (with or without vomiting, respiratory symptoms or systemic symptoms) was grouped as 
gastro-enteritis. 
Respiratory tract infections were the most heterogeneous group. This included any combination of 
signs and symptoms that indicated the presence of an infection of the lower or upper respiratory tract 
or the middle ear. 
Skin infections grouped all forms of pyoderma, bllt excluded fungal infections. 
All other infections were classed as nother" diseases. 
Potential Problems in determining infection rates 
Several factors may lead to over- or underestimation of the rates of infections. The most important 
and problematic were controlled in the operational nature of the definition of infection. The rules for 
diagnosis were chosen to minimize the possibilities of counting the same infection more than once and 
of including non-infectious diseases as infections. 
Problem - Multiple doctors 
Although most episodes of infectious disease were observed by myself personally at some stage in each 
illness, many were observed only by other doctors. Som'etimes a diagnosis had to be made from the 
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records of doctors who were not aware that they were to be used for the purposes of this study. Care 
had to be taken to use consistent criteria for diagnosing an infection. And, for those infants who were 
treated by multiple doctors, care had to be taken to count each individual episode exactly once. 
Problem · Non-infectious conditions which may be confused with 
infectious disease. 
Conditions such as wheezing may have an infectious aetiology, or (perhaps more commonly) have 
some other cause. This could lead to a bias towards the over-diagnosis of infection. The operational 
definition's rules attempted to avoid this. Diarrhoeal disease was assumed to be infectious in aetiology. 
Problem · Multiple consultations for the same infection 
Mothers with a sick child would often seek help more than once during the course of an infection, and 
often from more than one source of health care. Care was taken in analyzing the records to count such 
episodes as one infectious incident. 
Problem - Multiple simultaneous infections 
Concurrent infections are sometimes difficult to differentiate from one infection with multiple 
symptoms and signs. The criteria for diagnosis of infection were designed to err on the conservative 
side and hence may have slightly underestimated the true rates of infection. 
Problem - Prolonged infections and recurrent infections 
Diarrhoeal disease sometimes presented a diagnostic challenge in this category as did the child with a 
wheezing chest. Somewhat arbitrary criteria· were used to separate multiple diagnoses of prolonged 
infections from multiple diagnoses of recurrent infections. An incident was counted as an infection if it 
was at least 15 days after a similar infection. And one in ten episodes of wheezing were counted as 
infections.· The error is unlikely to be large ... 
Problem - Parents with different care-seeking behaviour 
Some parents frequently sought help for many trivial conditions, while other parents had a higher 
threshold for seeking care for their child. "Clinical judgment" was used to temper decision making, but 
it is likely that a few infectious episodes were not detected in children of the few less caring mothers. 
• I could find little assistance in the literature 
0 The most important "outlier• was a child who had recurrent otorrhoea. These episodes were analyzed as both one and many 
infections, but did not materially affect the results. 
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Weaning 
Weaning was measured with two variables called ''first bottle" and "last breast" in the tables of results. 
The variables give the age in months attained at which the child was first given milk formula and last 
offered the breast. (There were a number of working mothers whose infants were breast-fed at night 
and bottle-fed during the day.) 
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Laboratory methods 
Specimen collection and storage 
Blood 
Blood was sampled from a vein in the arm; eight ml was. taken into a sterile plastic syringe that had 
been moistened with preservative-free heparin (Pularin, Evans). · A further 2 ml was then taken into a 
new sterile plastic syringe. This portion was decanted into a tube containing K-EDTA as an 
anticoagulant, and used for the full blood count. The heparinized blood was transported in a plastic 
tube on ice. In the laboratory the specimens were centrifuged at 400 g for 10 minutes to separate cells 
from plasma. Plasma that was not used immediately for analysis was stored at -80°C. All blood 
specimens were collected between 8h00 and 9h30. 
Precautions were taken to prevent bacteriological or trace elemental contamination. The skin was 
swabbed with gauze soaked in 70% alcohol. All needles, syringes and tubes were sterile and 
disposable. Previously, quality control measures in the laboratory had shown that significant amounts 
of zinc contaminate specimens if proprietary alcohol swabs are used, but that needles, tubes, syringes 
and 70% ethanol on gauze do not interfere with zinc analysis·. 
Hair 
Hair for zinc analysis was taken dose to the scalp over the occiput. 
Bacterial and fungal cultures 
Material for bacterial and fungal cultures was taken on dry sterile cotton swabs and transported in 
sterile containers to the laboratory. 
Viral specimens 
Throat and rectal swabs were transported in Hepes buffered Hank's Lactalbumin hydrolysate medium. 
Faecal specimens were not specifically preserved. Processing of the specimens began within 24 hours 
of collection. 
• Personal communication, Dempster W, Institute of Child Health, University of Cape Town 
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Haematology 
.. ,. 
These tests were performed by the laboratories and staff of the haematology department of the Red 
Cross War Memorial Childrens Hospital under the direction of Ms R Pearl. 
Full blood count 
Full blood counts were made on a Coulter Counter model S plus II. The performance of the 
instrument was monitored for all parameters by frequent regular assays of 4C PLUS cell controls 
supplied by Coulter Diagnostics. 
Differential count 
Differential counts were performed manually on blood smears stained with May, Grunewald, Giemsa 
stain, while reticulocytes were counted from smears stained with brilliant cresyl blue. 
Biochemistry 
The biochemical measurements were made in the laboratory of the Institute of Child Health of the 
University of Cape Town under the direction of Mr WB Dempster and supervision of Mrs F Pocock. 
Red cell zinc protoporphyrin 
Blood zinc ptotoporphyrin was measured with a haematofluorometer • calibrated in units of ug/ g 
Hb(324>. Standardization of the Aviv haematofluorometer was accomplished by using a calibration 
slide supplied with the instrument. The slides were impregnated with rhodium B dye and correspond 
to readings of 15.5 and 3.1 ug of zinc protoporphyrin per gram of haemoglobin. The calibration is set 
at the factory and any deviation greater than 5% requires the instrument to be returned to factory for 
adjustment. This has occurred 3 times in 6 years. 
· Measurements of red cell zinc protoporphyrin in our laboratory have been compared with values of 
free erythrocyte protoporphyrin measured by the extraction procedure of Piomelli<398>. A correlation 
coefficient of 0.93 was obtained in 90 paired samples. 
Plasma ferritin 
The method employed in the assay of plasma ferritin has been described in detail by Dempster et 
at<132>. The immunoradio-metric assay employed anti-human ferritin antibody .. labelled with 1251 in 
• supplied by Aviv, 810 Towbin Avenue, Lakewood, New Jersey 08701, USA 
"* Made in the laboratories of the Institute of Child Health(l32) 
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the laboratory(lS4) and ferritin prepared from human splenic tissue as an antigen and standard(SO). The 
assay was performed in three stages following the method of Miles et aP44). 
Stage 1. Polystyrene tubes (Falcon Plastics 2052)* were coated with anti-human ferritin antibody by 
addition of 500 ul of rabbit anti-serum at a dilution of 1:10 000 in 0.2 M sodium hydrogen carbonate 
buffer /sodium carbonate buffer pH 9.2 and incubated for 24 hours at 4°C. The contents of the tubes 
were aspirated and washed twice with 2 ml of 0.1 % BSA buffer pH 8.0 and twice with 2 ml distilled 
water. The anti-human ferritin antibody remains adsorbed to the interior wall of the test tube. 
Stage 2. Two hundred ul of a known concentration of ferritin or of plasma with an unknown 
concentration was added to the coated tubes and incubated for 24 hours at 4°C. The ferritin forms an 
antigen-antibody complex with the anti-human ferritin on the tube wall. 
Stage 3. The contents of the tubes were aspirated and washed once with 2 ml 0.1 % BSA buffer. 
Thereafter 200 ul of 125I-labelled anti-human ferritin antibody (approximately 20 000 counts per minute 
(CPM)) were added to the tubes and incubated for 48 hours at 4°C; the antibody attached itself to the 
free antigen binding sites of the f erritin. Excess labelled antigen was removed by aspiration and 
washing the tubes twice with 2 ml of 0.04 M phosphate buffer pH 7.4. The radioactivity of the 
remaining antigen/antibody complex was measured in a gamma counter and was proportional to the 
amount of ferritin present. Standard concentrations of ferritin, ranging from 100 to 0.159 ug/1 
prepared in 4% BSA buffer pH 8.0 were measured in triplicate. Plasma from subjects was routinely 
diluted 1:30 in 4% BSA buff er and assayed in triplicate, 
Calculation of Results. A standard dose-response curve was constructed by plotting the logarithm of 
the concentration of ferritin against the logit transformation of the count of radioactivity. le log(ferritin 
concentration) was plotted on the X-axis with log(y/(1-y)) on the Y-axis, where y is the radioactivi,ty 
count. The infinite dose response was estimated by a computerized iterative technique which finds that 
value which gives the best fit (minimum residual sum of squares) to the straight line fitted to the 
observed points and the estimated infinite dose response. The final estimate of the infinite dose 
response was made by quadratic interpolation from the last three sets of observations. For routine 
analysis, counts in triplicate were observed for each test sample. These were then rescaled and 
converted to logits. Interpolation on the standard curve then estimated the ferritin concentration in the 
serum. 
#. Falcon Plastics (Div. Becton Dick.son & Co.), 1950 Williams Drive, Omard, California 93030, U.SA. 
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Plasma zinc 
The plasma zinc concentration was measured according to the method of Henry, Cannon and 
Winkelman<220>. The plasma was deproteinized with trichloroacetic acid, and the supernatent analyzed 
for zinc by atomic absorption at 214 nm on a Beckman model 1272M spectrophotometer. 
Hair zinc 
Hair zinc ·was analyzed according to a method adapted from that of V Yuzbarsiyan, Department of 
Paediatrics, Istanbul University, Turkey (personal communication). The hair was sequentially washed 
in hexane, in ethanol, then at least three times in deionized distilled water. It was then dried, weighed 
and digested in nitric acid before aspiration into a Beckman model 1272m atomic absorption 
spectrophotometer. (On a practical note, one may remark that the method is labour intensive; one 
technician was able to perform about 20 analyses per week.) 
Microbiology 
Bacterial and fungal characte.rization 
Specimens for bacterial and fungal characterization were processed in the microbiology laboratory of 
the Red Cross War Memorial Childrens Hospital under the direction of Dr D Hanslo. 
Viral characterization 
These studies were performed by the staff and virology laboratories of the Department of Medical 
Microbiology of the University of Cape Town under the direction of Professor JW Moodie and 
supervision of Drs JP MacIntyre and GA Keen. 
Immunological methods 
The immunological tests were made in the laboratory of the Institute of Child Health of the University 
of Cape Town under the direction of Professor DW Beatty and supervision of Ms J Hughes. These 
tests are more fully described than most others in this thesis because immunological methods have not 
reached the state of standardization that exists in biochemistry and haematology and results may vary 
greatly with seemingly minor variations in laboratory procedures. 
j.. 
Materials and laboratory reagents used in more than one assay. 
Microtiter equipment 
U-bottomed microtiter plates were manufactured by Greiner and by Nunc and supplied by Laboratory 
and Scientific and by the Weil Organization (Distr.) respectively. 
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Automatic pipettes were manufactured by Gilson, and supplied by Miles Seravac. 
Multiple pipettes were manufactured by Flow Titertek, and supplied by Miles Seravac. 
Pipette tips were supplied by Laboratory and Scientific. 
Reagents 
Saline: The salt solution used as a diluent was 0.9% NaCl. 
PBS pH 7.2: Phosphate buffered saline at pH 7.2 was prepared from 100 ml saline plus 23.9 ml 0.15M 
KH2P04 and 76 ml 0.15M N3:zHP04• 
PBS pH 6.4: Phosphate buffered saline at pH 6.4 was prepared from 100 ml saline plus 67.7 ml 0.15M 
; 
I<HzP04 and 32.2 ml 0.15M N3iHP04• 
EDTA-PBS: The composition of this was: NaCl 8.0 g, KCl 0.2 g, N3iHP04 1.15 g, KH2P04 0.2 g made 
up to I litre. Then 0.2 ml EDTA (55.836 g/1) was added to 100 ml of the PBS. 
Tris-NH4CI buffer: This was made from one part tris ((hydroxy methyl)-aminomethane (Merck)), 20.6 
g/1 at pH 7.3 and 9 parts NH4Cl 8.3 g/1. 
RPMI-Hepes consisted of RPMI-1640 medium (Gibco, USA) buffered with 25 mM Hepes (Schwarz 
Mann). 
RPMI-Hepes-bicarb was prepared as above with the addition of 2 g NaHCOiL. 
Lymphocytes: Blood mononuclear cells were isolated from freshly drawn heparinized blood by the 
Ficoll-Isopaque technique of Byum<50) and resuspended in RPMI-HEPES-bicarb at 2x106 cells/ml as 
described by Beatty and Dowdle(27). 
Tetanus antibody titration 
The procedure for tetanus antibody determination followed that of Stavitsky<476) and Sewer<456). 
Materials 
Erythrocytes: Fresh human group O blood (Rh positive or negative) was stored with 1 mg Na EDTA/ 
1 ml blood. 
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Tannie acid: The stock solution was prepared from O.l g tannic acid and 10 ml 0.9% NaCL It was 
stored at 4°C. The 0.006% tannic acid working solution was made fresh for use from 0.3 ml of the 
stock solution and 49.7 ml 0.9% saline. 
Tanning and coating of red cells 
Erythrocytes were washed 3 times in saline and then 0.25 ml red cells were suspended in 10 ml PBS 
pH 7.2. Storage was at 4°C for up to 7 days. The red cells were tanned after re-washing and re-
suspension to 2.5% in PBS pH 7.2. One volume of cell suspension with one volume of 0.006% tannic 
acid solution was incubated at 37°C for 15 minutes in an agitating water-bath. The suspension was then 
centrifuged, the supernatent discarded, and the cells washed twice in PBS pH 7.2. To coat tanned cells 
with tetanus toxoid, they were washed twice and resuspended to 2.5% concentration in PBS pH 6.4. 
One volume of tanned red cell suspension. 4 volumes of 1/3 dilution tetanus toxoid ( obtained from the 
South African Institute of Medical Research) and 4 volumes of PBS pH 6.4 were incubated for 10 
minutes in a water bath at 37°C. The erythrocytes were kept in suspension by shaking the tubes every 
30 seconds. After centrifuging, the supernatent was removed and the red cells washed and 
resuspended to 1 % dilution in 1/100 heat inactivated normal rabbit serum. 
Titration 
Tetanus antibody titration was carried out in U-type microtiter plates. Wells 2 to 12 had 0.025 ml 
diluent placed in them. The test serum was diluted 1/10 with 1/100 heat inactivated rabbit serum and 
0.05 ml placed into well 1. Serial dilutions of serum were made by transferring 0.025 ml from well 1 to 
well 2, thoroughly mixing the contents of well 2 and then transferring 0.025 ml from well 2 to well 3. 
The procedure was then repeated for wells 3 to 12 to ·produce dilutions of the test serum of 1/10, 1/20, 
1/40, ... , 1/20480 in wells 1, 2, 3, ... , 12. To the serum was added 0.025 ml of the coated tanned red 
cells. The plate was read after 3 to 12 hours incubation. Two controls were used on each plate: 1) 
uncoated tanned cells with serum (to test for non-specific binding factors in the serum), and 2) coated 
tanned cells with diluent (to provide a negative control). The titre of anti-tetanus antibody present in a 
serum was-the reciprocal of the highest dilution that produced hemagglutination. 
Polio antibody titration 
The procedure followed that recommended by the Institute Virion for the performance of complement 
fixation. 
Materials 
Virion reagents were obtained from Combined Medical Specialities. These were: 
Virion 1127 Polio virus complement fixing antigen 
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Virion 2127 
Virion 3127 
Virion 4127 
Control antigen for complement fixation 
Human antiserum, positive control 
Human antiserum, negative control 
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Haemolytic serum: Wellcome UDIS haemolytic serum was obtained from Wellcome Laboratories. 
Veronal-buffered saline (VBS) stock solution was prepared from 5.75 g diethylbarbituric acid 
dissolved in 500 ml hot distilled water. To this 3.75 g sodium diethylbarbituric acid and 85.0 g NaCl 
was added and the volume made up to 2000 ml with distilled water. Finally, 1.68 g MnC1i.6HzO and 
0.28 g CaC1i wer.e added and the stock solution autoclaved at 115°C. It was stored at 4°C. The 
working solution was prepared by diluting the stock solution 1 : 5 with distilled water just before use. 
Haemolysin or haemolytic serum stock solution was prepared from 94 ml VBS thoroughly mixed with 1 
ml of haemolytic serum (titre 1 in 6000) and 1 ml glycerol AR. to which 4 ml of 0.85% NaCl solution 
containing 5% phenol was added. The stock solution was stored at 4°C and diluted optimally 1 in 25 
with VBS just before use. 
Sheep Erythrocytes were obtained from the animal unit of the Cape Provincial Administration and 
stored for up to 6 weeks in Alseever's solution. A working suspension of erythrocytes was prepared by 
diluting the stock 1 in 10 with VBS and centrifuging for 7 minutes at 600 g. This was repeated 4 times, 
but centrifuging the cells for 10 minutes on the last occasion. The supernatent was carefully removed 
and the sedimented cells diluted to 2% in VBS. The erythrocyte concentration was measured with a 
photometer. The erythrocyte suspension was divided into aliquots and stored for up to 5 days. 
Guinea pig serum was obtained from the animal unit of the Cape Provincial Administration and used 
for its Complement. It was stored at -20°C and diluted optimally 1 in 20 with VBS immediately before 
use. For each new batch, complement activity was determined by titration according to the following 
scheme for microtitre plates. 
Complement titration 
===================================================-=-------
Step 1: complement dilution 
Stabilized C' ml 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 o.1b.1 
( diluted 1 in 2 with VBS) 
VBS ml 1. 9 2.4 2.9 3.4 3.9 4.4 4.9 5.4 5.96.4 
Step 2: complement titration 
Diluted C' ul 25 25 25 25 25 25 25 25 25 25 
Diluted antigen ul 25 25 25 25 25 25 25 25 25 25 
VBS ul 25 25 25 25 25 25 25 25 25 25 
===================================================---------
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The microtitre plates were covered with moistened filter paper and incubated overnight at 4°C and 
read the following day. The highest dilution causing complete haemolysis was used as the working 
dilution of complement. (This provided a 100% reserve as the complement was diluted 1 in 2 just 
before performing the titration.) 
Polio virus antibody titration 
Specimens: 20 ul of patients plasma or control serum were diluted with 180 ul VBS and inactivated for 
30 minutes at 56°C in a water-bath. Paired specimens from the same patient at the ages of 3 and 12 
months were tested simultaneously on the same plate. 
Antigens: Polio virus antigen (Virion 1127) and control antigen (Virion 2127) were restored 
with 1 ml distilled water and stored for up to one week in tightly stoppered tubes at 4°C. Working 
dilutions were 1 : 2 and 1 : 8 respectively, and were prepared on the day of use. 
Test: The test was performed in microtitre plates with 96 wells arranged in 12 columns numbered 1 to 
12 and 8 rows labelled A to H. The titration of a specimen was made in the wells of one row. As each · 
test employed one positive control serum (Virion 3127) and one negative control serum (Virion 4127), 
up to 6 specimens could be titrated on one plate. The method was as follows: 
1 25 ul of VBS were pipetted into wells 3 to 6 of a row. 
2 25 ul of specimen dilution 1 in 10 were pipetted into wells 1, 2, 3 and 8 
3 Serial dilutions were made with a 25 ul diluter from well 3 to well 6. This resulted in 
dilutions from 1 in 10 to 1 in 160 with reciprocal titres of 10, 20, 40, 80 and 160 in wells 2 to 6. 
4 25 ul of the working dilution of antigen were pipetted into wells 2 to 6. 
5 25 ul VBS were pipetted into well 1 as a negative control of antigen. 
6 25 ul of the working dilution of complement were pipetted into wells 1 to 6. 
7 Complement controls were prepared according to the following scheme: 
=======================================-====::!::========· ====· 
Tube No. l. 2 3 4 
=============== ======-==·====·=== ·===~=-=================== 
Working dilution of complement 1.2 ml 0.9 ml 0.6 ml 0.3 
ml 
VBS o.o ml 0.3 ml 0.6 ml 0.9 
ml 
Resulting complement units 2 1.5 1 0.5 
---=====================-=================================== 
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The complement controls were then pipetted as follows: 
----======================================================== 
Complement units 2 1.5 1 o.s 
---==============~========================================== 
Complement 25 ul 25 ul 25 ul 25 
ul 
Polio virus antigen 25 ul 25 ul 25 ul 25 
ul 
VBS 25 ul 25 ul 25 ul 25 
ul 
============================================================ 
8 A polio virus antigen/SRBC control was made by pipetting 25 ul polio virus antigen, 25 ul 1 
in 10 dilution of SRBC, and 25 ul VBS into a well. 
Haemolytic system: The haemolytic system to visualize the complement fixation was prepared daily. 
To 1 ml of haemolysin stock solution 24 ml VBS was added and the working solution prewarmed in a 
water-bath at 3'7°C for 10 minutes. The haemolysin was added dropwise to· an equal volume of 
prewarmed 2% erythrocyte suspension and mixed with a magnetic stirrer. Sensitization of the SRBC 
was accomplished by incubation at room temperature for 15 minutes. In the meanwhile, the microtitre 
plates were warmed in the incubator at 3'f)c for 15 minutes. 
50 ul of the freshly prepared haemolytic system was pipetted into all wells, including control wells. The 
microtiter plates were gently shaken and returned to the incubator for a further 20 to 30 minutes until 
the complement controls showed complete haemolysis in the wells with 2 and 1.5 units and traces of 
inhibition of haemolysis in the well with 1 unit of complement. 
The plates were then centrifuged at 400 rpm for 5 minutes and read within 2 hours. A well was 
considered positive if it showed from 50 to 100% inhibition of haemolysis. 
Lymphocyte subtyping 
T cells were counted by rosette formation with AET treated sheep red blood cells(34l). 
T cells and T cell subsets were enumerated using murine monoclonal antibodies; OKT3 for total T cell 
count, OKT4 for helper/inducer cells and OKT8 for suppressor/cytotoxic cells (Ortho Diagnostic 
Systems) as follows: 1xl06 mononuclear cells resuspended in 200 ml of phosphate buffered saline 
(PBS) were incubated for 30 minutes in an ice bath with 10 ul (0.05 ug) of monoclonal antibody. The 
cells were washed at 4°C, and 20 ul of 1/40 fluorescent labelled rabbit anti-mouse IgG (Miles-Yeda) 
was added; they were incubated on ice for 30 minutes, washed, resuspended in 30% glycerol in PBS 
and counted using fluorescent microscopy. 
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B lymphocytes were counted using a FITC (fluorescein isothiocyanate) conjugated F(ab')2 rabbit anti-
human IgG (Miles-Yeda) was employed. This enabled the number of cells with surface membrane 
immunoglobulin (SMIG) to be counted using fluorescent microscopy. 
Lymphocyte transformation by stimulation with PHA 
PHA stimulated lymphocyte transformation was performed in triplicate in microplates as described by 
Beatty and Dowdfe(28) and Beatty(26). 2x1<>5 mononuclear cells, 25 u1 of PHA (25 ug/ml final 
concentration) (Wellcome) and 25 ul of serum in a final volume of 200 u1 of RPMI-HEPES were 
placed in a well of a microtitre plate. In order to distinguish between cell and serum factors, the 
patient's cells were incubated in both autologous and normal sera, and normal cells in normal and 
patients' sera. The plates were incubated at 37°C for 72 hours in an humid atmosphere of 5% carbon 
dioxide and 95% air in a Hotpak incubator. Twenty four hours before completion of the incubation 
period 0.07 uCi 14C-thymidine (Radiochemical centre, Amersham, England, specific activity 60 
mCi/mmole) was added to each well. Radioactive lymphocytes were harvested onto glass fiber filter 
paper sheets (Skatron) using a multiple automatic sample harvester designed and built in· the 
laboratories of the University of Cape Town Medical SchooiC26). The glass fiber disks were dried, 
placed in 3 ml of scintillator solution (Instagel, Packard Instrument Co.) and·the radioactivity taken up 
by transformed lymphocytes counted in a Tricarb scintillation counter spectrophotometer (Packard 
Instrument Co.). The results were expressed as the arithmetic mean of the disintegrations per minute 
(dpm) of the triplicate cultures after the sample readings had been corrected for background 
radioactivity and counting efficiency. 
Neutrophil phagocytosis and killing activity 
The method for determining the phagocytic plus bactericidal efficiency of neutrophils has been 
described by Haddad, Beatty and Dowdle(ZOZ). Minor modifications were made to accommodate the 
smaller volume of blood obtainable from inf ants. 
Preparation of neutrophils 
All procedures were performed with aseptic techniques at room temperature. Two aliquots of 4 ml of 
heparinized blood was mixed in 15 ml Falcon tubes (Laboratory and Scientific) with 0.67 ml of 6% 
dextr<!,n (MW 200 000 to 275 000, BDH Biochemicals) in 0.85% NaCl. The cells were allowed to 
sediment for 30 minutes with the tubes held at a 45 degree angle. The plasma/leukocyte layer was 
aspirated with a pasteur pipette and centrifuged at 180 g for 10 minutes. After discarding the 
supernatent fluid, the button of cells was resuspended in 8 ml of Tris-NH4Cl buffer (to lyse 
contaminating red cells). The cells were kept in suspension for ten minutes in tlie buffer. After 
centrifugation for 10 minutes at 180 g, the pellets of cells were resuspended in 1 ml EDTA-PBS and 
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pooled in one tube with the volume made up to 8 ml. Centrifugation at 180 g for ten minutes, . 
aspiration of supernatent and re-suspension of the cells was repeated 3 times. The final pellet was 
resuspended in RPMI-Hepes. Standard methods were used to perform total leukocyte and ~erential 
counts, and the number of neutrophils were adjusted to 107 /ml with medium. The percentage of 
neutrophils harvested was computed. 
The viability of the cells was determined by the vital dye exclusion methoi140). Equal volumes of NaCl 
(1.8%) and trypan blue (2% in distilled water) were mixed immediately before the test. Equal volumes 
of this mixture and the cell suspension were then incubated for 10 minutes at room temperature. 
Staphylococcus aureus 
A strain of S. aureus (Oxford) was obtained from the Department of Bacteriology at the University of 
Cape Town Medical School. After overnight growth in tryptic soy broth (Difeo), 0.5 ml of culture 
material was added to 4.5 ml of fresh warm broth and incubated for 4 hours in a shaking water-bath at 
37°c. It had previously been established that the bacteria would now be in the late exponential log 
growth phase. After centrifugation of 2 ml of this culture at 1300 g for 20 minutes, the pellet was 
resuspended in 4 ml of RPMI-Hepes medium. The absorbance at 620 nm was measured and the 
corresponding viable count determined from a calibration curve established for this organism. This 
was adjusted to 108 organisms per ml with medium. 
Controls 
Neutrophils were prepared from a normal adult. Normal serum was obtained either from the normal 
cell donor or from a pool of normal human group AB serum. 
Phagocytosis and bactericidal assay 
The bactericidal assay was modified from the methods of Steibigel et a/477)_ The following were added 
to 12 x 75 mm plastic test tubes (Falcon 2054): 250 ul PMN suspension, 50 ul serum, 150 ul RPMI-
HEPES medium and 50 ul bacterial suspension, giving a neutrophil to bacteria ratio of 1 : 2. Control 
tubes without PMNs were also prepared. The tubes were incubated on a tilting mixer at 3-fJC and 100 
ul samples were removed at 0, 60, and 120 minutes. These were added to 900 ul sterile distilled water. 
The neutrophils were then further disrupted to release live ingested bacteria. This was achieved by 
sonication for 15 seconds at an amplitude of 6 um with an MSE ultrasonic disintegrator. It had 
previously been shown that sonication of this intensity and duration disrupted all leukocytes without 
affecting the viable count of S. aureus. The total remaining viable bacterial count was then determined 
by standard dilution techniques and plating. Samples from control tubes were treated in an identical 
manner. Colonies growing on blood-agar base were counted the day following plating. 
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Results at 1 and 2 hours were expressed as: 
(i) the bacterial count as a percentage of the initial inoculum 
& 
(ii) the bacterial count as a percentage of that for control cells 
lOO*Cswf Cc60 & lOO*Cs12o/Cc120 
(ill) the bacterial count as a pereentage of that for control AB serum 
& 
(iv) the ratio of the percentage change in colony counts for the subject to the percent~e change 
for the adult control. 
& 
Where C indicates the colony count, the suffix indicates the subject (s), the control cells (c) or the 
control AB serum (ab) and the subscript indicates the time at the start (o), at 1 hour (60) or at 2 hours 
(120). Although these methods are conceptually dissimilar, the results turned out to be equivalent. For 
this reason, the results are presented in chapter 6 in using method 1. 
Skin tests of delayed hypersensitivity 
The skin tests of delayed hypersensitivity were performed according to the recommendations of the 
WHO Committee on Primary Immunodeficiency(l84)_ 100 uI of the appropriate antigen was injected 
intradermally into the volar aspect of the forearm and the degree of induration read at 48 hours. The 
transv7rse diameter was measured and recorded as the response to the antigen. The reagents used 
were: 
Mantoux test 
Purified tuberculin, (PPD) 5 T.U./0.1 ml, was obtained from Evans Medical Ltd. 
Candida antigen test 
Candida albicans 1/10 w/v in 50% glycerin was obtained from Hollister Stier Laboratories. This was 
further diluted 1:10 in sterile buffered saline to give an antigen concentration of 1/100. The 1/100 
dilution is stable for 3 months when kept at 4°c(26). 
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Record keeping and statistical analysis 
Record keeping 
Each child in the study had a folder and a card, both of which were stored in numerical sequence 
according to the number allocated to the child on entry. The folder was used to store the data 
collection forms and laboratory test results. The card was used to record the milk issued to the child's 
caretaker and to note any incidents of morbidity. 
Data processing 
At the conclusion of the principal study, the data of interest were extracted from the records and 
entered into a Tektronix micro-computer. After checking twice against the manual record for clerical 
accuracy, the data were transferred to a Sperry mainframe computer for the statistical analysis. 
Sociological data of anecdotal interest were analyzed manually. 
Data from the subsidiary studies were stored and processed on a personal computer. 
Statistical analysis 
Computer programs employed 
For the principal study the BMDP suite of statistical programs were employed for analysisC138). The 
programs included P2D, for basic data description, P4F for frequency tables and chi square analysis, 
P6D for bivariate plots and linear regression, P7D for t tests with Bonferroni adjustment for multiple 
comparisons when appropriate, Pl V for analysis of variance and PlR for multiple linear regression. 
Some of the analyses for the smaller studies were made on a personal computer using Lotus 123 and 
included descriptive statistics, chi square analysis and t tests, both paired and two-sample. In these 
calculations P values were obtained from statistical tables. Since the values obtained are limits rather 
than. exact quantities, these P values are reported as being greater or smaller than some number, 
typically 5%. 
Missing data 
When a subject dropped out of the study or a test was not performed for a technical reason, the data 
collection for that subject would be incomplete. If the data for a subject were missing for one variable 
then that subject was omitted from all analyses involving that variable; other data from that subject was 
included in other analyses. 
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The numbers of subjects who did not complete the study and the reasons for their failure to do so are 
reported in chapter 6. 
Calculation of confidence intervals and type II errors 
The programs that were used to calculate the confidence intervals and probability of type II errors are 
listed in appendix 7. Chapter 6 contains an additional note on the application of confidence intervals 
and their relation to statistical significance, 
Significance levels 
The convention is adopted that a P value of 5% is "significant". However, when results are discussed, 
the actual P value is given in the text. 
Two-sided tests are used throughout. There is a case to be made for using one-sided tests in certain 
instances, but as the conversion is so simple ( division by 2 of the stated P value) and almost all the 
literature uses two#sided tests this convention has been adopted. 
Reporting of results 
Results are reported as arithmetic means unless otherwise noted in the text. The number of significant 
figures given is generally to 1 more decimal place than that used in the individual measurements. This 
convention should not be taken to imply a greater degree of accuracy in the measurements than .that 
afforded by the techniques employed. 
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Introduction 
This chapter describes the social setting of the principal study. In extrapolating the findings to other 
groups of children it is necessary to be aware of potentially confounding factors which may invalidate 
predictions and comparisons. Such factors include unambiguously measured variables such as age, sex, 
place and time, as well as "soft" data that attempt to quantify concepts such as socio-economic class, 
overcrowding and standard of home care. This chapter presents the "soft" data that provides the 
background information necessary for the reader to place the main study in its social context and to 
judge the validity of comparisons with other studies that he or she may wish to make. Where possible, 
statements are supported by data collected according to the protocols described in chapter 3. In 
contrast to the rest of this thesis however, it has sometimes been necessary to make subjective 
statements based on personal impressions. The personal impressions are based on eighteen months 
spent in the community, during which time each infant in the trial was examined on 15 to 20 twenty 
occasions and several visits were paid to each child's home. By the end of the study the families and 
the study teams knew each other fairly intimately. 
I shall begin with some personal impressions and observations that may help the reader to attain an 
understanding of the community of Bonteheuwel. These impressions try to convey some feeling for the 
culture and living conditions of the group under study. They may, however, not be applicable to the 
population of Bonteheuwel as a whole since the selection criteria would have tended to exclude the 
poorer sections. 
Personal impressions 
Bonteheuwel is the site of a Cape Town City Council subsidized housing scheme. Most of the 
dwellings are about 25 years old and consist of rows of semi-detached houses, usually with a single 
floor, but some are double storied. The houses have 2 or 3 living rooms plus kitchen, bathroom and 
inside toilet. The council leases the houses, but has little control over subletting by tenants. The 
shortage of housing has encouraged some people to build shacks in the few hundred square meters of 
garden behind their house. A typical "hokkie" is a single room with sand floor, no window, walls of old 
packing cases and roof of corrugated iron. It may house a family of four, who often could afford better 
quarters if they were available. 
The population of Bonteheuwel was 47 060 according to the 1980 population census with a population 
density of 141.78 persons per hectare·. The community is served by a civic center which has shops, post 
office, general practitioners in private practice, a cinema and the inevitable liquor store. The nearby 
• Technical Management Services Data Report No. 1 of 1984, City Engineer's Department, City of Cape Town. 
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municipal clinic offers preventative services targeted at children and selected adult groups. The only 
curative services are for tuberculosis and sexually transmitted diseases. The clinic is within walking 
distance for all residents. Cars are scarce and most people use the buses, taxis or trains for transport 
beyond their suburb. 
The people with whom I cart1e in contact were friendly and helpful. Alcohol abuse is a long standing 
problem, particularly amongst the men, and "recreational" drugs are now widely used. Marijuana and 
Mandrax: were in fashion; opiates and cocaine did not seem to be readily available. Litter is 
everywhere, so it was surprising to see how clean, neat and tidy it was inside homes even in the face of 
gross overcrowding. 
Several observations deserve a full social•anthropological study to probe their deeper significance. 
Windows and curtains were rarely opened; is this to shut the uncontrollable world out? There is a 
general deficiency in quantitive reasoning of any kind. Times, dates, frequencies, weights, volumes 
often seem to have no meaning. Is this a manifestation of a similar culturally felt inability to control 
destiny? Perhaps these questions are better answered by the poet and novelist. 
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Survey results 
Housing 
Table 4.1 and figure 4.1 show that 95% of the families lived in council houses and 5% lived in lean-to 
shacks built in the yards of the council houses. 
Table 4.1 Type of housing used by study families. Numbers living in council built houses and 
owner or lessee constructed shacks or "hokkies". 
TYPE 
Council 
Hokkie 
TOTAL 
No. 
123 
6 
% 
95% 
5% 
-----------
129 100% 
-----------
TYPE OF HOUSl~JG 
Figure 4. 1 
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Measures of crowding of accommodation 
The type of housing available in Bonteheuwel is in itself an indication of the chronic shortage of 
accommodation. Table 4.2 and figure 4.2 show the number of families considered by the project team 
to have poor, adequate and good housing. More objective criteria are given in tables 4.3, 4.4, 4.5, 4.6 
and figures 4.3, 4.4, 4.5, and 4.6. which show that as many as 75% of study families lived with others. 
The survey counted those living in "hokkies" as living alone if they did not share the shack with others. 
As the shack dwellers had to use the kitchen, bathroom and toilet facilities of the main house, a more 
realistic estimation of the extent of overcrowdi,ng might be obtained by adding 5% to the percentage of 
families sharing accommodation. 
The houses are small; only 17% have 3 living rooms and 61 % have two rooms used for sleeping as 
demonstrated in table 4.2 and figure 4.2. In many houses occupants had to sleep on mattresses in the 
sitting room/ dining room and it was often necessary for the beds to be shared. 
Tables and figures 4.5 and 4.6 show that the mean number of occupants was at least 7.6 persons per 
house*. This underestimates the true number because the survey did not count the number of non-
sibling children present in the house. At the time the survey was drawn up it was not realized that 
there would often be more than one mother and her children living in the same abode. A second 
difficulty in estimating the average occupancy of the houses arose from the large number of 
"transients~. Most houses would have a significant number of people, often young men, who stayed 
temporarily. The interviewee would often not consider these persons as living in the house and they 
would therefore not be counted. 
In retrospect, ambiguities in the questionnaires introduce an element of uncertainty in the data. For 
example, the questionnaires should not have attempted an immediate reduction to concepts such as 
"sibling" and "lodger", but instead should have taken a census of the persons who slept in the house 
during the previous 24 hours. In any event, the data do show how crowded the houses were and thus 
allow a qualitative estimate of the exposure of the study children to potential sources. of infection (ie 
siblings and adults) in the same dwelling. 
• 5.8 adults + 0.6 siblings + 1 study infant. 
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Table 4.2 Living conditions of study families: Numbers of families with poor, barely adequate 
and good living conditions in terms of crowding in the home. The measure of crowding was made on 
subjective grounds by the study team after several home visits. 
CONDITIONS No. % 
Poor 73 47% 
Adequate 31 11% 
Good 14 42% 
----------. 
TOTAL 144 100% 
=========== 
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Table 4 .. 3 Number of rooms used for sleeping by study families·. 
ROOMS No .. % 
1 29 21% 
2 83 61% 
3 23 17% 
-----------.
TOTAL 135 100% 
============ 
Note • Rounding is the cause of the failure to add to 100% 
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Table 4.4 Lodging arrangements of study families: Numbers lodging with family, or living in 
their own house (including rented or leased properties) or renting accommodation to tenants. 
TYPE No. % 
Family 72 56% 
own 43 34% 
Tenant 13 10% 
-----------
-----------
TOTAL 128 100% 
-----------
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. 
Table 4.S Number of adults in the houses of the study families . 
ADULTS .No .. % 
1 1 1% 
2 9 7% 
3 10 7% 
4 23 17% 
5 28 20% 
6 20 15% 
7 15 11% 
8 8 6% 
9 11 8% 
10 8 6% 
11 1 1% 
12 2 1% 
13 1 1% 
-========== 
TOTAL 137 100% MEAN = 5.8 
-----------
Note • Rounding is the cause of the failure to add to 100% 
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Table4.6 Number of siblings of the study infants 
. 
Sil:>s No. % 
0 69 51% 
1 32 24% 
2 18 13% 
3 11 8% 
4 2 1% 
5 2 1% 
=======-== 
134 100% 
=========== 
Note * Rounding is the cause of the failure to add to 100% 
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Measures of care of study subjects 
Table 4.7 shows that 65% of babies were cared for by mothers by day and by night and 11 % were 
entirely in the care of others~ Most children were well cared for physically and emotionally. In an 
attempt to quantify the subjective measure of care, the study team assigned a rating of 1 (poor), 2 
(adequate) or 3 (good) to each study child for the standard of hygiene employed in the home. The 
results are tabulated and graphically displayed in table 4.8 and figure 4.8 from which it can be seen that 
87% of the families employed good standards of personal hygiene and 13% tended to neglect their 
child's health. 
As some families tended to under~ or over-utilize health care facilities, their care-seeking behaviour 
was also rated on a scale of 1 to 3 for inadequate, adequate and over-protective care-seeking. These 
estimates are given in table 4.9 and figure 4.9 which show that 4% of mothers tended to seek 
professional advice later than appropriate and 3% of mothers were over-protective of their children. 
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Table 4.7 Caretaker of the study children by day and by night. 
DAY NIGHT 
No. % No. % 
MOTHER 87 65% 119 89% 
GRANDMOTHER 22 17% 7 5% 
AUNT 8 6% 5 4% 
OTHER 16 12% 2 2% 
========== ========== 
TOTAL 133 100% 133 100% 
========== ========== 
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Table 4.8 Standards of hygiene employed in the homes of study families estimated subjectively 
by the study team after several home visits. 
STANDARD No. % 
Poor 19 13% 
Adequate 10 7% 
Good 115 80% 
-----------
TOTAL 144 100% 
============ 
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Table 4.9 Care-seeking behaviour of families subjectively ranked as poor, good or over-
protective after 9 months of obsenation •• 
RANK No. % 
Poor 6 4% 
Good 133 92% 
Over-protective 5 3% 
----------
TOTAL 144 100% 
========== 
Note • Rounding is the cause of the failure to add to 100% 
CARE-SEEKl~JG BEHAVIOUR 
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Measures of family stability and unity 
Tables 4.10 and 4.11 and figures 4.10 and 4.11 show that 52% of mothers were married to the father of 
their child at the start of the study, but, by the end of the trial, a further 9% had remarried. Table 4.12 
shows that at the start of the trial, 51% of the mothers were actually living with the father of their child. 
The inference is easy to make that the ratio of unstable to stable families is uncomfortably high. The 
figures do not portray the scope of the extended family that we came to know during the study. 
However, tables 4.4 and 4.16 do hint at a wider role of the family in accommodation and fmance than 
might be found in white middle class South African families. 
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Table 4.10 Marital status of mothers on entry to the study· 
status No. % 
MARRIED 72 52% 
SINGLE 58 42% 
SEPARATED 3 2% 
COHABITING 3 2% 
DIVORCED 2 1% 
-----------
-----------
TOTAL 138 100% 
-----------
Note • Rounding is the cause of the failure to add to HK)% 
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Table 4.11 Changes in mothers' marital status during the study period. 
Status No., % 
NO CHANGE 125 91% 
MARRIED 12 9% 
DIVORCED 1 1% 
=========== 
TOTAL 138 100% 
=========== 
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Table 4.12 Cohabitation • Numbers of mothers (married or sing)e) of study infants who were 
living with the fathers of their child or were living separately. 
SC% I 
I 
Cohabitation 
COHABITING 
SEPARATED 
TOTAL 
No. 
70 
67 
% 
51% 
49% 
=========== 
137 100% 
-----------
-----------
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Measures of economic status 
At the start of the study, 3 months post partum, 70% of mothers were housewives. When the survey 
was conducted, about 6 months post partum, 35% of mothers were in part-time or temporary 
employment and 20% were in full-time jobs. Tables 4.14 and 4.15 show that 88% of fathers were 
employed, but that only in only 58% of families did fathers provide the principal source of income. 
Table 4.16 shows that only 69% of families had a regular source of earnings. In spite of this evidence 
of restricted fmancial circumstances, 89% of households had a television set*. Many homes also had a 
video recorder. 
• It would be interesting to know how the television sets were funded, but unfortunately the interview was not structured to 
obtain this information. For many families the television set was regarded as an absolute necessity, and a few hao the attitude 
that it certainly 'Was not to be relinquished in favour of money to pay rent, water or even electricity accounts! · 
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Table 4.13 Mothers' occupation 3 months post partum. 
Occupation No. % 
HOUSEWIFE 72 52% 
PART-TIME 47 34% 
FULL-TIME 20 14% 
~======= . = 
TOTAL 139 100% 
----------
MOTHERS 1 OCCUPATION 
Figure 4. 13 
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Table 4.14 · Fathers' occupation on entry to the study 
Occupation No. % 
TEACHER 1 1% 
SKILLED 32 24% 
SEMI.-SI<ILLED 32 24% 
UNSKILLED 52 39% 
UNEMPLOYED 16 12% 
=========== 
TOTAL 133 100% 
-
=========== 
FATHERS' OCCUPATION 
Figure 4. 14 
I 
' 
52 
.30~ 
32 32 
' 
20% -; 
I 
I 
I iS 
,a~ 1 I I i I /~ !)% 
TEACHER SKILLED SEMI-SKILLED IJNSKiLL.~D UNE~1PLOYED 
CHAPTER 4 THE COMMUNITY OF BONTEHEUWEL 4.21 
Table 4.15 " . Sources of income for the study families . 
source No. % 
FATHER 81 58% 
MOTHER 34 24% 
FAMILY 8 6% 
COMBINATION 6 4% 
OTHER 6 4% 
STATE GRANT 4 3% 
-----------
TOTAL 139 100% 
-----------
Note * Rounding is the cause of the failure to add to 100% 
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Table 4.16 Regularity of income for the study families estimated subjectively by the study team 
after 9 months observation. The criterion for assigning a subject to the category irregular was that 
money for food seemed to be a recurring problem. 
Regulari.ty 
REGULAR 
IRREGULAR 
TOTAL 
No. 
89 
40 
% 
69% 
31% 
-------------
129 100% 
=========== 
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Table 4.17 Presence of television sets in the homes of families of study infants. 
Television 
PRESENT 
ABSENT 
TOTAL 
No. 
118 
14 
% 
89% 
11% 
=========== 
132 100% 
=========== 
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Measures of age and educational attainments of parents 
Table 4.18 shows that the mean age of fathers of children in the study was 26 years while that of 
mothers was 24 years. The-youngest mother was aged 16, and 27% were under the age of 21 years. 
Table 4.18 Age of parents of study infants when the child was about 6 months of age. 
MOTHER FATHER 
AGE No. % ?,lo. % 
15-20 yrs 37 27% 13 10% 
21-25 yrs 42 31% 51 39% 
26-30 yrs 36 26% 41 31% 
31-35 yrs 16. 12% 18 14% 
36-40 yrs ·4 3% 7 5% 
41-45 yrs 1 1% 1 1% 
========== ----------. 
TOTAL 136 100% 131 100% 
========== -· --------
----------
MEAN AGE = 24. MEAN AGE = 26. 
AGE OF PARENTS 
Figure 4-. 18 
21-25 26-,30 31-JS 41-?5. 
k2 Motr.ers cs:sJ F" others 
CHAPTER 4 THE COMMUNITY OF BONTEHEUWEL 4.25 
Table 4.19 shows that only one parent had had tertiary education and that 3% of the mothers and 8% 
of the fathers had had no formal schooling at all. The average educational attainment was standard 5 
for both men and women. 
Table 4.19 Education of parents measured in years of formal schooling; from 1 to 6 is junior 
school, from 7 to 10 is high school and 13 is tertiary education·. 
Years MOTHER FATHER 
Education No. % No. % 
0 5 3% 9 8% 
1-2 12 8% 9 8% 
3-4 31 22% 18 15% 
5-6 54 38% 42 36% 
7-8 36 25% 31 26% 
9-10 5 3% 8 7% 
13 0 0% 1 1% 
========== ========== 
TOTAL 143 100% 118 100% 
---------- ----------
MEAN = 5.1 MEAN = 5.3 
Note • Rounding is the cause of the failure to add to 100% 
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Now have I toold you shortly in a clause 
The staat, th 'array, the nombre and eek the cause 
Why that assembled was this compaignye 
Also I prey you to foryeve it me 
Al have I nat set folk in hir degree, 
Heere in this tale, as that they sholde stonde. 
My wit is short, ye may wel understonde. 
The Canterbury Tales 
Geoffrey Chaucer 
Circa AD 1386 
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CHAPTERS RESULTS: INFANT FEEDING HABITS 
Introduction 
Infant feeding practices were of interest in the present research for two reasons. Firstly, as the main 
project was concerned with a trial of a milk formula with increased iron concentration, it would have 
been useful to have documented the actual quantities of formula ( and other foods) ingested. If the diet 
had been determined it would have been possible to estimate the total intake of iron and its availability. 
A second source of interest in feeding practices arose from ethical concerns about a possible conflict 
between the community's perception of the value of breast feeding and the influence of the trial of the 
infant milk formula. As was explained in chapter 2, mothers who were breast feeding were included in 
the trial and were encouraged to continue nursing their infants for as long as they wished. These 
mothers were also provided with milk formula, if they asked for it, in order to encourage their 
continued participation and continued breast feeding. The intention was that no mother should feel 
pressured to remove her child from the breast. 
Studies made 
Introduction 
Studies were made of the age at which children in the trial and children in the community were weaned 
from the breast; of the prevalence of breast feeding in the community before, during and after the trial; 
and of the reasons· for stopping breast feeding in trial children as well as in children from the 
community. In addition, a survey was made of the age at which various solid foods were introduced to 
infants in the trial. 
In the planning stages of the project it was imagined that, if each child was to be examined every 3 
weeks, it would be possible to gather an accurate history of the changes in the child's diet throughout 
the study. Two unforeseen factors rendered this plan unworkable. In the first place, if the child was 
well, he or she was often brought to the examination by a relative or friend of the mother who would 
not know what feeds the child was taking. With many mothers working, it was often the case that 
different people cared for the child during the day and during the night. 
A second and greater problem was cultural in nature. There was a widespread inability of people in 
the community to think quantitatively. Even intelligent, caring and cooperative mothers found it 
impossible to recall with accuracy how much milk the child had taken in the previous 24 hours. 
However, part of the problem in communicating may also, it seems with hindsight, have been due to a 
fear on the mother's part that she was being monitored in her use of the milk and that the supply of 
milk might be reduced if she was not "performing". Obtaining full dietary data would have entailed 
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several additional time-consuming visits by the study team to each child's home. As these resources 
were unavailable this part of the project was reluctantly abandoned. 
Ascertainment and Survey Construction 
Data for the children in the main trial was gathered throughout the study. At every contact, the 
parents or caretakers were asked the appropriate questions about feeding. 
Data for children in the community was acquired during three surveys conducted in the Bonteheuwel 
Health Clinic during April 1983, September/October 1983 and September/October 1984. The first 
survey was carried out shortly before the main study commenced, the second survey was made 
immediately after the last infant had been emolled in the trial, and the third was performed shortly 
after the trial had concluded. 
The Bonteheuwel Health Clinic provides immunization and other primary health care services. Most 
of the children attending the clinic are well, but some are brought for the treatment of minor ailments. 
Infants are weighed before being seen by the clinic staff, and mothers in this queue, with children of 12 
months of age or younger, were asked the age, sex. weight, age of first bottle feed, age of last breast 
feed and, if appropriate, the reason for weaning the child from the breast. 
Similar information was gathered in an ongoing fashion from mothers of children in the main study. In 
addition, they were also asked the age at which they introduced cereal, egg, fruit, vegetables and fish 
and meat to the child's regular diet. 
Acknowledgements 
The questionnaires were administered by Mrs D Phillips. 
Methodological Cautionary Note. 
Some methodological problems inherent in the study need to be borne in mind in evaluating these 
results. 
The body of data from the trial infants constitutes a longitudinal study from a well defined, 
homogeneous group whereas the surveys at the clinic are cross-sectional studies from an 
inhomogeneous and poorly defined group. Data from the two sets are not directly comparable. Even 
within the community group comparisons of one time period with another may be misleading because 
of the unselective nature of the surveys. 
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A further problem is that with the intention of improving the precision in collecting the data a small 
change was made to the form used for the third survey·. In retrospect it is now clear that this imposes 
an unknown change on the data which reduces the validity of comparisons made with the 2 surveys in 
1983. 
A third methodologic weakness in the study is the lack of a control group. If the surveys had also been 
conducted in a similar clinic in a community not subjected to the influences of the trial this would have 
provided a yardstick against which to evaluate the effects of the trial against the effects of changing 
customs. Lack of resources prohibited control surveys from being made. 
The age of the children was recorded as months attained. The surveys would have been more precise 
and accurate had the ages been recorded in decimals of a year. 
The prime reasons for mothers bringing their children to the clinic are for routine postnatal follow up 
and for immunization. The common age brackets of infants attending the clinic are thus less than 2 
months and between 3 and 6 months. Age groups that are uncommon at the clinic are 2 months and 
between 7 and 12 months. 
Results: 
The results of the surveys are shown in tables 5.1, 5.2 and 5.3 and in figures 5.1, 5.2. and 5.3. The data 
for children over the age of 6 months is not shown because the numbers are small and the results may 
be confusing. 
Age of weaning off breast 
Table 5.1 shows the age (in months) at which children were first offered a bottle of milk. The results 
for the study children are similar to those for the ~fants from the community. About 15% of babies 
were first offered milk in the first month of life. A third of infants begin drinking milk in each of the 
second and third months of life and by the end of the fourth month only 5% were exclusively breast 
fed. 
Because of the early introduction of milk feeds, the cross-sectional studies provide a relatively unbiased 
view and comparison with the trial children is valid. Weaning from the breast is often completed much 
later. A cross-sectional study with children at different ages will have many in various stages of the 
weaning process and it is thus not possible to compare the ages at which children are last given the 
breast. 
• The forms are included in appendix 6 
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Table 5.1 Age at which infants are first offered milk formula. Comparison between the infants 
in the trial and infants from the community of Bonteheuwel surveyed April 1983, September/October 
1983 and September/October 1984. 
Notes. 
AGE TRIAL MAR 1 83 SEPT 1 83 OCT 1 84 (months) 
0 26 17% 37 15% 18 16% 27 18% 
1 49 33% 56 23% 7 6% 38 26% 
2 51 34% 55 23% 21 19% 26 17% 
3 22 15% 58 24% 57 51% 44 30% 
4 1 1% 12 5% 7 6% 7 5% 
5 0 0% 15 6% 0 0% 5 3% 
6 0 0% 6 3% 1 1% 2 1% 
TOTAL 149 239 111 149 
MEAN AGE 1. 5 2.1 2.3 2.0 
The survey methods differ for the infants from the Trial and the Community. The results are riot strictly 
comparable. Details are given in the text. 
Rounding causes some of the columns of percentages not to total 100%. 
AGE OF FIRST WEANING 
Sonteh euwe! Heolth Clinic Survey 
so,; 
407. 
20% 
1oz 
0 2 5 6 >c 
IZ2J Triol cs::::sJ Mor 8.3 
ACE: (month!l) 
~ Sept 8.3 ~ Oct 84 
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Prevalence of breast feeding in Bonteheuwel 
Table 5.2 shows, for children in their first year of life, the prevalences of breast feeding, formula 
feeding and combined formula and breast feeding. The data are from surveys made in April 1983, 
September /October 1983 and September /October 1984. 
Figure 5.2 shows a linear trend for the prevalence of breast feeding to fall from around 80% in the first 
month of life to about 10% by 4 months of age. 
The figure shows a tendency for the prevalence of breast feeding to fall with time. As explained in the 
methods section, interpretation of this is hampered by lack of a control group for comparison and the 
slightly different data collection procedure adopted for the last survey. The difference between the 
April 1983 and September/October 1984 surveys (ie before and after the trial) is not statistically 
significant·. 
In view of the ethically sensitive nature of trials involving infant feeding formulas, studies similar to the 
main project should in future include well controlled and standardized surveys of breast feeding 
practices. 
• Regression analysis of prevalence of breast feeding (y) on age for the first 5 months (x) yielded: 
For the April 1983 group y = -16.14x + 83.0 
For the Sept/Oct 1984 group y = -14.57x + 73.76 
The F values for the slopes and intercepts are 0.3 and 1.35 respectively. The P values for significance tests of parallel slopes 
and equal intercepts are greater than 0.05. 
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Table 5.2 Prevalence of breast, formula and combined breast and formula feeding in 
Bonteheuwel in April 1983, September/October 1983 and September/October 1984 • 
AGE Formula Breast . Breast TOTALS 
(months) 
' Formula 
APRIL 198~ 
0 l 1% 4 5% 72 94% 77 
1 2 13% 4 25% 10 63% 16 
2 1 20% 2 40% 2 40% 5 
3 33 35% 29 31% 32 34% 94 
4 33 37% 34 38% 22 25% 89 
5 35 83% 5 12% 2 5% 42 
6 35 47% 33 44% 7 9% 75 
SEPTEMBER 12S3 
0 3 8% 2 6% 31 86% 36 
l 3 .33% 0 0% 6 67% 9 
2 0 0% 0 0% 4 100% 4 
3 18 44% 7 17% 16 39% 41 
4 17 63% 4 15% 6 22% 27 
5 16 100% 0 0% 0 0% 16 
6 15 68% 3 14% 4 18% 22 
OCTOBER 1984 
0 2 9% .4 18% 16 73% 22 
l 8 36% 2 9% 12 55% 22 
2 10 50% 3 15% 7 35% 20 
3. 18 60% 4 13% 8 27% 30 
4 30 88% 2 6% 2 6% 34 
5 15 65% 3 13% 5 22% 23 
6 20 83% 2 8% 2 8% 24 
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PREVALENCE OF BREAST FEEDING 
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Prevalence of exclusive breast feeding in the first year of life. 
Reasons for cessation of breast feeding 
5.7 
6 
Table 5.3 and figure 5.3 summarize the replies of mothers to the question 'Why did you stop breast 
feeding? No striking difference is apparent between the Trial group and the three Community surveys. 
The most common answers were the demands of employment and that the child was not getting 
enough milk from the breast. 
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Table 5.3 Reasons for stopping breast feeding given by mothers of the infants In the main trial 
and mothers In the community of Bonteheuwel. 
REASONS FOR WEANING 
REASON TRIAL MAR 1 83 SEPT 1 83 OCT 1 84 
Working 35 23% 96 40% 49 45% 57 36% 
Social 20 13% 6 2% 3 3% 5 3% 
No milk 80 54% 87 36% 45 42% 58 37% 
Breast disease 3 2% 15 6% 3 3% 11 7% 
Baby refused 5 3% 30 12% 3 3% 13 8% 
Other 6 4% 9 4% 5 5% 14 9% 
TOTALS 149 243 108 158 
= = = 
-
Note Rounding causes some of the columns of percentages not to total 100%. 
REASONS FOR WEANING 
Working Socicil No milk Brecst disease 8ciby refused Other 
[SSJ Mer 83 REASON f2.'2Za Sept 63 ~ Oct 84 
Figure 5.3 Reasons for stopping breast feeding offered by mothers in the main study and by 
mothers in the community of Bonteheuwel 
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Conclusions 
The results of the feeding surveys suggest that the prevalence of breast feeding in Bonteheuwel may 
have declined during the period of the main study although this was not statistically significant. It is not 
possible to attribute the change in feeding practices to the influence of the trial itself for various 
reasons that are detailed above. 
Having noted these problems in interpretation, it should also be noted that .the present study has gone 
further than similar previous studies which have not reported their influence on breast feeding(314• 1• 
323
• 
298>. Previous investigators, one may speculate, have operated in times when there was less 
awareness of the need to protect mothers, particularly in underdeveloped areas, from excessive 
promotion of infant formulas to the detriment of the health of their children. 
Future trials of infant milk formulas should include well controlled surveys of breast feeding practices 
so that more substantive conclusions can be drawn about their effects on infant feeding practices. 

CHAPTER 6 RESULTS: IRON FORTIFICATION 
Introduction 
The results from the principal study are reported and discussed in this chapter. Appendix 3 contains a 
more detailed tabulation of the statistical analyses that were made. Results of interest are extracted from 
the schedules in the appendix and presented in more easily read tables and graphs. 
The analysis is presented in three main sections. In the first, the validity of the Control group is 
established. In the second, the Test group is compared with the Control group in order to define the effects 
of the increased iron fortification in the milk formula offered to the Test group. In the third section of the 
analysis, an association is sought between iron status and immune function. Finally, evidence from the trial 
for the safety of iron fortification is reviewed. 
Statistical methods 
Introduction 
The statistical methods employed are described in chapter 3. This section explains the graphical 
representations used and some applications of the statistics. 
Graphical representation of numerical results 
The figures in this chapter use the same graphical conventions to compare results for the Test and Control 
groups, show the difference between the 2 groups, the confidence limits of the means and statistical 
significance from a t test. The mean value of a variable is represented by a bar and the 95% confidence 
interval is depicted by a vertical line. The difference between the two groups is shown by the difference in 
height between the bars. The difference is also shown graphically by a separate bar with a line representing 
the 95% confidence interval through it. If this confidence interval line does !!.Q.t. cross the x-axis the 
difference between the two groups is significant at the 5% level. These concepts are illustrated in figure 6.2 
which shows a significant difference and in figure 6.22 which shows a non-significant difference. 
Comparison of changes 
The results of the intervention employed in the trial are often expressed in terms of the values of variables 
measured at the end of the trial. In many instances however, the effect of the intervention is most 
rigorously measured by the change in that variable over the course of the study. This takes account of small 
differences that exist at the start of the trial. For example, the· difference in haemoglobin concentrations 
between the two groups was 0.35 g/ dl at the end of the trial. But the difference in the change in 
haemoglobins was 0.49 g/dl. The figures have all employed absolute values as these result in clear graphs 
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and the conclusions drawn from them are consistent with those drawn from a comparison of chan,ges. For 
. . . . 
precision, the tables and text, where appropriate, give the change. increase or decrease as well as the 
absolute magnitude of results. The paired t test was used to compute P values when changes were 
compared. 
Validity of the Control group 
(Comparison of Test and Control groups at 3 months) 
Rationale 
A key factor in determining the strength of inferences drawn from a controlled trial is the comparability of 
the control group with the test group. At the start of the trial the two groups should be identical with 
respect to all the variables to be compared. The care taken in the present study to construct control and 
test groups without bias was described in chapter 3. An important question remains to be answered: Were 
the Control and Test groups actually comparable? 
Methodology 
This question is answered by comparing the results of the various tests and measurements made at the age 
of 3 months. If the selection procedures worked as intended there should be no difference between the test 
results for the two groups. For this reason, the tables of results in the following sections show the results of 
tests made at 3 months of age although the discussion is focused on the differences found at 12 months. 
The statistical tests show that the groups may be· assumed to be equivalent at the start of the trial. And, 
apart from the evaluation below of the results for two classes of variable of particular interest, no further 
comment is made on the validity of the control group. 
Statistical tests for equivalence 
Before commenting on the results, a few remarks need to be made on statistical procedures used but not 
mentioned in the chapter on methods and materials. The appropriate statistical test is a test for equivalence 
rather than the usual test for a difference. The test for a difference often results in "P value" of statistical 
significance. If the P value is not significant, it does not follow that the two groups are necessarily 
equivalent<411). The reason for this is that a real difference might be missed by an inappropriate test. 
An additional complication in the search for evidence for equivalence is that when many variables are 
compared, it is to be expected that about 5% will appear to be significantly different purely by chance<70>. 
Interpretation of the statistical tests therefore involves consideration of factors other than the absolute level 
of the P value. 
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The approach to equivalence testing taken in this section is to see if the 95% confidence interval of the 
difference between the variable under consideration in the Control and Test groups contains a clinically or 
physiologically important disparity. The determination of what differences are important is necessarily 
arbitrary and subjective to a certain degree. But this should not be seen as a move from the "objective" 
concept of statistical significance to the subjective concept of importance, but as a step towards the 
quantification of what was actually determined by the study(l70). 
Iron status 
As iron status was the variable to be manipulated in the study (ie the independent or input variable) it is 
important to confirm the equivalence of the Control and Test groups at the start of the experiment. Table 
6.1 lists the major indices of iron status for the Control and Test groups . (Appendix 3 contains a full 
tabulation of all statistical analyses.) 
Table 6.1 Iron status at 3 months of age compared in the Control and Test groups in order to 
establish equivalence of the two groups. 
Index of Control Test p 95% CI of diff. Smallest 
Iron Status Mean Mean Value of means Important 
Diff. 
Haemoglobin 11. 28 11. 38 51% -0.19 0.37 +o.s 
(g/dl) 
Haematocrit 32.89 33.27 34% -0.41 1,17 +l.O 
( % ) 
Mean cell volume 82.06 82.10 97% -1.80 1. 87 +1.0 
(ul) 
Red cell ZPP 2.92 2.82 63% -a.so 0.30 +1. 
(ug/g Hb) 
ferritin 1 117 120 91% +10 
(ug/1) 
Notes P values were calculated from student's t test. 
95% CI= 95% confidence intervals. 
l The geometric means are shown for ferritin. 95% confidence limits were calculated for log(ferritin) 
and are shown in appendix 3. 
It may be seen from the table that no variable differs significantly between the Control and Test groups; the 
lowest P value is 34%. The 95% confidence interval includes zero difference for all the measures of iron 
status. The smallest clinical or physiologically important difference is greater than the measured difference 
for all the variables and is inside (by a narrow margin) the 95% confidence interval only for haematocrit 
and mean cell volume. 
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All the measures of iron status shown in table 6.1 show a slight tendency in favour of the Test group. This 
trend is far from reaching statistical significance and the differences are all minor. For the purposes of the 
present research it can thus be concluded that the Control and Test groups had comparable iron status at 
the start of the trial. 
Future studies of a similar nature should consider stratification of the subjects according to their iron status 
in order to ensure deterministically rather than stochastically that the two groups have equivalent iron 
nutrition-. 
Participation rate and gender 
Table 6.2 compares the Test and Control groups with respect to completion rate and gender. The table 
shows that the two groups are equivalent as far as the later two variables are concerned. The proportion of 
subjects who completed the trial differs between the Test and Control groups and a chi square test of 
significance yields a P value of 7%. 
This poses a question about the equivalence of the two groups: If the dropout rates are different between the 
Test and Contro/groups are the groups still equivalent with respect to other variables? 
One may speculate that the families who dropped out were indeed different in many other respects from 
the families who remained in the study. The consequence of this would be to reduce inhom?geneities in 
the remainder and thus the differences between the two· groups would be diminished. (With respect to 
completion rate the differences disappear entirely.) With such small numbers and incomplete data it is not 
possible to test this hypothesis. Although it seems unlikely that the disparity in completion rates is 
important, the possibility of some bias should be borne in mind when interpreting the effects of the 
experiment. 
\ 
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Table 6.2 Participation and Gender compared between the Control and Test groups. 
Control Test p 
Participation 
Number at start 74 75 
at completion 62 70 7% 
Sex 
Male 38 39 
Female 36 36 94% 
Notes P values are calculated from the chi square test. 
Specimen collection rates 
The failure to collect specimens was an unimportant problem, except for the initial full blood counts which 
were obtained from 122 of 149 subjects. Initial indices were missing in18 of 74 infants in the Control group 
and 9 of 75 in the Test group. Chi square analysis of this distribution yields a value of 3.81 which is very 
close to the value (3.84) for statistical significance at the 5% level. This raises the question whether there 
may have been some bias in assembling the 2 groups. 
This fear is dispelled by similar analyses of the distribution of missing specimens for other parameters. For 
example, a total of 9 specimens were not obtained for plasma ferritin and 15 for red cell zinc 
protoporphyrin at 3 months and chi square analysis yielded values of 0.45 and 0.08 which are very far from 
the value (3.84) denoting statistical significance at the 5% level. 
The uneven distribution of full blood counts at 3 months also raises the question of a possible bias in 
comparisons involving these parameters. Comparisons of changes over the trial period in haemoglobin, 
mean cell volume and red cell distribution width were made using paired samples from the same child at 
both 3 and 12 months. These gave essentially equivalent results as when group means were compared. The 
data are given in table 6.6 and 6.7. 
It may therefore be concluded that the uneven distribution in missing specimens neither indicates a bias in 
assembling the groups, nor affects interpretation of the results of the study. 
A number of factors accounted for the missing specimens. Since the infants were to receive 2 painful 
injections for the delayed cutaneous hypersensitivity tests, it was decided on ethical grounds not to attempt 
venesection more than twice. There were 9 complete failures to obtain blood specimens at the start of the 
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trial and 5 at the end. The first portion of blood was decanted into heparinized tubes for the plasma 
measurements and immune function tests. The latet portion of blood was placed into EDT A tubes for the 
full blopd count. In retrospect it seems that it may have been wiser to have collected the full blood counts 
first since they were more easily invalidated by minor degrees of platelet clumping and clotting than the 
other tests. 
Temporal comparisons 
Differences were sought, but were not found, for temporal disparity between the Control and Test groups. 
The variables that were available for examination were the ages of the children and the dates of entry to 
and exit from the study. The two groups did not differ significantly with respect to any of the 4 measures 
and the only trend that might have biased the study was the slightly longer participation period for the Test 
group viz 8.96 months compared with 8.85 months for the Control group. This would have tended to 
increase the number of infections observed in the Test group·. 
Table 6.3 Temporal variations compared between the Test and Control groups, Dates of birth, 
entry to the study and. exit from the trial are compared for the two groups as well as the ages of the 
subjects on entry and exit. 
Variable Control Test p 95% CI of diff. Power 
Mean Mean 
OATES (decimals of a year) 
Date of birth 83.30' 83.32 
Date of entry 83.54 83.56 
Date of exit 84.27 84.30 
AGES (months) 
Age on entry ,2. 96 2. 9-0 
Age at exit 11. 81 11.86 
Notes P values were calculated from student's t test. 
95% CI= 95% confidence intervals. 
Value of means Obs 10% 
29% -0.02 0.06 19 100 
33% -0.02 0.05 17 100 
14% -0.01 0.07 31 100 
14% -0.15 0.02 31 99 
41% -0.06 0.15 13 100 
The statistical power of the study was detennined for both the observed difference (Obs) and a 10% 
difference (Wt) from the combined mean for a type I error probability of 5%. 
Oates are given as the decade plus decimal of a year. for example, 83.30 is 20 April 1983. 
• Calculation of the rate of infection adjusts for differences in periods of observation. 
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Age related changes 
(Comparison of results at 3 and 12 months) 
Between the age of 3 and 12 months, major developmental changes are taking place and the reader will 
observe differences in many variables comparing the two age groups. It was not the purpose of this study to 
investigate such changes, and no further remarks will be made on this subject. 
Study children · Feeding practices 
Before considering the effects of the increased iron fortification it is of interest to examine the feeding 
practices of the study mothers. 
Breast feeding 
Results 
Table 6.4 compares the extent of breast feeding in the two groups. Mothers in the Control group began 
bottle feeding their infants at an average age of 1.53 months. This was not significantly different from the 
mean age of 1.49 months for the Test group. Mothers in the Control and Test groups completed the 
weaning process when their infants were 3.60 and 4.04 months of age respectively. The difference. is far 
from statistical significance with the 95% confidence interval ranging from -0.94 to 1.83 months. 
Table 6.4 Breast feeding compared between the Control and Test groups. The extent of breast 
feeding is measured by two estimates: the mean age at which milk formula was first given and the mean 
age at which the breast was last offered to the infant. 
Variable Cont:rol Test:. 
Mean Mean 
Age weaned( in months) 
First given formula 1.53 1.49 
Last given breast 3.60 4.04 
p 
Value 
83% 
52% 
95% CI of diff. Power 
of means Obs 10% 
-0.36 
-0.94 
0.29 
1. 83 
0% 16% 
0% · 0% 
Notes p values were calculated from student's t test. 
95% CI 2 95% confidence interval. 
lhe statistical power of the study was detennined for both the observed difference (Obs} and a 10% · 
difference (10%} from the combined.mean for a type I error probability of 5%. 
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Solid foods 
Introduction 
At every encounter with each child in the main study (ie at approximately tl;iree week intervals) the mother 
or caretaker was asked at what age cereal, egg. fruits, vegetables and fish/meat were added to the child's 
regular diet. 
Results 
The results are shown in table 6.5. The first solid foods to be given are cereals and vegetables which are 
introduced from the first to third month. Eggs and fruit are added about a month later and fish and meat 
are included slightly later still. There is no significant difference between the 2 groups. Interesting trends 
ar~ the earlier ages at which the Test group were offered egg. meat and fish in comparison with the Control 
group. The smallest P value, 6.4%, was for meat and fish. 
Table 6.5 Age of introduction to solid foods for the Control and Test groups. 
Food Cont.rol Test. p 95% CI of dift. Power 
.Mean .Mean Value o:f means Obs 10% 
Age Age 
Meat/Fish 5.19 4.36 6.4% -1.04 0.02 46% 44% 
Cereal 2.06 1 .. 93 >10% -0.21 0.31 0% 35% 
Egg 4.24 3.49 >10% -0.95 0.15 29% 30% 
Fruit 4.16 4.16 100% -0.48 Q.48 0% 40% 
vegetable 3.40 2.96 >10% -0.60 0.20 17% 36% 
Notes P values were calculated from student's t test. 
95% CI" 95% confidence interval. 
The statistical power of the study was determined for both the observed difference (Obs} and a 10% 
difference (10%} from the combined iooan for· a type I error probability of 5%. 
Discussion 
The survey of breast feeding practices and of the ages at which solid foods were introduced, showed trends 
that would have favoured the Test group, as far as iron nutrition is concerned since meat and fish not only 
contain readily available haem iron, but also promote the absorption of non-haem iron(l04, 237). The trends 
were not statistically significant. 
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The date at which a certain feeding practice is initiated, eg bottle feeding, provides a crude measure of 
nutrient intake. A complete dietary survey at various points in the trial would have provided answers to 
questions about quantity and frequency that the present surveys could not. Cook and Reusse/104) 
recommend that the development of a strategy for iron fortification include determination of iron intake 
from dietary surveys as the step following ascertainment of the prevalence of iron deficiency. The present 
project did not have the resources to attempt such a large project, but, as the present study demonstrates, 
lack of dietary information can hinder interpretation. None of the trials on which the present study was 
modeled have reported detailed dietary studies'7• 71• 77, 221• 285,294). 
A weakness in the methodology is that the ages at which events occurred were recorded as months attained. 
The precision and accuracy of the data would have been improved if decimals of a year had been 
employed(447). 
A weakness in the gathering of the data is that the information was obtained from the caretaker of the 
infants. If the mother was working, the information provided by the day-time caretaker may not have been 
as accurate as could have been provided by the mother. 
Conclusions and recommendations 
The trends shown in the feeding practices may indicate a confounding factor, both in terms of iron nutrition 
and in terms of immune function. This possible bias in favour of the Test group should be borne in mind in 
interpreting the results of the trial. 
It would be useful if future trials of iron fortification of infant foods include dietary surveys of ingestion of 
the food vehicle and inhibitors and facilitators of iron absorption<125). The aim should be to determine 
both the composition of the diet and the temporal relationship of ingestion of facilitators and/ or inhibitors 
of iron absorption to ingestion of the food vehicle. 
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The effect of increased iron fortification of milk formula on iron status 
(Comparison of Test and Control groups at 12 months) 
Introduction 
The first question to be asked of the trial is whether the increased iron fortification had the desired effect 
on the iron status of the groups. It was shown above that the Control and Test groups had essentially the 
same iron status at the start of the trial. Tables 6.7 and 6.8 show that at the end of the trial the Test group 
had statistically significantly better iron nutrition than the Control group as indicated by mean levels of 
haemoglobin (11.85 cf 11.49 g/dl, P = 4% ), red cell distribution width (14.44% cf 15.53%, P = 0.05% ), red 
cell zinc protoporphyrin (3.41 cf 3.95 ug/g Hb, P = 4%) and plasma ferritin (29.0 cf 17.3 ug/1, P. = 0.04% ). 
This pattern was expected but the magnitude of the changes were smaller than expected. To evaluate the 
results the following 3 sections compare the present study with (a) reference standards, (b) 
epidemiological surveys of populations, and (c) similar trials of iron fortification. The achievements of the 
trial are then ass_essed in terms of its aims, 
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Table 6.6 Haematological indicators of iron status at the start of the trial. 
Indicator of 
Iron Sta 'tus 
Control 
Hean 
Test; 
Hean 
P 95i CI of diff. Power 
AT 3 MONTHS OF AGE 
Red cell count 
{ 1012 / 1) 
Haemoglobin 
{g/dl) 
Haematocrit 
( % ) 
Mean cell volume 
(fl) 
Mean cell Hb 
(pg) 
4.01 4.06 
11.28 11.38 
32.89 33.27 
82.06 82.10 
28.12 28.11 
Mean cell Hb cone. 34.28 34.21 
(ug/dl) 
RBC width distr. 
( % ) 
Reticulocytes 
( % ) 
13.35 13.69 
2.01 2.28 
Notes· P values were calculated from student's t test. 
95% CI• 95% confidence interval. 
Value of means Obs lOi 
42% 
51% 
34% 
97% 
98% 
69% 
19% 
22% 
-0.07 
-0.19 
0.38 
-1.80 
-0.71 
-0.43 
-0.17 
-0.16 
0.17 
0.37 
1.17 
1.87 
0.69 
0.28 
0.84 
0.70 
13 99 
0 99 
16 99 
0 99 
0 99 
0 100 
'26 99 
23 17 
The statistical power of the study was detennined for both the observed difference (Obs) and a 10% 
· difference (10%) from the contiined mean for a type I error probability of 5% • 
. ·--·---------
·---- --·---·-··-· ·---····-------- ------------
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Table 6.8 Non-haematological indicators of iron status compared for the Control and Test groups 
at the start and end of the trial. 
Indicat:or of 
Iron St.at.us 
AT 3 MONTHS OF AGE 
Red cell ZPP 
Cont:rol . Test; 
(ug/g Hb) 
Ferritin 
(ug/1) 
Log ( f erri tin) 1 
(log(ug/1)) 
AT 1 YEAR OF AGE 
Red Cell ZPP 
Change in ZPP 
(ug/g Hb) 
.Mean Mean 
2.92 2.82 
155.61'157.20 
2.07 2.08 
3.95 3.41 
1.18 0.51 
Ferritin 23.80 37.70 
Change Ferritin -137.93-111.42 
·. (ug/1) 
Log ( ferri tin) 2 
Chng Log(ferritin) 
(log(ug/1)) 
1. 24 
-0.86 
1. 46 
-0.59 
Notes P values were calculated from student's t test. 
95% CI= 95% confidence intervals. 
P 95-t CI of di££. Power 
Value or .means Obs 10% 
63% 
94% 
91% 
4% 
2% 
1% 
24% 
0.04% 
0.10% 
-0.50 0.30 0 29 
-38.34 41.53 o 12 
-0.11 0.12 o 93 
-1.04 -0.04 56 30 
-1.23 -0.10· 63 0 
3,95 23.84 
-17.70 70.71 
0.10 
0.11 
0.35 
0.44 
78 
22 
95 
91 
0 
0 
58 
14 
Changes are reported as the mean of the variable at 12 nx:inths minus the mean value at 3 months. 
The statistical power of the study was detennined for both the observed d.ifference (Obs) and a 10% 
difference (10%) from the combined mean for a type I error probability of 5%. 
1 Geometric mean ferritin levels for Control and Test groups are 117 and 120 ug/1 respectively 
2 Geometric mean ferritin levels for Control and Test groups are 17.3 and 29.0 ug/1 respectively 
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ZINC P R O T O P O R P H Y R I N 
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Figure 6.3 Mean zinc protoporphyrin levels for the Test and Control groups at U months of age· 
Figure 6.4 
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g 
1.5 
u 
9 
/ 0.5 
I 
L o g ( F E R R I T I N ) 
CONTROL TEST DIFFERENCE 
Log(ferritin) for the Test and Control groups at 12 months of age· 
• The bars represent the means and the vertical lines through the bars represent the 95% confidence intervals 
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Comparison with reference levels for haematological indicators of iron status 
The haemoglobin levels achieved by the Control and Test groups compare favourably with "normal" levels 
established by early workers, eg Guest and Brown(lSl) (Source 1 in table 6.9) and Smith(423) (Source 2), but 
are slightly lower than that in the later textbook by Dacie and Lewis(llO) (Source 3). 
More recently, efforts have been made to defme reference levels for haematological parameters by 
excluding subjects with evidence of iron deficiency. Employing this principle, Saarinen and SiimesC396) 
(Source 4) proposed ideal iron nutritional objectives for haematological variables. With the exception of 
the red cell count, all parameters are substantially higher than those found in the trial groups. The ideal 
haemoglobin according to these standards is 1.2 g/dl greater than that of the Control group and 0.8 g/dl. 
greater than that of the Test group. The ideal mean cell volume at 77 fl is substantially higher than the 
mean cell volumes of 72 fl and 73 fl in the Control and Test groups. 
Reference levels for haematological parameters were published in the form of percentile curves by 
Dallman and SiimesC116) (Source 5). In establishing the reference curves Dallman and Slimes excluded 
subjects with evidence of iron deficiency in one or more laboratory tests. For haemoglobin in 1 year old 
· children these criteria were serum ferritin less than 10 ng/ml, serum transferrin saturation less than 16% 
and mean cell volume less than 70 fl. Centiles for mean cell volume were computed after excluding those 
subjects whose haemoglobin values were more than 2 standard deviations below the mean determined as 
above or who had serum ferritin below 10 ng/ml, transferrin saturation less than 16% or abnormal 
haemoglobin electrophoresis. This ensured that only iron sufficient subjects were included, but the authors 
caution that iron sufficient subjects with lower test values may have been excluded. The standards set by 
the 50th centiles are similar to those of Saarinen and Siimes. 
Yip et a/478) (Source 5) published similar reference levels for haematological parameters by combining 
results from several surveys. 
While these "reference" centile curves provide useful standards for clinical decisions they are less useful 
norms for population comparisons since they may be based on data that excluded iron sufficient subjects 
with parameters in the low range of normal. In addition, the proportions of the various 
haemoglobinopathies in the reference and study populations differs because of the exclusion criteria and 
differences in genetic composition of the American and Cape Town populations. 
From the foregoing it may be seen that neither of the study groups reached the levels of iron sufficiency 
indicated by ideal reference standards. 
The parameter that deviated most from the ideal was the mean cell volume. It is possible that this may be 
due to a large proportion of infants in the study with thalassaemia trait or heterozygotes for a 
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haemoglobinopathy. This is unlikely since Bird et af.39) found such conditions in 10.4% of "coloured" 
infants presenting to the Red Cross War Memorial Childrens Hospital with a mean cell volume less than 60 
f(. The prevalence is likely to be very much less in children with mean cell volumes greater than 60 fl. 
It is possible that the laboratory results are systematically low for the mean cellvolume but this is unlikely 
because the laboratory makes regular, frequent quality control assays with an internationally accepted 
standard. 
A more likely reason for the relatively low mean cell volumes in the study children is that their iron status 
was sub-optimal in spite of the iron fortification. 
If so, this might imply that mean cell volume is a more sensitive indicator of minor degrees of suboptimal 
iron status in a population than haemoglobin. Unfortunately, this parameter was not reported in the 
studies of Marsh et af.-323), Andelman and Sered(7) and Steke1<479) so it is not possible to test this hypothesis 
by reference to the literature. 
Since the red cell distribution width showed the smallest P values when the haematological parameters of 
the Control and Test groups were compared, it will be interesting to relate the results in the present study 
to reference levels when these are established. It seems that red cell distribution width is a sensitive 
indicator of suboptimal iron nutrition. 
A further conclusion is that the present study may reflect the community's position in a "secular trend" in 
haematological parameters analogous to the well known secular trend in stature. This speculation arises 
from the historical comparisons made in table 6.9 and is further confirmed in the next section. 
• There was 1 such child in the present study and he turned out on further investigation to have thalassaemia trait. 
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Table 6.9 
groups. 
Reference standards for haematological parameters compared with the Control and Test 
Source- Age R/5 
month 
Con:trol 12 
Test 12 
1 12 
2 12 
3 12 
4 12 
S 6-24 
6 12-24 
* Source 
Hb 
g/dl 
11.49 
11.85 
11.3 
11.6 
12 
12.7 
12.5 
12.3 
HC'P RBC 
i lG12 /l 
34.85 4.85 
35.80 4.90 
34.4 4.78 
35.2 4.6 
40 4.4 
37 4.7 
35.9 4.34 
MCV MCH MCHC RDW% 
:fl pg g/dl 
71.96 23.78 32.98 15.53 
73.20 24 .. 29 33ol4 14.44 
73 23.7 32.4 
77 25 33 
78 27 32.S 
77.7 26.8 34.3 
70 
79 27.4 34.4 
1 Guest GM, Brown EW. ·Erythrocytes and he!ooglobin of the blood in infancy and childhood. AMA Journal 
of Diseases of Children 1957; 93: 486-509<200 > 
2 Smith CH. Blood diseases of infancy and childhood. 3rd ed Mosby, St Louis 1972<423> 
3 Dacie JV, Lewis SM. Practica 1 Haematology 6th ed. Church11 l Livingstone, Edinburgh, 1984<110> 
4 Saarinen UM, Siimes MA. Developmental changes in red blood cell counts and indices after exclusion 
of iron deficiency by laboratory criteria and continuous iron supplementation. Pediatrics 1978: 92: 
412-416(435> 
5 Dallman PR, Siimes MA. Percentile curves for haenK>globin and red cell volume in infancy and 
childhood. Pediatrics 1979; 94: 26-31 <124> 
6 Yip R, Johnson C, Dallman PR. Age related changes in laboratory values used in the diagnosis of 
anaemia and iron deficiency. Am J Clin Nutr 1984; 39: 427-436<527 > 
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Comparison with epidemiological surveys of haematological indicators of iron 
status 
Interesting comparisons may be made with values found in an affluent community (Source 1 in table 6.10), 
with values found in a population survey in the USA (Source 4) and with values found in surveys in the 
Western Cape (Sources 2 and 3). 
In an affluent community in Canada, children at the age of one year had a mean haemoglobin 0.4 g/dl 
greater than the Test group and 0.8 g/dl greater than the Control groupC49). 
In Cape Town, Lanz.kowsky<262) showed in 1960 that the mean haemoglobin level was 11.2 g/dl for one year 
old white children, and 9.57 and 9.84 g/dl for »coloured" and black children. In 1984 Kirsten et af241) 
showed that the iron nutrition of "coloured" children had improved since the mean haemoglobin level was 
10.5 g/ di. His study was conducted in Heideveld, a community similar to that of Bonteheuwel. 
The effects of the extra iron employed in the present trial can be compared to the effects of the trial itself 
by contrasting the difference between the Control and Test groups with the difference between the Control 
group and the children in Kirsten's study. The Test group had a mean haemoglobin 0.36 g/dl greater than 
the Control group. In contrast, the Control group had a mean haemoglobin 1 g/ dl greater than infants in 
Kirsten's study. 
It may thus be inferred that the present study was effective in ensuring that the iron status of the both 
groups of children was substantially better than that of similar peers who did not participate in the trial: 
Yip et af482) studied haematocrits in white and black American children and found essentially equal mean 
levels. These are 1.5 and 0.5 percentage points greater than those in the Control and Test groups at 12 
months of age. 
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Table 6.10 
Test groups. 
Epidemiological surveys of haematological parameters compared with the Control and 
Sourcem Age R/S 
month 
Control 12 
Test 12 
1 12 
2 12 
3 
4 
12 
11-23 
* Source 
F 
M 
w 
C 
B 
w 
B 
Hb 
g/dl 
11.49 
11.85 
12.29 
12.24 
11.2 
9.57 
9.84 
10.S 
HCT 
% 
34.85 
35.80 
36.9 
36.7 
36.54 
36.33 
RBC 
1012/l 
4.85 
4.90 
MCV 
fl 
71.96 
73.20 
67.2 
MCH 
pg 
23.78 
24.29 
23 
HCHC 
g/dl 
32.98 
33.14 
RDW% 
15.53 
14.44 
1 Brault-Dubuc M, Nadeau M, Dickie J, Iron status of French Canadian children: a 3 year follow-up 
study. Hum Nutr: Appl Nutr 1983; 37A: 210-221<52> 
2 Lanzkowsky P. Mean haematological values in healthy infants and pre-school children in Cape Town. S 
Afr Med J 1960; 34: 469-471< 288> 
3 Kirsten GF, Heese H de V, de Villiers S, Den;>ster WS, Varkevisser HE, Hoffman M. The prevalence of 
iron deficiency in apparently healthy Cape Coloured infants. S Afr Med J 1984; 65: 378-380< 241 > 
4 Yip R, Schwartz S, Deinach AS. Haematocrit values in white, black and American Indian children with 
comparable iron status. Am J Dis Child 1984; 138: 824-827<531 > 
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Comparison with other trials of iron fortification for haematological indicators·of 
iron status 
Table 6.11 below ( extracted from table 2.16) lists the mean haemoglobins attained by infants in 3 clinical 
trials similar to the present study. It also shows that the iron and ascorbic acid levels in those trials was 
similar to that employed in the present study for the Control group. 
In all 3 studies children fed on the iron fortified milk had substantially higher mean haemoglobins than 
those on unfortified milks. It may be noted that these children's haemoglobin levels were also higher than 
those in even the Test group of the present study. The lowest was 11.9 g/dl and the highest 12.69g/dl, the 
Control and Test group's haemoglobins were 11.49 g/dl and 11.85 g/dl. 
Table 6.11 Haematological parameters from other trials of fortification of cow's milk based infant 
formula compared with those of the Test and Control groups . 
. 
Source AGE [IRON] [ASCORBIC ACID] MEANHb 
months mgFe/1 mgAA/1 g/dl 
Control 12 11.96 53 11.49 
Test 12 57.66 53 11.85 
Marsh1 9 12 55 12.69 
Unfortified milk ? ? 10.46 
Evaporated milk ? ? 9.67 
Artdelman2 12 12 55 11.9 
Evaporated milk ? ? 10.4 
StekeI3 9 15 100 12.2 
Unfortified milk ? ? 11.1 
Notes 
• Source 
1 Marsh A, Long H, Stierwalt RN. Comparative haematologic response to iron fortification of a milk fonnula for infants. 
Pediatrics 1959; 24: 404-412 
2 Andelman.MB, Sered BR Utilization of dietary iron by tenn infants. Am J Dis Child 1966; 111: 45-55(7) 
3 The ascorbic acid levels in the fonnulas used by Marsh et al and Andelman and Sered were not published. by these 
authors but are given in the article by Stekel on pages 181 and 182 of "Prevention of iron deficiency", Stekel A, 179-194 
in Iron nutrition in Infancy and Childhood. Edited by Stekel A, Nesti, Vevey/R.2J.ven Press, New York 1984. The 
haemoglobin levels from Stekel's study are read from figure 2 on page 184. 
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Assessment of achievements of the trial with respect to iron nutrition 
The first question addressed by the trial was: 
•' 
Does increasing the level of iron fortification of conventional infant milk f orrnula improve the 
iron nutrition of normal infants fed on the formula? 
The results presented above provide an affirmative answer to the question. but show that increasing iron 
alone, even in substantial quantities, is unlikely to make a clinically important difference. It is likely that the 
availability of iron added to milk formula is more dependent on the quantity of ascorbic acid than the 
quantity of ironC134• 133• 176• 519). The present study thus indirectly confirms the importance of ascorbic acid 
in facilitating the assimilation of iron. 
The study suggests that the mean cell volume may be a more sensitive indicator of sub-optimal iron status, 
since this was the haematological parameter which showed the greatest difference from reference levels. 
Table 6.7 shows that the red cell distribution width (RDW%) was the variable with the most statistically 
significant difference between the Test and Control groups. For the Test group the RDW% was 14.44% 
while for the Control group it was 15.53% with a P value of 0.05% for a 2 sample t test of the difference. 
The extra iron was associated with a smaller range of red cell sizes. Recent work(3S, 383) shows that the 
RDW% is a sensitive indicator of the iron status of the population and the present study bears this out. 
The study also raises the question of why the iron fortified milk formula was less successful in promoting 
optimal iron nutrition than similar formulas in similar trials. It is possible that the children ingested small 
quantities of the milk. Although it was not possible to gather data on this, it was the impression of the 
study team th·at the children received adequate amounts in almost all cases, Since the children grew 
adequately (mean standard deviation scores for weight were above O for both groups) their general 
nutrition was surely good. 
It is also possible, but unlikely, that the mothers relied too much on the formula and. did not give their 
children other haematinic foods in sufficient quantities. 
More likely is the possibility of a relative increase in inhibitors of iron absorption or the relative decrease in 
facilitators of iron assimilation with respect to the diets of children in the studies listed in table 6.11. 
Another possibility is that the children suffered from increa_sed iron losses. Diet is an unlikely cause and, as 
hookworm is rare in Cape Town·, it seems that increased iron losses are not probable. 
* Househam, KC. Epidemiology, clinical features, aetiology and course of acute infectious diarrhoea in infants. MD thesis. 
Univel"Sity of Cape Town 1985. 
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These results lead to the conclusion, articulated by Dallman et af.125), that more studies are needed "to 
detennine the overall influence on iron absorption of various types of fortified and unfortified transitional 
infant foods". 
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The effect of increased iron fortification of milk formula on immune function 
Introduction 
The second question addressed by the trial was: 
Does increased iron fortification of inf ant milk formula alter immunity as reflected by 
incidence of infection and laboratory tests of immune function? 
This section then, compares the Control and Test groups firstly for laboratory tests of immune function and 
secondly for incidence of infection in order to determine the effect of the increased iron fortification. The 
following 2 sections use classification and multivariate analysis to seek evidence for a relationship of iron 
status per se with immune function. 
Delayed cutaneous hypersensitivity 
Introduction 
Delayed cutaneous hypersensitivity is tested by the delayed reaction to an antigen injected intracutaneously. 
Such a reaction can only occur if the child has been sensitized by natural infection or by immunization. 
Two antigens were used in this study: PPD (purified protein derivative of Mycobacterium tuberculosis), and 
Candida antigen in the Mantoux and Candida tests. All the results tabulated are for children who had been 
immunized with BCG shortly after birth. 
In healthy children who have been immunized with BCG at birth the Mantoux test would be expected to be 
reactive (diameter of induration from 6 to 14 mm) or strongly reactive (diameter of induration > 14 mm) 
in 90% at 3 months and 72% at 18 monthl162. 207)_ The Mantoux test would also be expected to be 
reactive in a child infected with tuberculosis, but there was no reason to suspect this in any subject in this 
study. 
Healthy children develop an immunity to Candida at an early age and by the age of 1 year 80% of children 
would be expected to react to the delayed cutaneous hypersensitivity test(4l7)_ 
Results 
Tables 6.12 and 6.13 show that at one year of age the Test group responded more strongly than the Control 
group to Candida antigen, but showed lower reactivity in the Mantoux test. The differences were small and 
far from statistical significance. 
The data were also analyzed in order to determine reactivity of those children from whom Candida albicans 
had been isolated from a swab of a clinically suspicious lesion. In this group and in the group from whom 
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Candida albicans had not been isolated, the mean diameters of induration were 10.1 mm and 9 .2 mm 
respectively and a t test yielded a P value of 70% for the difference between the two groups. 
Table 6.13 shows that, at the age of one year, the Candida test elicited 5 mm or more of induration in 55% 
of Control infants and 63% of the Test group. For the Mantoux test the response rates were 58% and 52% 
respectively. 
Table 6.12 Delayed cutaneous hypersensitivity mean diameters of reaction compared in the Test 
and Control groups. 
Antigen Control 
Mean 
Test 
Mean 
p 
Value 
95% CI of diff. 
of means 
Power 
Obs 10% 
AT 3 MONTHS OF AGE 
Mantoux 5.96 
(mm induration) 
Candida 4.35 
(mm induration) 
AT 1 YEAR OF AGE 
Mantoux 8.05 
Change in Mantoux 2.25 
(mm induration) 
Candida 8.88 
Change in Candida 4.87 
(mm induration) 
4.32 
7.03 
1. 47 
9.75 
5.18 
Notes P values were calculated from student's t test. 
95% CI = 95% confidence intervals. 
53% 
97% 
43% 
62% 
56% 
84% 
-2.50 
-2.03 
-3.60 
-3.86 
-2.10 
-2.78 
1.30 
1.95 
1.56 
2.30 
3.83 
3.40 
0 
0 
12 
0 
0 
0 
0 
0 
0 
a 
a 
0 
The statistical power of the study was detennined for both the observed difference (Obs) and a 10% 
difference (10%) from the combined mean for a type I error probability of 5%. 
Changes are reported as the nean of the variable at 12 m::inths minus the nean value at 3 m::inths. 
Antigen, purified tuberculin 5 T.U./0.1 ml for the Mantoux test and 0.1 ml 1/100 Candida antigen, was 
injected intracutaneously on the volar aspect of the foreanns. The.transverse width of induration 
was neasured 48 hours later. 
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Table 6.13 Delayed cutaneous hypersensitivity response rates compared in the Test and Control 
groups. 
REACTION 0-4mm 5-9mm 10-30 mm 
Group No % No % No % Chi2 
AT 3 MONTHS OF AGE 
~andida 
.Control 46 65% 19 27% 6 8% 
Test 50 68% 17 23% 6 8% 0.25 
Mantoux 
Control 33 49% 31 46% 4 6% 
Test 39 56% ·27 39% 4 6% 0.74 
AT 1 YEAR OF AGE 
Candida 
Control 27 45% 14 23% 19 32% 
Test 26 39% 18 27% 24 36% 0.60 
Mantoux 
Control 25 42% 21 35% 14 23% 
Test 32 48% 22 33% 13 19% 0.53 
Notes P values were calculated from Chi square test; all were more than 10%. 
Antigen, purified tuberculin .5 T.U./0.1 ml for the Mantoux test and 0.1 ml 1/100 Candida antigen, was injected 
intracutaneously on the volar aspect of. the forearms. The transverse width of induration was measured 48 hours later. 
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6.27 
Figure 6.5 Candida test of delayed cutaneous hypersensitivity for the Test and Control groups at U 
* months of age 
Figure 6.6 
Ill 
Ill 
M A N T O U X T E S T 
CONTROL TEST DIFFERENCE 
Mantoux test compared for the Test and Control groups at 12 months of age· 
• The bars represent the means and the vertical lines through the bars represent the 95% confidence intervals 
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Discussion 
Although microbiological swabs were takeri only when Candida infection was clinically expected (there was 
no survey of all the children), it is to be expected that normal children who had yielded swabs positive for 
Candida albicans would have shown a greater reaction on average than the other children who would 
presumably include both a subgroup who had experienced subclinical infection and a subgroup who had not 
yet been exposed to Candida. The small difference that was found between the group who had proven 
exposure to Candida and the group whose exposure was unknown raises the suspicion that the test has poor 
discriminatory power for small variations in immune function. 
In the present study the Mantoux test was being used in an attempt to detect a difference in immune 
function between the Test and Control groups. It is also of interest to compare the results in the present 
study with surveys of reactivity to the Mantoux test in healthy children. This is done in table 6.14 where the 
present study is contrasted with a study designed to evaluate the effectiveness of locally produced PPD and 
to determine the "conversion rate• following immunization with BCG. At 3 months of age, the present 
study yielded a smaller mean diameter of reaction, but at 12 months of age the results are comparable to 
those from the studies of Fourie and Kibel<162• 207). The differences between studies are greater than the 
differences within studies for both the means and the standard deviations. The inference to be drawn from 
this is that the Mantoux test is more reliable for comparisons within a particular study than for comparisons 
between studies. 
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Table 6.14 Mantoux reaction compal"ed between the present study gr-oups and other studies. The 
reaction was the transverse diameter measured in mm 48 hours after intracutaneous injection of STU of 
PPD (purified protein derivative of Mycobacterium tuberculosis) on the volar aspect of the forearm. 
Study Mean Std N 
(mm) Dev 
AT 3 MONTHS OF AGE 
Contl"Ol1 5.96 S.48 68 
Test2 5.36 S.11 71 
Kibel3 7.3 4.0 21 
Kibel4 9.8 4.3 11 
AT 6 MONTHS OF AGE 
Kibel3 8.1 4.1 16 
Kibel4 1.7 2.4 3 
AT 12 MONTHS OF AGE 
Control1 8.05 7.48 60 
Test2 7.03 7.18 67 
AT 18 MONTHS OF AGE 
Kibel4 8.1 5.4 13 
Notes 1. The Control group in the present study, tested with British PPD 
2. The Test group in the present study, tested with British PPD 
3. Cape Coloured children tested with South African PP0(162• 207) 
4. Cape Coloured children tested with Japanese ppoC162, 207) 
Comparison with previous studies 
Gross et a/180) report that the dinitrochlorobenzene test in 5 iron deficient adults (mean haemoglobin 6.8 
g/ di) was similar to that of normal controls and did not change with iron therapy. 
Bhaskaram and Reddy(37) reported that the delayed cutaneous hypersensitivity test was positive in 4 of 9 
iron deficient children before iron replacement therapy. In 1 child it became positive after treatment. 
Haemoglobin levels ranged from 4 to 7 g/dl before treatment; responses to treatment were not stated. 
Joynson et af.229• 217• 216) report that the candida delayed cutaneous hypersensitivity test was positive in all 
U adult controls (mean haemoglobin 14.2 g/dl) but in only 3 of 12 iron deficient adults (mean haemoglobin 
9.0 g/dl). For PPD the results were positive in 10 and 5 subjects respectively. 
Chandra and and Saraya<91) reported trends towards decreased delayed cutaneous hypersensitivity 
responses in 20 iron deficient children to candida, PPD, mumps and trichophyton. For 
streptokinase/streptodornase the response of the iron deficient group was significantly depressed. Mean 
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ages and haemoglobins were not reported, so comparison with the present study is difficult. In addition, 
differences between the two groups in prevalence of infection and malnutrition can not be ruled out. 
In 28 obese children Chandra and Kutty<90) reported an impairment of iron nutrition as measured by serum 
ferritin. The obese children had lower serum zinc and significantly fewer individuals with positive delayed 
cutaneous hypersensitivity test with candida, mumps, trichophyton and streptokinase/streptodornase. 
Mean ages and haemoglobins were not reported. 
Similar results were reported by Chandra, Woodford and Hyam<89) but no details of iron status, ages or 
selection of their subjects were given. 
Kuvibidili258), in a carefully controlled study showed a significant impairment to dinitrochlorobenzene in 
mice with severe iron deficient anaemia. 
Krantman et af-249) tested 5 iron deficient infants and found positive responses to candida and tetanus in 2 
and 3 respectively. After treatment the mean haemoglobin rose from 8.36 to 12.04 g/dl and all responded 
to the delayed cutaneous hypersensitivity tests. Infection could not be entirely discounted as a possible 
confounding factor as the children had raised IgM concentrations. 
Macdougall et a/22.2) tested delayed .cutaneous hypersensitivity with diphtheria, candida and streptococcal 
antigen in 14 control children (Hb=12.8), 7 with latent iron deficiency (Hb=l0.8) and 11 with iron 
deficiency anaemia (Hb=8.1). Compared to controls, the iron deficient patients had significantly fewer 
positive tests; and after iron therapy they responded normally to the delayed cutaneous hypersensitivity 
tests. As the iron deficient children were selected from hospital patients, infection is a confounding factor 
whose influence cannot be evaluated. 
Summacy and conclusions 
In summary, the results of the delayed cutaneous hypersensitivity tests are inconclusive and do not suggest 
that the Test group had altered immune function. However the statistical power of the Mantoux and 
Candida tests was low and the difference in iron status was small so it is unlikely that a real difference 
would have been detected. 
Comparison with studies in the literature is difficult since the reported studies have compared groups with 
much greater differences in iron status. In contrast to the present study, many clinical studies could not 
rule out the confounding effects of malnutrition and infection as their subjects were hospitalized patients. 
A further problem that inhibits comparison is that clinical studies have followed clinical practice and 
reported their results in terms of the numbers of "positive" or ''negative" tests. This is, in a sense, discarding 
data; a more accurate and precise summary measure is the mean diameter of induration. 
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Specific antibody response to immunization 
Introduction 
The responses to immunization with live trivalent polio virus vaccine administered orally and tetanus toxoid 
administered intramuscularly are compared in table 6.15 for the Test and Control groups. The two tests 
measure specific antibody titre. Although the tests use the same outcome measure they evaluate different 
parts of the immune system since the antibodies are produced in response to different types of stimulation. 
Statistical note 
There is a theoretical difficulty in using the t test on data such as antibody titres which are far from 
normally distributed. The results shown in table 6.15 are from non-parametric stati_stical tests which avoid 
this sort of problem. 
The non-parametric tests do not readily lend themselves to graphical representation or to the calculation of 
confidence intervals. Logarithmic transformation of skewed data often brings the data close enough to 
Gaussian distribution · for parametric analysis. This was done for the titres and the analysis, shown in 
appendix 3, gave similar P values and trends to those obtained from the non-parametric statistics. Since the 
validity of the log transformation was thus confirmed, figures 6.7 and 6.8 compare the two groups for 
log(antibody titre). 
Results 
The Test group had a greater response to immunization than the Control group for polio but a smaller 
response for tetanus. The differences were far from statistical significance. 
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Table 6.15 Specific antibody responses to immunization compared between the Control and Test 
groups for polio and tetanus. The children were immunized at 6 and U weeks with 3 drops of trivalent 
oral live attenuated polio vaccine and 1 ml intra-muscular tetanus toxoid. Specific antibody titres were 
measured in the mothers on entry to the study and in the children at 3 and U months of age. 
Antibody Control 
Titre Rank 
MOTHERS 3 MONTHS POSTPARTUM 
Tetanus 
Polio 
INF ANTS AT 3 MONTHS OF AGE 
Tetanus 
Polio 
INFANTS AT I YEAR OF AGE 
Tetanus 
Polio 
55.21 
56.08 
60.02 
54.71 
60.41 
53.78 
Test 
Rank 
59.33 
58.65 
55.46 
59.76 
55.14 
60.50 
p 
Value 
49% 
52% 
40% 
40% 
39% 
27% 
Notes P values were calculated from Kruskal-Wallis and Mann-Whitney test statistics. 
The mean rank was computed by dividing the rank sum by the number of subjects. 
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Figure 6.7 Log(tetanus antibody titre) for the Test and Control groups at 12 months of age· 
• The bars represent the means and the vertical lines through the bars represent the 95% confidence intervals 
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Log(polio antibody titre) compared for the rest and Contro- groups at u months of 
Comparison with previous studies 
Chandra and Saraya<91) indicated that there was no difference in response to immunization with tetanus 
toxoid and Salmonella typhi vaccine in iron deficient children and controls. Mean ages and haemoglobins 
were not reported. 
KuvibidilaC255) found that antibody production against sheep red blood cells was severely depressed in iron 
deficient anaemic mice but not in pair-fed controls. In a related study, Kuvibidila and her colleagu~s(2S7) 
reported that the blastogenic response of B cells to bacterial lipopolysaccharide was significantly impaired 
in iron deficient mice. 
Macdougall and J acobi283) found non-significant tendencies for iron deficient children to respond less 
efficiently to immunization with diphtheria toxoid and Salmonella typhi vaccine. Both infection and 
nutritional factors were poorly controlled and their control group was probably also mildly iron deficient as 
their mean haemoglobin level was 10.95 g/dl. The test group's haemoglobins ranged from 4.6 to 7.4 g/dl. 
Malakhovsky et ai<291) also reported tendencies for decreased immune responses in iron deficient infants. 
Their paper does not provide sufficient data to evaluate the methods and results. 
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The clearest results are from the study of Nalder<333> who found a decreased response to immunization 
with tetanus toxoid in rats. There was a striking dose/response relationship between the level of iron in the 
• 
diet and antibody titre. As there was no pair-fed control group, however, the effects may be due to 
concomitant nutritional deficiencies. 
Summary 
In summary, the results of the ana.body analyses are inconclusive. The differences are not statistically 
significant and the power of the statistical analysis to detect a real difference is less than 50%. Previous 
studies have compared groups with much larger differences in iron status than that obtained in the present 
trial and have often not excluded malnutrition or infection. 
CHAPTER 6RESULTS: IRON FORTIFICATION 6.35 
Leukocyte counts 
Results 
The white cell counts for the Test and Control groups are compared in table 6.16. At three months of age 
there was no difference between the two groups. At 1 year of age the total white cell count was minimally 
lower in the Test group. The Test group had significantly more monocytes and fewer lymphocytes than the 
Control group. Smaller differences were manifest in the other classes of lymphocytes. 
Table 6.16 White cell counts compared at the start and end of the trial. 
Leukocytes Cont:rol Test: p 95% CI of diff. Power 
Mean Mean Value of means Obs 10% 
AT 3 MONTHS OF AGE 
Total Leukocytes 11.25 11.12 25% -0.46 1.76 21 53 
Polymorphs ( % ) 26.98 27.53 80% -3.78 4.88 0 24 
Lymphocytes ( % ) 64.78 65.06 90% -4.25 4.81 0 80 
Monocytes ( % ) 5.13 5.02 83% -1.13 0.90 0 17 
Eosinophils ( % ) 2.89 2.26 14% -1.48 0.22 31 0 
Basophils ( % ) 0.18 0.14 60% -0.21 0.12 0 0 
AT 1 YEAR OF AGE 
Total leukocytes 10.95 10.35 87% -0.97 1.15 0 53 
Polymorphs ( % ) 31. 32 34.79 11% -0.74 7.68 35 34 
Lymphocytes ( % ) 60.75 56.39 5% -8.66 -0.08 51 76 
Monocytes ( % ) 4.63 5.92 3% 0.13 2.45 59 15 
Eosinophils ( % ) 3.22 2.74 40% -1. 59 0.63 14 0 
Basophils ( % ) 0.10 0.11 88% -0.12 0.14 0 0 
Notes P values were calculated from student's t test. 
95% CI " 95% confidence intervals. 
The statistical power of the study was determined for both the observed difference (Obs) and a 10% 
difference {10%) from the combined mean for a type I error probability of 5%. 
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White cell counts for the Test and Control groups at 12 months of age· 
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Lymphocyte counts compared for the Test and Control groups at 12 months of age 
• The bars represent the means and the vertical lines through the bars represent the 95% confidence intervals 
• 
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Discussion 
The interpretation of the differences is not clear but the results would be consistent with the Control group 
having had more infections than the Test group, particularly if the infections were predominantly viral. 
The review of the literature in chapter 2 (see table 2.11) found no study that reported a depression of 
leukocytes or granulocytes in iron deficiency although their subjects had much greater degrees of iron 
depletion than those in the present study. 
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Lymphocyte subtypes 
· Introduction 
The many different functions of the immune system are carried out by specialized cells. Prominent among 
these are the T lymphocytes. These have been characterized by surface antigens which are "recognized" by 
specific monoclonal antibodies. Virtually all T lymphocytes are identified by the OKT3 antibody. OKT4 
and OK.TS antibodies "recognize" helper/inducer and suppressor/killer T cells respectively. Table 6.17 
displays the results of lymphocyte subtyping applied to the Test and Control groups at 3 and 12 months of 
age. 
Changes in these markers have been documented in severe immune deficiencies. In the present 
population, where subtle changes in immune function were hypothesized it was difficult to predict the 
direction of changes. 
Results 
The results in table 6.17 show that there was little difference between the Test and Control groups at both 3 
and 12 months of age. The statistical power of the test to detect a 10% difference between the Test and 
Control groups was low. 
Discussion 
The literature review found no previous study that reported on lymphocyte subtypes in relation to iron 
nutrition. Decreased proportions of T cells have been reported by Bhaskaram and Reddy(37), Chandra and 
SarayaC91), Srikantia et a/C431) and Krantman et a/249). Nutrition and infection were likely confounding 
factors in the first three investigations. Chandra and Kutty(90) found normal proportions of T cells in obese 
children with iron deficiency. 
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Table 6.17 Lymph- btyp · 
I 
. v .. .r-e su es compared m the Control and Test groups at the start and 
comp et10n of the trial Lymph yt b · · ofT cells and with • . I oc e.s were su ~ed with commercial monoclonal antibodies in the case 
commerc1a multivalent anti-gammaglobuJin to count B cells. 
Lymphocyte control Test p 95% CI of diff. Power 
Subtype Mean Mean Value of means of Test 
AT 3 MONTHS OF AGE 
Total T cells 69.47 67.98 39% -4.87 1.90 
14 97 
OKT3 
Helper-inducer 50.42 51.60 59% -3.11 5.48 
0 64 
OKT4 
Suppressor-killer 16.42 15.84 66% -3.16 2.00 
0 24 
OKT8 
Helper/suppressor 3.60 4.16 16% -0.21 1.33 
29 17 
OKT4/0KT8 ratio 
B cells 19.61 17.40 7% -4.58 
0.16 45 33 
SMIG 
AT 1 YEAR OF AGE 
Total T cells 74.14 72.59 44% -5.49 2.40 
12 95 
OKT3 
Helper-inducer 46.90 46.83 98% -4.87 
4.73" 0 48 
OKT4 
Suppressor-killer 22.53 22.94 81% -3.06 3.90 
0 . 25 
OKT8 
Helper/suppressor 2.53 2.41 62% -0.59 0.35 
0 18 
OKT4/0KT8 ratio 
Change OKT4/0KT8 -0.97 -1. 62 10% -1.44 0.13 
38 0 
OKT4/0KT8 ratio 
B cells 18.60 19.19 66% -2.10 
3.28 0 28 
SMIG 
Notes P values were calculated from student's t test. 
95% CI~ 95% confidence intervals. " 
Changes are reported as the mean of the variable at 12 !T()nths minus the mean value at 3 !T()nths. 
SMIG = surface membrane immunoglobulin positive cells. 
The statistical power of the study was detennined for both the observed difference (Obs) and a 10% 
difference (10%) from the combined mean for a type I error probability of 5%. 
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CHAPTER 6 RESULTS: IRON FORTIFICATION 
Lymphocyte stimulation with phytohaemagglutinin 
Introduction 
6Al 
The phytohaemagglutinin transformation test is a laboratory measure of the ability of lymphocytes to 
respond to foreign material. 
Results 
Table 6.18 shows that the Test group, with a mean stimulation index of 140%, responded marginally better 
than the Control group with a mean index of 142%. 
Table 6.18 Lymphocyte stimulation with phytohaemagglutinin (PHA) compared between the 
Control and Test groups. The infant's lymphocyte response is reported as a percentage of the response of 
an adult control. In order to distinguish cellular and serum effects the tests were performed with the 
infant's cells and serum, the infant's cells and serum from an adult control, and adult control .cells with 
serum from the infant. 
FHA Test 
Cells Serum 
AT 3 MONTHS OF AGE 
Infant Infant 
Infant 
Adult 
Adult 
Adult 
Infant 
Adult 
AT 1 YEAR OF AGE 
Infant Infant 
Infant Adult 
Adult Infant 
Adult Adult 
Control 
Hean 
Test 
Hean 
133.74 137.48 
138.78 143.11 
97.97 103.80 
100.00 100.00 
140.40 142.06 
142.83 143.39 
102.14 101.54 
100.00 10-0.00 
Change in Inf-Inf 15.03 -1.27 
Notes P values were calculated from student's t test. 
95% CI= 95% confidence intervals. 
p 
Value 
77% 
72% 
14% 
N/A 
92% 
96% 
90%. 
N/A 
37% 
. 95% CI of diff. 
of means 
-21.35 
-19.36 
-1.88 
-29.81 
-23.25 
-9.87 
28.83 
28.02 
13.53 
33.13 
24.35 
8.69 
-52.40 19.80 
Power 
Obs 10% 
14 29 
15. 32 
42 83 
12 
11 
12 
15 
25 
32 
68 
0 
Changes are reported as the mean of the test with cells and serum from the infants at 12 months minus 
the mean value at 3 months. 
The control results are 100% by definition. 
The statistical power of the study was determined for both the observed difference (Obs) and a 10%. 
difference (10%) from the combined mean for a type I error probability of 5%. 
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Figure 6.13 Lymphocyte responses to stimulation with phytohaemagglutinin for the Test and Control 
groups at 12 months of age· · 
Discussion 
The results show that the increased iron fortification had essentially no effect on iron status. 
Comparison with previous studies 
Table 2.8 in chapter 2 summarizes the results of studies found in the literature survey that reported on 
lymphocyte stimulation tests in iron deficiency. Of these, 8 documented significantly impaired responses to 
phytohaemagglutinin, 2 showed similar but non-significant trends and in 1 there was no change in iron 
deficiency. 
In the study with the anomalous resuitsC251>, all the children were severely iron deficient (the mean 
haemoglobin was 3.5 g/ dl) and 7 of the 8 had hookworm ova or parasites in the stools. 
The other clinical studies derived their subjects from hospital populations where confounding factors of 
nutrition and infection are prevalent. The only laboratory experiment(2S7) used pair-fed rats to control for 
nutritional deficiencies other than iron. These investigations all compared groups with greater differences 
• 
in iron status than existed in the present project. 
• The bars represent the means and the vertical lines through the bars represent the 95% confidence intervals 
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Neutrophil bactericidal indices 
· Introduction 
6.43 
The bactericidal test is an in vitro test of the ability of cells and serum to kill bacteria (in this case 
Staphylococcus aureus ). 
Results 
Table 6.19 shows that the bactericidal indices at 12 months were slightly better in the Test group than in the 
Control group; for instance, 105% compared with 94% at one hour. The Test group also manifested a 
greater improvement in killing ability from that at 3 months to that at 12 months of age. The 95% 
confidence intervals are relatively wide and the statistical power of the test is low so no definite conclusion 
can be drawn with respect to the effect of extra iron supplementation on the bactericidal index. 
Table 6.19 Neutrophil bactericidal indices compared between the Test and Control groups. The 
bactericidal index is expressed as the percentage of the initial inoculum of Staphylococcus aureus 
surviving after culture with neutrophils from the subject. 
Incubar.ion Conr.rol Tesr. 
Period Mean Mean 
AT 3 MONTHS OF AGE 
1 hour 108.84 102.52 
2 hours 124.41 111.00 
AT 1 YEAR OF AGE 
1 hour 105.14 94.00 
Change in index 15.05 -11.72 
2 hours 126.75 113.31 
Change in index 23.71 2.36 
Notes P values were calculated from student's t test. 
95% er= 95% confidence intervals. 
p 
Value 
58% 
43% 
44% 
21% 
57% 
52% 
95% CI of diff. Power 
of means Obs 10% 
-29.+8 16.52 0 0 
-47.13 20.31 0 0 
-40.10 17.81 22 20 
-69.05 15.52 24 24 
-60.53 33.65 18 17 
-88.51 45.80 0 0 
Changes are reported as the ~an of the variable at 12 rronths minus the ~an value at 3 !1¥)nths. 
The statistical power of the study was detennined for both the observed difference (Obs) and a 10% 
difference (10%) from the combined ~an for a type I error probability of 5%. 
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Figure 6.14 Neutrophil bactericidal indices for the Test and Control groups at U months of age· 
Discussion 
In appendix 3 the bactericidal indices are reported in several different ways. As the computational methods 
are fundamentally different some comment is indicated. Table 6.19 gives the percentage of the initial 
bacterial inoculum surviving after 1 and 2 hours. In appendix 3 the subjects are compared to the adult 
controls by computing the ratio of the colony counts in subject's test to. those of the control test at 1 and 2 
hours. In a more complex calculation the subjects were compared to the positive and negative controls 
( adult cells and pooled AB serum). As the various methods produced similar results only the simplest 
index is. reported here. 
Comparison with previous studies 
Decreased bactericidal activity has been reported in catalase positive organisms in 12 of 13 studies found in 
the literature survey. Their results are summarized in table 2.10, chapter 2. All these studies compared 
groups with much larger differences in iron status than in the present study··. With the exception of the 
• The bars represent the means and the vertical lines through the bars represent the 95% confidence intervals 
•• This can be inferred even if it was not explicitly stated as, for example, in 91, 86, 156. 
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report of Walter et azC459>, the design of the studies makes it difficult to discriminate between the effects of 
iron deficiency and coexisting infection or malnutrition or both·. 
Walter et al conducted an elegant study of the changes in bactericidal activity as iron status was restored to 
normal. But, even this design does not completely rule out the possibility of infection precipitating the 
seeking of medical help and thus inclusion in the study. On. referral, the mean haemoglobin of 10 infants 
was 7.9 g/dl. By day 15 it had improved to 9.6 g/dl in response to treatment with oral ferrous sulfate and 
the bactericidal capacity had risen from 59% to 91% (approximately equivalent to 41% and 9% in terms of 
the bactericidal index used in this report). From day 15 there was no further improvement in bactericidal 
capacity. 
Conclusion 
The bactericidal assay in the present study showed trends that paralleled results from other studies, but the 
statistical power of the study was low and no effect can be conclusively assigned to the extra iron 
fortification. 
• To be precise, one should also exclude from this judgment the experiment of Arbeter et af9> in which 2 rabbits were made iron 
deficient by bleeding. And, also, it should be noted that Masawe et af.7$) tested the bactericidal activity of whole blood. 
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Viral survey 
Introduction 
A survey of virus carriage rat.e was made on entry to the study and on exit. On entry, when the infants were 
3 months old, a faecal specimen was sent for viral culture. On exit, at 1 year of age, swabs from the rectum 
and from the nasopharynx were sent for viral analysis. 
Results 
The virus isolation rates are given in table 6.20. At 3 months of age, 18% of Control infants were excreting 
virus in the stool compared with 20% of Test infants. At 1 year of age, the isolation rates from rectal swabs 
were 36% and 38% respectively, while from nasopharyngeal swabs the rates were 14% for both groups. 
The types of viruses isolated are described in appendix 3. 
Table 6.20 Virus isolation rates compared for the Control and Test groups. At 3 months of age 
faecal specimens were cultured for viruses. At 12 months of age swabs were sent for viral culture from 
the rectum and from the nasopharynx. 
Group 3 Months 1 Year 1 year 
Faeces Rectal Swab Throat Swab 
No. % No. % ·No. % 
Control 11 18 23 36 9 14 
(No.) (61) (64) (64) 
Test 12 20 25 38 9 14 
(No.) (60) (66) (66) 
Notes P values calculated from the Chi square test were far from significant. 
Discussion 
The virus carriage rate was essentially equal in the Control and Test groups. This can be taken as evidence 
against the increased iron fortification having an adverse.effect on the bowel and nasopharyngeal viral flora. 
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Incidence of infection 
Introduction 
The rate of infection experienced by children in the Test and Control groups is analyzed in tables 6.21 and 
6.22. The first table compares the mean numbers of infections experienced in the two groups during the 
trial period while the second compares the mean incidence rates of infection. The incidence rates are 
expressed in numbers of infections per child per year and therefore remove the small bias introduced by a 
slightly longer mean period of observation for children in the Test group - 8.96 months compared with 8.85 
months for the Control group. 
· Analysis of numbers and of rates of infection leads to similar conclusions. Discussion is therefore confrned 
to table 6.22. 
Infections were graded according to severity and classed according to clinical type. Grade 1 illne.sses were 
of minor importance and did not warrant treatment. Grade 2 infections were of moderate importance and 
required treatment as an outpatient. Infections severe enough to require hospitalization were recorded as 
grade 3. 
Infections of grade 2 or 3 were also classed according to their clinical type, viz conjunctivitis, pyoderma, 
thrush, gastroenteritis and infections of the upper or lower respiratory tract (including otitis media). These 
classes were chosen after the study because they included sufficient numbers for meaningful analysis. 
Morbidity in infancy is not defined well enough to allow such classes to be defined in the planning stages of 
this study. Infections that did not fall into one of the above classes are tabulated as "other". Details of the 
operational definition of infection and the precautions taken to avoid counting infections more than once or 
missing infections are given in the Methods and Materials section of chapter 3. 
Results 
Table 6.22 shows that the Test group had fewer infections than the Control group for each grade of severity 
and for 5 of the 6 classes of infection. The Test group also had fewer infections in total than the Control 
group. No difference is statistically significant and the 95% confidence intervals are relatively wide. 
In the interests of planning future studies, a power analysis for each category of infection is presented in 
table 6.23. The statistical power of the trial to detect a 10% difference in infectious morbidity is less than 
25%, to detect a 25% difference in morbidity 81 %, and to detect a 50% difference in incidence rates the 
power is 99%. The difference actually observed between the two groups is 9.12%. 
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Table 6.21 Numbers or infections compared between the Test and Control groups. The infants were 
observed from the age of 3 months to 1 year. 
Infect;ion Cont;rol Test; p 95% CI of diff. Power 
Category Mean Hean Value of means Obs 101 
Severity of infection 
Minor 1.26 1.16 0.64 -0.52 0.32 0 0 
Important 3.34 3.13 0.58 -0.96 0.54 0 14 
Severe 0 .16. 0.11 0.44 -0.17 0.07 12 0 
TOTAL Infections 4.76 4.40 0.37 -1.15 0.43 15 21 
TYPE OF INFECTION 
Conjunctivitis 0.24 0.21 0.72 -0.18 0.12 0 0 
Other 0.27 0.14 0.12 -0.30 0.04 35 0 
Pyoderma 0.39 0.33 0.70 -0.35 0.24 0 0 
Thrush 0.40 0.36 0.72 -0.30 0.21 0 0 
Gastroenteritis 0.79 0.71• 0.64 -0.40 0.24 0 0 
Respiratory 1. 43 1.49 0.71 -0.39 a.so 0 0 
TOTAL Infections 4.76 4.40 0.37 -1.15 0.43 15 0 
Notes P values were calculated from student's t test. 
95% CI= 95% confidence intervals. 
The statistical power of the study was determined for both the observed difference (Obs) and a 10% 
difference (10%) from the combined ID!an for a type I error probability of 5%. 
CHAPTER 6 RESULTS: IRON FORTIFICATION 6.49 
Table 6.22 Incidence of infection compared between the Test and Control groups. The incidence is 
expressed as the average number of infections per infant per year. It was determined by dividing the 
number of infections each infant experienced by the number or days he or she participated in the trial and 
then calculating the mean rate or infection. 
Infection Control Test p 95% CI of di:f:f. Power 
Category Hean Hean Value of means Obs 101 
Severity of infection 
Minor 1.69 1.55 62% -0.70 0.42 0 0 
Important 4.51 4.16 48% -1.35 0.65 10 14 
Severe 0.22 0.15 43% -0.23 0.10 12 0 
TOTAL Infections 6.42 5.86 30% -1.61 0.49 18 21 
TYPE OF INFECTION 
Conjunctivitis 0.32 0.29 72% -0.24 0.17 0 0 
Other 0.37 0.19 11% -0.41 0.04 33 0 
Pyoderma 0.52 0.44 66% -0.49 0.31 0 0 
Thrush 0.54 0.48 68% -0.40 0.27 0 0 
Gastroenteritis 1. 07 0.95 59% -0.55 0.31 0 0 
Respiratory Infect. 1.90 1.98 80% -0.52 68 0 0 
TOTAL Infections 6.42 5.86 30% -1.61 0.49 18 21 
Notes P values were calculated from student's t test. 
95% CI = 95% confidence intervals. 
The statistical power of the study was detennined for both the observed difference (Obs) and a 10% 
difference (10%) from the combined nean for a type I error probability of 5%. 
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Table 6.23 Statistical power of the present study to.de.tect a difference in infection rate between the 
Test and Control groups with a 5% significance level. 
Variable DIFFERENCE.: Actual 10% 25% 50% 
SEVERI1Y OF INFECTION 
Minor 0 0 29 80 
Important 10 14 56 99 
Severe 12 0 0 20 
TOT AL Infections 18 21 81 99 
TYPE OF INFECTION 
Conjunctivitis 0 0 11 31 
Other 2J 0 0 2J 
Pyoderma. 0 0 0 22 
Thrush 0 0 12. 32 
Gastroenteritis 0 0 21 63 
Respiratory Infect. 0 O· 36 89 
TOT AL Infections 18 21 81 99 
Notes The differences for which the statistical power was calculated are that difference actually obsexved between the means 
and 10%, 25% and 50% of the mean for both groups combined. 
CHAPTER 6 RESULTS: IRON FORTIFICATION 
p 
e 
r 
C 
h 
i 
I 
d 
p 
e 
r 
8 
6 
4 
y 2 
e 
0 
r 
0 
I N C I D E N C E 0 F · I N F E C T I O N 
Total Minor Moderate Severe 
6.51 
Figure 6.15 
of age" 
Incidence of md.§ of infection compared for the Test and Control groups at 12 mon.its 
p 
e 
r 
C 
h 
f 
I 
d 
p 
e 
r 
8 
6 
4 
y 2 
e 
0 
r 
0 
Tot.al 
k:4~::~rol 
I N C I D E N C E 0 F I N F E C T I O N 
RTI G/E Thrush Pyodermo Other Eye Inf 
Figure 6.16 
of age· 
Incidence of~ of infection compared for the Test and Control groups at 12 months 
• The bars represent the means and the vertical lines through the bars represent the 95% confidence intervals 
6.52 
p 
• 0.5 
r 
C: 
h 0 
i 
I 
d -0.5 
p 
e 
r -I 
y 
e 
a -1 . 5 
r 
IRON NUTRITION AND IMMUNITY 
D I F F t R E N C E I N I N r E C T I O N R A T E 
Total Minor Hoderat.4ll SeverQ 
Figure 6.17 Difference in incidence of grades of infection at 12 months of age·. (Test group mean· 
Control group mean) 
p 
e 0.5 
r 
C: 
h 0 
I 
I 
d -0.5 
p 
e 
r -1 
y 
e 
a -1 .5 
r 
-2 
D I F F E R E N C E I N I N F E C T I O N R A T E 
Total RTI G/E Thrush Pyoderma Oth0r Eye Inf 
Figure 6.18 Difference in incidence of~ of infection at 12 months of age·. (Test group mean · 
Control group mean) 
• The bars represent the means and the vertical lines through the bars represent the 95% confidence intervals 
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Comparison with previous studies 
Chapter 2 contains a detailed analytical review of previous studies that have attempted to define the 
putative association of iron status with susceptibility to infection. Five studies in infants have been reported 
in sufficient detail for comparison to be made with the present study. 
Burman(7t) followed a group of infants from the age of 3 months to the age of 18 months. Children were 
allocated alternately to receive either placebo or an oral iron preparation to be taken daily. At one year of 
age the mean haemoglobins of the two groups were 11.75 and 11.76 g/dl. There was no difference in 
incidence of reported infection. The power of the study was not reported, but it is surely small. 
In a similar trial to the present one Andelman and Sered(7) compared the effect of fortification of an inf ant 
· milk formula with 12mg Fe/quart with unfortified formula. At one year of age, the mean haemoglobins of 
the two groups of infants were 11.9 and 10.4 g/dl respectively and the control group had had significantly 
more respiratory infection than the test group. Little information is given on how infections were 
diagnosed and no data are provided for other classes of infection. 
Cantwell(77) studied the effects of iron dextran in premature infants. The regimen resulted in the control 
group having a mean haemoglobin of 9.0 g/dl at 1 year while the iron treated group had a mean 
haemoglobin of 11.3 g/ dl. The control group had 39% more admissions than the test group over a 2 year 
period of observation. When acute wheezy bronchitis and asthma are excluded, the control group had twice 
the number of infection of the test group. Some methodologic problems are noted in chapter 2, but the 
study does suggest an aetiological role for iron deficiency in susceptibility to infection. 
Mackal285) compared infection rates in iron deficient infants treated with an oral iron preparation to 
infection rates in an untreated control group. The control group's mean haemoglobin at 1 year of age was 
10.0 g/dl while the treated group attained a mean haemoglobin of 11.3 g/dl. There was a remarkable 
relationship between infection rate and iron treatment. In both winter and in summer the test group had 
about half the number of infections that the controls experienced .. The relationship continued to hold when · 
the infections were classed as "specific fevers", respiratory infections, gastro-intestinal infections and "other". 
A major problem in interpretation was discussed at length by the author viz that the two groups were 
studied over different time periods. Even though she presented evidence that, in London, the infant death 
rate from infections did not change over that period, this retrospective open study leaves many confounding 
factors uncontrolled. 
The utility of iron dextran in preventing iron deficiency anaemia in the first year of life was studied by 
Oppenheimer et aP43) in Papua New Guinea. The iron-treated infants experienced a significantly 
increased incidence of malaria in the first year of life. The incidence of other infections was not discussed. 
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Conclusions 
The studies in temperate climates have suggested that iron deficiency predisposes to infection and the 
present study, while not reaching statistical significance, shows remarkable ·consistency in the parallel trends 
revealed. The sole study from the tropics indicates that iron dextran in young infants increases 
susceptibility to malaria. 
Figure 6.18 shows the difference in infection rates between the Control and Test groups. For "total 
infections" the difference amounts to 56 infections per 100 children per year. These are clinically important 
differences with substantial implications for public health. It is important that further studies be made in 
order to determine whether this is a chance association or the consequence of improved iron nutrition. 
The difficulties such studies will have in attaining adequate statistical power must be noted. The present 
study was designed to detect a difference in infection rates of 1 infection per child per year. The sample 
size calculations yielded 65 as the minimum number required in each group, assuming that the standard 
deviation of infection rate was 2.5. With the . data from the present study it can be estimated that a 
minimum of 230 infants would be required in each group to detect a difference of 0.59 in infection rates 
' 
with standard deviations of 2.8 and 3.3. 
Besides increasing the number of s_ubjects, steps that future studies could take to increase statistical power 
are to follow the subjects for a longer period or to increase the disparity in iron nutrition between the two 
groups or use a combination of these manoeuvres in order to improve the statistical power of the trial. The 
third option is limited by ethical considerations since gross iron deficiency should be treated and gross iron 
excess may be dangerous and should be avoided. The first and second options are limited only by 
availability of resources. In tropical areas a special consideration is the increased risk of malaria in iron 
sufficient children. 
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Summary of results of'immune function tests 
Laboratory and clinical tests of immune function were made in the Test and Control groups. These were 
delayed cutaneous hypersensitivity with Candida antigen and PPD, specific antibody response to 
immunization with oral polio vaccine and intramuscular tetanus toxoid, leukocyte counts, lymphocyte 
subtyping with monoclonal antibodies, lymphocyte stimulation with phytohaemagglutinin, and neutrophil 
bactericidal index and incidence of infection. The Test and Control groups had similar results with a clear 
trend emerging only for the incidence of infection; in 9 of 10 categories of infection the Test group had a 
lower incidence than the Control group. 
Each measure of immune function had a relatively wide 95% confidence interval and a low statistical 
power. However, the study is definitive in the confidence limits set for the means of the various indices of 
immune function and their differences between the two groups. From this analysis it is possible to state, for 
example, that the extra iron fortification is unlikely to have reduced the incidence of infection by more than 
25% or to have increased it by more than 8%. 
In all the immune function tests there is no evidence to suggest that the extra iron was harmful. 
The most intriguing results are the rates of infection which consistently favoured the Test group. One may 
calculate using the binomial function the probability of obtaining by chance this sort of distribution; it is 
· 3.5% *. Although it is tempting to do so, this value of 3.5% may not be taken as equivalent to the "P value" 
obtained from a significance test because the calculations rely on the assumption that the various categories 
of infection are statistically independent. Current medical knowledge would contradict this assumption. 
Defining an association between multiple variables is properly the function of multivariate analysis. The 
following section reports the multivariate analyses that were made in seeking an association of iron status 
with immune function. 
• Of the 10 categories of infection, 8 are statistically independent. The probability of at least 7 of 8 independent categories 
favouring the Test group is 11z8 + (8!/7!)*(1/28) = 9/256 = 3.52% 
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The association of iron status with immune function tests 
(Multivariate analyses) 
Classification of iron status 
Introduction 
The section above examined the results of the study in relation to the hypothesis that additional iron 
supplementation of infant milk formula would lead to improved immune function. The analysis therefore 
compared the Control group of infants with the Test group for incidence of infection (in several different 
categories of infection) and for performance in a variety of different laboratory measures of immune 
function. 
This section presents an analysis of immune function tests and the incidence rates of infection when the 
study subjects are categorized according to iron status. If iron deficiency depresses immune function and 
predisposes to infection then children classed as "iron deficient" should experience more infections and 
should have poorer immune function tests than children classed as "iron sufficient". 
The statistical procedures involved computing the mean and standard deviation for each variable within 
each category of iron status and then calculating the significance level for each pair-wise comparison. The 
Bonferroni procedure was used to adjust the significance level for the multiple comparisons made in this 
analysis. 
The method of classification 
There is no scheme of classification of iron status that simply and unambiguously measures the amount 
(relative to requirements) of iron available to the tissues, cells and enzymes that need it to perform their 
functions. This study made 10 tests that directly reflect the status of iron nutrition·. Five of these were 
used to classify (by computer) the status of iron nutrition of each child. The scheme is detailed in the 
following section. 
Categories of iron status 
Most children can be categorized with respect to iron status along the spectrum:- iron replete (Normal), 
depletion of iron stores (Depleted), biochemical evidence of iron deficiency (Deficient), and iron deficiency 
with anaemia (Deficient and anaemic). With this model of iron metabolism in mind, a classification 
system has been drawn up for use in the Department of Paediatrics and Child Health of the University of 
Cape Town and is described in tables 6.24 and 6.25. Table 6.24 gives reference values for the variables 
employed in allocating a set of results to a particular category of iron status. Table 6.25 gives the decision 
• These are: RBC, Hb, HCT, MCV, MCH, MCHC, RDW%, Reticulocyte count, plasma ferritin, and red cell ZPP. 
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criteria to be satisfied for each category. For example, a childdassi.fied as Normal will have a haemoglobin 
greater than 11.0 g/dl, plasma ferritin more than U ug/dJ and at least two of the following criteria true: 
mean cell volume greater than 70 fl, mean cell haemoglobin greater than 23 pg, and red cell zinc 
protoporphyrin less than 3.5 ug/ di. 
Some children do not fit into the categories of iron status defmed above and must be classed as 
Normochromic normocytic anaemic or placed in the Unclassified category. This may be because of normal 
biological variation or because of some abnormal condition affecting the variables used for categorization. 
For example, a number of infants with normal levels of ferritin have a normochromic normocytic anaemia 
(one of the causes of which may be the effects of infection(439). Their iron stores are probably normal, but 
they need to be kept in a separate group when associations of iron status with immune function tests are 
sought. A substantial number of children have tests of ·iron status with conflicting interpretations. There 
are several reasons for this, for example thalassaemia and haemoglobinopathies that occur in 10% of Cape 
Coloured children with a mean cell volume less than 65 n<39), and these will not be further mentioned. This 
group of children also needs to be kept separate when seeking relationships with iron status. 
Table 6.24 
TEST 
Reference values used in the classification of iron status of 1 year old infants. 
Haemoglobin(Hb) 
Ferritin(FRTN) 
Mean cell volume (MCV) 
Mean cell haemoglobin (MCH) 
Zinc protoporphyrin (ZPP) 
REFERENCE 
VALUE 
>11.0 g/dl 
>12.0 ug/1 
>70.0 fl 
>23.0 pg 
<3.5 ug/g 
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Table 6.25 Criteria for the classification of iron status in 1 year old infants. Reference values for 
the application of these decision criteria are given in table 6.24. 
IRON STATUS CRITERIA FOR CLASSIFICATION 
Hb FRTN > 1 of: MCV, MCH & ZPP 
Normal 
Depleted 
. Deficient 
Deficient and anaemic 
Unclassified 1 
Unclassified 2 
Unclassified 3 
Normochromic normocytic 
Anaemia 
y 
y 
y 
N 
y 
N 
N 
N 
y 
N 
N 
N 
y 
y 
N 
y 
y 
y 
N 
N 
N 
y 
y 
y 
Notes Yin the table indicates that the criterion in that column has to be satisfied for the category named in that row. 
N in the table indicates that the criterion in that column has to be NOT attained for the category named in that row. 
For example, a child with normal iron status has an Hb at least 11 g/dl, plasma ferritin at least 12 ug/1 and at least 2 of 
MCV, MCH and ZPP satisfying their respective criteria. 
Association of iron status with immune function 
Introduction 
Table 6.26 summarizes the results from computing the mean for each group of the infants according to iron 
status. Statistical tests included the t test. As none of the tests were significant (less than 5%) the P values 
are not included in the table. The results become difficult to interpret in this type of analysis because the 
number within a group becomes small. However, trends are apparent that are in keeping with the analysis 
in the main body of the report and that lend support to the hypothesis that deficient iron status is causally 
related to poor immune function. 
Incidence of infection - Normal iron status 
. Within the Normal group, in 9 of 10 categories of incidence of infection the infants in the Test group had 
lower rates of infection that those in the Control group - see tables 6.26 and 6.27. Tables 6.29 and 6.30 
show that of 10 measures of iron status, all except mean cell haemoglobin and mean cell haemoglobin 
concentration indicated better iron nutrition in the Test group. 
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Incidence of infection • Normochromic normocytic group 
In 7 of the ten categories of infection, the group categorized as Normochromic normocytic anaemic had 
more infections than the Normal group. This group presumably had normal body iron stores as their 
mean plasma ferritin was (by definition) at least 12 ug/I. The results are consistent with previous 
observations(439) that chronic infection blocks the transport of iron to erythrocytes·. 
Incidence of infection 
Comparison between between categories of iron status 
The trend of fewer infections with better iron nutrition is best shown when the Total number of infections is 
considered. For Test and Control groups combined, the class with Normal iron status had a lower 
incidence of infection than each of the categories of iron deficiency. 'A suggestion of a trend to more 
infections with increasing iron deficiency is also apparent. The numbers of children classified as Depleted, 
Deficient and Deficient and anaemic are small, 8, 7 and 8 respectively, compared to the 69 iron sufficient 
children. 
* The results are also consistent with other hypotheses, eg that anaemia per se predisposes to infection. But it is not the intention 
here to become in the philosopher's problem of induction so other theories are not discussed. 
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Table 6.26 Incidence of infection by severity according to the category of iron status. Incidence is 
tabulated as the number of infections per infant per year. The number of infants in each sub-group is 
shown in parentheses. 
IRON STAT/JS: 
NORMAL DEPLETED DEFICIEN'l' DEFICIENT UNCLASSI NORHO-
& ANAEllIC -FIED CHR./CYT 
SEVERITY OF INFECTION 
MINOR 
Control 2.09 4.76 1.02 1.73 2.65 1.38 
(25) (6) (7) (6) (13) (4) 
Test 1.82. 1.84 0 2.20 3.63 
(44) (2) (O) (2) (13) .(4) 
All 1.92 4.03 1.02 1.30 2.42 2.51 
MOOERATE 
Control 6.02 3.31 10.0 · 6.01 5.87 8.63 
(25) (6) (7) (6) (13) (4) 
Test 5.26 6.32 7.72 5.18 7.22 
(44) (2) (O) (2) (13) (4) 
All 5.54 4.06 10.00 6.43 5.52 7.90 
SEVERE 
Control 0.15 0.30 0.26 0.58 0.29 1.35 
(25) (6) (7) (6) (13) (4) 
Test 0.12 0.92 0 0.28 0.91 
( 44) (2) (O) (2) (13) (4) 
All 0.13 0.45 0.26 0.43 0.28 1.13 
TOTAL INFECTIONS 
Control 8.26 8.37 11.27 8.31 8.81 11.36 
(25) (6) (7) (6) (13) (4) 
Test 7.20 9.0 7,72 7.66 11.77 
( 44) (2) (O) (2) (13) (4) 
All 7.58 8.55 11.27 8.16 8.23 11.56 
Notes The t tests for statistical significance employed the 8onferroni adjustment for nult1ple comparisons. 
No P values were as small as 5%. 
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Table 6.27 Incidence of infection by type according to the category of iron status. Incidence is 
tabulat.ed as the number of infections per infant per year. The number of infants in each sub-group is 
shown m parentheses. 
IRON STATUS: 
NORMAL DEPLETED DEFICIENT DEFICIENT UNCLASSI NORH.0-
ANAEK!C -FIED CHR/CYT 
TYPE Of INFECTION 
CONJUNCTIVITIS 
Control 0.43 0.30 1.03 0.29 0.27 0.46 
(25) (6) (7) (6) (13) (4) 
Test 0.29 0.92 1.73 0.55 o.o 
( 44) (2) (O) (2) (13) (4) 
All 0.34 0.46 1.03 0.65 0.41 0.23 
OTHER INFECT! ONS 
Control 0.22 0.58 0.60 0.29 0.42 1.35 
(25) (6) {7) (6) (13) (4) 
Test 0.20 0 0 0.27 0.43 
( 44) (2) (O) (2) (13) ' (4) 
All 0.21 0.44 0.60 0.22 0.34 0.89 
PYODERMA 
Control 0.40 o.o 2.01 o.o 1.16 1.35 
{25) (6) (7) (6) (13) (4) 
Test 0.73 o.o 0.85 0.135 0 
( 44) (2) (O) (2) (13) (4) 
All 0.59 0 2.01 0.21 0.65 0.68 
THRUSH 
Control 0.80 0.60 1.76 · 0.58 0.29 · 0.46 
(25) (6) (7) (6) {13) ( 4) 
Test 0.56 4.50 0.85 0.28 0.0 
( 44) (2) (0) (2) (13) (4) 
All 0.65 1.58 1.76 0.65 0.28 0.23 
GASTROENTERITIS 
Control 1.52 0.59 0.51 1.46 1.67 3.2 
(25) (6) (7) (6) (13) (4) 
Test 1.21 0.89 2.56 0.95 3.12 
(44) (2) (O) (2) (13) (4) 
A 11 . 1.33 0.67 1.73 1.31 3.16 0.60 
RESPIRATORY TRACT INFECTION 
Control 2.76 1.52 1.79 3.96 2.36 3.62 
(25) (6) (7) (6) (13) (4) 
Test 2.27 0.92 1.73 3.0 4.58 
(44) (2) (0) (2) (13) (4) 
All 2.45 1.37 1.79 3.4 2.68 4.1 
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Table 6.28 Immune function indicators compared between categories of iron status. The number of 
infants in each sub-group is shown in parentheses 
IRON STATUS: 
NORMAL DEPLETED DEFICIENT DEFICIENT UNCLASSI NOR.MO-
ANAEMIC -FIED CBR./CY'r 
OKT4/0KT8 RATIO 
Control 2.25 3.71 2.56 2.13 2.66 2.45 
(22) (6) (7) (6) (11) (4) 
Test 2.52 1.06 3.20 2.23 2.07 
(44) (2) {O) (2) (13) (4) 
All 2.43 3.05 2.56 2.40 2A2 2.26 
PHA STIMULATION (Percentage of adult control) 
Control 61 94 162 84 122 106 
(11) (2) (3) (1) (4) (2) 
Test 153 119 110 117 
(25) (2) (0) (0) (7) (2) 
All 155 107 162 84 114 111 
BACTERICIDAL INDEX (Percentage of initial inoculum surviving at 1 hour) 
Control 103 115 67 118 100 185 
(9) (4) (3) (4) (7) (1) 
iest 90 63 70 98 
(18) (0) (O) (1) (5) (2) 
All 94 115 67 107 87 127 
CANDIDA SKIN TEST (nm induration) 
Control 5.96 11.37 13.0 13.5 10.00 0.25 
(23) (6) (7) (6) (13) {4) 
Test 13.5 13.50 19.0 7.70 4.5 
(42) (2) (0) (2) (13) (4) 
All 8.45 11.88 13.0 14.88 8.85 2.38 
MANTOUX TEST (nm induration) 
Control 6.48 6.67 11.57 6.33 9.46 9.25 
(23) (6) (7) (6) (13) (4) 
Test 7 .81 11.50 LOO 3.83 8.25 
· (42) (2) (0) (2) (12) (4) 
All 7.34 7 .87 11.57 5,00 6.76 8.75 
TETANUS ANTIBODY TITRE (titre) 
Control 2.03 l.87 1.86 2.06 2.05 1.66 
(25) (6) (7) (6) (11) (4) 
Test 1.98 1.61 0.95 1.89 1.54 
(44) (2) (O) (2) (13) (4) 
All 2.00 1.80 1.86 1.80 1.96 1.60 
POLIO ANTIBODY TITRE (titre) 
Control 1.62 0.98 1.66 1.40 L60 1.71 
(21) (6) (7) (6) (1) (3) 
Test 1.69 1.61 1.76 1.68 1.62 
(40) (1) . (O) (2) (12) (4) 
All 1.66 1.07 1.66 LSO 1.64 1.66 
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Tests of immune function 
Comparison between categories of iron status 
Results of the laboratory tests of immune function are summarized in table 6.28 for each category of iron 
status. The tests of leukocyte function, PHA stimulation and bactericidal assay, both show a trend towards 
"better" (i.e. more active) performance in the classes with better iron nutrition. The opposite trend is 
evident in the delayed hypersensitivity test with Candida antigen. The Mantoux test shows no clear trend. 
The ratio of Helper cells to Suppressor cells (OKT4/0KT8 ratio) does not vary much between the various 
categories. The specific antibody levels to polio and to tetanus both showed a trend to a ''better" (higher) 
response to immunization in the infants with more satisfactory iron nutrition. Although the trends are not 
statistically significant, these results not only tend to support the hypotheses of the study, but offer no 
evidence of harmful effects from iron supplementation of infant milk formulas. 
These trends should be interpreted even more cautiously than for the trends indentified in the comparison 
between the Test and Control groups for not only was no difference statistically significant according to the 
t test, but the confidence limits are wider and statistical power less than for the corresponding comparison 
reported in the previous section. 
Measures of iron nutrition 
Comparison between between categories of iron status 
Tables 6.29 and 6.30 give the mean values of those tests that reflect iron status. The results are shown to 
facilitate comparison with other studies and to illustrate the claims implied by the classification scheme. 
For example, from the description of the way in which the classification scheme was employed it may not be 
immediately apparent that the infants falling into the group called Nonnochromic nonnocytic were indeed 
normochromic-normocytic anaemic children. Inspection of table 6.29 and comparison with the Nonna/ 
group for MCH, MCV and Hb will confirm this. 
From a clinical point of view it is interesting to note the proportions in the various categories of iron status. 
Table 6.29 shows that only 25% of the Control group were iron replete but that 68% of the Test group fell 
into this category. The proportions classed as Nonnochromic nonnocytic or Unclassified were similar for 
the two groups; about 7% and 21 % respectively. This analysis clearly demonstrates the efficacy of the 
extra iron fortification in preventing iron deficiency. 
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Table 6.29 Mean values of haematologic parameters compared between the categories of.iron 
status. 
IRON STATUS: 
NOR.HAL DEPLETED DEFICIENT DEFICIENT UNCLASSI NOR.HO-
·ANAEMIC -FIED cBR/CYT 
RED CELL COUNT (1012/1) 
Control 4. 73 5.01 5.23 4.72 4.98 4.42 
Test 4.86 4.59 4.90 s~2a 4.28 
All 4.8 4.91 5.23 4.76 5.13 4.35 
HAEMOGLOBIN (g/dl) 
Control 11.92 12.70 11.34 10.13 11.04 10.70 
Test 12.23 U.85 10.85 11.12 10.64 
· A11 12.12 12.49 11 •. 40 10,31 11.08 10.67 
HAEMATOCRIT (%) 
Control. 35.68 38.43 35.03 31.68 33 • .70 32.45 
Test 36.72 36.10 32.80 34.43 31.42 
All 36.34 37.85 35.03 31.96 34.07 31.94 
MEAN CELL VOLUME (fl) 
Control 75.38 76.52 67.09 67.12 67.73 73.35 
Test 75.59 78.56 66.90 65.23 73.30 
All ·75.52 77.02 67.09 67.06 66.48 73.32 
MEAN CELL HAEMOGLOBIN (pg) 
Control 25.22 25.35 21.86 21.48 22.24 24.17 
Test 25,20 25.85 22.23 21.12 24,82 
All 25.21 25.47 21.86 21.67 21.68 24.50 
MEAN CELL HAEMOGLOBIN CONCENTRATION (ug/dl) 
Control 33.41 33.13 32.54 31.98 32.80 32.95 
Test 33.32 32.95 33.20 32.37 33.85 
All 33.35 33.09 32.54 32.29 32.58 33.40 
RED CELL DISTRIBUTION WIDTH(%) 
Control 14.50 14.13 16.59 17.18 16.48 16.67 
Test 13.87 14.30 14. 70 16.20 14.90 
All 14.10 14.17 16.59 16,56 16.34 .15.79 
RETICULOCYTE COUNT(%) 
Control 2.06 1.38 1.30 1.38 1.79 0.72 
Test 1.79 1.55 1.55 2.09 1.37 
A 11 1.89 1.42 1.30 1.42 1.94 1.05 
NUMBER{%) 
Control 25 (41) 6 (10) 7 (ll) 6 (10) 13 (21) 4 (7) 
Test 44 (68) 2 ( 3) 0 ( 0) 2 ( 3) 13 (20) 4 (6) 
All 69 (55) 8 ( 6) 7 ( 6) 8 ( 6) 26 (21) 8 (6) 
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Table 6.30 
status. 
Non-haematologic indicators of iron status compared between the categories of iron 
IRON STATUS: 
. NORMAL DEPLETED DEFICIENT DEFICIENT UNCLASsI· NORNO-
ANAEMIC -FIED CHR./CYT 
FERRITIN1 (ug/dl) 
Control 28.2 7.6 4.5 6.8 23.4 37.2 
Test 31.6 8.5 2.63 30.2 41.1 
All 30.9 7.8 4.5 6.0 26.9 39.8 
RED CELL ZINC PROTOPORPHYRIN (ug/g Hb) 
Control 3.43 3.30 4.69 5.60 4.23 3.45 
Test 3.11 2.80 4.00 4.35 3.35 
All 3.22 3.17 4.69 5.37 4.30 3.40 
NUMBER 
Control 25 6 7 6 13 4 
Test 44 2 0 2 13 4 
All 69 8 7 8 26 8 
1 Log(ferritin) was used in the calculations. 
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Multiple linear regression 
The relation of iron status to immune function was analyzed by multiple linear regression (MLR). Multiple 
linear regression is a mathematical technique for quantifying the "contribution" one variable makes to its 
association with another parameter. "Input" or predictor parameters are known as independent variables 
and "output" or predicted variables are called dependent variables. The multiple linear regression technique 
allows for more than one input variable and/or more than one dependent variable. The result of an 
analysis includes a set of coefficients of the dependent variables, a constant and a set of P values from 
significance tests of the coefficients. The analyses were all made with the BMDP suite of programi126). 
Many analyses were made and two sets were chosen to illustrate the kind of results that were obtained. 
Table 6.31 shows the coefficients when the independent variables were incidences of the various categories 
of infection. The dependent variables were study group, haemoglobin and iron status. Each dependent 
variable was subject to a separate investigation. Haemoglobin was chosen as an indicator of iron status for 
obvious reasons. 
Study group was selected in order to quantify the association with infection. To _perform the multiple linear 
regression a numerical value must be given to categorical variables such as group. The value of O was 
assigned to the Control group and 1 to the Test group. The values are arbitrary and unimportant except in 
their relation to one another. These values were chosen so that a positive coefficient would indicate that its 
variable is likely to have higher values for the Test group. 
For similar reasons, values of 1, 2, 3, and 4 were given to the categories of iron status Nomial, Depleted, 
Deficient, and Deficient and anaemic. Again, variables with positive coefficients are more likely to have 
higher values with iron deficiency. · 
Table 6.31 is difficult to interpret as the numerical values have no immediate intuitive interpretation. The P 
values are not shown since no coefficient was statistically significant. To aid in the interpretation of the 
table the trends shown by the multiple linear regression analyses are summarized in table 6.33. If a variable 
supports the hypothesis that iron deficiency is associated with increased susceptibility to infection an entry 
of Y is found in the table. If the variable does not support the hypothesis an entry of N is made. 
A slight tendency for infections to be increased in iron deficiency and decreased with extra iron fortification 
of infant milk formula is thus revealed by table 6.33. 
A similar set of analyses was made for the laboratory indicators of immune function and infection rates as 
predictors of iron status·. The results are tabulated in table 6.32 and the trends analyzed in table 6.34. No 
• These analyses omit PHA and bactericidal indices because they were made for separate halves of the study population. No child 
had both tests made. It is therefore not possible to include both together in an multiple linear regression analysis. 
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variable was statistically significantly associated with iron status. Overall, there is a slight tendency for the 
study's hypotheses to be supported. 
Table 6.31 Multiple linear regression (MLR) analysis of association of iron status with incidence of 
infection. The regression coefficients are tabulated for three separate analyses with incidences of 
infection as independent variables and with the dependent variables being the group code1, haemoglobin 
concentration and code for iron status2• 
INDEPENDENT DEPENDENT VARIABLES 
VARIABLES GROUP HAEMOGLOBIN FE STATUS 
Grade 1 
-0.05 0.02 -0.02 
Grade 2 -0.05 
Grade 3 -0.09 -0.21 0.45 
Thrush -0.63 -0.09 0.08 
Conjunctivitis · -0.004 -0.15 0.20 
Gastroenteritis 0.03 -0.01 
Respiratory Infection -0.04 -0.003 0.03 
Pyoderma 0.005 0.06 0.01 
Other -0.035 0.001 -0.03 
Notes 1 Group codes were: 0 = Control, 1 = Test 
2 Iron status codes were: 0 = Normal, 1 = Depleted, 2 = Deficient, 4 = Deficient anaemic 
3 A blank entry in the table is made for variables whose contribution to the MLR was minimal 
4 No coefficient reached statistical significance (P < 5%) 
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Table 6.32 Multiple linear regression (MLR) analysis of association of iron status with indicators 
of immune function. The regression coefficients are tabulated for three separate analyses with indicators 
of immune function as independent variables and with the dependent variables being the group code1, 
haemoglobin concentration and code for iron status2. 
INDEPENDENT DEPENDENT VARIABLES 
VARIABLES GROUP HAEMOGLOBIN FE.STATUS 
B Cells 0.01 ·0.002 .0.001 
Mantoux -0.001 -0.01 0.001 
Candida test 0.002 -0.005 0.03 
Grade 1 -0.03 0.04 -0.02 
Grade 2 -0.07 0.03 
Grade 3 -0.08 -0.23 0.43 
Thrush -0.06 -0.07 
Conjunctivitis -0.01 -0.13 0.10 
Gastroenteritis 0.04 0.01 -0;05 
Respiratory Infection -0.03 0.03 0.008 
Pyoderma 0.02 0.09 -0.0005 
Other -0.08 -0.07 
Tetanus titre 0.0001 -0.0001 .Q.0001 
Polio titre 0.002 0.002 -0.0008 
T4/T8 ratio 0.03 -0.02 0.03 
Notes 1 Group codes were: 0 = Control, 1 = Test 
2 Iron status codes were: 0 = Normal, 1 = Depleted, 2 = Deficient, 4 = Deficient anaemic 
3 A blank entry in the table is made for variables whose contribution to the MLR was minimal 
4 No coefficient reached statistical significance (P < 5%) 
Table 6.33 Trends shown by the multiple linear regression analyses (MLR) in table 6.31. The trend 
shown by the coefficient of the independent variables is indicated by a Y if it supports the hypothesis of 
iron deficiency increasing susceptibility to infection. An N indicates that the MLR does not support the 
hypothesis. 
INDEPENDENT DEPENDENT VARIABLES 
VARIABLES GROUP HAEMOGLOBIN FE STATUS 
Grade 1 y N 
Grade 2 y 
Grade 3 y y y 
Thrush y y y 
Conjunctivitis y y y 
Gastroenteritis N 
Respiratory Infection y y y 
Pyoderma N N y 
Other y N 
TOTALS Q i 2 .l 2 
Notes 1 Group codes were: 0 = Control, 1 = Test 
2 Iron status codes were: 0 = Normal, 1 = Depleted,.2 = Deficient, 4 = f)eficient anaemic 
3 A blank entry in the table is made for variables whose contribution to the MLR wai; minimal 
4 No coefficient reached statistical significance (P < 5%) 
N 
N 
N 
.l 
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Table 6.34 Trends shown by the multiple linear regression analyses (MLR) in table 6.32. The trend 
shown by the coefficient of the independent variables in indicated by a Y if it supports the hypothesis of 
iron deficiency depressing immune function. An N indicates that the MLR does not support the 
hypothesis. 
INDEPENDENT DEPENDENT VARIABLES 
VARIABLES GROUP HAEMOGLOBIN FE STATUS 
B Cells y N y 
Mantowi: N N 
Candida y N y 
Grade 1 y N 
Grade 2 y y 
Grade 3 y y y 
Thrush y y 
Conjunctivitis y y y 
Gastroenteritis N N 
Respiratory Infection y N y 
Pyoderma N N 
Other y 
Tetanus titre y N y 
Polio titre y y y 
T4/T8 ratio y N 
TOTAL 11 z ~ 2 ~ 
Notes 1 Group codes were: 0 = Control, 1 = Test 
2 Iron status codes were: 0 = Normal, 1 = Depleted, 2 = Deficient, 4 = Deficient anaemic 
3 A blank entry in the table is made for variables whose contribution to the MLR was minimal 
4 No coefficient reached statistical significance (P < 5%) 
Summary 
N-
N 
N 
N 
N 
N 
Q 
One hypothesis that motivated the present study was that iron deficiency depresses immune function. 
Confirmation of this was sought by comparing tests of immune function in infants categorized with respect 
to iron status as Normal, Depleted, Deficient and Deficient with anaemia. Confirmation of the hypothesis 
was also sought by multiple linear regression analysis. Both analyses identified weak trends that supported 
the theory. 
Discussion and conclusions 
The literature review failed to reveal any similar analyses in comparable trials. The design of the study 
created a relatively homogeneous set of subjects. This ensured that the confounding influences of 
malnutrition and serious illness were eliminated. It also resulted in most infants having better iron status 
than their peers as documented by Kirsten et al241) and discussed above. The trial could therefore only 
test the hypothesis for mild degrees of iron deficiencies. It may be concluded that mild iron deficiency does 
not have a major detrimental effect on immune function and resistance to infection. 
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Risks of increased iron fortification of milk formula 
Introduction 
The third · question addressed by the trial was the safety of increased iron fortification of infant milk 
formula. The evidence for and opinion on untoward effects of iron fortification were reviewed in chapter 2. 
Although unlikely, the risk most feared is of increasing susceptibility to infection by upsetting the host-
parasite competition for iron. It was shown above that the Test group had fewer infections than the Control 
group in all categories except respiratory illness for which the difference was minimal. In particular, the 
Test group had fewer episodes of diarrhoeal disease. 
It may thus be concluded that increased iron fortification is safe and poses no significant risk of increasing 
susceptibility to infection. 
At the start of the trial mothers were closely questioned about the acceptability of the formula. No mother 
noticed any abnormal colour or taste in the milk and no mother attributed colic., fussiness or change in 
bowel habits to the formula. The control and test formulas were indistinguishable by both mothers and the 
research team. 
The increased iron fortification was, it may be concluded, acceptable from the consumer's point of view. 
More important effects of iron fortification are on zinc absorption and growth. These are discussed in the 
following 2 sections. 
Indicators of zinc status 
Results 
The zinc status of the Test and Control groups is compared in table 6.36. Plasma zinc concentration is 
significantly lower in the Test group than in the Control group at the end of the trial. Hair zinc follows the 
same trend, but the difference is far from being statistically significant. 
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Table 6.36 Zinc status compared in the Control and Test groups 
Specimen 
AT 3 MONTHS ·oF AGE 
Plasma 
(ug/1) 
Hair 
(ug/g) 
AT 1 YEAR OF AGE 
Plasma 
Change in plasma 
(ug/1) 
Hair 
Change in hair 
(ug/g) 
Cont:rol 
Hean 
Test; 
Hean 
91.16 85.64 
224. 02 261. 31 
90.61 83.53 
-0.90 -3.32 
142.30 129.21 
-93.94-161.39 
Notes P values were calculated from student's t test. 
95% CI~ 95% confidence intervals. 
p 
Value 
15% 
32% 
5% 
64% 
54% 
27% 
95i CI of diff. 
of means 
-13.03 1.99 
-37.61 112.19 
-14.27 
-12.50 
0.12 
7.68 
..:.s4.92 20.14 
-187.81 52.90 
6.71 
Power 
Obs 10% 
30 64 
0 0 
49 66 
0 0 
0 
30 
0 
0 
Changes are reported as the mean of the variable at 12 months minus the mean value at 3 months. 
The statistical power of the study was detennined for both the observed difference (Obs) and a 10% 
difference (10%) from the combined mean for a type I error probability of 5%. 
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Plasma zinc concentrations for the Test and Control groups at 12 months or age· 
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Hair zinc concentrations for the Test and Control groups at 12 months of age 
• The bars represent the means and the vertical lines through the bats represent the 95% confidence intervals 
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Discussion 
These results were anticipated since similar associations with iron fortification have been found in other 
studiesC138>, although others have failed to confirm the competition between iron and zinc for 
absorption< 480). 
The trend shown by the hair results concurs. with the conclusion drawn by Hambidge that hair analyses are 
of limited worth<186>. It may not be clinically worthwhile to use hair zinc content as an index of body zinc 
status, but for population studies where blood samples are impractical it might yet prove to be a useful tool 
to measure long term effects. 
A note of caution should be added to the above inferences since the Test group had a substantially lower 
mean serum zinc at the start of the trial. This may indicate some imbalance in selection of the two groups, 
but the difference in zinc concentration widened during the study. As similar studies have shown that iron 
interferes with the absorption of zinc, the likelihood is increased that the initial difference was spurious. 
In view of these results, future studies of increased iron fortification should maintain the molar ratio of iron 
to zinc at the level commonly used in commercial milk formulas, ie 2.8 mol Fe/mol Zn. 
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Measures of growth and nutrition 
Results 
At 1 year of age the infants of the Test group were taller and heavier than those of the Control group. 
Table 6.37 shows that this trend is followed by other measures of growth, viz increase in weight, increase in 
length, standard deviation scores for weight and length and the increases in the standard deviation scores. 
Head circumference alone does not favour the Test group. No differences are statistically significant, but 
the increase in weight has a P value of 7%. 
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Table 6.37 Nutritional status and growth compared in the Control and Test groups. 
Nut:ri t:ional Control Test; p 95% CI of di.ff. Power 
Vari.able Hean Hean Value of means Obs 10% 
AT BIRTH 
Weight 3.41 3.37 40% -0.14 0.06 14 99 
(Kg) 
SD score weight 0.36 0.28 51% -0.31 0.16 0 0 
AT 3 MONTHS OF AGE 
Weight 6.06 6.04 82% -0.23 0.18 0 99 
(kg) . 
Length 59.13 59.12 97% -0.67 0.64 0 100 
(Cm) 
Head circumference 40.71 40.36 10% -0.75 0.07 37 100 
(Cm) 
SD score weight 0.48 0.51 75% -0.18 0.25 0 0 
SD score length -0.42 -0.31 31% -0.11 0.33 18 0 
AT 1 YEAR OF AGE 
Weight 10.09 10.33 24% -0.16 0.64 22 99 
Increase in weight 4.00 4.29 7% -0.03 0.62 43 71 
(Kg) 
Length 74.74 75.23 27% -0.38 1.37 20 100 
Increase in length 15.45 16.01 17% -0.24 1.36 28 96 
(Cm) 
Head circumference 46.71 46.54 44% -0.60 0.26 12 100 
(Cm) 
SD score weight 0.23 0.48 20% -0.13 0.63 26 0 
Change in SD score -0.25 -0.03 16% -0.09 Q;53 29 0 
SD score length -0.13 0.06 20% -0.11 a.so 25 0 
Change in SD score 0.25 0.32 58% -0.18 0.31 0 0 
Notes P values were calculated from student's t test. 
95% CI= 95% confidence intervals. 
Changes are reported as the mean of the variable at 12 11Dnths minus the mean value at 3 months. 
The SD score is the mean of standard deviation scores calculated from NCHS tables 
The statistical power of the study was detennined for both the observed difference (Obs) and a 10% 
difference (10%) from the combined mean for a type I error probability of 5%. 
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CONTROL TEST DIFFERENCE 
Mean weight standard deviation scores for the Test and Control groups at 12 months of 
L E N G T H S D S C O R E 
CONTROL TEST DIFFERENCE 
Mean length standard deviation scores for the Test and Control groups at 12 months of 
• The bars represent the means and the vertical lines through the bars represent the 95% confidence intervals 
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Discussion 
Head growth in infants is preserved in severe malnutrition and is a poor indicator of general nutrition. It is 
also difficult to measure head circumference as accurately as weight and length. This is reflected in the 
relatively larger standard deviation, larger P value and lower power of the head measurements compared 
with those of the other growth indices. 
In summary, the administration of extra iron to the Test group was associated with improved growth as 
measured by length and weight and this almost reached statistical significance. 
Discussion and conclusions 
The foregoing sections showed that the increased iron fortification was safe and acceptable, but that it was 
associated with decreased zinc levels in plasma and hair. Future trials of iron fortification should maintain 
the Fe:Zn molar ratio at about 2.8 and should monitor the effect on the absorption of other divalent metals. 

Lessons should be drawn from · our experience of what 
diets are best for men in health 
Hippocrates 
Regimen in Acute Disease 
Circa 400 BC 



CHAPTER 7 CONCLUSIONS AND RECOMMENDATIONS 
Introduction 
This thesis describes a clinical trial of an infant milk formula with 40 mg iron per 100 g which was 
compared with a conventional formula which had 8.3 mg iron per 100 g. The problem addressed by 
this study was articulated as 3 questions in the introductory chapter: 
Does increasing the level of iron fortification of conventional infant milk formula 
improve the iron nutrition of normal infants fed on the formula? 
Does increased iron fortification of infant milk formula alter immunity as reflected by 
incidence of infection and laboratory tests of immune function? 
Are there any harmful effects of increasing the quantity of iron in conventional inf ant 
milk formula? 
In short, the present study suggests that the answers to these questions are: 
1 Increasing the level of iron fortification does improve the iron nutrition of normal inf ants fed 
on the formula. But, this is to such a small amount that increased iron fortification on its 
own is not a practical method of combating iron.deficiency. 
2 Increased jron fortification of infant milk formula does not alter immunity. However, this is 
not surprising in view of the small difference in iron status created by the manipulation of 
iron fortification. 
3 The increased quantity of iron in the milk formula has no harmful effects. In particular, 
there was no suggestion of an increased susceptibility to infection or to diarrhoeal disease. 
However, a depression of zinc status was observed in the infants who conswned the milk 
with increased iron and this is potentially harmful. 
These conclusions are amplified in the following sections and a number of recommendations are made 
for further investigations. 
Possible confounding factors 
The trial of the infant milk formula controlled rigorously for factors which have confounded the 
interpretation of most previous studies of the role of iron in infection and immunity. The children were 
selected on the grounds of good health and excellent nutrition. That they maintained this throughout 
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the study may be partly due to the milk formula which was granted to the families, and partly due to 
the selection of children from better home environments. 
Possible confounding factors which may not have been controlled by the stratified allocation procedure 
were indicated by non-significant trends in completion rate, weaning, and introduction of solid foods. 
All these factors could weigh in the Test group's favour when considering indices of iron nutrition, 
measures of immune function or risks of increased iron fortification. 
However the weight that should be assigned to these possible confounding influences is limited by 
several methodological weaknesses. In the subsidiary surveys, ages were calculated from the mother's 
recollection of events and recorded in months rather than decimals of a year. Also, age of introduction 
of a food item is likely to be a poor proxy for quantity of food ingested and it gives no indication 
whether or not the food was consumed with milk formula. 
The effect of increased iron fortification on iron status 
In the planning stage of this project, it seemed from the results of other studies of fortification of infant 
milk formula that an increase of iron by a factor of almost 5 would have a marked effect on iron status 
of infants offered the formula. It was known that ascorbic acid was an important factor in enhancing 
the bioavailability of iron in milk formulas, but it was not suspected that the eventual availability of iron 
in the Test formula would be of the order of magnitude of 1 %. Or, to express this finding more 
dramatically, the bioavailability of the extra iron in the Test formula was about 0.02%. 
The derivation of these estimates of iron absorption is outlined in Table 7.1. Because of the difficulty 
in estimating storage iron from serum ferritin ( or body weight) in infancy these calculations assume 
that storage iron is constant. This should not, however, alter the conclusions which are drawn about 
the unexpectedly low bioavailability of iron in the Test formula. 
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Table 7.1 Absorption of iron in Control and Test groups calculated from the changes in weight 
and haemoglobin levels at the start and end of the trial. Storage iron is assumed constant. 
CONTROL 
3MONTHS 
Age (months) 2.96 
Hb (g/dl) 11.28 
Wt (kg) 6.06 
Fe in Hb (mg) 18735 
12 MONTHS 
Age (months) 11.81 
Hb (g/dl) 11.49 
Wt (kg) 10.09 
Fe inHb (mg) 317.86 
Change in Hb Fe (mg) 130.52 
Fe absorbed (mg/day) 0.291 
Fe in 500 ml formula ( mg) 5.98 
% Fe absorbed 4.87 
% extra Fe absorbed 
TEST 
·2.90 
11.38 
6.04 
188.13 
11.86 
11.85 
10.34 
335.81 
147.69 
0.295 
28.83 
1.02 
0.02 
CONVERSION FACTORS 
80 ml blood/kg body weight 
0.03425 mg Fe/g Hb 
100*(0.295-0.291)/(28.83--5.98) 
The present study indirectly confirms the importance of the ratio of ascorbic acid to iron in assuring 
that iron in infant milk formula is available for assimilation. Until further work allows more definitive 
recommendations to be made it would seem advisable to set the molar ratio of ascorbic acid to iron in 
cow's milk based infant formulas to at least 1.4:1 (the ratio in the Control formula in the present 
study), and perhaps as high as 4:1 as recommended by Gillooly et aP94). 
The low bioavailability of the iron in the fortified milk was a surprising fmding in view of previous 
measurements of absorption of iron from cow's milk formulas without added ascorbic acid. These 
have ranged from 2.9% to 19%<125• 136• 334• 418• 434• 438• 482). Until now it has been generally accepted as 
Cook and Bothwell state that, while milk does not promote iron absorption, it has significantly less 
inhibitory effects than infant cereals or solid foods(l04). 
The present study did not make a direct measurement of the absorption of iron from the infant milk 
formulas and it did not determine the quantities of milk and supplementary foods in the diet. These 
are two investigations that should be made in order to learn the availability of iron in fairly large 
concentrations in infant milk formula and to determine the effect of supplementary foods on the 
bioavailability of iron in infant milk formula and eventual iron status. This is particularly important in 
view of the contrast between the eventual iron status of the infants in the present study with those in 
similar studies elsewhere. For example, on the one hand, infants in a study in Helsinki who were fed 
on unfortified infant milk formula attained an excellent state of iron nutriture<432). While on the other 
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hand, although the Control infants in the present study were given a formula fortified with both iron 
and ascorbic acid, they reached substantially lower levels of iron nutrition than infants in the USA who 
were offered a similar formulaC7• 323). 
In categorizing the iron status of the infants in the present study it was noted that at the age of 1 year 
they had unusually low levels of mean red cell volume in comparison with reference standards. It 
would have been useful in assessing the likely reasons for · this discrepancy if the prevalences of 
thalassaemia, thalassaemia trait and the various haemoglobinopathies had been determined for the 
community studied. A study has been made of the prevalence of such genetic disorders in patients at 
the Red Cross War Memorial Childrens Hospital who have a mean cell volume less than 60 fl. This 
work needs to be extended to an unselected population.-
The relative utility of the several indicators of iron status has not been clearly determined. A useful 
study would be to determine these indicators before and after a therapeutic trial ( as Dailman et ai<123) 
have done) and then compare the predictive value of each indicator with the predictive value of every 
other indicator. 
The effect of increased iron fortification on immunity 
The results of the study on the effect of increased iron fortification on immunity (as measured by 
several laboratory tests and incidence of infection) was inconclusive because of the small increase in 
iron status in the Test group. 
Although not statistically significant, an intriguing finding was that the infants in the Test group had 
fewer infections than those in the Control group. This relationship held for 7 of 8 independent 
categories of infection, and in the sole exception the incidence was essentially equal. This finding has 
important implications for public health since it implies a "saving" of 56 infections per 100 infants per 
year. 
Clearly then, trials to define the relation between iron status and immune function more precisely are 
required since a possible public health benefit of this magnitude can not be ignored. The difficulties 
· such studies will have in attaining adequate statistical power must be noted. The present study was 
designed to detect a difference in infection rates of 1 infection per child per year. The sample size 
calculations yielded 65 as the minimum number required in each group and assumed that the standard 
deviation of infection rate was 2.5. With the data from the present study it can be estimated that a 
minimum of 230 infants would be required in each group to detect a difference of 0.59 in infection rates 
with standard deviations of 2.8 and 3.3. 
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Besides increasing the number of subjects, steps to increase statistical power might include extending 
the period of observation and increasing the disparity in iron status between control and test groups. It 
will be particularly important to learn if there is a threshold level of iron status below which 
susceptibility to infection is increased. The present study provides a hint that, if such a threshold exists, 
it could be relatively high. 
The. laboratory tests of immune function in themselves give little indication of the direction future 
research should take. But, taken in conjunction with previous work in the literature, they suggest a 
need for well designed and reported clinical studies. Such studies should control for confounding 
factors of infection and malnutrition and report in detail the method of .ascertainment of the subjects 
and their iron status. The time course to restoration of iron status to normal in patients with iron 
deficiency anaemia should be studied along with parameters of immune function. Careful selection of 
iron deficient subjects and comparison with the use of a placebo treatment for 1 or 2 weeks would 
enable the effects of infection and malnutrition to be controlled. 
Risks of increased iron fortification of infant milk formula 
The study found no evidence that increased iron fortification of infant milk formula was poorly 
tolerated or associated with increased susceptibility to infection. In particular, the incidence of 
diarrhoeal disease was not increased. The Test formula was indistinguishable from the Control 
formula as far as the infants, parents and study team were concerned. 
Previous work that has suggested that iron interferes with the absorption of zinc was confirmed. No 
symptoms or harmful effects could be attributed to the lower plasma and hair zinc levels found in the 
Test group, but two recommendations can made for future studies of iron fortification of infant milk 
formula. 
Firstly, such studies should maintain the molar ratio of iron to zinc at about 2.8:1. Secondly, since iron 
may also inhibit the absorption of other divalent metals, such studies should monitor their levels in the 
subjects. 
Epidemiological conclusions 
In the course of the study a number of incidental but independently valuable contributions were made 
in the field of epidemiology. 
The data on infectious morbidity in inf ants between the ages· of 3 and 12 months are valuable not only 
as a characterization of a particular community at a particular point in time, but also as a baseline for 
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planning health services and for comparing morbidity in other communities or in the same community 
in the future. 
The social data on the study families and the surveys on infant feeding practices are valuable for similar 
reasons. 
A hospital laboratory receives most of its specimens from ill subjects. Assessment of the pathogenicity 
of a particular isolate requires the carriage rate in normal subjects to be known. The survey of viral 
carriage rate in faecal specimens from healthy 3 and 12 month old infants and in nasopharyngeal swabs 
from 12 month old subjects thus provided useful information for the virology laboratory. Such a survey 
had not been previously made in Cape Town. 
The immunology laboratory which also receives most of its specimens from hospital patients has a 
similar problem in determining normal ranges. The present study helped to establish normal ranges in 
3 and 12 month old infants for several tests viz OKT3, OKT4, OKT8, surface membrane 
immunoglobulin, lymphocyte response to stimulation with phytohaemaglutinin and neutrophil 
bactericidal index. 
Valuable epidemiological information with respect to immunization programs was obtained with the 
surveys of polio and tetanus antibody levels. When the infants were 3 months of age the antibody levels 
were measured in both mother and child. They were measured again in the infants at the age of 12 
, 
months. This confirmed the efficacy of the immunization service (and vaccines) an_d will be a useful 
baseline for future surveillance efforts. 
Summary of contributions 
The contributions made by the present work may be briefly summarized. 
Infant milk formula fortified with milk and iron was shown to be less effective than similar formulas 
overseas .. (Future studies will probably find differences in supplementary foods and dietary habits to 
explain this fmding.) Fortification with extra iron resulted in minimally improved iron status and was 
surprisingly ineffectual. The increased iron fortification was not associated with altered immune 
function tests nor with changes in the incidence of infection. A relationship was sought between iron 
status and immune function tests and incidence of infection but the results were inconclusive because 
of low statistical power. However, concerns that have been raised in the literature about the safety and 
acceptability of large quantities of ir.on in infant milk formulas were shown to be unfounded. Reports 
of laboratory experiments showing that iron interferes with zinc absorption have been extended to the 
field and confirmed. Finally, a number of independently valuable epidemiological studies were made. 
These included determination of infectious morbidity, immunization responses and viral carriage rates 
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in infants, description of infant feeding practices and social characteristics of families in Bonteheuwe~ 
and normal ranges in infancy for a number of immunological tests. 
Conclusion 
In conclusion, it may be stated that increasing the level of iron fortification of cow's milk infant milk 
formula is not sufficiently effective in improving iron status to warrant a change in commercial practice. 
But, the potential rewards of improved iron status are such that further studies should be undertaken 
with increased fortification of iron, ascorbic acid and zinc. 
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APPENDIX 1 · Dropouts from the study 
STUDY NAME REASON 
No. 
1 Cynthia Davids Mother declined participation+ 
9 Yusuf Jamodien Mother scared of second blood test 
15 Redewaan Benjamin Mother declined participation • 
16 Lee-Ann Windvogel Mother scared of second blood test 
24 Carmelita Fredericks Moved away from Bonteheuwel 
. 
32 Mogamat Hendricks Mother declined participation 
54 Elroy Snyman Moved away from Bonteheuwel 
56 Ryan Greef 
. 
Mother declined participation 
59 Rishana Abrahams Mother declined participation+ 
82 Adele Henry Mother declined participation+ 
87 Donovan Wessels Moved away from Bonteheuwel 
89 Rosaline Manuel Mother declined participation· 
94 Shireen Jonathan Moved away from Bonteheuwel 
97 Quanita Jacobs Moved away from Bonteheuwel 
101 Nadeem Abrahams Moved away from Bonteheuwel 
120 Badronesa Hendricks Moved away from Bonteheuwel 
131 Feroza Mohammed Mother declined participation 
. 
+ Mother declined out of concern for her child 
* Mother declined out of lack of concern for her child 
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APPENDIX 2 · Research and Ethics Committee Approval 
UNIVERSITY OF CAPE TOWN 
!WITH WHICH !S INCORPORATED THE SOUTH AFRICAN COLLEGE! 
DEAN & PROFESSOR OF MEDICAL EDU CA TiON 
PROFESSOR D McKENZIE 
M.8 .. Ch.S .. M.Med.(Path I !Cape Town). D,p. Bact. 1Londl. 
TELEPHONE 47-1250 
17 May 1983 
Dr M Power et al 
Institute of Child Health 
Red Cross Childrens Hospital 
Dear Dr Power 
THE DEAN OF THE FACULTY OF MEDICINE 
MEDICAL SCHOOL 
OBSERVATORY 
7925 
Effects of iron deficiency on immune function and 
development of infants. 
I am pleased to inform you that the Ethics and 
Research Committee has raised no objections to your 
proposed study. 
Yours sincerely 
~:-
Prof JP deV van Niekerk 
CHAIRMAN 

APPENDICES A.3 
APPENDIX 3 - Tables of Statistical analyses 
BOTH GROUPS COMBINED 95ft CI 9St CI 
VARIABLE N Hfn Hax so Bottom Hean Top 
First bottle 147 0.0000 4.0000 0.9820 1.3499 1.5100 1.6701 
Last breast 130 0.0000 13.0000 3.9770 3.1409 3.8310 4.5211 
Date of birth 147 83.0920 83.4870 0.1150 83.2863 83.3050 83.3237 
Date@ 3/12 entry 147 83.3360 83.7000 0.1050 83.5309 83.5480 83.5651 
Date@ ly exit 134 84.0100 84.4810 0.1210 84.2693 84.2900 84.3107 
/ 
Age@ entry {months) 147 2.1710 3.9110 0.2580 2.8869 2.9290 2.9711 
Age at exit {months) 134 10.6550 12.8870 0.3130 11.7835 11.8370 11.8905 
WBC-3/12 122 5.0000 23.1990 3.1000 11.0474 11.6030 12.1586 
RBC-3/12 122 3.1390 4.9490 0.3310 3.9817 4.0410 4.1003 
.Hb-3/12 122 9.0000 12. 7990 0.7690 11.1952 11.3330 11.4708 
HCT-3/12 122 26.2990 37.7990 2.1910 32.7013 33.0940 33.4867 
MCV-3/12 122 57 .8990 92.7990 5.0730 81.1708 82.0800 82.9892 
MCH-3/12 122 19.2990 33.0000 -1.9410 27.7641 28.1120 28.4599 
MCHC-3/12 122 31.1990 37.0990 0.9800 34.0684 34.2440 34.4196 
ROW%-3/12 122 11.5000 20.7990 1.4040 13.2804 13.5320 13.7836 
PLT-3/12 122 221.0000 773.0000 115.3020 445.9330 466.5980 487 .2630 
RETICS-3/12 117 0.5990 7.2990 1.1820 1. 9416 2.1580 2.3744 
POLYs-3/12 121 7.0000 73.0000 11.9250 25.1347 27.2810 29.4273 
LYMPHs-3/12 121 24.0000 88.0000 12.4880 62.6864 64.9340 67.1816 
MONOs-3/12 121 0.0000 14.0000 2.7980 4.5624 5.0660 5.5696 
EOSINs-3/12 120 0.0000 11.0000 2.3440 2.1263 2.5500 2.9737 
BASOs-3/12 120 0.0000 2.0000 0.4490 0.0768 0.1580 0.2392 
WBC-ly 126 5.0990 20.0990 2.9820 10.4673 10.9930 11.5187 
RBC-ly 126 4.0690 6.0490 0.4030 4.8049 4.8760 4.9471 
RBC * 104 -0.2400 1.7000 0.3640 0.7282 0.7990 0.8698 
Hb-ly 126 9.0990 14.0990 0.9870 11.5050 11.6790 11.8530 
Hb * 104 -2.3000 2.6000 0.9830 0.0938 0.285.0 0.4762 
HCT-ly 126 27.0000 43.0000 2.9810 34.8124 35.3380 35.8636 I 
HCT * 104 -6.2000 9.8000 2.9260 1.4010 1.9700 2.5390 
... 
MCV-ly 126 53.0000 83.0000 5.4150 71.6473 72.6020 73.5567 
MCV * 104 -26.2000 1.3000 4.7480 -10.3533 -9.4300 -8.5067 
MCH-ly 126 16.1990 28.2990 2.0890 23.6737 24.0420 24.4103 ·t 
MCH * 104 -9.3990 -0.2000 1.8440 -4.3486 -3.9900 -3.6314 
MCHC-ly 126 30.5000 35.3990 0.9240 32.9031 33.0660 33.2289 
MCHC * 104 4.5990 3.4000 1.2550 -1.3480 -1.1040 -0.8600 
ROW%-ly 126 12.0000 21.5990 1.7890 14.6516 14.9670 15,2824 .... L 
ROW%* 104 -5.2990 8.0990 2.1470 0.9755 1.3930 1.8105 
PLT-ly 126 82.0000 672.0000 106.9340 330.1072 348.9600 367.8128 
RETICs-ly 122 0.2990 6.7990 1.1030 1.5463 1.7440 1.9417 
POLYs-ly 125 6.0000 67.0000 ll.9670 31.0015 33.1200 35.2385 
LYMPHs-ly 125 23.0000 88.0000 12.2540 56.3107 58.4800 60.6493 
MONOs-ly 125 0.0000 15.0000 3.3240 4.7156 5.3040 5.8924 
EOSINs-ly 125 0.0000 16.0000 3.1310 2.4137 2.9680 3.5223 
BASOs-ly 124 0.0000 2.0000 0.3570 0.0415 0.1050 0.1685 
ZPP-3/12 133 1.0000 8.7990 1.1570 2.6666 2.8650 3.0634 
FERRITIN-3/12 140 3.0000 704.0000 119.0510 136.5001 156.39,30 176.2859 
Log(ferritin) 3/12 140 0.4770 2.8480 0.3470 2.0160 2.0740 2.1320 
ZPP-ly 124 1.5000 ll.0990 1.4230 3.4161 3.6690 3.9219 
ZPP * 110 -5.1000 5.8990 1.5280 0.5353 0.8240 1.1127 
FERRITIN-ly 129 1.0000 244.0000 29.2050 26.1453 31.2330 36.3207 
FERRITIN " 121 -677 .0000 158,0000 122 .. 7910 -146.0091 -123.9090 -101.8089 
Log(ferritin) 1 y 129 0.0000 2.3870 0.3680 1.2929 1.3570 1.4211 
Log(ferritin) " 121 -1.9490 0.5400 0.4700 -0.7996 -0.7150 -0.6304 
ZINC-PLASMA-3/12 139 46.0000 236.0000 22.4670 84.6492 88.4170 92.1848 
BOTH GROUPS COMBINED 95t Cl 95* Cl 
VARIABLE N Hin /1ax so Bottom Hean Top 
ZINC-HAIR-3/12 78 54.5990 759.7990 164.6700 207.9373 245.0580 282.1787 
ZINC-PLASMA-ly 124 54.0000 204.0000 20.3730 83.1048 86.7260 90.3472 
ZINC-PLASMA* 115 -62.0000 62.0000 27.0900 -7.2298 -2.2260 2.7778 
ZINC-HAIR-ly 101 16.5990 536.5990 105.5560 114.7217 135.5580 156.3943 
ZINC-HAIR 11 52 -703.7990 253.1000 215.9730 -190.3598 -130.2590 -70.1582 
II Infect:grade 1+2+3 132 0.0000 12.0000 2.2890 4.1739 4.5680 4.9621 
#Infect.grade 1 132 0.0000 5.0000 1.2220 0.9946 1.2050 1.4154 
II Infect •. grade 2 132 0.0000 10.0000 2.1640 2.8544 3.2270 3.5996 
II Infect. grade 3 132 0.0000 1.0000 0.3440 0.0768 0.1360 0.1952 
II Infect. resp tract 132 0.0000 6.0000 1.2800 1.2266 1.4470 1.6674 
I Infect. diarrhoea 132 0.0000 4.0000 0.9280 0.5902 0.7500 0.9098 
# Infect. pyodenna 132 0.0000 5.0000 0.8570 0.2084 0.3560 0.5036 
#Infect.thrush 132 0.0000 3.0000 0.7260 0.2540 0.3790 0.5040 
II Infect other(-max) 131 0.0000 2.0000 0.4260 0.1094 0.1830 0.2566 
ff infect: other 132 0.0000 4.1450 0.6600 0.1610 6.2746 0.3882 
II Infect. other 132 0.0000 3.0000 0.4900 0.1206 0.2050 0.2894 
# Infect. conjunct. 132 0.0000 2.0000 0.4380 0.1516 0.2270 0.3024 
ff Infect:grade 1+2+3 132 0.0000 15.7740 3.0490 5.5950 6.1200 6.6450 
# Infect:grade 1 132 0.0000 6.5380 1.6180 1.3344 1.6130 1.8916 
# Infect:grade 2 132 0.0000 13.1450 2.8880 3.8268 4.3240 4.8212 
# Infect:grade 3 132 0.0000 1.4410 0.4660 0.1038 0.1840 0.2642 
II Infect: resp tract 132 0.0000 8.2330 1.7280 1.6455 1.9430 2.2405 
I Infect: diarrhoea 132 0.0000 5.4520 1.2410 0.7893 1.0030 1.2167 
I Infect: pyodenna 132 0.0000 6.5730 1.1470 0.2795 0.4770 0.6745 
I Infect: thrush 132 0.0000 3.9960 0.9700 0.3400 0.5070 0.6740 
# Infect:other(-max) 131 0.0000 2.7370 0.5680 0.1458 0.2440 0.3422 
II Infect: conjunct 132 0.0000 . 2.6460 0.5860 0.2031 0.3040 0.4049 
Mantoux 3/12 138 0.0000 21.0000 5.6200 4.7060 5.6520 15.5980 
Candida 3/12 144 0.0000 20.0000 6.0200 3.3414 4.3330 5.3246 
Mantoux l y 127 0.0000 26.0000 7.3130 6.2278 7.5120 8.7962 
Mantoux 11 121 · -20.0000 26.0000 8.5130 0.3028 1.8350 3.3672 
Candida 1 y 128 0.0000 28.0000 8.4350 7.8688 9.3440 10.8192 
Candida* 127 -17.0000 26.0000 8.7500- 3.4945 5.0310 6.5675 
Antibody tetanus ma 130 0.0000 5120.0000 478.1460 36.1875 119.1540 202.1205 
Antibody polio ma 138 0.0000 20.0000 4.7260 1.0885 1.8840 2.6795 
. log(Tetanus] ma 130 0.0000 3.7090 0.9950 0.9314 1.1040 1.2766 
log[Polio] ma 138 0.0000 1.3220 0.3980 0.1150 0.1820 0.2490 
Antibody tetanus 3m 139 0.0000 320.0000 35.0160 6.3577 12.2300 18.1023 
Antibody polio 3/12 129 0.0000 160.0000 39.5840' 30.0032 36.8990 43.7948 
log[Tetanus] 3/12 139 0.0000 2.5070 0.6800 0.3830 0.4970 0.6110 
log(Po 1 io] 3/ 12 129 0.0000 2.2070 0.6380 1.1669 1.2780 1.3891 
Antibody tetanus ly 130 0.0000 10240.0000 1025.6580 121.0307 299.0000 476.9693 
Antibody tetanus* 122 -280.0000 10230.0000 1059.3630 103.5791 293.4430 483.3069 
Antibody polio 1 y 128 0.0000 160.0000 52.7810 55.7689 65.0000 74.2311 
Antibody po 1 io 11 1,15 -160.0000 160.0000 66.7620 19.2334 31.5650 43.8966 
log[Tetanus] 1 yr 130 0.0000 4.0100 0.6590 1.8177 1.9320 2.0463 
log[Tetanus] 1 y • 122 -1.6130 3.7090 1.0550 1.2289 1.4180 1.6071 
log[[Polio] 1 yr 128 0.0000 2.2070 O.S330 1.5228 1.6160 1. 7092 
log[Polio] 1 yr* 115 -2.2070 2.2070 0.8400 0.2208 0.3760 0.5312 
OKT3 3/12 127 47.0000 88.0000 9.6260 67.0417 68.7320 70.4223 
OKT4 3/12 127 19.0000 87.0000 12.1920 48.8671 51.0080 53.1489 
OKT8 3/12 127 5.0000 42.0000 7.3290 14.8470 16.1340 17.4210 
SMIG 3/12 127 5.0000 43.0000 6.8030 17.3174 18.5120 19.7066 
OKT4/0KT8 3/12 127 0.7620 12.4290 2.2120 3.4916 3.8800 4.2684 
BOTH GROUPS COHBINED 95t CI 95t CI 
VARIABLE N Hin Hax SD Bottom Hean. Top 
OKT3 ly 126 40.0000 95.0000 11.1110 71.3351 73.2940 75.2529 
OKT4 ly 126 0.0000 75.0000 13.5010 44.4767 46.8570 49.2373 
OKTS ly 126 5.0000 67.0000 9.7870 21.0285 22,7540 24.4795 
SHIG ly 126 4.0000 46.0000 7.5760 · 17.5853 18.9210 20.2567 
OKT4/0KT8 ly 126 0.0000 8.1430 ·1.3140 2.2323 2.4640 2.6957 
OKT4/0KT8 * 109 -9.5270 3.4550 2.0670 -1.7184 -1.3260 -0.9336 
pha-pcps-3/12 56 0.0690 285.5790 46.4040 123.2555 135.6780 148.1005 
pha-pccs-3/12 56 · 0.1190 280.1690 43.8440 129.2819 141.0190 152.7561 
pha-ccps-3/12 56 62.3790 133.0490 14.5410 97.0973 100.9900 104.8827 
pha-pcps-ly 62 43.2190 360.0790 59.8510 126.2204 141.4150 156.6096 
pha-pccs-ly 62 63.8590 299.7090 45.2580 131.6822 143.1720 154.6618 
pha-ccps-ly 61 50.8290· 147.0890 17.4160 95.0780 101.7670 108.4560 
pha-pcps * 50 -161.8200 196.6400 62.5530 -12.1907 5.5780 23.3467 
Birth weight 147 3.0000 4.3690 0.3060 3.3401 3.3900 3.4399 
SO score weight brth 147 -0.7500 2.7500 0.7220 0.1983 0.3160 0.4337 
Weight@ 3/12 147 4.8490 8.1590 0.6320 5.9450 6.0480 6.1510 
Length@ 3/12 147 52.3990 65.8990 2.0060 58.7990 59.1260 59.4530 
Head circ @ 3/12 147 37.5990 44.6990 1.2630 40.3251 40.5310 40.7369 
SD score weight 3/12 147 -0.9040 2.6770 0.6650 0.3856 0.4940 0.6024 
SO score length 3/12.146 -2.0840 1.6840 0.6660 -0.4719 -0.3630 -0.2541 
Weight/(length)**3 3 146 23.4940 36.5870 2.1000 28.7955 29.1390 29.4825 
Weight@ ly 133 7.6590 13.6590 1.1740 10.0186 10.2200 10.4214 
Weight * 133 2.0000 6.5300 0.9470 3.9906 4.1530 4.3154 
Length @ ly · 134 68.3990 82.0000 2.5500 74.5613 74.9970 75.4327 
Length* 1.34 7 • .7000 25.9000 2.2349 15.3622 15.7440 16.1258 
Head circ@ ly 134 43.5990 50.5000 1.2650 46.4009 46.6170 46.8331 
SD score weight 1 y 133 -2.0990 3.0900 1.1130 0.1721 0.3630 0.5539 
SO score length 1 y 134 -2.0370 2.2750 0.8940 -0.1807 -0.0280 0.1247 
SD score length* 133 -2.4080 2.4330 0.7130 0.1687 0.2910 0.4133 
Weight/(length)**3y 133 19.9290 33.9580 2.0650 23.8208 24.1750 24.5292 
Bact % init 1hr 3/12 65 32.0000 224.0000 45.8430 94.2747 105.6310 116.9873 
Bact % init 2hr 3/12 65 27.0000 378.0000 67.8150 100.8007 117 .6000 134.3993 
Bact % ctl 1hr 3/12 65 30.2290 481.8090 101.6010 158.5412 183.7100 208.8788 
Bact % ctl 2hr 3/12 65 63.0690 2400.0000 378.7230 267. 6379 361.4560 455.2741 
Bact % AB 1 hr 3/12 65 13.0490 109.3190 19.5870 43.9939 48.8460 53.6981 
Bact % A8 2 hr 3/12 65 8.5190 105.5790 18.3790 28.5761 33.1290 37.6819 
SD score weight* 133 -2.0510 2.0630 0.9030 -0.2899 -0.1350 0.0199 
Bact nonn 1 hr 3/12 65 -142.8600 112.1590 39.3730 12.3734 22 .1270 31.8806 
Bact nonn 2 hr 3/12 65 -6.8600 106.4690 21.1110 17.4763 22.7060 27.9357 
Bact % init 1hr ly 57 20.0000 · 227.0000 54.3310 85.0634 99.4740 113.8846 
Bact % init 1hr * 46 -149.0000 172.0000 71.3750 -20.6831 0.5000 21.6831 
Bact % init 2hr ly 57 14.0000 347.0000 88.1520 96.5308 119.9120 143.2932 
Bact % init 2hr * 46 -193.0000 213.0000 111.8260 -21.0794 12.1090 45.2974 
Bact % ctl 1 hr ly 49 28.2290 487.1690 76.2880 107.9688 129.8700 151.7712 
Bact % ctl 1 hr* 39 -319.7800 341.7200 110.0500 -87.9522 -52.3080 -16.6638 
Bact% ctl 2 hr ly 57 32.4890 1446.1490 235.5080 142.1944 204.6600 267.1256 
Bact % AB 1 hr ly 50 8.0590 114.1890 27.6950 37.1440 45.0110 52.8780 
Bact % AB 2 hr ly 54 2.6290 91.4790 24.6650 25.8759 32.6050 39.3341 
Bact nonn 1 hr 1 y 46 -360.0000 142.5890 90.9340 -27.8309 -0.8430 26.1449 
Bact nonn 2 hr l y 54 -63.0900 83.8290 31.2870 3.3253 11.8610 20.3961 
hygiene 144 1.0000 3.0000 0.7000 2.5517 2.6670 2.7823 
daycare 144 1.0000 3.0000 0.3860 2. 7764 2.8400 2.9036 
crowding 144 1.0000 3.0000 0.9440 1.7885 1.9440 2.0995 
finance 144 1.0000 3.0000 0.7080 2.5084 2.6250 2.7416 
BOTH GROUPS COMBINED 95~ CI 95t CI 
VARIABLE N Min Max SD Bottom Mean Top 
careseeking 144 1.0000 3.0000 0.2640 1.9425 1.9860 2.0295 
MDI-pre 31 0.0000 0.0000 
POI-pre 31 0.0000 0.0000 
MDI-diff (Post) 22 0.0000 0.0000 
PDI-diff (Post) 22 o~oooo 0.0000 
Meat/Fish 142 2.0000 10.0000 1.6200 4.6513 4.9200 5.1887 
Cereal 146 0.0000 5.0000 0.7900 1.9508 2.0800 2.2092 
Egg 142 0.0000 9.0000 1.6800 3.7513 4.0300 4.3087 
Fruit 137 1.0000 9.0000 1.4200 3.9201 4.1600 4.3999 
Vegetable 147 1.0000 8.0000 1.2400 3.0979 3.3000 3.5021 
CONTROL GROUP 95% Cl 95-t Cl 
VARIABLE N Min Max so Bottom Mean Top 
First bottle 72 0.0000 4.0000 1.0210 1.2881 1.5280 1. 7679 
Last breast 62 . 0,0000 13.0000 3.7610 2.6422 3.5970 4.5518 
Date of birth 72 83.0950 83.4890 0.1180 83.2673 83.2950 83.3227 
Date@ 3/12 entry 72 83.3360 83.7000 0.1080 83.5146 83.5400 83.5654 
Date@ ly exit 63 84.0100 84.4810 0.1230 84.2420 84,2730 84.3040 
Age@ entry (months) 72 2.5070 3.9110 0.2570 2.9016 2.9620 3.0224 
Age at exit (months) 63 10.6550 12.8870 0.3510 11.7246 11.8130 11.9014 
WBC-3/12 56 5.0000 18.8000 2.9700 10.4559 11.2510 12.0461 
RBC-3/12 56 3.1390 4.6990 0.2990 3.9340 4.0140 4.0940 
Hb-3/12 56 9.0000 12.5990 0.7230 11.0895 11.2830 11.4765 
HCT-3/12 56 26.2990 36.7990 2.0090 32.3492 32.8870 33.4248 
MCV-3/12 56 71.1990 92.7990 4.6550 80.8158 82.0620 83.3082 
MCH-3/12 56 23.2990 30.8990 1.8080 27.6330 28.1170 28.6010 
MCHC-3/12 56 32.0990 37 .0990 1.0290 34.0075 34.2830 34.5585 
RDW%-3/12 56 11.6990 20.7990 1.4400 12.9635 13.3490 13.7345 
PLT-3/12 56 244.0000 704.0000 111.8390 428.9535 458.8930. 488.8325 
RETICS-3/12 53 · 0.5990 7.2990 1.1720 1.6881 2.0110 2.3339 
POLYs-3/12 55 8.0000 53.0000 10.7520 24.0765 26.9820 29.8875 
LYMPHs-3/12 55 42.0000 87.0000 11.2510 61.7416 64.7820 67.8224 
MONOs-3/12 55 0.0000 14.0000 2.9760 4.3228 5.1270 5.9312 
EOSINs-3/12 55 0.0000 ll.0000 2.8520 2.1203 2.8910 3.6617 
BASOs-3/12 55 0.0000 2.0000 0.5120 0.0436 0.1820 0.3204 
WBC-ly 61 5.0990 20.0990 3.2020 9. 7172 10.9470 12.1768 
RBC-ly 61 4.0690 5.6390 0.3920 4.6994 4.8500 5.0006 
RBC * 46 0.1100 1.7000 0.3840 0.6610 0.7750 0.8890 
Hb-ly 61 9.3990 13.6990 0.9380 11.1337 11.4940 11.8543 
Hb * 46 -2.3000 2.6000 1.0380 -0.2951 0.0130 0.3211 
HCT-ly 61 29.8990 41.7990 2.8080 33.7695 34.8480 35.9265 
HCT * 46 -6.2000 9.8000 3.1120 0.4984 1.4220 2.3456 
MCV-ly 61 61.2990 81.3990 5.1020 70.0035 71.9630 73.9225 
MCV * 46 -26.2000 -2.0990 5.1370 -11.7636 -10.2390 -8. 7144 
MCH-ly 61 19.7990 27.0990 1.9670 23.0195 23.7750 24.5305 
MCH * 46 -9.3990 -0.2000 2.0020 -5.0242 -4.4300 -3.8358 
MCHC-ly 61 31.0000 34.7990 0.9060 32.6350 32.9830 33.3310 
MCHC * 46 -4.5990 1.2000 1.2780 -1.7443 -1.3650 -0.9857 
RDW%-1y 61 12.5990 21.5990 1.8090 14.8352 15.5300 16.2248 
ROW%* 46 -5.2990 8.0990 2.2020 1.6035 2.2570 2.9105 
PLT-ly 61 142.0000 672.0000 102. 7590 315.2381 354.7050 394.1719 
RETICs-ly 58 0.2990 . 6. 7990 1.2540 1.3494 1.6790 2.0086 
POLYs-ly 60 7.0000 60.0000 10.8370 28.5185 31.3170 34.1155 
LYMPHs-ly 60 37.0000 88.0000 11.0690 57.8916 60.7500 63.6084 
MONOs-ly 60 0.0000 14.0000 3.1350 3.8234 4.6330 5.4426 
EOSINs-ly 60 0.0000 16.0000 3.6920 2.2636 3.2170 4.1704 
BASOs-ly 60 0.0000 2.0000 0.3540 0.0086 0.1000 0.1914 
ZPP-3/12 65 1.0000 8.7990 1.2370 2.6086 2.9150 3.2214 
FERRITIN-3/12 71 3.0000 704.0000 120.6420 127.0568 155.6060 184.1552 
Log(ferritin) 3/12 71 0.4770 2.8480 0.3590 1.9850 2.0700 2.1550 
ZPP-ly 59 2.0990 8.3990 1.4890 3.5621 3.9500 4.3379 
ZPP * 51 -5.1000 5.8990 1.7970 0.6748 1.1800 1.6852 
FERRITIN-ly 60 1.0000 106.0000 19.3290 18.8085 23.8000 28. 7915 
FERRITIN * 57 -677.0000 3.0000 122.8240 -170.5075 -137.9300 -105.3525 
Log(ferritin) 1 y 60 0.0000 2.0250 0.3760 1.1399 1.2370 1.3341 
log(ferritin) * 57 -1.9490 0.3010 0.4430 -0.9795 -0.8620 -0.7445 
ZINC-PLASMA-3/12 70 46.0000 263.0000 26.0030 84.9582 91.1570 97.3558 
CONTROL GROUP 9St CI 95Js CI 
VARIABLE N Min Max SD Bottom Mean Top 
ZINC-HAIR-3/12 34 72.0990 661.5990 129.7440 178.8025 224.0230 269.2435 
ZINC-PLASMA-ly 56 54.0000 204.0000 23.4890 84.3189 90.6070 96.8951 
ZINC-PLASMA* 52 -61.0000 53.0000 28.3830 ...a.8024 -0.9040 6.9944 
ZINC-HAIR-ly 49 16.5990 536.5990 114.9890 109.2853 142.2970 175.3087 
ZINC-HAIR * 24 -588.3000 227.2990 173.4560 -167.0126 -93.9370 -20.8614 
# Infect:grade 1+2+3 62 0.0000 12.0000 2.4610 4.1332 4.7580 5.3828 
#Infect.grade 1 62 0.0000 5.0000 1.2270 0.9465 1.2580 1.5695 
#Infect.grade 2 62 0.0000 10.0000 2.3040 2.7541 3.3390 3.9239 
# Infect. grade 3 62 0.0000 1.0000 0.3710 0.0668 0.1610 0.2552 
#Infect.resp tract 62 0.0000 5.0000 1.2860 1.1035 1.4300 1.7565 
# Infect. diarrhoea 62 0.0000 4.0000 0.9600 0.5463 0.7900 1.0337 
# Infect. pyodenna 62 0.0000 5.0000 0.9300 0.1509 0.3870 0.6231 
#Infect.thrush 62 0.0000 3.0000 0.7350 0.2164 0.4030 0.5896 
# Infect other(-max) 51 0.0000 2 .. 0000 0.4620 0.0526 0.2300 0.4074 
# infect: other 62 0.0000 4.1450 0.7870 0.1712 0.3710 0.5708 
#Infect.other 62 0.0000 3.0000 0.5770 0.1275 0.2740 0.4205 
#Infect.conjunct. 52 0.0000 2.0000 0.4680 0.1232 0.2420 0.3608 
# Infect:grade 1+2+3 62 0.0000 15.7740 3.3040 5.5782 6.4170 7.2558 
# Infect:grade 1 62 0.0000 6.5380 1.6190 1.2760 1.6870 2.0980 
# Infect:grade 2 62 0.0000 13.1450 3.1050 3.7227 4.5110 5.2993 
# Infect:grade 3 62 0.0000 1.4410 0.5020 0.0906 0.2180 0.3454 
# Infect: resp tract 62 0.0000 7.3560 1.7630 1.4534 1.9010 2.3486 
# Infect: diarrhoea 62 0.0000 5.4520 1.2950 0.7362 1.0650 1.3938 
# Infect: pyodenna 62 0.0000 6.5730 1.2600 0.2041 0.5240 0.8439 
# Infect: thrush 62 0.0000 3.9280 0.9860 0.2937 0.5440 0.7943 
# Infect:other(-max) 61 0.0000 2.7370 0.6230 0.0697 0.3090 0.5483 
# Infect: conjunct 62 0.0000 2.6460 0,6260 0.1651 0.3240 0.4829 
Mantoux 3/12 68 0.0000 18.0000 5.4840 4.6289 5.9560 7.2831 
Candida 3/12 71 0.0000 20.0000 6.1440 2.8981 4,3520 5.8059 
Mantoux 1 y 60 0.0000 26.0000 7.4840 6.1173 8.0500 9.9827 
Mantoux * 57 -13.0000 26.0000 8.6030 -0.0358 2.2460 4.5278 
Candida 1 y 60 0.0000 28.0000 8.5910 6.6645 8.8830 11.1015 
Candida* 60 -10.0000 26.0000 8.0920 2.7773 4.8670 6.9567 
Antibody tetanus ma 62 0.0000 320.0000 99.3110 41.2396 66.4520 91.6644 
Antibody polio ma 69 0.0000 20.0000 5.1680 0.7878 2.0290 3.2702 
log[Tetanus] ma 62 0.0000 2.5070 0.9870 0.8134 1.0640 1.3146 
log[Pol io] ma 69 0.0000 1.3220 0.4110 0.0833 0.1820 0.2807 
Antibody tetanus 3m 70 0.0000 160.0000 23.3390 5.7223 11.2860 16.8497 
Antibody polio 3/12 60 0.0000 160.0000 41.0080 25.5772 36.1670 46.7568 
log[Tetanus] 3/12 70 0.0000 2.2070 0.6810 0.3977 0.5600 0.7223 
log(Polio] 3/12 60 0.0000 2.2070 0.6680 1.0655 1.2380 1.4105 
Antibody tetanus ly 61 0.0000 1280.0000· 233.3070 102.8523 192.4590 282.0657 
Antibody tetanus* 58 -140.0000 1280.0000 243.3600 117 .5882 181.5520 245.5158 
Antibody polio 1 y 61 0.0000 160.0000 49.9060 39.1935 58.3610 77 .5285 
Antibody polio* 52 -160.0000 160.0000 62.9960 12.0845 29.6150 47 .1455 
log(Tetanus] 1 yr 61 0.0000 3.1080 0.5890 1.7528 1.9790 2.4052 
log(Tetanus] 1 y * 58 -1.3220 3.1080 1.0150 1.1392 1.4060 1.6728 
log[[Polio] 1 yr 61 0.0000 2.2070 0.5710 1.3267 1.5460 1.7653 
log[Polio] 1 yr* 52 -2.2070 2.2070 0.8750 0.1485 0.3920 0.6355 
OKT3 3/12 64 54.0000 87 .0000 9.1940 67.1731 69.4690 71. 7649 
OKT4 3/12 64 24.0000 80.0000 11.6000 47.5253 50.4220 53.3187 
OKT8 3/12 64 5.0000 42.0000 6.9390. 14.6892 16.4220 18.1548 
SMIG 3/12 64 7.0000 33.0000 5.9700 18.1182 19.6090 21.0998 
OKT4/0KT8 3/12 64 1.3330 12.0000 1.8160 3.1485 3.6020 4.0555 
CONTROL GROUP 95t Cl 9~ Cl 
VARIABLE N Min Max 50 Bottom Mean Top 
OKT3 ly 57 43.0000 95.0GOO 10.9270 71.2417 74.1400 77 .0383 
OKT4 ly 57 0.0000 70.0000 14.8960 42.9440 46.8950 50.8460 
0KT8 ly 57 5.0000 55.0000 10.2330 19.8118 22.5260 25.2402 
SMIG ly 57 8.0000 44.0000 7.4470 16.6208 18.5960 20.5712 
OKT4/0KT8 ly 57 0.0000 8.1430 1.4440 2.1460 2.5290 2.9120 
OKT4/0KT8 * 49 -3.9610 3.4550 1.5630 -1.4137 -0.9650 -0.5163 
pha-pcps-3/12 27 0.0690 221.3990 53.5480 112.5975 133.7420 154.8865 
pha-pccs-3/12 27 0.1190 255.3990 46.3090 120.4910 138.7770 157.0630 
pha-ccps-3/12 27 62.3790 120.5490 14.0440 92.4255 97 .9710 103.5165 
pha-pcps-ly 24 81.6590 316.0790 53.6140 117 .8109 140.3980 162.9851 
pha-pccs-ly 24 75.9390 299.7090 47.1900 122.9522 142.8330 162. 7138 
pha-ccps-ly 23 75.6490 129.6390 12.9770 96.5373 102.1350 107.7327 
pha-pcps * 21 -114.9100 196.6400 75.7950 -19.3642 15.0320 . 49.4282 
Birth weight 72 3.0000 4.3690 0.3060 3.3401 3.4120 3.4839 
SO score weight brth 72 -0.6250 2.7500 0.6990 0.1918 0.3560 0.5202 
Weight@ 3/12 72 4.9590 8.1490 0.6510 5.907i 6.0600 6.2129 
Length@ 3/12 72 54.6990 63.1990 1.8710 58.6924 59.1320 59.5716 
Head circ@ 3/12 72 38.3990 44.6990 1.3710 40.3829 40.7050 41.0271 
SD score weight 3/12 72 -0.9040 2.6770 0.7030 0.3108 0.4760 0.6412 
SD score length 3/12 72 -2.0840 1.1250 0.6470 -0.5710 -0.4190 -0.2670 
Weight/(length)**3 3 72 24.2430 33.7040 1.8770 28.8120 29.2530 29.6940 
Weight@ ly 63 7.6590 13.5590 1.1890 9.7936 10.0930 10.3924 
Weight* 63 2.0000 5.9500 0.9180 3.7659 3.9970 4.2281 
Length@ ly 63 68.3990 78.7990 2.5380 74.0970 74.7360 75.3750 
Length* 63 11.8990 20.8000 2.1150 14.9165 15.4490 15.9815 
Head circ @ ly 63 44.1990 50.5000 1.2500 46.3923 46.7070 47.0217 
SD score weight 1 y 63 -2.0990 3.0900 1.1510 -0.0598 0.2300 0.5198 
SD score length 1 y 63 -2.0090 1.5560 0.8420 -0.3450 -0.1330 0.0790 
SO score length* 63 -1.4320 2.0050 0.6830 0.0830 0.2550 0.4270 
Weight/(length)**3y 63 20.1160 28.3550 1.6870 23.6943 24.1190 24.5437 
Bact % init 1hr 3/12 32 47.0000 224.0000 47.2770 91.8198 108.8440 125.8682 
Bact % init 2hr 3/12 32 41.0000 378.0000 80.2400 95.5120 124.4060 153.3000 
Bact % ctl 1hr 3/12 32 30.2290 481.8090 117.5690 150.3601 192.6960 235.0319 
Bact % ctl 2hr 3/12 32 63.0690 1618.1790 332.0210 257.2392 376. 7980 496.3568 
Bact % AB 1 hr 3/12 32 13.0490 109.3190 21.9410 42.7622 50.6630 58.5638 
Bact % AB 2 hr 3/12 32 8.5190 105.5790 22.0670 27.2258 35.1720 43.1182 
SO score weight* 63 -2.0510 1.5320 0.8820 -0.4751 -0.2530 -0.0309 
Bact norm 1 hr 3/12 32 -142.8600 112.1590 49.8930 2.9068 20.8730 38.8392 
Bact norm 2 hr 3/12 32 -6.8600 106.4690. 25.7090 15,8383 25.0960 34.3537 
Bact % init 1hr ly 28 25.0000 222.0000 51.4820 85.2137 105.1430 125.0723 
Bact % init 1hr * 21 -80.0000 118.0000 63.3790 -13.7138 15.0480 43.8098 
Bact % init 2hr ly 28 25.0000 291.0000 80.6920 95.5132 126.7500 157.9868 
Bact % init 2hr * 21 -193.0000 194.0000 104.8590 -23.8716 23.7140 71.2996 
Bact % ctl 1 hr ly 25 41.6590 315.3790 59.2130 106.3632 130.7530 155.1428 
Bact % ctl 1 hr* 18 -319.7800 66.1900 95.9220 -98.1023 -50.6030 -3.1037 
Bact % ctl 2 hr ly 28 32.4890 638.4590 138.3580 146.4691 200.0290 253:5889 
Bact % AB 1 hr ly 22 16.0190 114.1890 27.9830 35.9581 48.3310 60.7039 
Bact % AB 2 hr ly 25 4.1490 81.4390 21.3020 25.0247 33.7990 42.5733 
Bact norm 1 hr 1 y 22 -360.0000 142.5890 91.9240 -37.1348 3.5100 44.1548 
Bact norm 2 hr 1 y 25 -63.0900 64.9490 27.4270 1.0148 12.3120 23.6092 
hygiene 71 1.0000 3.0000 0.6800 2.5571 2.7180 2.8789 
daycare 71 2.0000 3.0000 0.4010 2.7091 2.8040 2.8989 
crowding 71 1.0000 3.0000 0.9490 1.7894 2.0140 2.2386 
finance 71 1.0000 3.0000 0.6750 2.5023 2.6620 2.8217 
CONTROL GROUP 9~ CI 95!t CI 
VARIABLE N Hin Max SD Bottom Hean Top 
careseeking 71 1.0000 3.0000 0.3160 1.9112 1.9860 2.0608 
MDI-pre 9 5.0000 109.2297 113.0000 116.7703 
POI-pre 9 7.2000 98.9707 104.4000 109.8293 
MDI-diff (Post) 14 7.5000 -0.2992 4.0000 8.2992 
PDI-diff (Post) 14 2.9000 -2.1623 -0.5000 1.1623 
Meat/Fish 68 2.0000 10.0000 1.8200 4.7496 5.1900 5.6304 
Cereal 71 0.0000 5.0000 0.7900 1.8731 2.0600 2.2469 
Egg 68 1.0000 9.0000 1.8200 3.7996 4.2400 4.6804 
-Fruit 67 2.0000 9.0000 1.4200 3.8137 4.1600 4.5063 
Vegetable 72 1.0000 8.0000 1.3900 3.0734 3.4000 3. 7266 
TESTGROlJP 95* CI 95ft CI 
VARIABLE N Min Max so Bottom Mean Top 
First bottle 75 0.0000 3.0000 0.9500 1.2745 1.4930 1.7115 
Last breast 68 0.0000 13.0000 4.1800 3.0325 4.0440 5.0555 
Date of birth 75 83.0920 83.4890 0.1120 83.2892 83.3150 83.3408 
Date@ 3/12 entry 75 83.3500 83.7000 0.1020 83.5335 83.5570 83.5805 
Date@ ly exit 71 84.0880 84.4790 0.1180 84.2761 84.3040 84.3319 
Age@ entry (months) 75 2.1710 3.4790 0.2580 2.8396 2.8990 2.9584 
Age at exit (months) 71 11.0750 12.5270 0.2760 11.7927 11.8580 11.9233 
WBC-3/12 66 6.2990 23.1990 3.1980 11.1160 11.9020 12.6880 
RBC-3/12 66 3.3090 4.9490 0.3560 3.9755 4.0630 4.1505 
Hb-3/12 66 9.5990 12.7990 0.8090 11.1762 11.3750 11.5738 
HCT-3/12 66 28.1990 37.7990 2.3350 32.6961 33.2700 33.8439 
MCV-3/12 66 57 .8990 90.8990 5.4380 80.7595 82.0960 83.4325 
MCH-3/12 66 19,2990 33.0000 2.0620 27.6012 28.1080 28.6148 
MCHC-3/12 66 31.1990 36.3990 0.9440 33.9790 34.2110 34.4430 
RDW%-3/12 66 11.5000 17.3990 1.3640 13.3518 13.6870 14.0222 
PlT-3/12 66 221.0000 773.0000 118.6180 443.9839 473.1360 502.2881 
RETICS-3/12 64 0.6990 5.7990 1.1850 1.9841 2.2800 2.5759 
POLYs-3/12 66 7.0000 73.0000 12.8970 24.3604 27.5300 30.6996 
LYMPHs-3/12 66 24.0000 88.0000 13.5170 61.7390 65.0610 68.3830 
. MONOs-3/12 66 1.0000 14.0000 2.6630 4.3605 5.0150 5.6695 
EOSINs-3/12 65 0.0000 7 .0000 1.7190 1.8213 2.2620 2.7027 
BASOs-3/12 65 0.0000 2.0000 0.3900 0.0414 0.1380 0.2346 
WBC-ly 65 5.5000 17.2990 2.7840 10.3463 11.0360 11. 7257 
RBC-ly 65 4.1490 6.0490 0.4150 4.7972 4.9000 5.0028 
RBC * 58 -0.2400 1.4900 0.3490 0.7253 0.8170 0.9087 
Hb-ly 65 9.0990 14.0990 1.0080 U,6033 11.8530 12.1027 
Hb * 58 -1.6000 2.3990 0.8890 0.2663 0.5000 0.7337 
HCT-ly 65 27.0000 43.0000 3.0860 35.0335 35.7980 36.5625 
HCT * 58 -5.1990 8.9000 2. 7180 1.6906 2.4050 3.1194 
MCV-ly 65 53.0000 83.0000 5.6680 71. 7979 73.2020 74.6061 
MCV * 58 -19.6000 1.3000 4.3530 -9.9321 -8.7880 -7.6439 
MCH-ly 65 16.1990 28.2990 2.1830 23.7522 24 .• 2930 24.8338 
MCH * 58 -8.3010 -0.2000 1.6430 -4.0728 -3.6410 -3.2092 
MCHC-ly 65 30.5000 35.3990 0.9410 32.9109 33.1440 33.3771 
MCHC * 58 -2.8990 3.4000 1.2070 -1.2132 -0.8960 -0.5788 
RDW%-ly 65 12.0000 21.5000 1.6120 14.0397 14.4390 14.8383 
ROW%* 58 -2.5000 5.4000 1.8510 0,2225 0.7090 1.1955 
PlT-ly 65 82.0000 623.0000 111.2360 316.0134 343.5690 371.1246 
RETICs-ly 64 0.2990 5.3990 . 0.9520 1.5643 1.8020 2.0397 
POLYs-ly 65 6.0000 67.0000 12.7800 31.6191 34.7850 37.9509 
LYMPHs-ly 65 23.0000 82.0000 12.9880 53.1676 56.3850 59.6024 
·MONOs-ly 65 1.0000 15.0000 3.3970 5.0815 5.9230 6.7645 
EOSINs-ly 65 0.0000 11.0000 2.5140 2.1152 2.7380 3.3608 
BASOs-ly 64 0.0000 2.0000 0.3620 0.0186 0.1090 0.1994 
ZPP-3/12 68 1.0990 7.1990 1.0830 2.5559 2.8180 3.0801 
FERRITIN-3/12 69 20.0000 565.0000 118.2690 128.7984 157.2030 185.6076 
Log(ferritin} 3/12 69 1.3010 2.7520 0.3370 1.9961 2.0770 2.1579 
ZPP-ly 65 1.5000 11.0990 1.3220 3.0855 3.4130 3.7405 
ZPP * 59 -2.4010 3.9000 1.1810 0.2073 0.5150 0.8227 
FERRITIN-ly 69 1.0000 244.0000 34.5000 29.4101 37.6960 45.9819 
FERRITIN " 64 -538.0000 158.0000 122.3670 -141.9786 -111.4220 -80.8654 
Log(ferritin) ·1 y 69 0.0000 2.3870 0.3290 1.3830 1.4620 1.5410 
Log(ferritin) " 64 -1.6230 0.5400 0.4570 -0.6991 -0.5850 -0.4709 
ZINC-PLASMA-3/12 69 55.0000 134.0000 17.9640 81.3236 85.6380 89.9524 
TEST GROUP 95* CI 95t CI 
VARIABLE N Hin Hax SD Bottom Hean Top 
ZINC-HAIR-3/12 44 54.5990 759.7990 187.1310 204.4564 261.3130 318.1696 
ZINC-PLASMA-ly 68 54.0000 142.0000 16.9150 79.4357 83.5290 87.6223 
ZINC-PLASMA* 63 -62.0000 62.0000 26.1530 -9.9017 -3.3170 3.2677 
ZHIC-HAIR-ly 52 18.0000 457.0000 96.5280 102.3453 129.2070 156.0687 
ZINC-HAIR * 28 -703.7990 253.1000 245.5570 -256.4509 -161.3930 -66.3351 
# Infect:grade 1+2+3 70 0.0000 9.0000 2.1290 3.8925 4.4000 4.9075 
I Infect. grade 1 70 0.0000 5.0000 1.2230 0.8655 1.1570 1.4485 
# Infect. grade 2 70 0.0000 9.0000 2,0420 2.6422 3.1290 3.6158 
#Infect.grade 3 70 0.0000 1.0000 0.3200 0.0377 0.1140 0.1903 
#Infect.resp tract 70 0.0000 6.0000 1.2820 1.1804 1.4860 1.7916 
#Infect.diarrhoea 70 0.0000 3.0000 0.9030 0.4987 0.7140 0.9293 
I Infect. pyodenna 70 0.0000 4.0000 0. 7930 0.1400 0.3290 o. 5180 
# Infect. thrush 70 0.0000 3.0000 0.7230 0.1846 0.3570 0.5294 
I Infect other(-max) 70 0.0000 2.0000 0.3910 0.0498 0.1430 0.2362 
# infect: other 70 0.0000 2.5520 0.5130 0.0657 0.1880 0.3103 
I# Infect. other 70 0.0000 2.0000 0.3910 0.0498 0.1430 0.2362 
#Infect.conjunct. 70 0.0000 1.0000 0.4130 0.1155 0.2140 0.3125 
I Infect:grade 1+2+3 70 0.0000 11.8930 2.8030 5.1918. 5.8600 6.5282 
# Infect:grade 1 70 0.0000 6.5380 1.6260 1.1604 1.5480 1.9356 
# Infect:grade 2 70 0.0000 11.8930 2.6920 3.5163 4.1580 4. 7997 
I# Infect:grade 3 70 0.0000 1.3480 0.4330 0.0508 0.1540 0.2572 
# Infect: resp tract 70 0.0000 8.2330 1.7080 1.5718 1.9790 2.3862 
# Infect: diarrhoea 70 0.0000 4.1340 1.1980 0.6624 0.9480 1.2336 
# Infect: pyodenna 70 0.0000 5.2860 1.0450 0.1859 0.4350 0.6841 
I Infect: thrush 70 0.0000 3.9960 0.9610 0.2459 0.4750 0.7041 
# Infect:other(-max) 70 0.0000 2.5520 0.5130 0.0657 0.1880 0.3103 
# Infect: conjunct 70 0.0000 1.4090 0.5530 0.1542 0.2860 0.4178 
Mantoux 3/12 70 0.0000 21.0000 5. 7740 3.9805 5.3570 6.7335 
Candida 3/12 73 0.0000 20.0000 5.9390 2.9296 4.3150 5.7004 
Mantoux 1 y 67 0.0000 22.0000 7 .1770 5.2798 7.0300 8.7802 
Mantoux * 64 -20.0000 22.0000 8.4830 -0.6493 1.4690 3.5873 
Candida 1 y 68 0.0000 27 .0000 8.3390 7.7320 9.7500 11. 7680 
Candida * 67 -17.0000 25.0000 9.3580 2.8969 5.1790 7 .4611 
Antibody tetanus ma 68 0.0000 5120.0000 652.9100 9.2084 167.2060 325.2036 
Antibody polio ma 69 0.0000 20.0000 4.2730 0.7128 1.7390 2. 7652 
log[Tetanus] ma 68 0.0000 3.7090 1.0080 0.8971 1.1410 1.3849 
log[Polio] ma 69 0.0000 1.3220 0.3890 0.0876 0.1810 0.2744 
Antibody tetanus 3m 69 0.0000 320.0000 43.9750 2.6265 13.1880 23.7495 
Antibody polio 3/12 69 0.0000 160.0000 38.5930 28.2671 37.5360 46.8049 
log(Tetanus] 3/12 69 0.0000 2.5070 0.6780 0.2692 0.4320 0.5948 
log[Pol io] 3/12 69 0.0000 2.2070 0.6140 1.1665 1.3140 1.4615 
Antibody tetanus ly 69 0.0000 10240.0000 1388.6840 59.6681 393.1880 726. 7079 
Antibody tetanus* 64 -280.0000 10230.0000 1442.1780 34.7141 394.8440 754.9739 
Antibody polio 1 y. 67 0.0000 160.0000 54.9420 57 .6467 71.0450 84.4433 · 
Antibody polio* 63 -140.0000 160.0000 70.1800 15.5054 33.1750 50.8446 
log(Tetanus] 1 yr 69 0.0000 4.0100 o. 7170 1.7178 1.8900 2.0622 
log(Tetanus] 1 y * 64 -1.6130 3.7090 1.0980 1.1558 1.4300 1.7042 
log[[Polio] 1 yr 67 0.0000 2.2070 0.4920 · 1.5590 1.6790 1.7990 
log[Polio] 1 yr* 63 -1.6130 2.2070 0.8180 0.1570 0.3630 0.5690 
OKT3 3/12 63 47.0000 88.0000 10.0630 65.4504 67 .9840 70.5176 
OKT4 3/12 63 19.0000 87 .0000 12.8310 48.3725 51.6030 54.8335 
OKT8 3/12 63 5.0000 42.0000 7.7510 13.8895 15.8410 17.7925 
SMIG 3/12 63 5.0000 43.0000 7.4390 15.5240 17 .3970 19.2700 
OKT4/0KT8 3/12 63 0.7620 12.4290 2.5370 3.5232 4.1620 4.8008 
TEST GROUP 95% CI 95% Cl 
VARIABLE N Hin Hax so Bottom Hean Top 
OKT3 ly 69 40.0000 93.0000 11.2920 69.8820 72.5940 75.3060 
OKT4 ly 69 16.0000 75.0000 12.3430 43.8616 46.8260 49.7904 
OKT8 ly 69 7.0000 67.0000 9.4740 20.6666 22.9420 25.2174 
SMIG ly 69 4.0000 46.0000 7.7260 17.3324 19.1880 21.0436 
OKT4/0KT8 ly 69 0.3580 5.9000 1.2040 2.1208 2.4100 2.6992 
OKT4/0KT8 * 60 -9.5270 1.6920 2.3750 -2.2343 -1.6210 -1.0077 
pha-pcps-3/12 29 89.7990 285 .• 5790 39.4990 122.4799 137.4810 152.4821 
pha-pccs-3/12 29 78.4190 280,1690 42.1350 127.1048 143.1070 159.1092 
pha-ccps-3/12 29 66.9090 133.0490 14.6710 98.2282 103.8000 109.3718 
pha-pcps-ly 38 43.2190 360.0790 64.UOO 120.9845 142.0580 163.1315 
pha-pccs-ly 38 . 63.8590 298.2690 44.6370 128.7272 143.3860 158.0448 
pha-ccps-ly 38 50.8290 147.0890 19.7890 95.0453 101.5440 108.0427 
pha-pcps * 29 -161.8200 108.5100 51.2680 -20.7388 -1.2680 18.2028 
Birth weight 75 3.0000 4.2090 0.3060 3.2986 3.3690 3.4394 
SO score weight brth 75 -0.7500 2.5240 o. 7470 0.1062 0.2780 0.4498 
Weight@ 3/12 75 4.8490 8.1590 0.6180 5.8938 6.0360 6.1782 
length@ 3/12 75 52.3990 65.8990 2.1410 58.6275 59.1200 59.6125 
Head circ@ 3/12 75 37.5990 43.0990 1.1340 40.1041 40.3650 40.6259 
SO score weight 3/12 75 -0.5670 2.4530 0.6300 0.3671 0.5120 0.6569 
SO score length 3/12 74 -1.8850 1.68,40 0.6850 -0.4657 -0.3070 -0.1483 
Weight/(1ength)**3 3 74 23.4940 36.5870 2.3040 28.4953 29.0290 29.5627 
Weight@ ly 70 8.0090 12.9190 1.1570 10.0582 10.3340 10.6098 
Weight* 70 2.5400 6.5300 0.9580 4.0646 4.2930 4.5214 
Length@ ly 71 69.8990 82.0000 2.5560 74.6241 75.2290 75.8339 
Length* 71 7.7000 25.9000 2.5250 15.4085 16.0060 16.6035 
Head circ@ ly 71 43.5990 50.0000 1.2820 46.2336 46.5370 46.8404 
SO score weight 1 y 70 -1.4610 2.5570 1.0720 0.2254 0.4810 0,7366 
SD·score length 1 y 71 -2.0370 2.2750 0.9340 -0.1560 0.0650 0.2860 
SD score length* 70 -2.4080 2.4330 0.7430 0.1469 0.3240 0.5011 
Weight/( length)**3y 70 19.9290 33.9580 2.3630 23.6627 24.2260 24. 7893 
Bact % init 1hr 3/12 33 32.0000 224.0000 44.9180 86,6068. 102.5150 118.4232 
Bact % lnit 2hr 3/12 33 27.0000 237.0000 53.5660 92.0290 111.0000 129.9710 
Bact % ctl 1hr 3/12 33 52.9390 427.2690 84.2370 145.1625 174.9960 204.8295 
Bact % ctl 2hr 3/12 33 86.4790 2400.0000 423.8000 196.4856 346.5790 496.6724 
Bact % AB 1 hr 3/12 33 16.1590 93.3290 17.1590 41.0070 47.0840 53.1610 
Bact % AB 2 hr 3/12 33 8.7390 69.4090 13.9850 26.1961 31.1490 36.1019 
SD score weight* 70 -1.8290 2.0630 0.9150 -0.2481 -0.0300 0.1881 
Bact norm 1 hr 3/12 33 -34.7900 88.3990 26.1900 14.0685 23.3440 32.6195 
Bact norm 2 hr 3/12 33 -2.3400 .64.9590 
' 
15.4850 14.9048 20.3890 25.8732 
Bact % init 1hr ly 29 20.0000 227.0000 57.3120 72.2338 94.0000 115. 7662 
Bact % init 1hr * 25 -149.0000 172.0000 76.5750 -43.2612 -11. 7200 19.8212 
Bact % init 2hr ly 29 14.0000 347.0000 95.7650 76.9400 113.3100 149.6800 
Bact % init 2hr * 25 -160.0000 213.0000 118.6110 -46.4959 2.3600 51.2159 
Bact % ct I 1 hr ly 24 28.2290 487 .1690 92.1160 90.14.23 128.9500 167.7577 
Bact % ctl 1 hr* 21 -247.2300 341.7200 123.2280 -109.7096 -53.7880 2.1336 
Bact % ctl 2 hr ly 29 42.5490 1446.1490 304.0170 93.6702 209.1310 324.5918 
Bact % AB 1 hr ly 28 8.0590 100.6090 27.6920 31.6821 42.4020 53.1219 
Bact % AB 2 hr ly 29 2.6290 91.4790 27.5720 21.1036 31.5750 42.0464 
Bact nonn 1 hr 1 y 24 -,,286.6700 101.8490 91.8060 -43.5101 -4.8330 33.8441 
Bact nonn 2 hr 1 y 29 -54.3700 83.8290 34.7530 -1. 7266 11.4720 24.6706 
hygiene 73 1.0000 3.0000 0.7190 2.4483 2.6160 2.7837 
daycare 73 1.0000 3.0000 0.3710 2.7905 2.8770 2.9635 
crowding 73 1.0000 3.0000 0.9420 1.6573 1.8770 2.0967 
finance 73 1.0000 3.0000 0.7420 2.4159 2.5890 2.7621 
TEST GROUP 9St CI 95-t CI 
VARIABLE N Hin Hex so Bottom Hean Top 
careseeking 73 1.0000 3.0000 0.2040 1.9384 1.9860 2.0336 
MDI-pre 22 10.7000 105.5689 110.3000 115.0311 
POI-pre 22 7.9000 94.0070 97.5000 100.9930 
MDI-diff (Post} 8 5.0000 -7.6765 -3.6000 0.4765 
PDI-diff (Post} 8 8.9000 -5.4561 1.8000 9.0561 
Meat/Fish 74 2.0000 9.0000 1.3800 4.3603 4.6800 4.9997 
Cereal 75 0.0000 4.0000 0.7900 1.9283 2.1100 2.2917 
Egg 74 0.0000 7.0000 1.5200 3.4879 3.8400 4.1921 
Fruit 70 1.0000 9.0000 1.4100 3.8239 4.1600 4.4961 
Vegetable 75 1.0000 6.0000 1.0600 2.9562 3.2000 3.4438 
9~ CI of DIFFERENCE of MEANS POWER for alpha .. St, & dfff: 
VARIABLE Bottom Hean Top p N_S_PCT BETA Observ 10% 25ft 501; 
First bottle -0.0350 -0.3563 0.2863 0.8325 6090 0.9999 0.0001 0.1565 0.6328 0.9902 
Last breast 0.4470 -0.9379 1.8319 0.5239 611 0.9999 0.0001 0.0001 0.2753 0.7709 
Date of birth 0.0200 -0.0175 0.0575 0.2945 254 0.8149 0.1851 1.0000 1.0000 1.0000 
· Date @ 3/12 entry 0.0170 -0.0172 0.0512 0.3306 293 0.8315 0.1685 1.0000 1.0000 1.0000 
Date @ ly exit 0.0310 -0.0102 0.0722 0.1359 116 0.6865 0.3135 1.0000 1.0000 1.0000 
Age@ entry (months) -0.0630 -0.1470 0.0210 0.1402 128 0.6883 0.3117 0.9916 0.9982 1.0000 
Age at exit (months) 0.0450 -0.0623 0.1523 0.4086 373 0.8660 0.1340 1.0000 1.0000 1.0000 
WBC-3/12 0.6510 -0.4625 1.7645 0.2492 174 0.7886 0.2114 0.5332 0.9905 0.9938 
RBC-3/12 0.0490 -0.0701 0.1681 0.4184 351 0.8694 0.1306 0.9915 0.9980 1.0000 
Hb.;.3/12 0.0920 '."0.1853 0.3693 0.5131 539 0.9999 0.0001 0.9924 1.0000 1.0000 
HCT-3/12 0.3830 -0.4054 1.1714 0.3373 252 0.8359 0.1641 0.9925 1.0000 1.0000 
MCV-3/12 0.0340 -1.7984 1.8664 0.9703 172471 0.9999 0.0001 0.9929 1.0000 1.0000 
MCH-3/12 -0.0090 -0.7103 0.6923 0.9804 360571 0.9999 0.0001 0.9923 0.9999 1.0000 
MCHC-3/12 -0.0720 -0.4259 0.2819 0.6883 1435 0.9999 0.0001 0.9995 1.0000 1.0000 
RDW%-3/12 0.3380 -0.1654 0.8414 0.1864 132 0.7365 0.2635 0.9906 0.9957 1.0000 
PLT-3/12 14.2430 -27.3257 55.8117 0.4988 506 0.9999 0.0001 0.5970 0.9908 0.9943 
RETICS-3/12 0.2690 -0.1648 0.7028 0.2204 148 0.7672 0.2328 0.1694 0.6834 0.9904 
POLYs-3/12 0.5480 -3.7798 4.8758 0.8023 3667 0.9999 0.0001 0.2388 0.8660 0.9912 
LYMPHs-3/12 0.2790 -4.2542 4.8122 0.9033 15520 0.9999 0.0001 0.8014 0.9918 0.9963 
MONOs-3/12 -0.1120 -1.1276 0.9036 0.8273 4834 0.9999 0.0001 . 0.1699 0.6854 0.9904 
EOSINs-3/12 -0.6290 -1.4751 0.2171 0.1435 106 0.6921 0.3079 0.0001 0.3150 0.8350 
BASOs-3/12 -0.0440 -0.2072 0.1192 0.6003 803 0.9999 0.0001 0.0001 0.0001 0.1633 
WBC-ly 0.0890 -0.9672 1.1452 0.8673 8692 0.9999 0.0001 0.5320 0.9905 0.9938 
RBC-ly 0.0500 -0.0926 0.1926 0.4892 502 0.8968 0.1032 0.9916 0.9980 1.0000 
RBC * 0.0420 -0.1009 0.1849 0.5578 580 0.9999 0.0001 0.1975 0.7822 0.9908 
Hb-ly 0.3590 0.0151 o. 7029 0.0410 57 0.4656 0.5344 0.9915 0.9980 1.0000 
Hb * 0.4870 0.1120 0.8620 0.0114 30 0.2794 0.7206 0.0001 0.0001 0.1168 
HCT-ly . 0.9500 -0.0925 1.9925 0.0739 74 0.5706 0.4294 0.9915 0.9979 1.0000 
HCT * 0.9830 -0.1521 2.1181 0.0886 67 0.6044 0.3956 0.0001 0.1411 0.3969 
MCV-ly 1.2390 -0.6669 3.1449 0.2005 146 0.7495 0.2505 0.9920 0.9993 1.0000 
MCV * 1.4510 -0.3954 3.2974 0.1221 81 0.6612 0.3388 0.1757 0.7070 0.9905 
MCH-ly 0.5180 -0.2164 1.2524 0.1649 124 0 .7163 0.2837 0.9914 0.9976 1.0000 
MCH * 0.7890 0.0801 1.4979 0.0295 40 0.4089 0.5911 0.1992 0.7878 0.9908 
MCHC-ly 0.1610 -0.1651 0.4871 0.3305 253 0.8325 0.1675 1.0000 1.0000 1.0000 
MCHC * 0.4690 -0.0161 0.9541 0.0581 54 0.5250 0.4750 0;0001 0.2026 0.6096 
ROW%-ly -1.0910 -1.6944 -0.4876 0.0005 19 0.0583 0.9417 0.9904 0.9951 1.0000 
ROW%* -1.5480 -2.3365 -0.7595 0.0002 13 0.0353 0.9647 0.0001 0.1446 0.4089 
PLT-ly -11.1360 -48.9666 26.6946 0.5612 712 0.9999 0.0001 0.4383 0.9901 0.9931 
RETICs-ly 0.1230 -0.2739 0.5199 0.5381 621 0.9999 0.0001 0.1432 0.5780 0.9900 
POLYs-ly 3.4680 -0.7448 7 .6808 0.1058 90 0.6359 0.3641 0.3379 0.9645 0.9922 
LYMPHs-ly -4.3650 -8,6550 -0.0750 0.0462 59 0.4864 0.5136 0. 7589 0.9915 0.9958 
MONOs-ly 1.2900 0.1298 2.4502 0.0297 49 0.4116 0.5884 0.1511 0.6115 0.9901 
EOSINs-iy -0.4790 -1.5899 0.6319 0.3958 329 0.8606 0.1394 0.0001 0.2612 0.7420 
BASOs-ly 0.0090 -0.1184 0.1364 0.8844 12167 0.9999 0.0001 0.0001 0.0001 0.1308 
ZPP-3/12 -0.0970 -0.4953 0.3013 0.6336 llOO 0.9999 0.0001 0.2918 0.9388 0.9918 
FERRITIN-3/12 1.5970 -38.3398 41.5338 0.9371 43004 0.9999 0.0001 0.1214 0.4823 0.9634 
Log(ferritin) 3/12 0.0070 -0.1094 0.1234 0.9053 19025 0.9999 0.0001 0.9341 0.9929 0.9985 
ZPP-ly -0.5370 -1.0367 -0.0373 0.0353 53 0.4411 0.5589 0.3012 0.9491 0.9919 
ZPP * -0.6650 -1.2327 -0.0973 0.0220 39 0.3672 0.6328 0.0001 0.1089 0.2965 
FERRITIN-ly 13.8960 3.9490 23.8430 0.0066 32 0.2205 o. 7795 0.0001 0.3369 0.8629 
FERRITIN * 26.5080 -17.6979 70.7139 0.2374 164 0.7796 0.2204 0.0001 0.2811 0.7828 
Log(ferritin) 1 y 0.2250 0.1022 0.3478 0.0004 19 0.0520 0.9480 0.5825 0.9907 0.9942 
Log{ferritin) * 0.2770 0.1146 0.4394 0.0010 20 0.0856 0.9144 0.1435 0.5795 0.9900 
ZINC-PLASMA-3/12 -5.5190 -13.0257 l.9877 0.1482 126 0.6986 0.3014 0.6354 0.9910 0.9947 
95t CI of DIFFERENCE of MEANS POWER for alpha • St, & diff : 
VARIABLE Bottom Mean Top p N_S_PCT BETA Observ 10% 25J; 50% 
ZINC-HAIR-3/12 37.2900 -37.6075 112 .1875 0.3245 150 0.9999 0.0001 0.0001 0.0001 0.0001 
ZINC-PLASMA-ly -7.0780 -14.2746 0.1186 0.0538 62 0.5132 0.4868 0.6556 0.9910 0.9948 
ZINC-PLASMA * -2.4130 -12.5029 7.6769 0.6365 975 0.9999 0.0001 0.0001 0.0001 0.0001 
ZINC-HAIR-ly -13.0900 -54.9201 28.7401 0.5361 503 0.9999 0.0001 0.0001 0.0001 0.0001 
ZINC-HAIR * -67.4560 -187.8139 52.9019 0.2657 78 0.7032 0.2968 0.1315 0.1788 0.2882 
# Infect:grade 1+2+3 -0.3580 -1.1484 0.4324 0.3718 315 0.8509 0.1491 0.2071 0.8065 0.9909 
#Infect.grade 1 -0.1010 -0.5236 0.3216 0.6375 1130 0.9999 0.0001 0.0001 0.2880 o. 7970 
# Infect. grade 2 -0.2100 -0.9583 0.5383 0.5795 820 0.9999 0.0001 0.1394 0.5611 0.9863 
#Infect.grade 3 -0.0470 -0.1660 0.0720 0.4361 414 0.8769 0.1231 0.0001 0.0001 0.2032 
#Infect.resp tract 0.0560 -0.3870 0.4990 0.7132 4038 0.9999 0.0001 0.0001 0.3592 0.8912 
#Infect.diarrhoea -0.0760 -0.3969 0.2449 0.6402 1151 0.9999 0.0001 0.0001 0.2109 0.6292 
# Infect. pyodenna -0.0580 -0.3547 0.2387 0.6970 1689 0.9999 0.0001 0.0001 0.0001 0.2202 
# Infect. thrush -0.0460 -0.2974 0.2054 0.7174 1928 0.9999 0.0001 0.0001 0.1149 0.3147 
I Infect other(-max) -0.0870 -0.2345 0.0605 0.2471 184 0.7857 0.2143 0.0001 0.0001 0.2326 
ii infect: other -0.1830 -0.4093 0.0433 0.1136 99 0.6466 0.3534 0.0001 0.0001 0.2243 
I Infect. other -0.1310 -0.2991 0.0371 0.1249 106 0.6672 0.3328 0.0001 0.0001 0.2262 
#Infect.conjunct. -0.0280 -0.1797 0.1237 0. 7191 1894 0.9999 0.0001 0.0001 0.1137 0.3108 
I Infect:grade 1+2+3 -0.5570 -1.6088 0.4948 0.2971 230 0.8164 0.1836 0.2094 0.8109 0.9909 
ii Infect:grade 1 -0.1390 -0.6989 0.4209 0.6240 1047 0.9999 0.0001· 0.0001 0.2924 0.8045 
# Infect:grade 2 -0.3530 -1.3512 0.6452 0.4848 516 0.8955 0.1045 0.1402 0.5650 0.9874 
# Infect:grade 3 -0.0640 -0.2250 0.0970 0.4339 408 0.8758 0.1242 0.0001 0.0001 0.2032 
# Infect: resp tract 0.0780 -0.5203 0.6763 0.7961 3797 0.9999 0.0001 0.0001 0.3558 0.8869 
· # Infect: diarrhoea -0.1170 -0.5464 0.3124 0.5906 869 0.9999 0.0001 0.0001 0.2107 0.6288 
# Infect: pyodenna -0.0890 -0.4861 0.3081 0.6568 1285 0.9999 0.0001 0.0001 0.0001 0.2207 
# Infect: thrush -0.0690 -0.4046 0.2666 0.6828 1527 0.9999 0.0001 0.0001 0.1152 0.3158 
# Infect:other(-max) -0.1210 -0.3174 0.0754 0.2277 169 0.7701 0.2299 0.0001 0.0001 0.2330 
# Infect: conjunct -0.0380 -0.2410 0.1650 0.7151 1842 0.9999 0.0001 0.0001 0.1138 0.3112 
Mantoux 3/12 -0.5990 -2.4958 1.2978 0.5335 679 0.9999 0.0001 0.0001 0.3083 0.8265 
Candida 3/12 -0. 0370 -2.0275 1.9535 0.9707 204807 0.9999 0.0001 0.0001 0.1900 0.5686 
Mantoux 1 y -1.0200 -3.5963 1.5563 0.4347 396 0.8765 0.1235 0.0001 0.2978 0.8126 
Mantoux * -0.7770 -3.8566 2.3026 0.6184 928 0.9999 0.0001 0.0001 0.0001 0.0001 
Candida 1 y 0.8670 -2.0977 3.8317 0.5639 731 0.9999 0.0001 0.0001 0.3390 0.8656 
Candida* 0.3120 -2.7778 3.4018 0.8417 6089 0.9999 0.0001 0.0001 0.1286 0.3576 
Antibody tetanus ma 100.7540 -65.0953 266.6033 0.2316 172 0:7751 0.2249 0.0001 0.0001 0.1070 
Antibody polio ma -0.2900 -1.8865 1.3065 0. 7201 2054 0.9999 0.0001 0.0001 0.0001 0.2142 
log[Tetanus] ma 0.0770 -0.2698 0.4238 0.6580 1291 0.9999 0.0001 0.0001 0.3446 0.8727 
log[Polio] ma -0.0010 -0.1357 0.1337 0.9921 999999 0.9999 0.0001 0.0001 0.0001 0.2654 
Antibody tetanus 3m 1.9020 -9.8833 13.6873 0.7500 2621 0.9999 0.0001 0.0001 0.0001 0.1786 
Antibody polio 3/12 1.3690 -12.5104 15.2484 0.8455 6472 0.9999 0.0001 0.0001 0.2592 0.7377 
log[Tetanus] 3/12 -0.1280 -0.3560 0.1000 0.2675 217 0.8022 0.1978 0.0001 0.1904 0.5703 
log[Polio] 3/12 0.0760 -0.1474 0.2994 0.5015 544 0.9999 0.0001 0.2036 0.7999 0.9908 
Antibody tetanus ly 200.7290 -155.6047 557.0627 0.2671 200 0.8012 0.1988 0.0001 0.0001 0.1341 
Antibody tetanus* 213.2920 -166.5834 593.1674 0.2685 189 0.8019 0.1981 0.0001 0.0001 0.1193 
Antibody polio 1 y 12.6840 -5.7393 31.1073 0.1755 132 0.7265 0.2735 0.1041 0.4062 0.9299 
Antibody polio * 3.5600 -21.3225 28.4425 0.7774 2724 0.9999 0.0001 0.0001 0.0001 0.2414 
log[Tetanus] 1 yr -0.0890 -0.3185 0.1405 0.4436 423 0.8802 0.1198 0.3769 0.9803 0.9926 
log[Tetanus] 1 y * 0.0240 -0.3563 0.4043 0.9004 14970 0.9999 0.0001 0.1133 0.4463 0.9530 
log[[Polio] 1 yr 0.1330 -0.0530 0.3190 0.1589 123 0.7106 0.2894 0.3962 0.9882 0.9927 
log[Polio] 1 yr* -0.0290 -0.3424 0.2844 0.8570 6511 0.9999 0.0001 0.0001 0.0001 0.2208 
OKT3 3/12 -1.4850 -4.8693 1.8993 0.3870 323 0.8572 0.1428 0.9720 0.9936 1.0000 
OKT4 3/12 1.1810 -3.1136 5.4756 0.5871 823 0.9999 0.0001 0.6431 0.9910 0.9947 
OKT8 3/12 -0.5810 -3.1638 2.0018 0.6571 1231 0.9999 0.0001 0.2353 0.8593 0.9912 
SMIG 3/12 -2.2120 -4.5791 0.1551 0.0667 71 0.5522 0.4478 0.3349 0.9633 0.9922 
OKT4/0KT8 3/12 0.5600 -0.2139 1.3339 0.1553 119 0.7054 0.2946 0.1710 0.6895 0.9904 
95t CI of DIFFERENCE of MEANS POWER for alpha "' St, & diff : 
VARIABLE Bottom Hean Top p N_S_PCT BETA Observ lat 25% SOis 
OKT3 ly -1.5460 -5.4885 2.3965 0.4391 398 0.8781 0.1219 0.9523 0.9931 0.9990 
OKT4 ly .:.0.0690 -4.8714 4.7334 0.9775 296540 0.9999 0.0001 0.4805 0.9903 0.9934 
OKT8 ly 0.4160 -3.0644 3.8964 0.8135 4285 0.9999 0.0001 0.2527 0.8921 0.9914 
SMIG ly 0.5920 -2.1009 3.2849 0.6643 1267 0.9999 0.0001 0.2820 0.9279 0.9917 
OKT4/0KT8 ly -0.1190 -0.5859 0.3479 0.6156 942 0.9999 0.0001 0.1829 0.7317 0.9906 
OKT4/0KT8" -0.6560 -1.4388 0.1268 0.1000 75 0.6246 0.3754 0.0001 0.1362 0.3818 
pha-pcps-3/12 3.7390 -21.3489 28.8269 0.7663 1203 0.8567 0.1433 0.2876 0.8564 1.0000 
pha-pccs-3/12 4.3300 -19.3645 28.0245 0.7155 800 0.8469 0.1531 0.3166 0.9151 1.0000 
pha-ccps-3/12 5.8290 -1.8768 13.5348 0.1352 47 0.5791 0.4209 0.8304 1.0000 1.0000 
pha-pcps-ly 1.6600 -29.8113 33.1313 0.9163 10152 0.8847 0.1153 0.2464 0.6989 1.0000 
pha-pccs-ly 0.5530 -23.2465 24.3525 0.9631 52317 0.8933 0.1067 0.3198 0.9180 1.0000 
pha-ccps-ly -0.5910 -9.8742 8.6922 0.8990 6783 0.8815 0.1185 0.6783 1.0000 1.0000 
pha-pcps * -16.3000 -52.4018 19.8018 0.3685 114 0.8527 0.1473 0.0001 0.0001 0.0001 
Birth weight -0.0430 -0.1428 0.0568 0.3995 389 0.8610 0.1390 0.9915 0.9979 1.0000 
SO score weight brth -0.0780 -0.3141 0.1581 0.5132 662 0.9999 0.0001 0.0001 0.0001 0.2615 
Weight@ 3/12 -0.0240 -0.2309 0.1829 0.8211 5368 0.9999 0.0001 0.9909 0.9965 1.0000 
Length@ 3/12 -0.0120 -0.6686 0.6446 0.9711 216275 0.9999 0.0001 0.9986 1.0000 1.0000 
Head circ@ 3/12 -0.3400 -0.7495 0.0695 0.1027 105 0.6317 0.3683 0.9997 1.0000 1.0000 
SD score weight 3/12 0.0360 -0.1814 0.2534 0.7453 2635 0.9999 0.0001 0.0001 0.2008 0.6055 
SD score length 3/12 0.1120 -0.1061 0.3301 0.3122 272 0.8238 0.1762 0.0001 0.1324 0.3696 
Weight/(1ength)**3 3 -0.2240 -0.9125 0.4645 0.5211 678 0.9999 0.0001 0.9926 1.0000 1.0000 
Weight@ ly 0.2410 -0.1617 0.6437 0.2391 182 0.7807 0.2193 0.9904 0.9952 LOOOO 
Weight* 0.2960 -0.0267 0.6187 0.0719 77 0.5661 0.4339 0.7113 0.9913 0.9954 
Length@ ly 0.4930 -0.3792 1.3652 0.2655 205 0.8004 0.1996 0.9981 1.0000 1.0000 
Length* 0.5570 -0.2446 1.3586 0.1721 136 0.7229 0.2771 0.9642 0.9934 0.9996 
Head circ@ ly -0.1700 -0.6038 0.2638 0.4397 427 0.8784 0.1216 1.0000 1.0000 1.0000 
SO score weight 1 y 0.2510 -0.1304 0.6324 0.1951 150 0.7449 0.2551 0.0001 0.0001 0.1594 
SD score length 1 y 0.1980 -0.1074 0.5034 0.2021 156 0,7508 0.2492 0.0001 0.0001 0.0001 
SD score length* 0.0690 -0.1767 0.3147 0.5776 826 0.9999 0.0001 0.0001 0.0001 0.2156 
Weight/(1ength)**3y 0.1070 -0.6044 0.8184 0.7665 2878 0.9999 0.0001 0.9915 0.9980 1.0000 
Bact % init 1hr 3/12 -6.3290 -29.1824 16.5244 0.5819 408 0.9999 0.0001 0.0001 0.0001 0.0001 
Bact % init 2hr 3/12 -13.4060 -47.1261 20.3141 0.4299 198 0.9999 0.0001 0.0001 0.0001 0.0001 
Bact % ctl 1hr 3/12 -17.7000 -68.2760 32.8760 0.4869 255 0.9999 0.0001 0.0001 0.0001 0.0001 
Bact % ctl 2hr 3/12 -30.2190 -219.3218 158.8838 0.7505 1224 0.9999 0.0001 0.0001 0.0001 0.0001 
Bact % AB 1 hr 3/12 -3.5790 -13.3254 6.1674 0.4658 232 0.9999 0.0001 0.0001 0.0001 0.0001 
Bact % AB 2 hr 3/12 -4.0230 -13.1510 5.1050 0.3818 161 0.9999 0.0001 0.0001 0.0001 0.0001 
SD score weight* 0.2230 -0.0860 0.5320 0.1550 125 0.7068 0.2932 0.0001 0.0001 0.0001 
Bact nonn 1 hr 3/12 2.4710 -17.1949 22.1369 0.8026 1980 0.9999 0.0001 0.0001 0.0001 0.0001 
Bact nonn 2 hr 3/12 . -4.7070 -15.1897 5. 7757 0.3730 155 0.9999 0.0001 0.0001 0.0001 0.0001 
Bact % init 1hr ly -11.1430 -40.0963 17.8103 0.4438 184 0.7819 0.2181 0.1998 0.4968 0.9665 
Bact % init 1hr • -26.7680 -69.0540 15.5180 0.2087 54 0.7607 0.2393 0.0001 0.0001 0.0001 
Bact % init 2hr ly -13~4400 -60.5307 33.6507 0.5697 335 0.8171 0.1829 0.1740 0.3424 0.8068 
Bact % init 2hr * -21.3540 -88.5089 45.8009 0.5249 214 0.9999 0.0001 0.0001 0.0001 0.0001 
Bact % ct1 1 hr ly -1.8030 -46.1233 42.5173 0.9351 14046 0.9999 0.0001 0.0001 0.3013 0.8172 
Bact % ctl 1 hr* -3.1850 -75.7628 69.3928 0.9296 9419 0.9999 0.0001 0.0001 0.0001 0.1087 
Bact % ctl 2 hr ly 9.1020 -117 .0558 135.2598 0.8856 5235 0.8790 0.1210 0.1471 0.2273 0.4613 
Bact % AB 1 hr ly -5.9290 -21.8648 10.0068 0.4581 169 0.8874 0.1126 0.0001 0.2843 0.7905 
Bact % AB 2 hr ly -2.2240 -15 .8472 11.3992 0.7445 961 0.8525 0.1475 0.1696 0.3190 0.7541 
Bact nonn l hr 1 y -8.3430 -62.9893 46.3033 0.7598 931 0.9999 0.0001 0.0001 0.0001 0.0001 
Bact nonn 2 hr 1 y -0.8400 -18.1371 16.4571 0.9228 10862 0.8859 0.1141 0.1199 0.1499 0.1997 
hygiene -0.1020 -0.3327 0.1287 0.3842 362 0.8559 0.1441 0.6199 0.9909 0.9945 
daycare 0.0730 -0.0542 0.2002 0.2524 215 0.7956 0.2044 0.9901 0.9943 1.0000 
crowding -0.1370 -0.4485 0.1745 0.3847 366 0.8570 0.1430 0.2344 0.8577 0.9912 
finance -0.0730 -0.3069 0.1609 0.5386 726 0.9999 0.0001 0.5955 0.9908 0.9943 
95% CI of DIFFERENCE of MEANS POWER for alpha ,. 5%", & diff : 
VARIABLE Bottom Hean Top p N 5 PCT BETA Observ l()J; 25% SOJ; 
careseeking 0.0000 -0.0874 0.0874 0.9930 999999 0.9999 0.0001 0.9901 0.9944 1.0000 
MDI-pre -2.7000 -10.3688 4.9688 1.0000 95 0.8956 0.1044 0.0001 0.0001 0.0001 
POI-pre -6.9000 -13.1420 -0.6580 0.0500 10 0.4112 0.5888 0.0001 0.0001 0.0001 
MDI-diff (Post) -7. 6000 -13.8234 -1.3766 0.0200 6 0.3223 0.6777 0.0001 0.0001 0.0001 
PDI-diff (Post) 2.3000 -3.0262 7.6262 1.0000 48 0.8585 0.1415 0.0001 0.0001 0.0001 
Meat/Fish -0.5100 -1.0433 0.0233 0.0000 76 0.5357 0.4643 0.4376 0.9901 0.9931 
Cereal 0.0500 -0.2086 0.3086 0.0000 1918 0.9999 0.0001 0.3500 0.9694 0.9923 
Egg -0.4000 -0.9548 0.1548 0.0000 134 0.7074 0.2926 0.2958 0.9433 0.9918 
Fruit 0.0000 -0.4783 0.4783 0.0000 999999 0.9999 0.0001 0.3965 0.9883 0.9927 
Vegetable -0.2000 -0.6020 0.2020 0.0000 292 0.8311 0.1689 0.3616 0.9741 0.9924 

A.4 IRON NUTRITION AND IMMUNITY 
APPENDIX 4 - Composition of Control and Test milk formulas 
COMPOSITION OF LACTOGEN FULL PROTEIN 
According to the manufacturer's label, Lactogen full protein is made from partially skimmed milk, sucrose, 
maltodextrin, com oil, lactose, vitamins, ferrous sulfate, zinc sulfate and copper sulfate. Its average 
composition is Fat: 19.0% (including 3.8% com oil, rich in unsaturated fatty acids), Protein: 21.6%, 
Lactose: 31.6%: Sucrose: 12.0%: Maltodextrin: 8.0%, Ash: 4.8%: Moisture: 3.0%. Energy per 100 g 
powder = 1940 kj. 
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Vitamin and mineral content of LACTOGENFULLPROTEIN 
Nutrient 
Vitamin A 
Vitamin 03 
Vitamin E 
Vitamin C 
Vitamin Bl 
Vitamin B2 
Vitamin B4 
Vitamin B12 
Niacin 
Pantothenic acid 
Vitamin K 
Folic acid 
Biotin 
Choline 
Inositol 
Iron for Control group 
for Test group 
Copper 
Zinc 
Manganese 
Calcium 
Phosphorus 
Sodium 
Magnesium 
Chloride 
Potassium 
per 100 g 
1390 IU 
280 IU 
5.5 IU 
37 mg 
0.28 mg 
0.4 mg 
0.35 mg 
lug 
3.5 mg 
2 mg 
38 ug 
42 ug 
10 ug 
35 mg 
21 mg 
8.3 mg 
40 mg 
0.28 mg 
3.5 mg 
24 ug 
770 mg 
600 mg 
320 mg 
70 mg 
725 mg 
970 mg 
per litre 
2003 IU 
403 IU 
7.9 IU 
53 mg 
0.40 mg 
0.58 mg 
0.50 mg 
1.4 ug 
5.1 mg 
2.9 mg 
54.8 ug 
60.5 ug 
14.4 ug 
50.5 mg 
30. 3 mg 
11.96 mg 
57.66 mg 
O. 40 mg 
5.1 mg 
34 .. 6 ug 
1109.9 mg 
865 mg 
461 mg 
101 mg 
1045 mg 
1398 mg 
Note The concentrations of nutrients per 100 g formula are the manufacturer's specifications. The concentrations of 
nutrients per litre were calculated according to the manufacturer's recommendation for reconstitution: 8 measures of 4 
g for 200 ml water. When reconstituted, the fluid volume was 222 ml. The values in the left hand column were 
multiplied by 320/222 to obtain the right hand set of figures. 
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APPENDIX S - Programs 
Program to Stratify Subjects 
IRONNUTRITION AND IMMUNITY 
This program was written for the Tektronix microcomputer 
lREM STRATIFY 
2 REM Program to stratify subjects according to number of siblings and weight 
3REM 
5 GOTO 100 
100 INIT 
110 P=41 
120 DIM A0(2), A$(72), Z$(132) 
130PAGE 
140 PRINT "STRATIFY ROUTINE" 
150 PRINT "J _J _Enter number of file containing the data" 
160 INPUT IO 
170FIND IO 
180 READ @33:AO 
190 DIM C$(90 + 8* AO(l) ),BO(A0(2),A0(1)),A(30,8),B(30,8),N(8) 
200 DIM Al(8),B1(8) 
210 READ @33:C$ 
220 READ @33:BO,ZO 
230 N(l) = (IO-INT(I0/2)*2)"'2 + 1 
240 FOR l=l TO 8 
250 IF I= 1 THEN 290 
260 N(I)=3 
270 IF N(I-1)=1 THEN 290 
280 N(I)=l 
290A(I)=O 
300 Bl(I)=O 
310 FOR J = 1 TO 30 
320 A(J ,I)= 0 
330 B(J,I) =0 
340NEXT J 
350NEXTI 
360 Nl=A0(2) 
370 FOR 1=1 TO Nl 
380 IF BO(l,3) < 3000 0 R BO(I,3) > 4999 THEN 520 
390 J = BO(I,5) 
400 PRINT BO(I,3),J 
410 IF J>15 OR J<l THEN 520 
420J=8MINJ 
430 IF N(J)=2 OR N(J) =3 THEN 470 
440 Al(J) =Al(J) + 1 
450 A(Al(J),J) =BO(I,l) 
460 GOTO 490 
470 Bl(J) = Bl(J) + 1 
480 B(Bl(J),J) =BO(I,1) 
490 N(J) = N(J) + 1 
500 IF N(J)<5 THEN 520 
510 N(J)=l 
520NEXTI 
530 A$=SEG(C$,1,72) 
540 PRINT @P: USING "P, 4X,72A":A$ 
APPENDICES 
550 PRINT @P: USING "/ / /": 
560 PRINT @P: USING "/14A'':"Number of sibs" 
570 FOR l=l TO 8 
580 PRINT @P: USING 590:1,1; 
590 IMAGE 4D,4D,2X,S 
600NEXTI 
610 PRINT @P: 
620 FOR I=l TO 8 
630 PRINT @P: USING "lOA,S":" TST CTL " 
640NEXTI 
650 PRINT @P: USING N / j": 
660 FOR J = 1 TO 30 
670 IF A(J,l)+B(J,1)=0 THEN 820 
680 FOR l=l TO 8 
690 IF A(J,l)=O THEN 730 
700 PRINT @P: USING 710:A(J,I); 
710 IMAGE 40,S 
720GOT0750 
730 PRINT @P: USING 740: 
740 IMAGE 4X,S 
750 IF B(J,I) =0 THEN 780 
760 PRINT @P: USING 710:B(J,1); 
770GOTO 790 
780 PRINT @P: USING 740: 
790 PRINT @P: USING "2X,S": 
800NEXTI 
810 PRINT @P: 
820 NEXT J 
830 PRINT @P: USING "P,4X,72A":A$ 
840 PRINT @P: USING "//4A,36X,7A":"TEST","CONTROL" 
850 FOR 1=8 TO 1 STEP -1 
860 PRINT@P:USING "//15A,1D":"Number of sibs=",I 
870 FOR J = 1 TO 30 
880 IF A(J,l)=O AND B(J,l)=O THEN 970 
890 IF A(J ,I)= 0 THEN 920. 
900 PRINT @P: USING "4D,36X,S":A(J,I); 
910GOT0940 
920 PRINT @P: USING "40X,40,S":B(J,I); 
930 GOTO 960 
940 IF B(J,I) =0 THEN 960 
950 PRINT @P: USING "40,S":B(J,I); 
960 PRINT @P: USING"//": 
970NEXT J 
980NEXTI 
990PAGE 
1000 PRINT "THE END" 
1010END 
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Program to Calculate 95% Confidence Limits and "NS%" 
This program was written in dBase Ill and runs on an IBM compatable PC. 
Note/* 
Note/* 
PROGRAM TO CALCULATE 95% CONFIDENCE LIMITS OF MEANS 
Note/* REFERENCES: 
Note/* Colton T. Statistics in Medicine. Little Brown & Co. Boston 1974 
Note/*. 
Note/* 
Note/* 
Note/* 
Note/* 
Gardner MJ, Altman DG. Confidence limits rather than P values: 
estimation rather than hypothesis testing. 
British Medical Journal 1986: 292; 746-750 
Note/* INPUT VARIABLES: 
Note/* Variable Name (ie Lotus Lable) of the variable 
Note/* N ALL, N CTL, N TST Numbers in All, Control and Test Groups 
Note/* Mean ALL, Mean CTL, Mean TST 
Note/* - Means-in All, Control and Test Groups 
Note/* SD _ALL, SD_ CTL, SD_ TST1 . 
Note/* Standard Deviations in All, Control and Test 
Note/* Groups 
Note/* CALCULATED VARIABLES: 
Note/* MAF, MCF, MTF Lower bound (Floor) of 95% confidence limit 
Note/* MAC, MCC, MTC Upper bound (Ceiling) of 95% confidence limit 
Note/* MD Difference of Test and Control Means 
Note/* MDF, MDC 95% confidence limits of the Difference 
Number required to reach 5% significance 
given beta = 100% 
Note/* N_5_PCT 
Note/* 
Note/* FILES: 
Note/* STATS.dbf Contains the statistics 
NB Must have above the fields Note/* 
Note/* 
Note/* 
Note/* 
T95TAB.dbf Table of Significance limits of the t 
Note/* 
Note/* 
Note/* 
.Note/* 
Note/* 
clear 
set echo off 
set talk off 
N.ndx 
set default to c 
za=l.96 
zb=O 
select 1 
use t95tab index n 
select 2 
use stats 
go top 
rl=O 
do while .not. eof () 
clear 
rl=rl+l 
@1,1 say 'record ' 
distribution from Documenta Geigy, Ciba-Geigy 
Scientific Tables 7th edition pp 32-35 
*"'*** NB t for alpha = 0.025 ***** 
Index for above table 
&& 5% alpha for N 5% 
&& use·l.645 for 10% beta for N 5% 
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? r1 
@3,1 say variable 
na=n all 
if na<l 
na=l 
endif 
if na>200 
na=200 
endif 
nc=n ctl 
if nc<-1 
nc=l 
endif 
if nc>200 
nc=200 
endif. 
nt=n tst 
if nt<l 
nt=l 
endif 
if nt>200 
nt=200 
endif 
nd=n all-2 
if nd<l 
nd=l 
endif 
if nd>200 
nd=200 
endif 
select 1 
seek na 
ta=t95 
seek nc 
tc=t95 
seek nt 
tt=t95 
seek nd 
td=t95 
select2 
replace maf with (mean _all - ta*sd _ all/sqrt(n_ all)) 
replace mac with (mean_all + ta*sd_all/sqrt(n_all)) 
replace mcf with ( mean ctl - tc*sd ctl/ sqrt( n ctl)) 
replace mcc with (mean-ctl + tc*sd ctl/sqrt(n ctl)) 
replace mtf with (meanjst - tt*sd _t;/sqrt(n_t~°t)) 
replace mtc with (mean_ tst + tt*sd _tst/sqrt(n _tst)) 
replace md with (mean tst - mean ctl) 
sd _pooled=sqrt(((n_tst=i.)*sd _ tst**2 + (n _ ctl-l)*sd _ ctl**2)/(n_tst + n _ ctl-2)) 
se _ diff=sd _pooled*sqrt(l/n _tst + 1/n _ ctl) 
replace mdf with (md-td*se diff) 
replace mdc with (md + td*se diff) 
if mean ctl < > mean tst -
replace N 5 PCT with 
min(999999,2*(;d _pooled*(za + zb)/(mean _ ctl-mean _tst))"2) 
else 
replace N _ 5 _ PCT with 999999 
endif 
A..9 
A.10 
skip 
enddo 
@ 15,15 say 'd on e' 
IRON NUTRITION AND IMMUNITY 
APPENDICES 
dBase III Program to Calculate Beta (type II error) 
The following program was written in dBase III and runs on an IBM compatible PC. 
Note/* This program calculates Beta given the numbers, means and 
Note/* standard deviations of Control and Tests sets of data. 
Note/* Beta is the type II error and is calculated for alph,a = 0.025 for a one-
Note/* sided significance test from tables for the noncentral t distribution 
No~/* . 
Note/* 
Note/* 
Note/* 
Note/* 
Note/* 
Note/* 
REFERENCE: Statistical principles in experimental design 
Winer BJ, McGraw-Hill, 1971 Tokyo 
table C.13 page 884, and pages 33-35. 
Note/* VARIABLES: 
Note/* Variable Name (eg Lotus Lable) of the variable 
Note/* N crL, N TST Numbers in Control and Test Groups 
Note/* M~an cr:C, Mean TST Means in Control and Test Groups 
Note/* Mean -ALL, N ALL Mean and Number for both groups combined 
Note/* SD CTL, SD TST Standard Deviations in Control and Test Groups 
Note/* Bet"'i -Type II error for Alpha = 5%, observed cliff. 
Note/* Power 1. - beta 
Note/* BetalOpc Type II error for Alpha = 5%, cliff = 10% mean 
Note/* PowerlOpc 1. • betalOpc 
Note/* Power25pc Power for 25% difference 
Note/* Power50% Power for 50% difference 
Note/* 
Note/* 
Note/* FILES: 
Note/* STATS.db£ Contains the statistics 
Note/* NB Must have above the fields 
Note/* NONCENTR.dbf Contains the areas for calculating Beta from 
Note/* the noncentral t distribution. 
Note/* F.ndx Index for,NONCENTR 
Note/* 
Note/* 
Note/* 
Note/* 
Note/* 
BETAPROC.PRG Procedur~ file for interpolating Beta 
Note/* 
Note/* 
CLEAR 
set default to c 
set console on 
set talk off 
set echo off 
from the tables 
SET PROCEDURE TO BETAPROC 
bell = chr(7) 
b=O 
. select 1 
use noncentr index f 
select 2 
use stats 
A.11 
A.U 
go top 
clear 
rl=O 
DO WHILE .not. eofO 
clear 
• rl=rl+l 
@ 1,1 say 'record # ' 
??.rl 
? variable 
@ 4,1 say mean_ all 
IF MEAN ctl < mean TST 
- -Vl=MEAN CTL 
V2== MEAN TST 
Sl=SD_CTL 
S2=SD TST 
Nl=N CTL 
N2=N-TST 
ELSE 
Vl=MEAN TST 
V2= MEAN-CTL 
Sl=SD TST 
S2=SD CTL 
Nl=N TST 
N2=N-CTL 
ENDIF 
FF= Nl + N2-2 
VAR = ((Nl-l)*Sl *Sl + (N2-l)*S2*S2)/FF 
D = (V2-Vl)/SQRT(VAR/Nl + VAR/N2) 
DO TYPEII WITH FF,D,B 
SELECT2 
replace beta with b 
REPLACE POWER WITH 1. • B 
. IRON NUTRITION AND IMMUNITY 
NOTE/* CALCULATE BETA & POWER FOR 10% DIFFERENCE 
D = abs((O.l*mean_all)/SQRT(VAR/Nl + VAR/N2)) 
DO TYPEII WITH FF,D,B 
SELECT2 
replace betalOpc with b 
REPLACE POWERlOpc WITH 1. - B 
Note/* calculate power for a 25% difference 
D = abs((0.25*mean_all)/sqrt(var/nl + var/n2)) 
do typeii with ff,d,b 
select 2 
replace power25pc with 1. - b 
Note/* calculate power for a 50% difference 
d = abs((05*mean all)/sqrt(var/nl + var/n2)) 
do typeii with ff, d, b 
select 2 
replace power50pc with 1. • b 
SKIP 
ENDDO 
set console on 
. LIST OFF V ARIABLE,BETA 
CLEAR 
dose all 
@ 1,1 SAY 'DONE' 
RETURN 
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NOTE/* THIS PROCEDURE FILE 'BETAPROC.PRG' CONTAINS ROUTINES TO CALCULATE 
NOTE/* THE TYPE II OR BETA ERROR 
NOTE/* IT IS CALLED FROM THE PROGRAM 'BETA.PRG' 
NOTE/" THE FILES AND VARIABLES USED ARE DOCUMENTED IN THAT FILE 
NOTE/* 
NOTE/* 
NOTE/"' 
PROCEDURE TYPEII 
PARAMETERS FF,D,B 
b=O 
IF FF>30 AND. FF<40 
FF= 30 + INT(FF /34.5)*10 
ENDIF 
IF FF>40 AND. FF<60 
FF=INT(40 + INT(FF/49.5)*20 + 0.01) 
ENDIF 
IF FF>lOO 
FF=INT(lOO + INT(FF/149)*100 +.01) 
FF=MIN(200,FF) 
ENDIF 
SELECT 1 
SEEK FF 
DO FINDBETA WITH D,B 
B=MAX(O, MIN(0.9999, B)) 
RETURN 
NOTE/* 
NOTE/* 
NOTE/* 
PROCEDURE FINDBETA 
PARAMETERS D,B 
IF D > = BETAOl 
B = 0.01 + (0.01- O.OO)*(BETAOl • D)/(BETAOO • BETAOl) 
RETURN 
ENDIF 
* 
IF D > = BETA05 
B = 0.05 + (0.05 - O.Ol)*(BETA05 - D)/(BETAOl • BETA05) 
RETURN 
ENDIF 
* 
IF D > = BETAlO 
B = 0.10 + (0.10 - 0.05)*(BETA10 - D)/(BETA05 • BETAlO) 
RETURN 
ENDIF 
* 
IF D > = BETA20 
B = 0.20 + (0.20 - 0.10)*(BETA20 - D)/(BETA10 • BETA20) 
RETURN 
ENDIF 
* 
IF D > = BETA30 
B = 0.30 + (0.30 - 0.20)*(BETA30 - D)/(BETA20 • BETA30) 
RETURN . 
ENDIF 
* 
IF D >; BETA40 
B = 0.40 + (0.40. 0.30)*(BETA40 - D)/(BETA30 • BETA40) 
A.14 
* 
RETURN 
ENDIF 
IF D > = BETASO 
IRON NUTRITION AND IMMUNITY 
B = 0.50 + (0.50 - 0.40)*(BETA50 - D)/(BETA40 • BETASO) 
RETURN 
ENDIF 
* 
IF D > = BETA60 
* 
B = 0.60 + (0.60 - 0.50)*(BETA60 - D)/(BETASO • BETA60) 
RETURN 
ENDIF 
IFD >= BETA70 
* 
B = 0.70 + (0.70 - 0.60)"'(BETA70 • D)/(BETA60 - BETA70) 
RETURN 
ENDIF 
IF D > = BETA80 
* 
B = 0.80 + (0.80 • 0.70)*(BETA80 - D)/(BETA70 - BETA80) 
RETURN 
ENDIF 
IF D > = BETA90 
* 
B = 0.90 + (0.90 - 0.80)*(BETA90 - D)/(BETA80 - BETA90) 
RETURN 
ENDIF 
IF D > = BETA999 
* 
B = 1 + (1 - 0.90)*(BETA999 - D)/(BETA999 - BETAlO) 
RETURN 
ENDIF 
If D < beta999 
b=.9999 
? bell 
? 'DELTA= ', D, ', but should be> O!!!!!!!!!!!!' 
? bell 
? bell 
? bell 
·1 bell . 
return 
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'APPENDIX 6 • Forms for consent and data collection 
NMM: 
HOP.DER VAN: 
UNIVERSiTEIT Vl\fI KMPSTI\D 
Dtl'I\R'l'EHENT VAN PED1A1'RIE EN KINDERG!sSONDIIEID 
Dl\l'UH: 
Ek gee my toesteinming dat my kind deur D1iddel van bloed en veltoetae 
onder•ock "ord. Ek besef dat my kind nie noodweudig direk baat sal vind 
by hierdie toetse nie, maar dat sulke ondersoeke mag hydra tot o~s 
kennis van antler klnders se siektes. 
Oie aard en gevare van die toetse is deur, die betrokke dokter aan my 
verduidelik. 
CE'J'EKEN: 
GETUIES: I. (Dokter) 
2. 
NAflE: 
HOTIIER OF: 
UNIVf,RS11"i OF CAPE TOWN 
DEPARTHEll'f OF PAEDIATRICS AND CHILD IIEALl'II 
~: 
1 hereby consent to my child being investigated by means of blood and 
skin tests. 
I realise these tests will not necessarily benefit my child directly, 
but that they may lea<! to a better understanding of other chUdren' s 
illnesses. 
The nature and risks of the test have been explained to me by the doctor 
concerned. 
~: 
WITNESSES: I. (Doctor) 
2. 
(') g 
~ 
= 
-
-0 
"d 
~ 
..... 
r.> 
..... 
"d 
~ 
-(I) 
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Iron and immune function 
IRON AND IMMUNITY - DATA PROFORMA - FIRST EXAMINATION 
NUMilER: 
--------
DATE: 
GROUP: (Control 
NAME OF MOTHER: 
NAME OF CHILD: 
DATE OF BIRTH: 
AGE: 
SEX: Male 
ADDRESS: 
l, Test 
Female 
ANTE NATAL: Normal 
BIRTH: NVD 
BIRTHWEIGIIT: 
2 
Ahnormal 
Assisted 
2 
2 C/S 3 
POST NATAL: Well = I Neonatal .Jaondice (Not treated) 
Other, specify= 3 
2 
ANY HOSPITAL TREATMENT STNCE lllRTH? YES= l 
CURRENT FEEDING: Breast Breast & bottle 
Bottle 3 
NO= 2 
2 
Brand of milk if on formula------------
(Klim, Nespray = l; SMA, S26 = 2; Lactogen, Nan J; Pelargon 
lnfosoy, lsomll = 5; Skim = 6; Other = 7) 
,, 
SOCIAL DATA: 
MARITAL: 
CHILDREN: 
FINANC I.AL/ EMPLOYMENT: 
HOUSING: 
LEGAL: 
ALCOHOL: 
HEALTH: 
OTIIER: 
(TO l:IE COMl'LE'J'Efl IHIR [NG STUDY) 
Age fJ.rst given bottle (mc,nths) 
Age last given breast 
Reason for weaning: \forking Other Social. 
Not enough m.i.Lk J Urerist nLsease 
Other, spec.i.fy 5 Refused llreast 6 
i\ge at introduction 
Age at introduction 
Age at introduction 
Age at introduction 
Age ar. introduction 
SOCIAL.DATA 
Marital Status 
o( cereals 
of eggs 
of vegetables 
of fruit 
of meat 
Marr led 
Widowed 
Single 
.ind fish 
Living together 
J Separated 
5 Divorced 
4 
6 
Education of Mother: Standard passed--------------
Post-School qualifications: Degree 
(Mo.cher) Ni.l 
Education of Father: Standard passed 
Post-School qualifications: Degree 
(Father) Nll 
4 
4 
Diploma 2 Other 
Diploma 2 Other 
Occupation of of Mother------·----------------
Occupation of Breadwinner: 
Source of income: Mother 
State Grant 4 
Father 
Other 
2 
5 
ls financial support regular? Yes = J No = 2 
Family living: Alone 
Friends ) 
Extended Family 
With other;; 
2 
4 
Extended family 
Combination 
N/A = J 
) 
) 
) 
6 
Baby lives with: Both parents 
Neither pa rent 
Number of Adults: 
J 
4 
One parent 
Number of Siblings: ----------------
Number of Children less than 10 years: 
Number of rooms used for sleeping: 
Social Stability Score 
Weight: ___ kg Height: cm 
Head Circumference: cm 
EVIDtNCE OF INFECTION: 
Fever 
Skin rash, l.mpet igo, 
Ears: otitis externa, otltis media 
Nose: coryza, purulent 
l~roat: tonsillitis, pharyngitis 
Mouth: 
Resp: 
Other: 
gum sepsis, herpes, candida 
croup, lower airway infection 
diarrhoea, worms 
specify 
Clinical impression: Well g O Viral 
Swabs sent: specify site(s) 
I Bacterial 
Skin 
ll. R. T. I. 
L. R.1'. I. 
G.f.Inf. 
Systemic: 
2 Other 
bacterial pathogens---~-~---
viral pathogens 
Viral Sur:vey: 
Stool Virus Isolates 
Haternal Antihody Titers: 
Tetanus 
u .... 1-1 ..... 
) 
Study Number: 
Mantoux 
Candida 
WBC 
RBC 
lib 
HCT 
MCV 
MCI! 
MCllC 
PLT 
% ·reties 
% neut rophil s 
;; lymphs 
% monocytes 
% eosinoph1ls 
% basophils 
Ferritin 
FEP 
IgG 
lgM 
IgA 
Sm lg 
OKT3 
OKT4 
OKT8 
PllA Stim 
Dactericidol Index 
Antitetanus-toxoid 
Anti-polio 
lNTERMEllll\TE FOLL01~-ur 
fix No ln(ect Mx 
V S No Oate Feeds Sx R (: S 0 0 H Etc Rx Wdght Length !le-;,l 
03 
04 
05 
06 
07 
08 I 
09 
10 
II 
12 
l3 
14 
15 
16 
17 
18 
l 9 
20 
21 
22 
23 
24 
25 
') 
rnoN AND IMMUNITY DATA l'llOFORMA -· FINAL EXAMINATlON 
~: 
(Fill in intermediate follow-up sheet) 
Viral Survey: 
Isolates throat 
Isolates stool 
Speciill lnvestlgat l.olis: 
Mantoux 
Candida 
wnc 
1rnc 
Hb 
IICT 
NCV 
MCH 
MCHC 
PL'I' 
,: reties 
% neutrophils 
,: lymphs 
,: tuonocytes 
% eosinophils 
% basophtls 
Ferri tin. 
IgC 
lgt·l 
lg A 
Sm lg 
OKTJ 
OKTI, 
0KT8 
I'll/\ St im 
Bactericidal Index 
Antitetanus-toxoid 
Anti-polio 
Autologous rosettes 
RBC C]b-rcceptors 
No Infects on Ex 
C u L G s nn: 
!N'fEllMEIHATE FOLl.OW-UP 
SWAB 
SlTE 
llx 
Vi Ila Fu Pc Ile 
GRAlllNG 
llx Ex RxO RxH 
DATE: 
APPENDIX A 
DATA COLLECTION PROFORMA 
AGE OFF BREAST AND REASON 
MONTHS 
AGE AT INTRODUCTION OF SOLIDS 
(MONTHS) 
AGE SEX WEIGHT FEEDING 
(MONTHS) 
CODES: ~: Male= l 
Feeding: Breast 
Female" 2 
l · 
' 
Breast & Bottle= 2; 
CEREAL EGG VEG & FISH & 
FRUIT MEAT 
Bottle"' 3; No milk = 4; 
(Cow's milk• 3.1; SMA, S26 = 3.2; Lactogen, Nespray • 3.3; Pelargon = 3.4 Infasoy, Isomil 3.5; 
Skim milk= 3.6; Other= 3.7) 
Reasons for stopping breast feeding: Working• l; Other social reasons• 2; 
"Too little milk"" 3; Breast disease= 4; Other • 5 
INFANT FEEDING SURVEY 
/ /1984 
Number Age 
th 
Sex Weight Feeding 
1 
Age off Breast Reason for weaning 
mon s Formu a Measures I First bottle Last breast 
25ml 
l 
2 
3 
4-
5 
6 
7 
8 
9 i-10 
11 
12 
13 
14 
15 ... 
16 
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Infant Feeding Survey 
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